<SEC-DOCUMENT>0001821268-24-000276.txt : 20240920
<SEC-HEADER>0001821268-24-000276.hdr.sgml : 20240920
<ACCEPTANCE-DATETIME>20240920160736
ACCESSION NUMBER:		0001821268-24-000276
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		14
FILED AS OF DATE:		20240920
DATE AS OF CHANGE:		20240920

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADVENT CONVERTIBLE & INCOME FUND
		CENTRAL INDEX KEY:			0001219120
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-280964
		FILM NUMBER:		241313455

	BUSINESS ADDRESS:	
		STREET 1:		227 W. MONROE STREET
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-827-0100

	MAIL ADDRESS:	
		STREET 1:		227 W. MONROE STREET
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVENT CLAYMORE CONVERTIBLE SECURITIES & INCOME FUND
		DATE OF NAME CHANGE:	20030219
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>gug88033-424b2.htm
<DESCRIPTION>AVK
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:AVK="http://guggenheiminvestments.com/20240918">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_CEF%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_AVK_guggenheiminvestments.com_20240918 -->
<!-- Field: Set; Name: xdx; ID: xdx_047_20240919_20240919 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DEntityCentralIndexKey_0001219120 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-09-19" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-09-19" id="Fact000004" name="dei:EntityCentralIndexKey">0001219120</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-09-19" id="xdx2ixbrl0010" name="dei:DocumentType">424B2</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="avk-20240918.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-09-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001219120</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-19</xbrli:startDate>
        <xbrli:endDate>2024-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000015" toRefs="Footnote000025"/>
  <ix:relationship fromRefs="Fact000017" toRefs="Footnote000026"/>
  <ix:relationship fromRefs="Fact000018" toRefs="Footnote000028"/>
  <ix:relationship fromRefs="Fact000021" toRefs="Footnote000029"/>
  <ix:relationship fromRefs="Fact000022" toRefs="Footnote000030"/>
  <ix:relationship fromRefs="Fact000023" toRefs="Footnote000031"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times LT Std Bold,serif; margin: 5pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>PROSPECTUS <span id="xdx_909_edei--DocumentType_dxL_c20240919__20240919_z1NmTYCwHB9b" title="::XDX::424B2"><span style="-sec-ix-hidden: xdx2ixbrl0010">SUPPLEMENT</span></span><br/>
(to Prospectus dated September 12, 2024)&#160;</b></p>


<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>


<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>11,533,627 Common Shares</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b><span id="xdx_902_edei--EntityRegistrantName_c20240919__20240919_zAw7Gi1zARg6"><ix:nonNumeric contextRef="AsOf2024-09-19" id="Fact000011" name="dei:EntityRegistrantName">Advent Convertible and Income Fund</ix:nonNumeric></span></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Issuable Upon Exercise of Transferrable Subscription
Rights to Subscribe for Common Shares</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 10pt; text-indent: 0.5in">Advent Convertible Income Fund (the &#8220;Fund&#8221;)
is a diversified, closed-end management investment company.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 10pt; text-indent: 0.5in">The Fund is issuing transferable rights (&#8220;Rights&#8221;)
to its common shareholders of record (&#8220;Record Date Shareholders&#8221;) as of 5:00 p.m., Eastern time, on September 20, 2024 (the
&#8220;Record Date&#8221;), entitling the holders of Rights to subscribe for up to an aggregate of 11,533,627 of the Fund&#8217;s common
shares of beneficial interest, par value $0.001 per share (&#8220;Common Shares&#8221;) (the &#8220;Offer&#8221;). Record Date Shareholders
will receive one Right for each outstanding Common Share held on the Record Date. The Rights entitle their holders to purchase one new
Common Share for every three Rights held (1-for-3). Any Record Date Shareholder who owns fewer than three Common Shares as of the Record
Date may subscribe, at the Subscription Price, for one full Common Share in the Offer. In addition, Record Date Shareholders who fully
exercise their Rights (other than those Rights that cannot be exercised because they represent the right to acquire less than one Common
Share) will be entitled to subscribe for additional Common Shares that remain unsubscribed as a result of any unexercised Rights. This
over-subscription privilege is subject to a number of limitations and subject to allotment.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 10pt; text-indent: 0.5in">The subscription price per Common Share to
be issued in the Offer (the &#8220;Subscription Price&#8221;) will be determined based upon a formula equal to 92.5% of the average of
the last reported sale price of a Common Share on the New York Stock Exchange (the &#8220;NYSE&#8221;) on the date on which the Offer
expires, as such date may be extended from time to time, and each of the four (4) preceding trading days (the &#8220;Formula Price&#8221;).
If, however, the Formula Price is less than 90% of the net asset value (&#8220;NAV&#8221;) per Common Share at the close of trading on
the NYSE on the Expiration Date (as defined below), then the Subscription Price will be 90% of the Fund&#8217;s NAV per Common Share at
the close of trading on the NYSE on the Expiration Date. The Fund will pay a sales load on the Subscription Price. The Offer will expire
at 5:00 p.m., Eastern time, on October 17, 2024, unless extended as described in this Prospectus Supplement (the &#8220;Expiration Date&#8221;).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 10pt; text-indent: 0.5in">Rights holders will not know the Subscription
Price at the time of exercise and will be required initially to pay for both the Common Shares subscribed for pursuant to the primary
subscription and, if eligible, any additional Common Shares subscribed for pursuant to the over-subscription privilege at the estimated
Subscription Price of $11.42 per Common Share and, except in limited circumstances, will not be able to rescind their subscription.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 10pt; text-indent: 0.5in"><b>Exercising your Rights and investing
in the Fund&#8217;s Common Shares involves a high degree of risk. See &#8220;Risks&#8221; on page 23 of the accompanying
Prospectus.</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 10pt; text-indent: 0.5in"><b>The Offer will dilute the ownership interest
and voting power of the Common Shares owned by Common Shareholders who do not fully exercise their Rights. Common Shareholders who do
not fully exercise their Rights should expect, upon completion of the Offer, to own a smaller proportional interest in the Fund than before
the Offer. Further, if the net proceeds per Common Share from the Offer are at a discount to the Fund&#8217;s NAV per Common Share, this
Offer will reduce the Fund&#8217;s NAV per Common Share.</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><b>Neither the Securities and Exchange Commission
(&#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these securities or determined if this Prospectus
Supplement or the accompanying Prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0; text-align: right"><i>(continued on following page)</i></p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 65%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td>
    <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b><span style="text-decoration: underline">Per Share</span></b></span></td>
    <td style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b><span style="text-decoration: underline">Total<sup>(1)</sup></span></b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Estimated Subscription Price<sup>(2)</sup>	 </span></td>
    <td style="padding-right: 0.15in; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$11.42</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$131,714,020</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Estimated Sales Load<sup>(2)(3)</sup>	</span></td>
    <td style="padding-right: 0.15in; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$0.43</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$4,939,276</span></td></tr>

<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="width: 65%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Proceeds, before expenses, to the Fund<sup>(2)(3)(4)</sup>	</span></td>
    <td style="width: 18%; padding-right: 0.15in; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$10.99</span></td>
    <td style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$126,774,744</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: right"><i>(notes on following page)</i></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Common Shares are expected
to be delivered on or about November 8, 2024, unless the Offer is extended.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 1in">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>UBS Investment Bank</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">This Prospectus Supplement is dated September
20, 2024.</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><i>(notes from previous page)<br/>
</i>______________________</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><sup>(1)</sup></td><td>Assumes that all Rights are exercised at the estimated Subscription Price. All of the Rights may not be exercised.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><sup>(2)</sup></td><td>Estimated on the basis of 92.5% of the average of the last reported sales price per Common Share at the close of trading on the NYSE
on September 13, 2024 and each of the four (4) preceding trading days. See &#8220;Terms of the Offer&#8212;Subscription Price.&#8221;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><sup>(3)</sup></td><td>In connection with the Offer, UBS Securities LLC will act as dealer manager for the Offer (the &#8220;Dealer Manager&#8221;). The
Fund has agreed to pay the Dealer Manager a fee for its financial structuring and soliciting services equal to 3.75% of the Subscription
Price per Common Share for each Common Share issued pursuant to the exercise of Rights (including the over-subscription privilege). Based
on the Estimated Subscription Price, this Dealer Manager fee would amount to $0.43 per Common Share and a total sales load of $4,939,276,
assuming all Rights are exercised. The Dealer Manager will reallow a part of its fees to other broker-dealers that have assisted in soliciting
the exercise of the Rights. The Dealer Manager fee will be borne by the Fund and indirectly by all of its Common Shareholders, including
those who do not exercise their Rights.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><sup>(4)</sup></td><td>Offering expenses borne by the Fund (including the reimbursement described below) are estimated to be approximately $619,100 in the
aggregate, or $0.01 per Common Share (assuming the Rights are fully exercised). The Fund has agreed to pay the Dealer Manager up to $150,000
as a partial reimbursement for its expenses incurred in connection with the Offer. Offering expenses will be borne by the Fund and indirectly
by all of its Common Shareholders, including those who do not exercise their Rights.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><i>(continued from previous page)</i></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund has declared a regular September monthly distribution
to Common Shareholders in an amount of $0.1172 per share payable on September 30, 2024, with a record date of September 13, 2024, which
will not be payable with respect to Common Shares that are issued pursuant to the Offer. The Fund has also declared a regular October
monthly distribution to Common Shareholders in an amount of $0.1172 per share payable on October 31, 2024, with a record date of October
2, 2024, which will not be payable with respect to Common Shares that are issued pursuant to the Offer after such record date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">NAV dilution resulting from the Offer is not currently
determinable because it is not known how many Common Shares will be subscribed for, what the NAV or market price of the Common Shares
will be on the Expiration Date or what the Subscription Price will be. Any such dilution will disproportionately affect non-exercising
Common Shareholders. If the Subscription Price is substantially less than the then current NAV, this dilution could be substantial. However,
assuming all of the Common Shares are sold at the estimated Subscription Price (which includes a sales load) and after deducting all expenses
related to the issuance of the Common Shares, the Fund's current NAV per Common Share would be reduced by approximately $0.32, or 2.62%.
The distribution to Common Shareholders of transferable Rights, which themselves have intrinsic value, will afford non-participating Record
Date Shareholders the potential of receiving cash payment upon the sale of the Rights, receipt of which may be viewed as partial compensation
for any dilution of their interests that may occur as a result of the Offer. There can be no assurance that a market for the Rights will
develop or, if such a market develops, what the price of the Rights will be. See "Risks Related to the Offer" in this Prospectus
Supplement. Except as described herein, Rights holders will have no right to rescind their subscriptions after receipt of their payment
for Common Shares by the Subscription Agent for the Offer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Investment Objective</i>. The Fund&#8217;s investment
objective is to provide total return through a combination of capital appreciation and current income. There can be no assurance that
the Fund will achieve its investment objective, and you could lose some or all of your investment.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Investment Strategy.</i> Under normal market conditions,
the Fund invests at least 80% of its Managed Assets (as defined in this Prospectus) in a diversified portfolio of convertible securities
and non-convertible income producing securities. Under normal market conditions, the Fund will invest at least 30% of its Managed Assets
in convertible securities and may invest up to 70% of its Managed Assets in non-convertible income securities. The Fund may </p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">invest without
limitation in foreign securities. The Fund also uses a strategy of writing (selling) covered call options on up to 25% of the securities
held in the portfolio, thus generating option writing premiums. &#8220;Managed Assets&#8221; means the total assets of the Fund, including
assets attributable to the Fund&#8217;s use of leverage, minus the sum of its accrued liabilities (other than liabilities incurred for
the purpose of creating leverage).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Listing and Symbol</i>. The Fund&#8217;s currently
outstanding Common Shares are, and the Common Shares offered by this Prospectus Supplement and the accompanying Prospectus, will be, subject
to notice of issuance, listed on the NYSE under the symbol &#8220;AVK.&#8221; As of September 13, 2024, the NAV of the Fund&#8217;s Common
Shares was $12.23 per share, and the last reported sale price for the Fund&#8217;s Common Shares on the NYSE was $12.24 per Common Share,
representing a premium to NAV of 0.08%. The Rights will be, subject to notice of issuance, admitted for trading on the NYSE under the
symbol &#8220;AVK RT&#8221; during the course of the offer. Trading in the Rights on the NYSE may be conducted until the close of trading
on the NYSE on the last business day prior to the Expiration Date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s securities do not represent a
deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution and are not federally
insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Capitalized terms used herein that are not otherwise
defined shall have the meanings assigned to them in the accompanying Prospectus.</p>


<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 5pt; text-align: center; text-indent: 0.5in"><b>TABLE OF CONTENTS</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 5pt; text-align: center; text-indent: 0.5in"><b></b></p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%">
  <tr>
    <td style="padding: 0.75pt; width: 91%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="padding: 0.75pt; text-align: right; width: 9%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding: 0.75pt; text-align: center; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif"><b>Page</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif"><b>Prospectus Supplement</b></span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">About this Prospectus
    Supplement</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">v</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Where You Can Find
    More Information</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">v</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Incorporation by Reference</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">vi</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Prospectus Supplement
    Summary</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">S-1</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Summary of Fund Expenses</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">S-8</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Capitalization</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">S-9</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Use of Proceeds</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">S-9</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Terms of the Offer</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">S-10</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Risks Related to the
    Offer</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">S-22</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Plan of Distribution</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">S-23</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Legal Matters</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">S-25</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Independent Registered
    Public Accounting Firm</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">S-25</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif"><b>Prospectus</b></span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding: 0.75pt; text-align: center; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif"><b>Page</b></span></td></tr>
</table>

<table cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%; width: 91%"><span style="font-family: Times New Roman, Times, Serif">ABOUT THIS PROSPECTUS</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%; width: 9%"><span style="font-family: Times New Roman, Times, Serif">1</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">WHERE YOU CAN FIND
    MORE INFORMATION</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">2</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">INCORPORATION BY REFERENCE</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">2</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">PROSPECTUS SUMMARY</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">4</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">SUMMARY OF FUND EXPENSES</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">9</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">FINANCIAL HIGHLIGHTS</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">10</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">THE FUND</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">12</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">USE OF PROCEEDS</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">12</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">MARKET AND NET ASSET
    VALUE INFORMATION</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">12</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">INVESTMENT OBJECTIVE
    AND POLICIES</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">13</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">THE FUND&#8217;S INVESTMENTS</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">13</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">USE OF LEVERAGE</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">19</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">RISKS</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">23</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">MANAGEMENT OF THE
    FUND</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">24</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">NET ASSET VALUE</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">25</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">DISTRIBUTIONS</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">26</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">DIVIDEND REINVESTMENT
    PLAN</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">28</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">DESCRIPTION OF CAPITAL
    STRUCTURE</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">28</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">DESCRIPTION OF SUBSCRIPTION
    RIGHTS THAT MAY BE ISSUED</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">30</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">ANTI-TAKEOVER PROVISIONS
    IN THE FUND&#8217;S GOVERNING DOCUMENTS</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">31</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">CERTAIN PROVISIONS
    OF DELAWARE LAW, THE DECLARATION OF TRUST AND BY-LAWS</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">32</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">CLOSED-END FUND STRUCTURE</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">35</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">TAX MATTERS</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">36</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">PLAN OF DISTRIBUTION</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">42</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">SERVICING AGENT, TRANSFER
    AGENT, CUSTODIAN AND ADMINISTRATOR</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">44</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">LEGAL MATTERS</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">44</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">INDEPENDENT REGISTERED
    PUBLIC ACCOUNTING FIRM</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">44</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">FISCAL YEAR END AND
    REPORTS TO SHAREHOLDERS</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">44</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">PRIVACY PRINCIPLES
    OF THE FUND</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">45</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">TABLE OF CONTENTS
    OF STATEMENT OF ADDITIONAL INFORMATION</span></td>
    <td style="padding: 0.75pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">46</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 5pt; text-align: center; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>ABOUT THIS PROSPECTUS SUPPLEMENT</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt">This document
has two parts. The first part is this Prospectus Supplement, which describes the terms of the Offer. The second part is the accompanying
Prospectus, which contains more general information about the securities that the Fund may offer from time to time, some of which may
not apply to this Offer. If information in this Prospectus Supplement is inconsistent with the accompanying Prospectus, you should rely
on this Prospectus Supplement. You should carefully read this Prospectus Supplement and the accompanying Prospectus, together with the
additional information described under the heading &#8220;Where You Can Find More Information.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt">This Prospectus
Supplement and the accompanying Prospectus and the SAI, contain (or will contain) or incorporate (or will incorporate) by reference forward-looking
statements, within the meaning of the federal securities laws, that involve risks and uncertainties. These statements describe the Fund&#8217;s
plans, strategies, and goals and the Fund&#8217;s beliefs and assumptions concerning future economic and other conditions and the outlook
for the Fund, based on currently available information. In this Prospectus Supplement and the accompanying Prospectus, words such as
&#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;objectives,&#8221; &#8220;goals,&#8221; &#8220;future,&#8221;
&#8220;intends,&#8221; &#8220;seeks,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; and similar
expressions, and the negative of such terms, are used in an effort to identify forward-looking statements, although some forward-looking
statements may be expressed differently. By their nature, all forward looking statements involve risks and uncertainties, and actual
results could differ materially from those contemplated by any forward looking statements. Although the Fund believes that the expectations
expressed in these forward looking statements are reasonable, actual results could differ materially from those projected or assumed
in these forward looking statements. The Fund&#8217;s future financial condition and results of operations, as well as any forward looking
statements, are subject to change and are subject to inherent risks and uncertainties, such as those disclosed in the &#8220;Risks&#8221;
sections of this Prospectus Supplement, the accompanying Prospectus and the Fund&#8217;s most recent Annual Report, which describe certain
currently known risk factors that could cause actual results to differ materially from the Fund&#8217;s expectations. The Fund urges
you to review carefully that section for a more detailed discussion of the risks associated with an investment in the Fund&#8217;s securities.
All forward looking statements contained or incorporated by reference in this Prospectus Supplement and the accompanying Prospectus are
made as of the date of this Prospectus Supplement. The Fund does not intend, and undertakes no obligation, to update any forward looking
statement. The Fund is not entitled to the safe harbor for forward-looking statements pursuant to Section 27A of the Securities Act.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt">You should
rely only on the information contained or incorporated by reference in this Prospectus Supplement and the accompanying Prospectus. The
Fund has not authorized any other person to provide you with different information. If anyone provides you with different or inconsistent
information, you should not rely on it. The Fund is not making an offer to sell these securities in any jurisdiction where the offer
or sale is not permitted. You should not assume that the information in this Prospectus Supplement and the accompanying Prospectus is
accurate as of any date other than the date of this Prospectus Supplement. The Fund&#8217;s business, financial condition and results
of operations may have changed since that date. The Fund will amend this Prospectus Supplement and the accompanying Prospectus if, during
the period that this Prospectus Supplement and the accompanying Prospectus is required to be delivered, there are any subsequent material
changes.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>WHERE YOU CAN FIND MORE INFORMATION</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt">The Fund is
subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) and the
1940 Act, and in accordance therewith files, or will file, reports and other information with the SEC. Reports, proxy statements and
other information filed by the Fund with the SEC pursuant to the informational requirements of the Exchange Act and the 1940 Act can
be inspected and copied at the public reference facilities maintained by the SEC, 100 F Street, N.E., Washington, D.C. 20549. The SEC
maintains a web site at www.sec.gov containing reports, proxy and information statements and other information regarding registrants,
including the Fund, that file electronically with the SEC.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt">This Prospectus
Supplement and the accompanying Prospectus constitute part of a Registration Statement filed by the Fund with the SEC under the Securities
Act, and the 1940 Act (File Nos. 333-280964 and 811-21309). This Prospectus Supplement and the accompanying Prospectus omit certain of
the information contained in the Registration Statement, and reference is hereby made to the Registration Statement and related exhibits
for further information with respect to the Fund and the Common Shares offered hereby. Any statements contained herein or in the accompanying
Prospectus concerning the provisions of any document are not necessarily complete, and, in</p>

<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt">each instance, reference is made to the copy of such document filed as an exhibit to the Registration
Statement or otherwise filed with the SEC. Each such statement is qualified in its entirety by such reference. The complete Registration
Statement may be obtained from the SEC upon payment of the fee prescribed by its rules and regulations or free of charge through the SEC&#8217;s
website (www.sec.gov).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt">The Fund will
provide without charge to each person, including any beneficial owner, to whom this Prospectus Supplement and the accompanying Prospectus
are delivered, upon written or oral request, a copy of any and all of the information that has been incorporated by reference in this
Prospectus Supplement or the accompanying Prospectus. You may request such information by calling (800) 345-7999 or by writing to Guggenheim
Funds Distributors, LLC at 227 West Monroe Street, 7th Floor, Chicago, Illinois, 60606, or you may obtain a copy (and other information
regarding the Fund) from the SEC&#8217;s website (www.sec.gov). Free copies of this Prospectus Supplement, the accompanying Prospectus,
the SAI and any incorporated information will also be available from the Fund&#8217;s website at www.guggenheiminvestments.com/cef/fund/avk.
Information contained on the Fund&#8217;s website is not incorporated by reference into this Prospectus Supplement or the accompanying
Prospectus and should not be considered to be part of this Prospectus Supplement or the accompanying Prospectus.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>INCORPORATION BY REFERENCE</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt">This Prospectus
Supplement and the accompanying Prospectus are part of a registration statement that the Fund has filed with the SEC. The Fund is permitted
to &#8220;incorporate by reference&#8221; the information that it files with the SEC, which means that the Fund can disclose important
information to you by referring you to those documents. The information incorporated by reference is an important part of this Prospectus,
and later information that the Fund files with the SEC will automatically update and supersede this information.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt">The documents
listed below, and any reports and other documents subsequently filed with the SEC pursuant to Rule 30(b)(2) under the 1940 Act and Sections
13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offering, are incorporated by reference into this Prospectus
Supplement and the accompanying Prospectus and deemed to be part of this Prospectus and the accompanying Prospectus from the date of
the filing of such reports and documents:</p>

<ul style="margin-top: 0in; list-style-type: disc">

<li style="margin: 6pt 0; font-size: 9pt">the Fund&#8217;s Statement of Additional Information, dated September 12, 2024, filed with this
Prospectus Supplement (&#8220;SAI&#8221;);</li>

<li style="margin: 6pt 0; font-size: 9pt"><span style="background-color: white">the Fund&#8217;s Annual Report on Form&#160;N-CSR for
the fiscal year ended October&#160;31, 2023, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">December&#160;29, 2023</a> (&#8220;Annual
Report&#8221;);</span></li>

<li style="margin: 6pt 0; font-size: 9pt"><span style="background-color: white">the Fund&#8217;s Semi-Annual Report on Form N-CSRS for
the period ended April 30, 2024, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126824000124/gug87515avk-ncsr.htm">July 3, 2024</a> (&#8220;Semi-Annual Report&#8221;); </span></li>

<li style="margin: 6pt 0; font-size: 9pt"><span style="background-color: white">the financial highlights contained within the Fund&#8217;s
Annual Report on Form N-CSR for the fiscal year ended October 31, 2018, filed with the SEC on <a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180419000003/gug75351-ncsr.htm">January 4, 2019</a>;</span></li>

<li style="margin: 6pt 0; font-size: 9pt"><span style="background-color: white">the Fund&#8217;s definitive proxy statement on Schedule&#160;14A
for its 2024 annual meeting of shareholders, filed with the SEC on <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">August 2, 2024</a> (&#8220;Proxy
Statement&#8221;);</span></li>

<li style="margin: 6pt 0; font-size: 9pt"><span style="background-color: white">the Fund's Current Report on Form 8-K, filed with the SEC on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126824000269/gug88055avk8k.htm">September 18, 2024</a>; and</span></li>

</ul>

<ul style="margin-top: 0in; list-style-type: disc">

<li style="margin: 0 0 12pt; font-size: 9pt"><span style="background-color: white">the Fund&#8217;s description of common shares contained
in its Registration Statement on Form&#160;8-A (File No.&#160;001-31663) filed with the SEC on <a href="https://www.sec.gov/Archives/edgar/data/1219120/000095017203001191/s426975.txt">April&#160;10,
2003</a></span></li>

</ul>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; margin-left: 0pt; text-indent: 20pt">To obtain
copies of these filings, see &#8220;Where You Can Find More Information.&#8221;</p>


<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->vi<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>PROSPECTUS SUPPLEMENT SUMMARY</b></p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in"><i>This is only a summary
    of information contained elsewhere in this Prospectus Supplement and the accompanying Prospectus. This summary does not contain all of
    the information that you should consider before investing in the Fund&#8217;s Common Shares. You should carefully read the more detailed
    information contained in this Prospectus Supplement and the accompanying Prospectus and the Statement of Additional Information, dated
    September 12, 2024 (the &#8220;SAI&#8221;), especially the information set forth under the headings &#8220;Investment Objective and Policies&#8221;
    and &#8220;Risks.&#8221;</i></p></td></tr>
  <tr style="vertical-align: top">
    <td style="border-left: Black 1pt solid; width: 35%; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: justify"><span style="font-size: 9pt"><b>The Fund 	</b></span></td>
    <td style="border-right: Black 1pt solid; width: 65%; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><span style="font-size: 9pt">Advent Convertible and Income Fund is a diversified, closed-end management investment company registered under the 1940 Act. </span></td></tr>
  </table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; width: 35%; padding-bottom: 6pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-size: 9pt"><b>
    &#8239;&#8239;&#8239;Purpose of the Offer 	</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 65%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">The board of trustees of the Fund (the &#8220;Board&#8221;), based
    on the recommendations of and presentations by the Adviser, and others, has determined that it is in the best interests of the Fund and
    its Common Shareholders to conduct the Offer (as defined below) and thereby generate net proceeds from the offering to purchase portfolio
    securities in accordance with the Fund&#8217;s investment objective and policies. In making this determination, the Board considered a
    number of factors, including potential benefits and costs. In particular, the Board considered the Adviser&#8217;s belief that the Offer
    would better enable the Fund to take advantage more fully of existing and future investment opportunities for convertible securities and
    non-convertible income producing securities that may be or may become available, consistent with the Fund&#8217;s investment objective
    to seek high total return with an emphasis on current income.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Offer seeks to provide an opportunity to existing Common Shareholders
    to purchase Common Shares at a discount to market price (subject to the sales load described in this Prospectus Supplement). The Board
    considered that the distribution to Common Shareholders of transferable Rights (as defined below), which may themselves have intrinsic
    value, also will afford non-participating Record Date Shareholders (as defined below) the potential of receiving cash payment upon the
    sale of the Rights, receipt of which may be viewed as partial compensation for any dilution of their interests that may occur as a result
    of the Offer. There can be no assurance that a market for the Rights will develop or, if such a market does develop, what the price of
    the Rights will be.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">In making its determination that the Offer is in the best interests
of the Fund and its Common Shareholders, the Board also considered various additional factors, including: (i) the size, pricing and structure
of the Offer, including the transferability of the Rights and the ability of the Dealer Manager to purchase and exercise Rights; (ii)
that the Offer, if it is well-subscribed, could increase the liquidity of the Common Shares on the NYSE, where the Common Shares are
traded; (iii) the opportunity the Offer represents for current Common Shareholders to buy Common Shares at a discount to NAV or market
price, or, in some cases, both; (iv) the costs of the Offer, including fees paid to the Dealer Manager, and dilution of Common Shareholders&#8217;
interests through the Offer; (v) the possible negative effect of the Offer on the market price of Common Shares; and (vi) that the Offer
will increase the Fund&#8217;s asset base and thus allow it to spread fixed expenses over a larger base of assets and that continued
growth in the</p></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; width: 35%; padding-bottom: 6pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"/>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; width: 65%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Fund&#8217;s asset base may lead to reductions in the Fund&#8217;s
expense ratio. The Board noted that the Adviser has an inherent conflict of interest in recommending the Offer because its fees are based
on a percentage of the Fund&#8217;s Managed Assets (as defined in the Prospectus) and the greater the Managed Assets of the Fund, the
greater the compensation paid to the Adviser.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">There can be no assurance that the Offer (or the investment of the
    proceeds of the Offer) will be successful. The completion of the Offer may result in an immediate dilution of the NAV per Common Share
    for all existing Common Shareholders, including those who fully exercise their Rights. For a discussion of the potential impact of the
    Offer on current Common Shareholders, such as dilution, see &#8220;Risks Relating to the Offer&#8221; in this Prospectus Supplement.</p></td></tr>

<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in; width: 35%"><span style="font-size: 9pt"><b>&#8239;&#8239;Important Terms of the Offer 	</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 65%">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">In the Offer, the Fund is issuing transferable Rights to its Record
    Date Shareholders as of 5:00 p.m., Eastern Time, on the Record Date (September 20, 2024) entitling the holders of those Rights to subscribe
    for up to an aggregate of 11,533,627 of the Fund&#8217;s Common Shares. Record Date Shareholders will receive one Right for each outstanding
    whole Common Share held on the Record Date. The Rights entitle their holders to purchase one Share for every three Rights held (1-for-3).
    Fractional Common Shares will not be issued upon the exercise of Rights; accordingly, Rights may be exercised only in integer multiples
    of three, except that any Record Date Shareholder who owns fewer than three Common Shares as of the Record Date may subscribe, at the
    Subscription Price (defined below), for one full Common Share. Assuming the exercise of all Rights, the Offer will result in an approximately
    33 1/3% increase in the Fund&#8217;s Common Shares outstanding. The Offer is not contingent upon any number of Rights being exercised.
    The subscription period commences on September 20, 2024 and ends at 5:00 p.m., Eastern Time, on the Expiration Date, October 17, 2024,
    unless otherwise extended. See &#8220;Terms of the Offer&#8212;Important Terms of the Offer.&#8221;</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Fund has declared a regular September monthly distribution to
    Common Shareholders in an amount of $0.1172 per share payable on September 30, 2024, with a record date of September 13, 2024, which will
    not be payable with respect to Common Shares that are issued pursuant to the Offer. The Fund has also declared a regular October monthly
    distribution to Common Shareholders in an amount of $0.1172 per share payable on October 31, 2024, with a record date of October 2, 2024,
    which will not be payable with respect to Common Shares that are issued pursuant to the Offer after such record date.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Fund will bear the expenses of the Offer and all such expenses
    will be borne indirectly by the Fund&#8217;s Common Shareholders, including those who do not exercise their Rights. These expenses include,
    but are not limited to, the Dealer Manager fee and reimbursement of Dealer Manager expenses, the expenses of preparing, printing and mailing
    the Prospectus Supplement and accompanying Prospectus and Rights subscription materials for the Offer, SEC registration fees and the fees
    assessed by service providers (including the costs of the Fund&#8217;s counsel and the Fund&#8217;s independent registered public accounting
    firm) in connection with the Offer.</p></td></tr>
  </table>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; width: 35%; padding-bottom: 6pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-size: 9pt"><b>&#8239;&#8239;Important Dates to Remember 	</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; width: 65%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Record Date: September 20, 2024</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Subscription Period: September 20, 2024 &#8211; October 17, 2024*</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Final Date Rights Will Trade: October 16, 2024*</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Expiration Date and Pricing Date: October 17, 2024*</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Subscription Certificate and Payment for Shares Due+: October 17,
    2024*</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Notice of Guaranteed Delivery and Payment for Shares Due+: October
    17, 2024*</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Subscription Certificates Pursuant to Guarantees of Delivery Due+:
    October 18, 2024*</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Confirmation Mailed to Participants: October 25, 2024*</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Final Payment for Shares Due: November 8, 2024&#8224;*</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Issuance Date: October November 8, 2024*</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt 14.25pt; text-indent: -14.25pt">*&#160;&#160;Unless
    the Offer is extended.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt 14.25pt; text-indent: -14.25pt">+	 A holder exercising Rights
    must deliver by 5:00 p.m. Eastern Time on October 17, 2024 (unless the Offer is extended) either (a) a Subscription Certificate and
    payment for shares or (b) a notice of guaranteed delivery and payment for shares.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt 14.25pt; text-indent: -14.25pt">&#8224;	Any additional amount due
    (in the event the Subscription Price exceeds the estimated Subscription Price). See &#8220;Terms of the Offer&#8211;&#8211;Payment for
    Shares.&#8221;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-size: 9pt"><b>&#8239;&#8239;Subscription Price 	</b></span></td>
    <td style="border-right: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><span style="font-size: 9pt">The Subscription Price for the Common Shares will be determined based on a Formula Price equal to 92.5% of the average of the last reported sale price of a Common Share on the NYSE on the date on which the Offer expires, as such date may be extended from time to time, and the four (4) preceding trading days. If, however, the Formula Price is less than 90% of the NAV per Common Share at the close of trading on the NYSE on the Expiration Date, then the Subscription Price will be 90% of the Fund&#8217;s NAV per Common Share at the close of trading on the NYSE on the Expiration Date. Because the Expiration Date of the subscription period will be October 17, 2024 (unless the subscription period is extended), Rights holders will not know the Subscription Price at the time of exercise and will be required initially to pay for both the Common Shares subscribed for pursuant to the primary subscription and, if eligible, any additional Common Shares subscribed for pursuant to the over-subscription privilege at the estimated Subscription Price of $11.42 per Common Share and, except in limited circumstances, will not be able to rescind their subscription. See &#8220;Terms of the Offer&#8212;Subscription Price.&#8221; </span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-size: 9pt"><b>&#8239;&#8239;Oversubscription Privilege 	</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><span style="font-size: 9pt">Record Date Shareholders who exercise all the Rights issued to them (other than those Rights that cannot be exercised because they represent the right to acquire less than one Common Share) are entitled to subscribe for additional Shares at the same Subscription Price pursuant to the over-subscription privilege, subject to certain limitations and subject to allotment. If sufficient remaining Shares are available following the primary subscription, all Record Date Shareholders&#8217; over-subscription requests will be honored in full. </span></td></tr>
  </table>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in; width: 35%"/>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; width: 65%"><span style="font-size: 9pt"> Investors who are not Record Date Shareholders, but who otherwise acquire Rights pursuant to the Offer, are not entitled to subscribe for any Shares pursuant to the over-subscription privilege. If sufficient Shares are not available to honor all over-subscription requests, unsubscribed Shares will be allocated pro rata among those Record Date Shareholders who over-subscribe based on the number of Common Shares they owned on the Record Date. See &#8220;Terms of the Offer&#8212;Over-Subscription Privilege.&#8221;</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; width: 35%; padding-bottom: 6pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-size: 9pt"><b>&#8239;&#8239;Sale and Transferability of Rights 	</b></span></td>
    <td style="border-right: Black 1pt solid; width: 65%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Rights will be, subject to notice of issuance, admitted for trading
    on the NYSE under the symbol &#8220;AVK RT&#8221; during the course of the Offer. Trading in the Rights on the NYSE may be conducted until
    the close of trading on the NYSE on the last business day prior to the Expiration Date. The Fund will use its best efforts to ensure that
    an adequate trading market for the Rights will exist, although there can be no assurance that a market for the Rights will develop. Assuming
    a market exists for the Rights, the Rights may be purchased and sold through usual brokerage channels or sold through the Subscription
    Agent (as defined in this Prospectus Supplement).</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Record Date Shareholders who do not wish to exercise any of the Rights
    issued to them pursuant to the Offer may instruct the Subscription Agent to try to sell any unexercised Rights. Although the Rights are
    expected to trade on the NYSE through the last business day prior to the Expiration Date, Subscription certificates representing the Rights
    to be sold through the Subscription Agent must be received by the Subscription Agent by 5:00 p.m., Eastern time, on October 10, 2024 (or,
    if the subscription period is extended, by 5:00 p.m., Eastern time, on the fifth business day prior to the extended Expiration Date).
    Upon the timely receipt by the Subscription Agent of appropriate instructions to sell Rights, the Subscription Agent will ask the Dealer
    Manager if it will purchase the Rights. If the Dealer Manager purchases the Rights, the sales price paid by the Dealer Manager will be
    based upon the then-current market price for the Rights. If the Dealer Manager declines to purchase the Rights of a Record Date Shareholder
    that have been duly submitted to the Subscription Agent for sale, the Subscription Agent will attempt to sell such Rights in the open
    market.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Alternatively, the Rights evidenced by a subscription certificate
    may be transferred until the Expiration Date in whole or in part by endorsing the subscription certificate for transfer in accordance
    with the accompanying instructions. See &#8220;Terms of the Offer&#8212;Sale and Transferability of Rights.&#8221;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-size: 9pt"><b>&#8239;&#8239;Method for Exercising Rights 	</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Rights are evidenced by subscription certificates that will be
mailed to Record Date Shareholders (except as described below under &#8220;Terms of the Offer&#8212;Requirements for Foreign Shareholders&#8221;)
or, if their Common Shares are held by Cede &amp; Co. or any other depository or nominee, to Cede &amp; Co. or such other depository
or nominee. Rights may be exercised by completing and signing the subscription certificate and mailing it in the envelope provided, or
otherwise delivering the completed and signed subscription certificate to the Subscription Agent, together with payment in full of the
estimated Subscription Price for the Shares subscribed for. Completed</p></td></tr>
  </table>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in; width: 40%"/>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 60%">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt"> subscription certificates and payments must be received by the Subscription
    Agent by 5:00 p.m., Eastern time, on the Expiration Date at the offices of the Subscription Agent. Rights also may be exercised by contacting
    your broker, banker, trust company or other intermediary, which can arrange, on your behalf, to guarantee delivery of payment and of a
    properly completed and executed subscription certificate. A fee may be charged for this service by your broker, bank, trust company or
    other intermediary. In addition, your broker, bank, trust company or other intermediary may impose a deadline for exercising Rights earlier
    than 5:00 p.m., Eastern time, on the Expiration Date. See &#8220;Terms of the Offer&#8212;Method for Exercising Rights&#8221; and &#8220;Terms
    of the Offer&#8212;Payment for Shares.&#8221;</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Rights holders who have exercised their Rights will have no right to
rescind their subscription after receipt by the Subscription Agent of the completed subscription certificate together with payment for
Shares subscribed for, except as described under &#8220;Terms of the Offer.&#8221;&#160;</p></td></tr>

<tr style="vertical-align: top">
    <td style="border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.25in; text-indent: -0.25in"><span style="font-size: 9pt"><b>&#8239;&#8239;Requirements for Foreign Shareholders</b></span></td>
    <td style="border-right: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><span style="font-size: 9pt">Subscription certificates will not be mailed to Record Date Shareholders whose addresses are outside the United States (for these purposes, the United States includes the District of Columbia and the territories and possessions of the United States) (&#8220;Foreign Shareholders&#8221;). The Subscription Agent will send a letter via regular mail to Foreign Shareholders to notify them of the Offer. The Rights of Foreign Shareholders will be held by the Subscription Agent for their accounts until instructions are received to exercise the Rights. If instructions have not been received by 5:00 p.m., Eastern time, on October 10, 2024, five business days prior to the Expiration Date (or, if the subscription period is extended, on or before the fifth business day prior to the extended Expiration Date), the Subscription Agent will ask the Dealer Manager if it will purchase the Rights of Foreign Shareholders. If the Dealer Manager declines to purchase the Rights, the Subscription Agent will attempt to sell such Rights in the open market. The net proceeds, if any, from the sale of those Rights will be remitted to these Foreign Shareholders. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.25in; text-indent: -0.25in"><span style="font-size: 9pt"><b>&#8239;&#8239;U.S. Federal Income Tax Considerations	</b></span></td>
    <td style="border-right: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><span style="font-size: 9pt">We urge you to consult your own tax adviser with respect to the particular tax consequences of the Offer. See &#8220;Terms of the Offer&#8212;U.S. Federal Income Tax Considerations&#8221; for more information on the tax consequences of the Offer.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.25in; text-indent: -0.25in"><span style="font-size: 9pt"><b>&#8239;&#8239;Distribution Arrangements 	</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">UBS Securities LLC will act as Dealer Manager for this Offer.
Under the terms and subject to the conditions contained in the Dealer Manager Agreement among the Dealer Manager, the Fund and the Adviser,
the Dealer Manager will provide financial structuring services in connection with the Offer and will solicit the exercise of Rights and
participation in the over-subscription privilege. The Fund has agreed to pay the Dealer Manager a fee for its financial structuring and
soliciting services equal to 3.75% of the Subscription Price per Share for each Share issued pursuant to the exercise of Rights, including
the over-subscription privilege. The Fund has also agreed to pay the Dealer Manager up to $150,000 as a partial reimbursement for its
reasonable out-of-pocket expenses incurred in connection with the</p></td></tr>
  </table>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.25in; text-indent: -0.25in; width: 35%"/>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 65%">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt"> Offer, including reasonable out-of-pocket fees and expenses, if any
    and not to exceed $10,000, incurred by the Dealer Manager, Selling Group Members, Soliciting Dealers and other brokers, dealers and financial
    institutions in connection with their customary mailing and handling of materials related to the Offer to their customers. The fees paid
    to the Dealer Manager and other expenses of the Offer will be borne by the Fund and indirectly by all of its Common Shareholders, including
    those who do not exercise their Rights. The Dealer Manager will reallow a portion of its fees to other broker-dealers who have assisted
    in soliciting the exercise of Rights. The Fund and the Adviser have each agreed to indemnify the Dealer Manager for losses arising out
    of certain liabilities, including liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">Prior to the expiration of the Offer, the Dealer Manager may independently
    offer for sale Shares it has acquired through purchasing and exercising the Rights, at prices it sets. Although the Dealer Manager may
    realize gains and losses in connection with purchases and sales of Shares, such offering of Shares is intended by the Dealer Manager to
    facilitate the Offer, and any such gains or losses are not expected to be material to the Dealer Manager. The Dealer Manager&#8217;s fee
    for its financial structuring and soliciting services is independent of any gains or losses that may be realized by the Dealer Manager
    through the purchase and exercise of the Rights and the sale of Shares. See &#8220;Terms of the Offer&#8212;Distribution Arrangements.&#8221;</p></td></tr>
</table>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; width: 35%; padding-bottom: 6pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-size: 9pt"><b>&#8239;&#8239;Adviser 	</b></span></td>
    <td style="border-right: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; width: 65%; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><span style="font-size: 9pt">Advent Capital Management, LLC (&#8220;Advent&#8221; or the &#8220;Adviser&#8221;) serves as the investment adviser to the Fund and is responsible for the day-to-day management of the Fund&#8217;s portfolio of securities, which includes buying and selling securities for the Fund. Advent is a registered investment adviser, based in New York, which specializes in convertible and high-yield securities for institutional and individual investors. As of May 31, 2024 Advent managed more than $7.8 billion in assets.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-size: 9pt"><b>&#8239;&#8239;Benefits to the Adviser 	</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><span style="font-size: 9pt">The
    Adviser will benefit from the Offer, in part, because the investment management fee paid by the Fund to the Adviser is based on
    &#8220;Managed Assets&#8221; of the Fund. It is not possible to state precisely the amount of additional compensation the Adviser
    will receive as a result of the Offer because it is not known how many Shares will be subscribed for and because the proceeds of the
    Offer will be invested in additional portfolio securities which will fluctuate in value. However, assuming (i) all Rights are
    exercised, (ii) the Fund&#8217;s average NAV during the twelve-month period beginning September 13, 2024 is $12.23 per Common Share
    (the NAV per Common Share on September 13, 2024) (iii) the Subscription Price is $11.42 per Share, and (iv) for purposes of this
    example, the Fund increases the amount of leverage it has outstanding while maintaining approximately the same percentage of total
    assets attributable to leverage, and after giving effect to the Dealer Manager fee and other estimated offering expenses, the
    Adviser would receive additional investment management fees of approximately $1,175,200, for the twelve-month period beginning
    September 13, 2024, and would continue to receive additional investment management fees, as a result of the Offer, based</span></td></tr>
  </table>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in; width: 35%"/>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt; width: 65%">on
the Fund&#8217;s Managed Assets attributable to the Shares issued in the Offer and related additional leverage, thereafter. </td></tr>
<tr style="vertical-align: top">
    <td style="border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><span style="font-size: 9pt"><b>&#8239;&#8239;Listing and Symbol 	</b></span></td>
    <td style="border-right: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><span style="font-size: 9pt">The Fund&#8217;s currently outstanding Common Shares are, and it is expected that the Common Shares offered by this Prospectus Supplement and the accompanying Prospectus will be, subject to notice of issuance, listed on the NYSE under the symbol &#8220;AVK.&#8221; As of September 13, 2024, the NAV of the Fund&#8217;s Common Shares was $12.23 per share, and the last reported sale price for the Fund&#8217;s Common Shares on the NYSE was $12.24 per Common Share, representing a premium to NAV of 0.08%. The Subscription Rights for Common Shares offered by this Prospectus Supplement and the accompanying Prospectus, will be, subject to notice of issuance, admitted for trading on the NYSE under the symbol &#8220;AVK RT&#8221; during the course of the offer. Trading in the Rights on the NYSE may be conducted until the close of business on the October 16, 2024 on the last business day prior to the Expiration Date.</span></td></tr>
<tr style="vertical-align: top">
    <td style="border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-bottom: 6pt; padding-left: 0.25in; text-indent: -0.25in"><span style="font-size: 9pt"><b>&#8239;&#8239;Risks 	</b></span></td>
    <td style="border-right: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><span style="font-size: 9pt">See
    &#8220;Risks Related to the Offer&#8221; beginning on page S-22 of this Prospectus Supplement and &#8220;Risks&#8221; beginning on
    page 23 of the accompanying Prospectus for a discussion of factors you should consider carefully before deciding to invest in the
    Fund&#8217;s Common Shares.</span></td></tr>
</table>

<table cellspacing="0" cellpadding="0" style="font-size: 8pt; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 9pt Times New Roman, Times, Serif; width: 35%; padding-right: 5.4pt; padding-left: 0.25in; text-indent: -0.25in"><span style="font-size: 9pt"><b>&#8239;&#8239;Use of Proceeds 	</b></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 65%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Fund estimates the net proceeds of the Offer to be approximately
    $126,155,600. This figure is based on the estimated Subscription Price per Common Share of $11.42 and assumes all new Common Shares offered
    are sold and that the estimated Dealer Manager fee of $0.43 per share and the expenses related to the Offer, estimated at approximately
    $619,100, are paid.</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Fund intends to invest the net proceeds of the offering in accordance
    with its investment objective and policies as stated in the accompanying Prospectus. It is currently anticipated that the Fund will be
    able to invest substantially all of the net proceeds of the offering in accordance with its investment objective and policies within three
    months after the completion of the offering. Pending such investment, it is anticipated that the proceeds will be invested in cash, cash
    equivalents or other securities, including U.S. government securities or high quality, short-term debt securities. The Fund may also use
    the proceeds for working capital purposes, including the payment of distributions, interest and operating expenses, although the Fund
    currently has no intent to issue Securities primarily for these purposes.</p></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>SUMMARY OF FUND EXPENSES</b></p>

<p id="xdx_987_ecef--PurposeOfFeeTableNoteTextBlock_c20240919__20240919_zqJg1mcTaS9j" style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 11pt; text-indent: 0.5in"><ix:nonNumeric contextRef="AsOf2024-09-19" escape="true" id="Fact000012" name="cef:PurposeOfFeeTableNoteTextBlock">The following table contains information about
the costs and expenses that Common Shareholders will bear directly or indirectly. The table is based on the capital structure of the Fund
as of	 April 30, 2024 (except as noted below) after giving effect to the Offer, assuming that the Offer is fully subscribed resulting
in the receipt of net proceeds from the Offer of approximately $126,155,600. If the Fund issues fewer Common Shares in the Offer and the
net proceeds to the Fund are less, all other things being equal, the total annual expenses shown would increase. The purpose of the table
and the example below is to help you understand the fees and expenses that you, as a holder of Common Shares, would bear directly or indirectly.</ix:nonNumeric></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"><sup>&#160;</sup></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0"></p><ix:nonNumeric contextRef="AsOf2024-09-19" escape="true" id="Fact000014" name="cef:ShareholderTransactionExpensesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_883_ecef--ShareholderTransactionExpensesTableTextBlock_zIEQaJaJBUEf" summary="xdx: Disclosure - ShareholderExpenses" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 0.05in; padding-left: 5.4pt; width: 67%"><b>Shareholder Transaction Expenses</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 33%">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.05in; padding-left: 5.4pt">	Sales load (as a percentage of offering price)</td>
    <td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right">		<span id="xdx_903_ecef--SalesLoadPercent_c20240919__20240919_fKDEp_zBIEIjSLkX45"><ix:nonFraction name="cef:SalesLoadPercent" contextRef="AsOf2024-09-19" id="Fact000015" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.75</ix:nonFraction>%</span><sup>(1)</sup></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.05in; padding-left: 5.4pt">	Offering expenses borne by the Fund (<span id="xdx_901_ecef--BasisOfTransactionFeesNoteTextBlock_c20240919__20240919_zQfoEx0thtv5"><ix:nonNumeric contextRef="AsOf2024-09-19" escape="true" id="Fact000016" name="cef:BasisOfTransactionFeesNoteTextBlock">as a percentage of offering price</ix:nonNumeric></span>)		</td>
    <td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90B_ecef--OtherTransactionExpensesPercent_c20240919__20240919_fKDIp_zEewHJNBUBza"><ix:nonFraction name="cef:OtherTransactionExpensesPercent" contextRef="AsOf2024-09-19" id="Fact000017" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.47</ix:nonFraction>%</span><sup>(2)</sup></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.05in; padding-left: 5.4pt">	Dividend Reinvestment Plan fees 		</td>
    <td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"><span id="xdx_902_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20240919__20240919_fKDMp_zVhJLu1xDkF"><ix:nonFraction name="cef:DividendReinvestmentAndCashPurchaseFees" contextRef="AsOf2024-09-19" id="Fact000018" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">None</ix:nonFraction></span><sup>(3)</sup></td></tr>
</table></ix:nonNumeric>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<ix:nonNumeric contextRef="AsOf2024-09-19" escape="true" id="Fact000020" name="cef:AnnualExpensesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_88B_ecef--AnnualExpensesTableTextBlock_zLc5FAh9pwJ6" summary="xdx: Disclosure - Expenses" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 67%; padding-right: 0.05in; padding-left: 5.4pt"><span style="font-size: 9pt"><b><br/>
Annual Expenses</b></span></td>
    <td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><b>Percentage of Net Assets <span style="text-decoration: underline"></span></b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><b><span style="text-decoration: underline">Attributable to Common Shares</span></b></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.05in; padding-left: 5.4pt"><span style="font-size: 9pt">Management fees<sup>(4)</sup></span></td>
    <td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"><span id="xdx_903_ecef--ManagementFeesPercent_c20240919__20240919_fKDQp_zhPleqhQFJN"><ix:nonFraction name="cef:ManagementFeesPercent" contextRef="AsOf2024-09-19" id="Fact000021" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.95</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.05in; padding-left: 5.4pt"><span style="font-size: 9pt">Interest expense<sup>(5)</sup></span></td>
    <td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt"><span id="xdx_909_ecef--InterestExpensesOnBorrowingsPercent_c20240919__20240919_fKDUp_zTYx6gjEefm3"><ix:nonFraction name="cef:InterestExpensesOnBorrowingsPercent" contextRef="AsOf2024-09-19" id="Fact000022" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.13</ix:nonFraction>%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.05in; padding-left: 5.4pt"><span style="font-size: 9pt">Other expenses<sup>(6)</sup></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt"><span id="xdx_904_ecef--OtherAnnualExpensesPercent_c20240919__20240919_fKDYp_zUC3QYWAQ39c"><ix:nonFraction name="cef:OtherAnnualExpensesPercent" contextRef="AsOf2024-09-19" id="Fact000023" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.78</ix:nonFraction>%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.05in; padding-left: 5.4pt"><span style="font-size: 9pt">Total annual expenses </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt"><span id="xdx_90B_ecef--TotalAnnualExpensesPercent_c20240919__20240919_zwIUGFabTa8b"><ix:nonFraction name="cef:TotalAnnualExpensesPercent" contextRef="AsOf2024-09-19" id="Fact000024" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">5.86</ix:nonFraction>%</span></span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 10%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in"></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 9pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><sup id="xdx_F08_zVsPMEJl3ETb">(1)</sup></td><td id="xdx_F13_zddH8TaxPCu9"><ix:footnote id="Footnote000025" xml:lang="en-US">The Dealer Manager will receive a fee for its financial structuring and soliciting services equal to 3.75% of the Subscription Price
per Share for each Share issued pursuant to the exercise of Rights, including the over-subscription privilege. The Dealer Manager will
reallow to broker-dealers in the selling group to be formed and managed by the Dealer Manager selling fees equal to 2.00% of the Subscription
Price per Share for each Share issued pursuant to the Offer as a result of their selling efforts. In addition, the Dealer Manager will
reallow to other broker-dealers that have executed and delivered a soliciting dealer agreement and have solicited the exercise of Rights
solicitation fees equal to 0.50% of the Subscription Price per Share for each Share issued pursuant to the exercise of Rights as a result
of their soliciting efforts, subject to a maximum fee based on the number of Common Shares held by each broker-dealer through The Depository
Trust Company (&#8220;DTC&#8221;) on the Record Date.</ix:footnote></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 9pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><sup id="xdx_F0B_zSzCbi2Nlnif">(2)</sup></td><td id="xdx_F17_z4jhq5Cy7np"><ix:footnote id="Footnote000026" xml:lang="en-US"><span id="xdx_909_ecef--OtherTransactionFeesNoteTextBlock_c20240919__20240919_zj1ns6FgLET7"><ix:nonNumeric contextRef="AsOf2024-09-19" escape="true" id="Fact000027" name="cef:OtherTransactionFeesNoteTextBlock">The fees and expenses of the Offer will be borne by the Fund and indirectly by all of its Common Shareholders, including those who
do not exercise their Rights, and will result in a reduction of the Fund&#8217;s NAV. Offering expenses borne by the Fund (including the
reimbursements described below) are estimated to be approximately $619,100 in the aggregate, or $0.01 per Common Share (assuming the Rights
are fully exercised). The Fund has agreed to pay the Dealer Manager up to $150,000 as a partial reimbursement for its expenses incurred
in connection with the Offer. Offering expenses will be borne by the Fund and indirectly by all of its Common Shareholders, including
those who do not exercise their Rights.</ix:nonNumeric></span></ix:footnote></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 9pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><sup id="xdx_F0B_z95AMjIH6kVb">(3)</sup></td><td id="xdx_F12_zVjAlpC00kg2"><ix:footnote id="Footnote000028" xml:lang="en-US">Common Shareholders will incur brokerage charges if they direct Computershare Trust Company, N.A., as Plan Agent for the Common Shareholders,
to sell their Common Shares held in a dividend reinvestment account.</ix:footnote></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 9pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><sup id="xdx_F0C_z2kBe8VTRpKg">(4)</sup></td><td id="xdx_F19_zcovjfZpWB2i"><ix:footnote id="Footnote000029" xml:lang="en-US">The Fund pays the Adviser an annual management fee, payable monthly in arrears, in an amount equal to 0.54% of the Fund&#8217;s average
daily Managed Assets. Common Shareholders bear the portion of the investment advisory fee attributable to the assets purchased with the
proceeds of leverage, which means that Common Shareholders effectively bear the entire management fee. The contractual management fee
rate of 0.54% of the Fund&#8217;s Managed Assets represents an effective management fee rate of 0.95% of net assets attributable to Common
Shares, assuming leverage of 43.0% of the Fund&#8217;s Managed Assets (the Fund&#8217;s outstanding leverage as of April 30, 2024).</ix:footnote></td></tr></table>



<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 9pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><sup id="xdx_F0B_zl12G56xUtOa">(5)</sup></td><td id="xdx_F1C_zWlh8uovoF5j"><ix:footnote id="Footnote000030" xml:lang="en-US">Includes interest payments on borrowed funds and interest expense on reverse repurchase agreements. Interest payments on borrowed
funds is based upon the Fund&#8217;s outstanding borrowings under the Credit Agreement as of April 30, 2024, in an amount equal to 21.5%
of the Fund&#8217;s Managed Assets, at an annual interest rate cost to the Fund of 5.97% (the weighted average interest rate paid by the
Fund during the six months ended April 30, 2024). Interest expenses on reverse repurchase agreements is based on the Fund&#8217;s outstanding
reverse repurchase agreements as of April 30, 2024, representing 21.5% of the Fund&#8217;s Managed Assets at an annual interest rate cost
to the Fund of 4.80% (the weighted average interest rate cost incurred by the Fund during the six months ended April 30, 2024). The actual
amount of interest expense incurred by the Fund will vary over time in accordance with the amount of borrowings and reverse repurchase
agreements and variations in market interest rates.</ix:footnote></td></tr></table>
<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 9pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><sup id="xdx_F00_zgpw5j8KKneb">(6)</sup></td><td id="xdx_F16_zyBjyKV4fPEe"><ix:footnote id="Footnote000031" xml:lang="en-US"><span id="xdx_903_ecef--OtherExpensesNoteTextBlock_c20240919__20240919_zug6dTeFVxe6"><ix:nonNumeric contextRef="AsOf2024-09-19" escape="true" id="Fact000032" name="cef:OtherExpensesNoteTextBlock">&#8220;Other Expenses&#8221; are based on estimated amounts for the six months ended April 30, 2024.</ix:nonNumeric></span></ix:footnote></td></tr></table>
<ix:nonNumeric contextRef="AsOf2024-09-19" escape="true" id="Fact000034" name="cef:ExpenseExampleTableTextBlock"><div id="xdx_88B_ecef--ExpenseExampleTableTextBlock_dU_zTTUhF20tiq2">

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><b>Example</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">As required by relevant SEC regulations, the
following Example illustrates the expenses that you would pay on a $1,000 investment in Common Shares, assuming (1) &#8220;Total annual
expenses&#8221; of 5.86% of net assets attributable to Common Shares, (2) the sales load of 3.75% and estimated offering expenses of 0.47%,
and (3) a 5% annual return*:</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 66%; padding-right: -5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 9%; padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b><span style="text-decoration: underline">1 Year</span></b></span></td>
    <td style="width: 7%; padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b><span style="text-decoration: underline">3 Years</span></b></span></td>
    <td style="width: 9%; padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b><span style="text-decoration: underline">5 Years</span></b></span></td>
    <td style="width: 9%; padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b><span style="text-decoration: underline">10 Years</span></b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: -5.4pt; padding-left: 0.2in; text-indent: -0.2in"><span style="font-size: 9pt">Total Expenses Incurred</span></td>
    <td style="padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90E_ecef--ExpenseExampleYear01_c20240919__20240919_zxM7p4rOFDHb">$<ix:nonFraction name="cef:ExpenseExampleYear01" contextRef="AsOf2024-09-19" id="Fact000035" format="ixt:numdotdecimal" decimals="0" unitRef="USD">101</ix:nonFraction></span></span></td>
    <td style="padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_907_ecef--ExpenseExampleYears1to3_c20240919__20240919_zQzS24PNnqBi">$<ix:nonFraction name="cef:ExpenseExampleYears1to3" contextRef="AsOf2024-09-19" id="Fact000036" format="ixt:numdotdecimal" decimals="0" unitRef="USD">216</ix:nonFraction></span></span></td>
    <td style="padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90C_ecef--ExpenseExampleYears1to5_c20240919__20240919_zA52UfuJ7c9l">$<ix:nonFraction name="cef:ExpenseExampleYears1to5" contextRef="AsOf2024-09-19" id="Fact000037" format="ixt:numdotdecimal" decimals="0" unitRef="USD">329</ix:nonFraction></span></span></td>
    <td style="padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_909_ecef--ExpenseExampleYears1to10_c20240919__20240919_zTnhDx5sONRi">$<ix:nonFraction name="cef:ExpenseExampleYears1to10" contextRef="AsOf2024-09-19" id="Fact000038" format="ixt:numdotdecimal" decimals="0" unitRef="USD">604</ix:nonFraction></span></span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">___________</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><b>*</b></td><td><b>The Example should not be considered a representation of future expenses or returns. Actual expenses may be higher or lower than
those assumed</b>. <b>Moreover, the Fund&#8217;s actual rate of return may be higher or lower than the hypothetical 5% return shown in
the Example.</b> The Example assumes that all dividends and distributions are reinvested at NAV.</td></tr></table></div></ix:nonNumeric>

<p style="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> <b>CAPITALIZATION</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>



<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in">The following table sets forth the Fund&#8217;s capitalization
at April 30, 2024:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt">
<tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(i)</td><td>on a historical
basis;</td></tr>
</table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(ii)</td><td>on an as adjusted basis to reflect the issuance by the Fund of 14,030 Common Shares pursuant to the Dividend Reinvestment Plan from
May 1, 2024 through the date of this Prospectus Supplement.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(iii)</td><td>on an as further adjusted basis to reflect the assumed sale of 11,533,627 Common Shares pursuant to Rights to purchase Common Shares
at a price of $11.42 per share in the Offer less the Dealer Manager fee of $0.43 per Common Share and estimated offering expenses payable
by the Fund of $0.01 per Common Share.</td></tr></table>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="vertical-align: bottom; text-align: center; width: 48%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>Actual <span style="text-decoration: underline"><br/>
(unaudited)</span></b></span></td>
    <td style="vertical-align: bottom; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>As Adjusted <span style="text-decoration: underline">(unaudited)</span></b></span></td>
    <td style="vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b>As Further Adjusted <span style="text-decoration: underline">(unaudited)</span></b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><b>Short-Term Debt:</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Borrowings</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right">$	314,021,361</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p></td>
    <td style="text-align: right; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right">$	314,373,765</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p></td>
    <td style="text-align: right; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right">$	314,373,765</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><b>Common Shareholder&#8217;s Equity:</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Common Shares of beneficial interest, par value $0.001 per share; unlimited shares authorized, 34,593,769 shares issued and outstanding (actual), 34,607,799 shares issued and outstanding (as adjusted) and 46,141,426 shares issued and outstanding (as further adjusted)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt">34,594</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt">34,608</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt">46,142</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Additional paid-in capital</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt">473,551,078</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt">473,723,906</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt">599,868,016</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Total distributable earnings (loss)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt">(58,016,517)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt">(58,016,517)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt">(58,016,517)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Net assets</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">$	415,569,155</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">$	415,741,997</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">$	541,897,641</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>USE OF PROCEEDS</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Fund estimates the net proceeds of the Offer
to be approximately $126,155,600. This figure is based on the estimated Subscription Price per Common Share of $11.42 and assumes all
new Common Shares offered are sold and that the estimated Dealer Manager fee of $0.43 per share and the expenses related to the Offer,
estimated at approximately $619,100, are paid.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Fund intends to invest the net proceeds of
the offering in accordance with its investment objective and policies as stated in the accompanying Prospectus. It is currently anticipated
that the Fund will be able to invest substantially all of the net proceeds of the offering in accordance with its investment objective
and policies within</p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt">three months after the completion of the offering. Pending such investment, it is anticipated that the proceeds will
be invested in cash, cash equivalents or other securities, including U.S. government securities or high quality, short-term debt securities.
The Fund may also use the proceeds for working capital purposes, including the payment of distributions, interest and operating expenses,
although the Fund currently has no intent to issue Securities primarily for these purposes.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>TERMS OF THE OFFER</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Purpose of the Offer</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Board, based on the recommendations of and
presentations by the Adviser, and others, has determined that it is in the best interests of the Fund and its Common Shareholders to conduct
the Offer and thereby to increase the assets of the Fund available for investment. In making this determination, the Board considered
a number of factors, including potential benefits and costs. In particular, the Board considered the Adviser&#8217;s belief that the Offer
would better enable the Fund to take advantage more fully of existing and future investment opportunities for convertible securities and
non-convertible income producing securities that may be or may become available, consistent with the Fund&#8217;s investment objective
to seek high total return with an emphasis on current income.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Offer seeks to provide an opportunity to
existing Common Shareholders to purchase Common Shares at a discount to market price (subject to the sales load described in this Prospectus
Supplement). The Board considered that the distribution to Common Shareholders of transferable Rights, which may themselves have intrinsic
value, also will afford non-participating Common Shareholders of record on the Record Date, the potential of receiving cash payment upon
the sale of the Rights, receipt of which may be viewed as partial compensation for any dilution of their interests that may occur as a
result of the Offer. There can be no assurance that a market for the Rights will develop or, if such a market does develop, what the price
of the Rights will be.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In making its determination that the Offer is
in the best interests of the Fund and its Common Shareholders, the Board also considered various additional factors, including: (i) the
size, pricing and structure of the Offer, including the transferability of the Rights and the ability of the Dealer Manager to purchase
and exercise Rights; (ii) that the Offer, if it is well-subscribed, could increase the liquidity of the Common Shares on the NYSE, where
the Common Shares are traded; (iii) the opportunity the Offer represents for current Common Shareholders to buy Common Shares at a discount
to NAV or market price, or, in many cases, both; (iv) the costs of the Offer, including dilution of Common Shareholders&#8217; interests
through the Offer and fees paid to the Dealer Manager; (v) the possible negative effect of the Offer on the market price of Common Shares;
and (vi) that the Offer will increase the Fund&#8217;s asset base and thus allow it to spread fixed expenses over a larger base of assets
and that continued growth in the Fund&#8217;s asset base may lead to reductions in the Fund&#8217;s expense ratio. The Board noted that
the Adviser has an inherent conflict of interest in recommending the Offer because its fees are based on a percentage of the Fund&#8217;s
Managed Assets (the greater the Managed Assets of the Fund, the greater the compensation paid to the Adviser).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">There can be no assurance that the Offer (or
the investment of the proceeds of the Offer) will be successful. The completion of the Offer may result in an immediate dilution of the
NAV per Common Share for all existing Common Shareholders, including those who fully exercise their Rights (as defined below). For a discussion
of the potential impact of the Offer on current Common Shareholders, such as dilution, see &#8220;Risks Relating to the Offer&#8221; in
this Prospectus Supplement.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Important Terms of the Offer</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In the Offer, the Fund is issuing transferable
Rights to its Record Date Shareholders as of 5:00 p.m., Eastern time, on the Record Date (September 20, 2024), entitling the holders of
those Rights to subscribe for up to an aggregate of 11,533,627 of the Fund&#8217;s Common Shares. Record Date Shareholders will receive
one Right for each outstanding whole Common Share of the Fund held on the Record Date. The Rights entitle their holders to purchase one
Share for every three Rights held (1-for-3). Fractional Common Shares will not be issued upon the exercise of Rights; accordingly, Rights
may be exercised only in integer multiples of three, except that any Record Date Shareholder who owns fewer than three Common Shares as
of the Record Date may subscribe, at the Subscription Price (as defined on the next page), for one full Common Share. Assuming the exercise
of all Rights, the Offer will result in an approximately 33 1/3% increase in the Fund&#8217;s Common Shares outstanding.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Record Date Shareholders who exercise all the
Rights issued to them (other than those Rights that cannot be exercised because they represent the right to acquire less than one Common
Share) are entitled to subscribe for </p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt">additional Shares at the same Subscription Price pursuant to the over-subscription privilege, subject
to certain limitations and subject to allotment. Investors who are not Record Date Shareholders, but who otherwise acquire Rights to purchase
Shares pursuant to the Offer, are not entitled to subscribe for any Shares pursuant to the over-subscription privilege. See &#8220;&#8212;Over-Subscription
Privilege&#8221; below. The distribution to Record Date Shareholders of transferable Rights may afford non-participating Record Date Shareholders
the opportunity to sell their Rights for some cash value, receipt of which may be viewed as partial compensation for any economic dilution
of their interests resulting from the Offer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The subscription period commences on September
20, 2024, and ends at 5:00 p.m., Eastern time, on the Expiration Date, October 17, 2024 unless otherwise extended.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Fund has declared a regular September monthly
distribution to Common Shareholders in an amount of $0.1172 per share payable on September 30, 2024, with a record date of September 13,
2024, which will not be payable with respect to Common Shares that are issued pursuant to the Offer. The Fund has also declared a regular
October monthly distribution to Common Shareholders in an amount of $0.1172 per share payable on October 31, 2024, with a record date
of October 2, 2024, which will not be payable with respect to Common Shares that are issued pursuant to the Offer after such record date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">For purposes of determining the maximum number
of Shares a Rights holder may acquire pursuant to the Offer, broker-dealers, trust companies, banks or others whose Common Shares are
held of record by Cede &amp; Co., the nominee for the DTC, or by any other depository or nominee, will be deemed to be the holders of
the Rights that are held by Cede &amp; Co. or such other depository or nominee on their behalf.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Rights are transferable and, subject to notice
of issuance, will be admitted for trading on the NYSE under the symbol &#8220;AVK RT&#8221; during the course of the Offer. Trading in
the Rights on the NYSE may be conducted until the close of trading on October 16, 2024, the last business day prior to the Expiration
Date. See &#8220;&#8212;Sale and Transferability of Rights.&#8221; It is expected that the Shares, once issued, will be listed on the
NYSE under the symbol &#8220;AVK.&#8221; The Rights will be evidenced by subscription certificates which will be mailed to Record Date
Shareholders, except as discussed under &#8220;&#8212;Requirements for Foreign Shareholders.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Rights may be exercised by filling in and signing
the subscription certificate and mailing it in the envelope provided, or otherwise delivering the completed and signed subscription certificate
to Equiniti Trust Company, the subscription agent for the Offer (the &#8220;Subscription Agent&#8221;), together with payment at the estimated
Subscription Price for the Shares subscribed for. For a discussion of the method by which Rights may be exercised and Shares may be paid
for, see &#8220;&#8212;Method for Exercising Rights&#8221; and &#8220;&#8212;Payment for Shares.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Fund has retained UBS Securities LLC as
Dealer Manager to provide the Fund with financial structuring and soliciting services relating to the Offer, including advice with
respect to the structure, timing and terms of the Offer. In determining the structure of the Offer, the Board considered, among
other things, using a fixed-pricing versus a variable-pricing mechanism, the benefits and drawbacks of conducting a non-transferable
versus a transferable rights offering, the anticipated effect on the Fund and its existing Common Shareholders if the Offer is not
fully subscribed, the anticipated dilutive effects on the Fund and its existing Common Shareholders of the Offer and the experience
of the Dealer Manager in conducting rights offerings. The Board also considered that the Adviser would benefit from the Offer
because the management fee paid to the Adviser is based on the Fund&#8217;s Managed Assets, which would increase as a result of the
Offer. See &#8220;&#8212;Benefits to the Adviser.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Important Dates to Remember</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Record Date: September 20, 2024</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Subscription Period: September 20, 2024 &#8211;
October 17, 2024*</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Final Date Rights Will Trade: October 16, 2024*</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Expiration Date and Pricing Date: October 17,
2024*</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Subscription Certificate and Payment for Shares
Due+: October 17, 2024*</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Notice of Guaranteed Delivery and Payment for
Shares Due+: October 17, 2024*</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Subscription Certificates Pursuant to Guarantees
of Delivery Due+: October 18, 2024*</p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Confirmation Mailed to Participants: October
25, 2024*</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Final Payment for Shares Due: November 8, 2024&#8224;*</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Issuance Date: November 8, 2024*</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right">*</td><td style="width: 5pt"/><td style="text-align: justify">Unless the Offer is extended.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right">+</td><td style="width: 5pt"/><td style="text-align: justify">A holder exercising Rights must deliver by 5:00 p.m. Eastern Time on October 17, 2024 (unless
the Offer is extended) either (a) a Subscription Certificate and payment for shares or (b) a notice of guaranteed delivery and payment
for Shares.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: right">&#8224;</td><td style="width: 5pt"/><td style="text-align: justify">Any additional amount due (in the event the Subscription Price exceeds the estimated Subscription
Price). See &#8220;The Offer&#8211;&#8211;Payment for Shares.&#8221;</td>
</tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Subscription Price</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Subscription Price per Common Share will
be determined based on a Formula Price equal to 92.5% of the average of the last reported sale price of a Common Share on the NYSE on
the date on which the Offer expires, as such date may be extended from time to time, and each of the four (4) preceding trading days.
If, however, the Formula Price is less than 90% of the NAV per Common Share at the close of trading on the NYSE on the Expiration Date,
then the Subscription Price will be 90% of the Fund&#8217;s NAV per Common Share at the close of trading on the NYSE on the Expiration
Date. In each case, NAV will be calculated as of the close of trading on the NYSE on the applicable day.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Because the Expiration Date of the subscription
period will be 	October 17, 2024 (unless the subscription period is extended), Rights holders may not know the Subscription Price at
the time of exercise and will be required initially to pay for both the Shares subscribed for pursuant to the primary subscription and,
if eligible, any additional Shares subscribed for pursuant to the over-subscription privilege at the estimated Subscription Price of $11.42
per Share. See &#8220;&#8212;Payment for Shares.&#8221; A Rights holder will have no right to rescind his subscription after the Subscription
Agent has received a completed subscription certificate together with payment for the Shares subscribed for. The Fund does not have the
right to withdraw the Rights or to cancel the Offer after the Rights have been distributed.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The NAV per share of the Fund&#8217;s Common
Shares at the close of business on September 13, 2024 was $12.23, and the last reported sale price of a Common Share on the NYSE on that
day was $12.24, representing a premium to NAV of 0.08%.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Over-Subscription Privilege</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Record Date Shareholders who exercise all the
Rights issued to them (other than those Rights that cannot be exercised because they represent the right to acquire less than one Common
Share) are entitled to subscribe for additional Shares that were not subscribed for by other holders of Rights at the same Subscription
Price pursuant to the over-subscription privilege, subject to certain limitations and subject to allotment. If sufficient remaining Shares
are available following the primary subscription, all Record Date Shareholders&#8217; over-subscription requests will be honored in full.
Investors who are not Record Date Shareholders, but who otherwise acquire Rights pursuant to the Offer, are not entitled to subscribe
for any Shares pursuant to the over-subscription privilege. If sufficient Shares are not available to honor all over-subscription requests,
unsubscribed Shares will be allocated pro rata among those Record Date Shareholders who over-subscribe based on the number of Common Shares
they owned on the Record Date. The allocation process may involve a series of allocations in order to ensure that the total number of
Shares available for over-subscriptions is distributed on a pro rata basis.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Record Date Shareholders who are fully exercising
their Rights during the subscription period should indicate, on the subscription certificate that they submit with respect to the exercise
of the Rights issued to them, how many Shares they desire to acquire pursuant to the over-subscription privilege.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Banks, broker-dealers, trustees and other nominee
holders of Rights will be required to certify to the Subscription Agent, before any over-subscription privilege may be exercised with
respect to any particular beneficial owner, as to the aggregate number of Rights exercised during the subscription period and the number
of Shares subscribed for pursuant to the over-subscription privilege by such beneficial owner, and that such beneficial owner&#8217;s</p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt">
primary subscription was exercised in full. Nominee holder over-subscription forms will be distributed to banks, brokers, trustees and
other nominee holders of Rights with the subscription certificates.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Fund will not offer or sell any Shares that
are not subscribed for during the subscription period or pursuant to the over-subscription privilege.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Fund has been advised that one or more of
the officers or employees of the Adviser may exercise all of the Rights initially issued to them and may request additional Shares pursuant
to the over-subscription privilege. An exercise of the over-subscription privilege by such persons will increase their proportionate voting
power and share of the Fund&#8217;s assets.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Sale and Transferability of Rights</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Rights will be, subject to notice of issuance,
admitted for trading on the NYSE under the symbol &#8220;AVK RT&#8221; during the course of the Offer. Trading in the Rights on the NYSE
may be conducted until the close of trading on October 16, 2024 on the last business day prior to the Expiration Date. The Fund will use
its best efforts to ensure that an adequate trading market for the Rights will exist, although there can be no assurance that a market
for the Rights will develop. Assuming a market exists for the Rights, the Rights may be purchased and sold through usual brokerage channels
or sold through the Subscription Agent.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Trading of the Rights on the NYSE will be conducted
on a when-issued basis until and including the date on which the subscription certificates evidencing Rights are mailed to Record Date
Shareholders and thereafter will be conducted on a regular-way basis until and including the last NYSE trading day prior to the completion
of the Subscription Period. The Common Shares are expected to begin trading ex-Rights on the Record Date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Rights that are sold will not confer any right
to acquire any Common Shares pursuant to the over-subscription privilege, if any, and any Record Date Shareholder who sells any Rights
(other than those Rights that cannot be exercised because they represent the right to acquire less than one Common Share) will not be
eligible to participate in the over-subscription privilege, if any.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><i>Sales through the Subscription Agent and the
Dealer Manager. </i>Record Date Shareholders who do not wish to exercise any or all of the Rights issued to them pursuant to the Offer
may instruct the Subscription Agent to try to sell any unexercised Rights. Although the Rights are expected to trade on the NYSE through
the last business day prior to the Expiration Date, subscription certificates representing the Rights to be sold by the Subscription Agent
must be received by the Subscription Agent on or before 5:00 p.m., Eastern time, on October 10, 2024 (or, if the subscription period is
extended, by 5:00 p.m., Eastern time, on the fifth business day prior to the extended Expiration Date).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Upon the timely receipt by the Subscription Agent
of appropriate instructions to sell Rights, the Subscription Agent will ask the Dealer Manager if it will purchase the Rights. The sale
price of any Rights sold to the Dealer Manager will be based upon the then-current market price for the Rights. The proceeds from each
of such sales to the Dealer Manager will be remitted to the Subscription Agent, which will hold such proceeds in an account segregated
from the Subscription Agent's own funds pending distribution to each selling Record Date Shareholder. It is expected that following each
such sale of Rights to the Dealer Manager, the proceeds from each such sale will be received by the Subscription Agent within two business
days of the sale and that the proceeds will then be remitted by the Subscription Agent to the selling Record Date Shareholder within one
business day following the Expiration Date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">If the Dealer Manager declines to purchase the
Rights of a Record Date Shareholder that have been duly submitted to the Subscription Agent for sale, the Subscription Agent will attempt
to sell such Rights in the open market. If the Rights can be sold in such manner, all of such sales will be deemed to have been effected
at the weighted-average price of all Rights sold by the Subscription Agent in such open market transactions throughout the subscription
period. The proceeds from such sales will be held by the Subscription Agent in an account segregated from the Subscription Agent's own
funds pending distribution to the selling Record Date Shareholders. It is expected that the proceeds of such open market sales will be
remitted by the Subscription Agent to the selling Record Date Shareholders within one business day following the Expiration Date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Subscription Agent will also attempt to sell
(either to the Dealer Manager or in open market transactions) all Rights that remain unclaimed as a result of subscription certificates
being returned by the postal authorities to the </p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt">Subscription Agent as undeliverable as of the fifth business day prior to the Expiration
Date. The Subscription Agent will hold the proceeds from those sales in an account segregated from the Subscription Agent&#8217;s own
funds for the benefit of such non-claiming Record Date Shareholders until such proceeds are either claimed or revert to their state of
residence.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">There can be no assurance that the Subscription
Agent will be able to complete the sale of any Rights, and neither the Fund, the Dealer Manager nor the Subscription Agent have guaranteed
any minimum sale price for the Rights. If a Record Date Shareholder does not utilize the services of the Subscription Agent and chooses
to use another broker-dealer or other financial institution to sell Rights issued to that Record Date Shareholder pursuant to the Offer,
then the other broker-dealer or financial institution may charge a fee to sell the Rights.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><i>Other Transfers</i>. The Rights evidenced
by a subscription certificate may be transferred in whole by endorsing the subscription certificate for transfer in accordance with the
instructions accompanying the subscription certificate. A portion of the Rights evidenced by a single subscription certificate (but not
fractional Rights) may be transferred by delivering to the Subscription Agent a subscription certificate properly endorsed for transfer,
with instructions to register such portion of the Rights evidenced thereby in the name of the transferee and to issue a new subscription
certificate to the transferee evidencing the transferred Rights. If this occurs, a new subscription certificate evidencing the balance
of the Rights, if any, will be issued to the Record Date Shareholder or, if the Record Date Shareholder so instructs, to an additional
transferee. The signature on the subscription certificate must correspond with the name as written upon the face of the subscription certificate
in every particular, without alteration or enlargement or any other change. A signature guarantee will be required in connection with
a transfer of Rights. If required, a signature guarantee must be provided by an &#8220;eligible guarantor institution&#8221; (as defined
in Rule 17Ad-15 of the Securities Exchange Act of 1934, as amended).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Record Date Shareholders wishing to
transfer all or a portion of their Rights (but not fractional Rights) should allow at least ten business days prior to the
Expiration Date for: (i) the transfer instructions to be received and processed by the Fund&#8217;s Transfer  Agent;
(ii) a new subscription certificate to be issued and transmitted to the transferee or transferees with respect to transferred Rights
and to the transferor with respect to retained Rights, if any; and (iii) the Rights evidenced by the new subscription certificate to
be exercised or sold by the recipients of the subscription certificate. Neither the Fund nor the Subscription Agent nor the Dealer
Manager shall have any liability to a transferee or transferor of Rights if subscription certificates are not received in time for
exercise or sale prior to the Expiration Date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Except for the fees charged by the Dealer Manager,
the Subscription Agent and EQ Fund Solutions, LLC, the information agent for the Offer (the &#8220;Information Agent&#8221;) (which are
expected to be paid from the proceeds of the Offer by the Fund), all commissions, fees and other expenses (including brokerage commissions
and transfer taxes) incurred or charged in connection with the purchase, sale or transfer of Rights will be for the account of the transferor
of the Rights, and none of these commissions, fees or other expenses will be paid by the Fund, the Adviser, the Information Agent, the
Subscription Agent or the Dealer Manager. Rights holders who wish to purchase, sell, exercise or transfer Rights through a broker, bank
or other party should first inquire about any fees and expenses that the holder will incur in connection with the transactions.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Fund anticipates that the Rights will be
eligible for transfer through, and that the exercise of the primary subscription and the over-subscription may be effected through, the
facilities of DTC or the Subscription Agent until 5:00 p.m., Eastern time, on the Expiration Date. Your broker, bank, trust company or
other intermediary may impose a deadline for transferring Rights earlier than 5:00 p.m. Eastern time, on the Expiration Date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Method for Exercising Rights</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Rights are evidenced by subscription certificates
that will be mailed to Record Date Shareholders (except as described under &#8220;&#8212;Requirements for Foreign Shareholders&#8221;
below) or, if their Common Shares are held by Cede &amp; Co. or any other depository or nominee on their behalf, to Cede &amp; Co. or
such other depository or nominee. Rights may be exercised by completing and signing the subscription certificate and mailing it in the
envelope provided, or otherwise delivering the completed and signed subscription certificate to the Subscription Agent, together with
payment in full at the estimated Subscription Price for the Shares subscribed for by the Expiration Date as described under &#8220;&#8212;Payment
for Shares.&#8221; Rights may also be exercised through the broker of a holder of Rights, who may charge the holder of Rights a servicing
fee in connection with such exercise. Rights may also be exercised by </p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt">contacting your broker, bank, trust company or other intermediary,
which can arrange, on your behalf, to guarantee delivery of a properly completed and executed subscription certificate pursuant to a notice
of guaranteed delivery by the close of business on the first business day after the Expiration Date. A fee may be charged for this service.
Completed subscription certificates and payments must be received by the Subscription Agent by 5:00 p.m., Eastern time, on the Expiration
Date (unless delivery of subscription certificate is effected by means of a notice of guaranteed delivery as described below under &#8220;&#8212;Payment
for Shares&#8221;) at the offices of the Subscription Agent at one of the addresses set forth below under &#8220;&#8212;Subscription Agent.&#8221;
Your broker, bank, trust company or other intermediary may impose a deadline for exercising Rights earlier than 5:00 p.m. Eastern time,
on the Expiration Date. Fractional Common Shares will not be issued upon exercise of Rights.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><i>Shareholders who are Record Owners</i>. Shareholders
who are record owners of Common Shares can choose between either option set forth under &#8220;&#8212;Payment for Shares.&#8221; If time
is of the essence, option (2) will permit delivery of the subscription certificate after the Expiration Date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><i>Investors whose Common Shares are Held by
a Nominee</i>. Investors whose Common Shares are held by a nominee, such as a bank, broker, trustee or other intermediary, must contact
that nominee to exercise their Rights. In that case, the nominee will complete the subscription certificate on behalf of the investor
and arrange for proper payment by one of the methods set forth below under &#8220;&#8212;Payment for Shares.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><i>Nominees</i>. Nominees, such as banks, brokers,
trustees or depositories for securities, who hold Common Shares for the account of others should notify the respective beneficial owners
of such Common Shares as soon as possible to ascertain those beneficial owners&#8217; intentions and to obtain instructions with respect
to the Rights. If the beneficial owner so instructs, the nominee should complete the subscription certificate and submit it to the Subscription
Agent with the proper payment as described under &#8220;&#8212;Payment for Shares.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Banks, brokers, trustees and other nominee holders
of Rights will be required to certify to the Subscription Agent, before any over-subscription privilege may be exercised with respect
to any particular beneficial owner who is a Record Date Shareholder, as to the aggregate number of Rights exercised during the subscription
period and the number of Shares subscribed for pursuant to the over-subscription privilege by the beneficial owner, and that the beneficial
owner exercised all the Rights issued to it pursuant to the Offer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><i>Requirements for Foreign Shareholders. </i>Subscription
certificates will not be mailed to Record Date Shareholders whose addresses are outside the United States (for these purposes, the United
States includes the District of Columbia and the territories and possessions of the United States) (&#8220;Foreign Shareholders&#8221;).
The Subscription Agent will send a letter via regular mail to Foreign Shareholders to notify them of the Offer. The Rights of Foreign
Shareholders will be held by the Subscription Agent for their accounts until instructions are received to exercise the Rights. If instructions
have not been received by 5:00 p.m., Eastern time, on October 10, 2024, five business days prior to the Expiration Date (or, if the subscription
period is extended, on or before the fifth business day prior to the extended Expiration Date), the Subscription Agent will ask the Dealer
Manager if it will purchase the Rights. If the Dealer Manager declines to purchase the Rights, the Subscription Agent will attempt to
sell such Rights in the open market. The net proceeds, if any, from the sale of those Rights will be remitted to those Foreign Shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Expenses of the Offer</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Fund will bear the expenses of the Offer
and all such expenses will be borne indirectly by the Fund&#8217;s Common Shareholders, including those who do not exercise their Rights.
These expenses include, but are not limited to, the Dealer Manager fee, reimbursement of the Dealer Manager&#8217;s expenses, the expenses
of preparing, printing and mailing the prospectus and Rights subscription materials for the Offer (including reimbursement of expenses
of the Dealer Manager, Selling Group Members, Soliciting Dealers and other brokers, dealers and financial institutions), SEC registration
fees and the fees assessed by service providers (including the cost of the Fund&#8217;s counsel and independent registered public accounting
firm) in connection with the Offer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Subscription Agent</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Equiniti Trust Company, LLC is the Subscription
Agent for the Offer. The Subscription Agent will receive for its administrative, processing, invoicing and other services a project management
fee, plus certain per transaction fees and reimbursement for all out-of-pocket expenses related to the Offer. The fees and expenses of
the Subscription Agent are included in the fees and expenses of the Offer and therefore will be borne by the Fund and indirectly by </p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt">all
Common Shareholders, including those who do not exercise their Rights. Questions regarding the subscription certificates should be directed
by mail to the Information Agent at EQ Fund Solutions, LLC, 55 Challenger Road, Suite 201, Ridgefield Park, New Jersey 07660. Shareholders
may also subscribe for the Offer by contacting their broker dealer, trust company, bank or other nominee.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Completed subscription certificates must be sent
together with proper payment of the estimated Subscription Price for all Shares subscribed for in the primary subscription and the over-subscription
privilege (for Record Date Shareholders) to the Subscription Agent by one of the methods described below. Alternatively, Rights holders
may arrange for their financial intermediaries to submit notices of guaranteed delivery through DTC to be received by the Subscription
Agent along with proper payment of the estimated Subscription Price for all Shares subscribed for in the primary subscription and the
over-subscription privilege (for Record Date Shareholders) prior to 5:00 p.m, Eastern time, on the Expiration Date. The Fund will accept
only properly completed and executed subscription certificates actually received at any of the addresses listed below, prior to 5:00 p.m,
Eastern time, on the Expiration Date, or by the close of business on the first business day after the Expiration Date following timely
receipt of a notice of guaranteed delivery. See &#8220;&#8212;Payment for Shares.&#8221;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%">
  <tr>
    <td style="padding: 0.75pt; width: 43%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="padding: 0.75pt; width: 57%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Subscription
    Certificate Delivery Method</span></td>
    <td style="border-bottom: black 1pt solid; padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Address/Number</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Notice
    of Guaranteed Delivery:</span></td>
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Contact
    your broker-dealer, trust company, bank or other</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">nominee
    to notify the Fund of your intent to exercise the</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Rights.</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">First
    Class Mail, Express Mail or</span></td>
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Equiniti
    Trust Company, LLC</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">or
    Overnight Courier:</span></td>
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Operations
    Center</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Attn:
    Reorganization Department</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">55
    Challenger Rd., Suite 200</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">&#160;</span></td>
    <td style="padding: 0.75pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Ridgefield
    Park, NJ 07660</span></td></tr>
  </table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Fund will honor only subscription certificates
received by the Subscription Agent prior to 5:00 p.m, Eastern time, on the Expiration Date at one of the addresses listed above. Delivery
to an address other than those listed above will not constitute good delivery.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Information Agent</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Information Agent for the Offer is EQ Fund
Solutions, LLC. If you have questions or need further information about the Offer, please write the Information Agent at EQ Fund Solutions,
LLC, 55 Challenger Road, Suite 201, Ridgefield Park, New Jersey 07660 or call (866) 342-1635. Any questions or requests for assistance
concerning the method of subscribing for Shares or additional copies of this Prospectus Supplement and the accompanying Prospectus or
subscription certificates should be directed to the Information Agent. Common Shareholders may also contact their brokers or nominees
for information with respect to the Offer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Information Agent will receive a fee for
its services, plus reimbursement for all out-of-pocket expenses related to the Offer. The fees and expenses of the Information Agent are
included in the fees and expenses of the Offer and therefore will be borne by the Fund and indirectly by all of its Common Shareholders,
including those who do not exercise their Rights.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Expiration of the Offer</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Offer will expire at 5:00 p.m., Eastern time,
on October 17, 2024, unless the Fund extends the subscription period. Rights will expire on the Expiration Date and may not be exercised
after that date. If the Fund extends the subscription period, the Fund will make an announcement as promptly as practicable. This announcement
will be issued no later than 9:00 a.m., Eastern time, on the next business day following the previously scheduled Expiration Date. Without
limiting the manner in which the Fund may choose to make this announcement, the Fund will not, unless otherwise required by law, have
any obligation to publish, advertise or otherwise communicate this announcement other than by making a release to the Dow Jones News Service
or any other means of public announcement as the Fund may deem proper.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Payment for Shares</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Rights holders who wish to acquire Shares pursuant
to the Offer may choose between the following methods of payment:</p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(1) 	 	A Rights holder can send the properly
completed and executed subscription certificate together with payment for the Shares subscribed for during the subscription period and,
if eligible, for any additional Shares subscribed for pursuant to the over-subscription privilege to the Subscription Agent based upon
an estimated Subscription Price of $11.42 per Share. A subscription will be accepted when payment, together with the executed subscription
certificate, is received by the Subscription Agent at one of the addresses set forth under &#8220;&#8212;Subscription Agent&#8221;, the
payment and the properly completed and executed subscription certificate must be received by the Subscription Agent by 5:00 p.m, Eastern
time, on the Expiration Date. The Subscription Agent will deposit all checks received by it for the purchase of Shares into a segregated
account of the Fund pending proration and distribution of Shares. A payment pursuant to this method must be in U.S. dollars by check drawn
on a bank located in the United States, must be payable to &#8220;Equiniti Trust Company, LLC&#8221; and must accompany a properly completed
and executed subscription certificate for such subscription to be accepted.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">(2) 	 	Alternatively, a subscription
will be accepted by the Subscription Agent if, by 5:00 p.m. Eastern time, on the Expiration Date, the Subscription Agent has
received a notice of guaranteed delivery by mail or email from a bank, a trust company or an NYSE member guaranteeing delivery of a
properly completed and executed subscription certificate. In order for the notice of guarantee to be valid, full payment for the
Shares subscribed for during the subscription period and, if eligible, for any additional Shares subscribed for pursuant to the
over-subscription privilege, based upon an estimated Subscription Price of $11.42 per Share, must be received by the Subscription
Agent with the notice of guaranteed delivery. The Subscription Agent will not honor a notice of guaranteed delivery unless a
properly completed and executed subscription certificate is received by the Subscription Agent by the close of business on the first
business day after the Expiration Date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">On the confirmation date, which will be six
business days following the Expiration Date, a confirmation will be sent by the Fund&#8217;s Transfer Agent to each Rights holder
exercising its Rights (or, if a Rights holder&#8217;s Common Shares are held by DTC or any other depository or nominee, to DTC
and/or that other depository or nominee) showing (i) the number of Shares acquired during the subscription period, (ii) the number
of Shares, if any, acquired pursuant to the over-subscription privilege, (iii) the per Share and total purchase price for the Shares
and (iv) any additional amount payable to the Fund by the Rights holder or any excess to be refunded by the Fund to the Rights
holder, in each case based on the Subscription Price as determined on the Expiration Date. Any additional payment required from a
Rights holder must be received by the Subscription Agent within ten business days after the confirmation date (which confirmation
date is October 25, 2024, unless the subscription period is extended). Any excess payment to be refunded by the Fund to a Rights
holder will be mailed by the Subscription Agent to such Rights holder as promptly as practicable. All payments by a Rights holder
must be in U.S. dollars by personal check drawn on a bank located in the United States and payable to &#8220;Equiniti Trust Company,
LLC.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Whichever of the two methods described above
is used, issuance and delivery of the Shares subscribed for are contingent upon actual payment for such Shares. No certificates will be
issued or delivered with respect to Shares issued and sold in the Offer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Rights holders who have exercised their Rights
will have no right to rescind their subscription after receipt of the completed subscription certificate together with payment for Shares
by the Subscription Agent.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">If a Rights holder who acquires Shares during
the subscription period or pursuant to the over-subscription privilege (for Record Date Shareholders) does not make payment of any amounts
due by the Expiration Date, the Fund reserves the right to take any or all of the following actions through all appropriate means: (i)
find other Record Date Shareholders for the subscribed and unpaid-for Shares; (ii) apply any payment actually received by the Fund toward
the purchase of the greatest whole number of Shares that could be acquired by the Rights holder upon exercise of such Rights acquired
during the subscription period or pursuant to the over-subscription privilege; and/or (iii) exercise any and all other rights or remedies
to which the Fund may be entitled, including, without limitation, the right to set off against payments actually received by it with respect
to such subscribed Shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The method of delivery of completed subscription
certificates and payment of the Subscription Price to the Subscription Agent will be at the election and risk of exercising Rights holders,
but if sent by mail it is recommended that such forms and payments be sent by registered mail, properly insured, with return receipt requested,
and that a sufficient number of days be allowed to ensure delivery to the Subscription Agent and clearance of payment by 5:00 p.m., Eastern
time, on the Expiration Date. Because uncertified personal checks may take at least five business</p>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"> days to clear, exercising Rights holders
are strongly urged to pay, or arrange for payment, by means of certified or cashier&#8217;s check with the Right holder&#8217;s name and
Subscription Agent account number identified on the check.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">All questions concerning the timeliness, validity,
form and eligibility of any exercise of Rights will be determined by the Fund, which determinations will be final and binding. The Fund,
in its sole discretion, may waive any defect or irregularity, or permit a defect or irregularity to be corrected within such time as it
may determine, or reject the purported exercise of any Right. Subscriptions will not be deemed to have been received or accepted until
substantially all irregularities have been waived or cured within such time as the Fund determines in its sole discretion. The Fund will
not be under any duty to give notification of any defect or irregularity in connection with the submission of subscription certificates
or incur any liability for failure to give such notification.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Delivery of Shares</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Participants in the Fund&#8217;s dividend reinvestment
plan (the &#8220;Plan&#8221;) will have any Shares acquired pursuant to the Offer credited to their dividend reinvestment accounts in
the Plan. Common Shareholders whose Common Shares are held of record by DTC or by any other depository or nominee on their behalf or their
broker-dealers&#8217; behalf will have any Shares acquired during the subscription period credited to the account of DTC or other depository
or nominee. No certificates will be issued or delivered with respect to Common Shares issued and sold in the Offer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>U.S. Federal Income Tax Considerations</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The following is a general summary of U.S. federal
income tax considerations with respect to the Offer for Record Date Shareholders and other Rights holders who are U.S. Persons as defined
below. The following summary supplements the discussion set forth in the accompanying Prospectus and SAI under the headings "U.S.
Federal Income Tax Considerations" and is subject to the qualifications and assumptions set forth therein. Please refer to such discussion
for a general description of the U.S. federal income tax considerations with respect to an investment in Common Shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The summary below is based upon the Code, Treasury
regulations promulgated thereunder (&#8220;Treasury regulations&#8221;), judicial authorities, published positions of the Internal Revenue
Service (the &#8220;IRS&#8221;) and other applicable authorities, all as in effect on the date hereof and all of which are subject to
change or differing interpretations possibly with retroactive effect. The discussion does not address all of the tax consequences that
may be relevant to a particular Record Date Shareholder or other Rights holder, including those subject to special treatment under U.S.
federal income tax laws such as financial institutions, insurance companies, broker-dealers, tax-exempt organizations, foreign persons,
or persons holding Rights or Common Shares as part of a straddle or conversion transaction. This discussion is limited to Record Date
Shareholders and other Rights holders that hold Common Shares as capital assets. No ruling has been or will be sought from the IRS regarding
any matter discussed herein. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary
to any of the tax aspects set forth below. Record Date Shareholders and other Rights holders should consult their tax advisors as to the
U.S. federal income tax consequences of the Offer that are relevant to their particular situations, as well as the effects of state, local
and non-U.S. tax laws.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">For purposes of this discussion, a &#8220;U.S.
Person&#8221; means a holder that is, for U.S. federal income tax purposes, any one of the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"/><td style="text-align: justify">an individual who is a citizen or resident of the United States;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"/><td style="text-align: justify">a corporation or other entity treated as a corporation that is created or organized in or
under the laws of the U.S. or any state thereof or the District of Columbia;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"/><td style="text-align: justify">a trust if a court within the U.S. is able to exercise primary supervision over the administration
of the trust and one or more U.S. persons have the authority to control all substantial decisions of the trust or the trust has a valid
election in effect under applicable Treasury regulations to be treated as a U.S. person; or</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right">&#8226;</td><td style="width: 5pt"/><td style="text-align: justify">an estate, the income of which is includible in gross income for U.S. federal income tax
purposes regardless of its source.</td>
</tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">If a partnership (or any other entity or arrangement
treated as a partnership or other pass-through entity for U.S. federal income tax purposes) holds a Right, the U.S. federal income tax
treatment of a partner generally will depend upon the status of the partner and the activities of the partnership. Partners and partnerships
holding Rights should </p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt">consult their tax advisors concerning the U.S. federal income and other tax consequences relevant to their particular
situation.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><i>Issuance of Rights, Basis and Holding Period</i>.
Record Date Shareholders should not recognize taxable income in connection with the receipt of a Right pursuant to the Offer, provided
that the distribution does not have the result of causing some Record Date Shareholders to receive an increase in their proportionate
interest in the assets or earnings and profits of the Fund and other Record Date Shareholders to receive cash or property. The distribution
of the Rights in the Offer should not have the effect of causing some Record Date Shareholders to receive an increase in their proportionate
interest in the assets or earnings and profits of the Fund and other Record Date Shareholders to receive cash or property. Therefore,
no income should be recognized by any Record Date Shareholders in connection with the issuance of the Rights pursuant to the Offer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Except as provided in the following sentence,
the basis of a Right received by a Record Date Shareholder will be zero and the basis of the Common Share with respect to which the Right
was issued (the &#8220;Old Common Share&#8221;) will remain unchanged. The Record Date Shareholder must allocate a portion of the basis
of the Old Common Share to the Right in proportion to their respective fair market values on the date of distribution if (i) either (a)
the fair market value of the Right on the date of distribution is at least 15% of the fair market value of the Old Common Share on that
date, or (b) the Record Date Shareholder affirmatively elects (in the manner set out in Treasury regulations) to allocate to the Right
a portion of the basis of the Old Common Share and (ii) the Right does not expire unexercised in the hands of the Record Date Shareholder
(i.e., the Record Date Shareholder either exercises or sells the Right following its issuance).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The basis of a Right purchased in the market
will generally be its purchase price.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The holding period of the Rights received in
the Offer will include the Record Date Shareholder&#8217;s holding period for the Common Shares with respect to which the Rights were
issued.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><i>Expiration of the Rights</i>. Record Date
Shareholders who receive Rights in the Offer with respect to their Common Shares and who allow such Rights to expire unexercised will
not recognize any gain or loss, and no adjustment will be made to the basis of the holder&#8217;s Common Shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">If a Right that has been purchased in the market
expires unexercised, the holder will recognize a loss equal to the basis of the Right. If the Right was held as a capital asset, loss
on the expiration of the Right generally will be a capital loss. The deductibility of capital losses is subject to a number of limitations
under the Code.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><i>Sale of the Rights</i>. Upon the sale of a
Right, the seller will recognize gain or loss equal to the difference between the amount realized on the sale and the seller&#8217;s basis
in the Right. Any gain or loss on the sale of a Right will be capital gain or loss if the Right is held as a capital asset (which in the
case of Rights issued to Record Date Shareholders will depend on whether the Old Common Share is held as a capital asset), and will be
a long-term capital gain or loss if the holding period of the Right, as determined under the discussion herein, is deemed to exceed one
year at the time of the disposition.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><i>Exercise of the Rights, Basis and Holding
Period of Acquired Shares</i>. No gain or loss will be recognized by a Rights holder upon the exercise of a Right, and the basis of any
Common Share acquired upon exercise of the Right (the &#8220;New Common Share&#8221;) will equal the sum of the (i) basis, if any, of
the Right(s) exercised and (ii) the Subscription Price for the New Common Share. The holding period for the New Common Share acquired
through exercise of the Right will begin on the date of exercise of the Right (or, in the case of a Right purchased in the market, potentially
the day after the date of exercise).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Employee Benefit Plan Considerations</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Common Shareholders that are employee
benefit plans subject to the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;) (including corporate
savings and 401(k) plans, each, an ERISA Plan), Keogh plans of self-employed individuals, Individual Retirement Accounts
(&#8220;IRAs&#8221;) and other plans subject to Section 4975 of the Code (with ERISA Plans, each a &#8220;Plan&#8221; and
collectively, the &#8220;Plans&#8221;) should be aware that additional contributions of cash to the Plan (other than rollover
contributions or trustee-to-trustee transfers from other Plans) made in order to exercise Rights would be treated as Plan
contributions and, when taken together with contributions previously made, may subject a Plan to excise taxes for excess or
nondeductible contributions. In the case of Plans qualified under Section 401(a) of the Code and certain other plans, additional
cash contributions could cause the</p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"> maximum contribution limitations of Section 415 of the Code or other qualification rules to be
violated. Plans contemplating the receipt of additional cash contributions to exercise Rights should consult with their counsel
prior to receiving or using such contributions.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Plans and other tax exempt entities, including
governmental plans, should also be aware that if they borrow in order to finance their exercise of Rights, they may become subject to
the tax on unrelated business taxable income under Section 511 of the Code. If any portion of an IRA is used as security for a loan to
the individual for whose benefit the IRA is established, the portion so used may be treated as distributed to such individual.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Each fiduciary of a Plan should consider, to
the extent applicable, the fiduciary standards of ERISA and the Code in the context of the Plan's particular circumstances before making
any decision regarding the exercise or other disposition of rights (and in the case of a transferee, the acquisition of rights), and any
investment in Common Shares as a consequence thereof. Under ERISA and the Code, any person who exercises any discretionary authority or
control over the administration of a Plan or the management or disposition of the assets of a Plan, or who renders investment advice for
a fee or other compensation to a Plan, is generally considered to be a fiduciary of the Plan. Accordingly, among other factors, the fiduciary
should consider whether the exercise or transfer of Rights and any investment in Common Shares would satisfy the prudence, diversification
and conflicts of interests requirements of ERISA, to the extent applicable, and would be consistent with its fiduciary responsibilities,
and the documents and instruments governing the Plan.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">To the extent the Fund, the Adviser or certain
of their respective affiliates or other parties involved with the Offer, or in the case of a transfer of Rights, the transferee, might
be considered a "party in interest" or a "disqualified person" with respect to a Plan, prohibited transactions may
arise under ERISA and/or Section 4975 of the Code in connection with exercises or transfers of Rights unless made pursuant to an available
statutory, regulatory, individual or class exemption. In this regard the U.S. Department of Labor has issued prohibited transaction class
exemptions that may apply. These exemptions include transactions effected on behalf of a Plan by a "qualified professional asset
manager" (prohibited transaction exemption 84-14) or an "in-house asset manager" (prohibited transaction exemption 96-23),
transactions involving insurance company general accounts (prohibited transaction exemption 95-60), transactions involving insurance company
pooled separate accounts (prohibited transaction exemption 90-1), and transactions involving bank collective investment funds (prohibited
transaction exemption 91-38). In addition, Section 408(b)(17) of ERISA and Section 4975(d)(20) of the Code provide relief from the prohibited
transaction provisions of ERISA and Section 4975 of the Code for certain transactions, provided that neither the issuer of the securities
nor any of its affiliates (directly or indirectly) have or exercise any discretionary authority or control or render any investment advice
with respect to the assets of any Plan involved in the transaction and provided further that the Plan receives no less and pays no more
than "adequate consideration" (within the meaning of Section 408(b)(17) of ERISA and Section 4975(f)(10) of the Code). There
can be no assurance that any of the above exemptions or any other exemption would apply, or that all of the conditions of any such exemptions
would be satisfied, with respect to all otherwise prohibited transactions involving Rights or any Common Shares obtained pursuant to any
Rights.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Governmental plans, certain church plans and
non-U.S. plans may not be subject to the prohibited transaction provisions of ERISA or the Code but may be subject to similar laws ("Similar
Laws"). Fiduciaries of any such plans should consult with counsel before exercise or transfer of Rights.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Because of the foregoing, the person making the
decision (the "fiduciary") on behalf of a Plan or a governmental, church or foreign plan will be deemed to represent on behalf
of itself and the Plan that the exercise or other disposition (and in the case of any transferee the acquisition) of the Rights (and the
investment in Common Shares pursuant to any exercise) will not result in a non-exempt prohibited transaction under ERISA or Section 4975
of the Code or any applicable Similar Law. In addition, the fiduciary making any decision on behalf of a Plan to exercise, acquire or
transfer Rights will be deemed to have represented, warranted and acknowledged that neither the Fund nor the Adviser, nor any of their
respective affiliates, representatives or agents has provided or will provide advice in a fiduciary capacity with respect to the exercise,
acquisition or disposition of Rights by the Plan, unless an exemption applies permitting such status.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Due to the complexity of these rules and the
penalties for non-compliance, Plans should consult with their counsel regarding the consequences of their exercise, acquire or transfer
of Rights under ERISA and the Code or any applicable Similar Law. Each holder of Rights has the exclusive responsibility for ensuring
that its acquisition,</p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt">exercise or other disposition of the Rights, as applicable, does
not violate the fiduciary or prohibited transaction rules of ERISA, the Code or any applicable Similar Laws. The provision of this offering
memorandum and the provision of any Rights to, or the transfer of Common Shares to a Plan pursuant to the exercise of Rights by, a Plan
is in no respect a representation or recommendation by the Fund, the Adviser or of their respective affiliates, representatives or agents
that such an investment is appropriate or advisable for, or meets all relevant legal requirements with respect to investments by, Plans
or plans subject to Similar Laws generally or by any particular Plan or plan subject to Similar Law.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Benefits to the Adviser</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Adviser will benefit from the Offer, in part,
because the investment management fee paid by the Fund to the Adviser is based on the Fund&#8217;s Managed Assets. It is not possible
to state precisely the amount of additional compensation the Adviser will receive as a result of the Offer because it is not known how
many Common Shares will be subscribed for and because the proceeds of the Offer will be invested in additional portfolio securities which
will fluctuate in value. However, assuming (i) all Rights are exercised, (ii) the Fund&#8217;s average NAV during the twelve-month period
beginning September 13, 2024 is $12.23 per Common Share (the NAV per Common Share on September 13, 2024) (iii) the Subscription Price
is $11.42 per Share, and (iv) for purposes of this example, the Fund increases the amount of leverage outstanding while maintaining approximately
the same percentage of total assets attributable to leverage, and after giving effect to the Dealer Manager fee and other estimated offering
expenses, the Adviser would receive additional investment management fees of approximately $1,175,200 for the twelve-month period beginning
September 13, 2024, and would continue to receive additional investment management fees as a result of the Offer, based on the Fund&#8217;s
Managed Assets attributable to the Shares issued in the Offer and related additional leverage, thereafter.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Investment Considerations and Dilution</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Upon completion of the Offer, Common Shareholders
who do not exercise their Rights fully will own a smaller proportional interest in the Fund than would be the case if the Offer had not
been made. Furthermore, if you do not participate in the over-subscription privilege, if it is available, your percentage ownership may
also be diluted.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In addition, because the Subscription Price per
Share is likely to be less than the Fund&#8217;s NAV per Common Share, the Offer will likely result in a dilution of the Fund&#8217;s
NAV per Common Share for all Common Shareholders, irrespective of whether they exercise all or any portion of their Rights. Although it
is not possible to state precisely the amount of such a decrease in value, because it is not known at this time what the Subscription
Price will be, what the NAV per Common Share will be on the Expiration Date or what proportion of Shares will be subscribed for, the dilution
could be substantial.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The impact of the Offer on NAV per share is shown
by the following example, assuming a $11.42 Subscription Price and assuming full exercise of the Rights:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 8pt">
  <tr style="vertical-align: bottom">
    <td style="font: 9pt/115% Arial, Helvetica, Sans-Serif; padding: 0.75pt; width: 54%"><span style="font-family: Times New Roman, Times, Serif"><b>Expense</b><sup>(1)</sup></span></td>
    <td style="font: 9pt/115% Arial, Helvetica, Sans-Serif; padding: 0.75pt; width: 46%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt/115% Arial, Helvetica, Sans-Serif; padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">NAV<sup>(2)</sup></span></td>
    <td style="font: 9pt/115% Arial, Helvetica, Sans-Serif; padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">$12.23</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt/115% Arial, Helvetica, Sans-Serif; padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">Subscription
    Price</span></td>
    <td style="font: 9pt/115% Arial, Helvetica, Sans-Serif; padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">$11.42</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt/115% Arial, Helvetica, Sans-Serif; padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">Reduction
    in NAV ($)<sup>(3)</sup></span></td>
    <td style="font: 9pt/115% Arial, Helvetica, Sans-Serif; padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">$0.32</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt/115% Arial, Helvetica, Sans-Serif; padding: 0.75pt 0.75pt 0pt"><span style="font-family: Times New Roman, Times, Serif">Reduction
    in NAV (%)</span></td>
    <td style="font: 9pt/115% Arial, Helvetica, Sans-Serif; padding: 0.75pt"><span style="font-family: Times New Roman, Times, Serif">2.62%</span></td></tr>
  </table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"><sup>(1)</sup></td><td>Assumes that all Rights are exercised pursuant to the primary subscription and/or over-subscription privilege.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"><sup>(2)</sup></td><td>Assumes that the Fund&#8217;s NAV on the Expiration Date is $12.23 per Common Share (the NAV per Common Share on September 13, 2024).</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"><sup>(3)</sup></td><td>Assumes $0.01 per Common Share in estimated offering expenses and Dealer Manager fee of $0.43 per Common Share, each payable by the
Fund.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Record Date Shareholders will experience a decrease
in the NAV per Common Share held by them, irrespective of whether they exercise all or any portion of their Rights.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The distribution of transferable Rights, which
may themselves have value, will afford non-participating Common Shareholders the potential of receiving a cash payment upon the sale of
the Rights, receipt of which may</p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"> be viewed as partial compensation for the economic dilution of their interests, although there can be
no assurance that a market for the Rights will develop.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>RISKS RELATING TO THE OFFER</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Dilution Risk</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">As a result of this Offer, it is anticipated
that even if you fully exercise your Rights, you should expect to incur immediate economic dilution and, if you do not exercise all of
your Rights, you will incur voting dilution. Further, both the sales load and the expenses associated with the Offer paid by the Fund
will immediately reduce the NAV of each Common Shareholder&#8217;s Common Shares. To the extent that the number of Common Shares outstanding
after the Offer will have increased proportionately more than the increase in the size of the Fund&#8217;s net assets, you will, at the
completion of the Offer, experience immediate dilution of NAV. The percentage increase in Common Shares outstanding that will occur if
all the Rights are exercised is 33 1/3%. In addition, if the Subscription Price for the Offer is less than the Fund&#8217;s NAV per Common
Share as of the Expiration Date, you would experience additional immediate dilution of NAV as a result of the Offer. If the Subscription
Price is substantially less than the current NAV per Common Share at the expiration of the Offer, such dilution could be substantial.
It is anticipated that the existing Common Shareholders will experience immediate dilution even if they fully exercise their Rights. In
addition, whether or not you exercise your Rights, you will experience a dilution of NAV of the Common Shares because you will indirectly
bear the expenses of this Offer, which include, among other items, SEC registration fees, printing expenses and the fees assessed by service
providers (including the cost of the Fund&#8217;s counsel and independent registered public accounting firm). This dilution of NAV will
disproportionately affect Common Shareholders who do not exercise their Rights. The Fund cannot state precisely the amount of any decrease
because it is not known at this time how many Common Shares will be subscribed for or what the NAV or market price of the Fund&#8217;s
Common Shares will be on the Expiration Date or what the Subscription Price will be. For example, based on the Fund&#8217;s NAV and the
market price of Common Shares on September 13, 2024, and on each of the four (4) preceding trading days, the Subscription Price would
be less than NAV and there would be dilution. Assuming full exercise of the Rights being offered at the Subscription Price and assuming
that the Expiration Date were September 13, 2024, it is estimated that the per Common Share dilution resulting from the Offer would be
$0.32 or 2.62%.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In addition to the economic dilution described
above, if you do not exercise all of your Rights, you will incur voting dilution as a result of this Offer. This voting dilution will
occur because you will own a smaller proportionate interest in the Fund after the Offer than you owned prior to the Offer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The fact that the Rights are transferable may
reduce the effects of dilution as a result of the Offer. Rights holders can transfer or sell their Rights. The cash received from the
sale of Rights may be viewed as partial compensation for any possible dilution. There can be no assurances, however, that a market for
the Rights will develop or that the Rights will have any value in that market.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Increase in Share Price Volatility; Decrease in Share Price</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Offer may result in an increase in trading
of the Common Shares, which may increase volatility in the market price of the Common Shares. The Offer may result in an increase in the
number of Common Shareholders wishing to sell their Common Shares, which would exert downward price pressure on the price of Common Shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Under-Subscription</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">It is possible that the Offer will not be fully
subscribed. Under-subscription of the Offer could have an impact on the net proceeds of the Offer and whether the Fund achieves any benefits.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Risks of Acquiring Rights to Purchase Common Shares</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Shares of closed-end funds such as the Fund frequently
trade at a discount to NAV. Since inception, the Fund&#8217;s Common Shares have frequently traded at a discount in relation to NAV. See
&#8220;Description of Common Shares.&#8221; If the Formula Price is less than 90% of NAV on the Expiration Date, then the Subscription
Price will likely be greater than the market price of a Common Share on that date. In addition, the Formula Price, even if above 90% of
NAV, may still be above the market price of a Common Share on the Expiration Date. If either event occurs, the Rights will have no value,
and a person who exercises Rights will experience an immediate loss of value.</p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">There can be no assurance that a market for the
Rights will develop or, if such a market develops, what the price of the Rights will be. Changes in market conditions may result in the
Common Shares purchasable upon exercise of the Rights being less attractive to investors at the Expiration Date. This may reduce or eliminate
the value of the Rights. Investors who receive or acquire Rights may find that there is no market to sell Rights that they do not wish
to exercise.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>PLAN OF DISTRIBUTION</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Distribution Arrangements</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">UBS Securities LLC will act as Dealer Manager
for this Offer. Under the terms and subject to the conditions contained in the Dealer Manager Agreement among the Dealer Manager, the
Fund and the Adviser, the Dealer Manager will provide financial structuring and solicitation services in connection with the Offer and
will solicit the exercise of Rights and participation in the over-subscription privilege. The Offer is not contingent upon any number
of Rights being exercised. The Dealer Manager will also be responsible for forming and managing a group of selling broker-dealers (each
a &#8220;Selling Group Member&#8221; and collectively the &#8220;Selling Group Members&#8221;), whereby each Selling Group Member will
enter into a Selling Group Agreement with the Dealer Manager to solicit the exercise of Rights and to sell Common Shares purchased by
the Selling Group Member from the Dealer Manager. In addition, the Dealer Manager will enter into a Soliciting Dealer Agreement with other
soliciting broker-dealers (each a &#8220;Soliciting Dealer&#8221; and collectively the &#8220;Soliciting Dealers&#8221;) to solicit the
exercise of Rights. See &#8220;&#8212;Compensation to Dealer Manager&#8221; for a discussion of fees and other compensation to be paid
to the Dealer Manager, Selling Group Members and Soliciting Dealers in connection with the Offer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Fund and the Adviser have each agreed to
indemnify the Dealer Manager for losses arising out of certain liabilities, including liabilities under the Securities Act. The Dealer
Manager Agreement also provides that the Dealer Manager will not be subject to any liability to the Fund in rendering the services contemplated
by the Dealer Manager Agreement except for any act of willful misfeasance, bad faith or gross negligence of the Dealer Manager or reckless
disregard by the Dealer Manager of its obligations and duties under the Dealer Manager Agreement.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Prior to the expiration of the Offer, the Dealer
Manager may independently offer for sale Common Shares it has acquired through purchasing and exercising the Rights, at prices that may
be different from the market price for such Common Shares or from the price to be received by the Fund upon the exercise of Rights. The
Dealer Manager is authorized to buy and exercise Rights (for delivery of Common Shares prior to the expiration of the Offer), including
unexercised Rights of Record Date Shareholders whose record addresses are outside the United States that are held by the Subscription
Agent and for which no instructions are received, and to sell Common Shares to the public or to Selling Group Members at the offering
price set by the Dealer Manager from time to time. In addition, the Dealer Manager has the right to buy Rights offered to it by the Subscription
Agent from electing Record Date Shareholders, and the Dealer Manager may purchase such Rights as principal or act as agent on behalf of
its clients for the resale of such Rights.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In order to seek to facilitate the trading
market in the Rights for the benefit of non-exercising Common Shareholders, and the placement of the Common Shares to new or
existing investors pursuant to the exercise of the Rights, the Dealer Manager Agreement provides for special arrangements with the
Dealer Manager. Under these arrangements, the Dealer Manager is expected to purchase Rights on the NYSE. The number of Rights, if
any, purchased by the Dealer Manager will be determined by the Dealer Manager in its sole discretion. The Dealer Manager is not
obligated to purchase Rights or Common Shares as principal for its own account to facilitate the trading market for Rights or for
investment purposes. Rather, its purchases are expected to be closely related to interest in acquiring Common Shares generated by
the Dealer Manager through its marketing and soliciting activities. The Dealer Manager intends to exercise Rights purchased by it
during the Subscription Period but prior to the Expiration Date. The Dealer Manager may exercise those Rights at its option on one
or more dates, which are expected to be prior to the Expiration Date. The subscription price for the Common Shares issued through
the exercise of Rights by the Dealer Manager prior to the Expiration Date will be the greater of 92.5% of the last reported sale
price of a Common Share on the NYSE on the date of exercise or 90% of the Fund&#8217;s NAV per Common Share at the close of trading
on the NYSE prior to the date of exercise. The price and timing of these exercises are expected to differ from those described
herein for the Rights offering. The Subscription Price will be paid to the Fund and the dealer manager fee with respect to such
proceeds will be paid by the Fund on the applicable settlement date(s) of such exercise(s). </p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In connection with the exercise of Rights and
receipt of Common Shares, the Dealer Manager intends to offer those Common Shares for sale to the public and/or through Selling Group
Members it has established. The Dealer Manager may set the price for those Common Shares at any price that it determines, in its sole
discretion. The Dealer Manager has advised that the price at which such Common Shares are offered is expected to be at or slightly below
the closing price of the Common Shares on the NYSE on the date the Dealer Manager exercises Rights. No portion of the amount paid to the
Dealer Manager or to a Selling Group Member from the sale of Common Shares in this manner will be paid to the Fund. If the sales price
of the Common Shares is greater than the subscription price paid by the Dealer Manager for such Common Shares plus the costs to purchase
Rights for the purpose of acquiring those Common Shares, the Dealer Manager will receive a gain. Alternatively, if the sales price of
the Common Shares is less than the Subscription Price for such Common Shares plus the costs to purchase Rights for the purpose of acquiring
those Common Shares, the Dealer Manager will incur a loss. The Dealer Manager will pay a concession to Selling Group Members in an amount
equal to approximately 2.00% of the aggregate price of the Common Shares sold by the respective Selling Group Member. Neither the Fund
nor the Adviser has a role in setting the terms, including the sales price, on which the Dealer Manager offers for sale and sells Common
Shares it has acquired through purchasing and exercising Rights or the timing of the exercise of Rights or sales of Common Shares by the
Dealer Manager. Persons who purchase Common Shares from the Dealer Manager or a Selling Group Member will purchase Common Shares at a
price set by the Dealer Manager, which may be more or less than the Subscription Price, based on the Formula Price mechanism through which
Common Shares will be sold in the Rights offering, and at a time set by the Dealer Manager, which is expected to be prior to the Expiration
Date, and will not have the uncertainty of waiting for the determination of the Subscription Price on the Expiration Date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Dealer Manager may purchase Rights as principal
or act as agent on behalf of its clients for the resale of such Rights. The Dealer Manager may realize gains (or losses) in connection
with the purchase and sale of Rights and the sale of Common Shares, although such transactions are intended by the Dealer Manager to facilitate
the trading market in the Rights and the placement of the Common Shares to new or existing investors pursuant to the exercise of the Rights.
Any gains (or losses) realized by the Dealer Manager from the purchase and sale of Rights and the sale of Common Shares are independent
of and in addition to its fee as Dealer Manager. The Dealer Manager has advised that any such gains (or losses) are expected to be immaterial
relative to its fee as Dealer Manager.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Since neither the Dealer Manager nor persons
who purchase Common Shares from the Dealer Manager or Selling Group Members were Record Date Shareholders, they would not be able to participate
in the over-subscription privilege.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">There is no limit on the number of Rights the
Dealer Manager can purchase or exercise. Common Shares acquired by the Dealer Manager pursuant to the exercise of Rights acquired by it
will reduce the number of Common Shares available pursuant to the over-subscription privilege, perhaps materially, depending on the number
of Rights purchased and exercised by the Dealer Manager.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Although the Dealer Manager can seek to facilitate
the trading market for Rights as described above, investors can acquire Common Shares at the Subscription Price by acquiring Rights on
the NYSE and exercising them in the method described above under &#8220;Terms of the Offer&#8212;Method for Exercise of Rights&#8221;
and &#8220;Terms of the Offer&#8212;Payment for Shares.&#8221;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In the ordinary course of their businesses, the
Dealer Manager and/or its affiliates may engage in investment banking or financial transactions with the Fund, the Adviser and their affiliates.
In addition, in the ordinary course of their businesses, the Dealer Manager and/or its affiliates may, from time to time, own securities
of the Fund or its affiliates.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The principal business address of the Dealer
Manager is 1285 Avenue of the Americas, New York, New York 10019.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"><b>Compensation to Dealer Manager</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Pursuant to the Dealer Manager Agreement, the
Fund has agreed to pay the Dealer Manager a fee for its financial structuring and solicitation services equal to 3.75% of the Subscription
Price per Common Share for each Common Share issued pursuant to the exercise of Rights, including the over-subscription privilege.</p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Dealer Manager will reallow to Selling Group
Members in the Selling Group to be formed and managed by the Dealer Manager selling fees equal to 2.00% of the Subscription Price for
each Common Share issued pursuant to the Offer or the over-subscription privilege as a result of their selling efforts. In addition, the
Dealer Manager will reallow to Soliciting Dealers that have executed and delivered a Soliciting Dealer Agreement and have solicited the
exercise of Rights, solicitation fees equal to 0.50% of the Subscription Price for each Common Share issued pursuant to the exercise of
Rights as a result of their soliciting efforts, subject to a maximum fee based on the number of Common Shares held by such Soliciting
Dealer through DTC on the Record Date. Fees will be paid to the broker-dealer designated on the applicable portion of the subscription
certificates or, in the absence of such designation, to the Dealer Manager.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">In addition, the Fund, has agreed to pay the
Dealer Manager an amount up to $150,000 as a partial reimbursement of its expenses incurred in connection with the Offer, including reasonable
out-of-pocket fees and expenses, if any, and not to exceed $10,000, incurred by the Dealer Manager, Selling Group Members, Soliciting
Dealers and other brokers, dealers and financial institutions in connection with their customary mailing and handling of materials related
to the Offer to their customers. The fees described above are one-time fees payable on each date on which the Fund issues Common Shares
after the Expiration Date with respect to the Dealer Manager, and on or before the tenth business day following the day the Fund issues
Common Shares after the Expiration Date with respect to a Selling Group Member or Soliciting Dealer. No other fees will be payable by
the Fund or the Adviser to the Dealer Manager in connection with the Offer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>LEGAL MATTERS</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Certain legal matters will be passed on by Skadden,
Arps, Slate, Meagher &amp; Flom LLP, Chicago, Illinois, as special counsel to the Fund in connection with the Offer. Certain legal matters
will be passed on by Dechert, LLP, New York, New York, as special counsel to the Dealer Manager in connection with the Offer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">PricewaterhouseCoopers LLP, 300 Madison Avenue,
New York, New York 10017, is the independent registered public accounting firm of the Fund. The independent registered public accounting
firm is expected to render an opinion annually on the financial statements and financial highlights of the Fund.</p>

<p style="font: 10pt Times LT Std Bold,serif; margin: 5pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Bold,serif; margin: 5pt 0 0 6pt"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Bold,serif; margin: 5pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Bold,serif; margin: 5pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Bold,serif; margin: 5pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BASE
<span style="letter-spacing: -0.1pt">PROSPECTUS</span></b></span></p>

<p style="font: 10pt Times LT Std Bold,serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times LT Std Bold,serif; margin: 7.45pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 14pt Times LT Std Bold,serif; margin: 0 17.85pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt; letter-spacing: -0.1pt"><b>$150,000,000</b></span></p>

<p style="font: 14pt Times LT Std Bold,serif; margin: 6.2pt 17.85pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>ADVENT
CONVERTIBLE AND INCOME <span style="letter-spacing: -0.2pt">FUND</span></b></span></p>

<p style="font: 14pt Times LT Std Bold,serif; margin: 6.2pt 17.85pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt"><b>&#160;Common
Shares</b></span></p>

<p style="font: 12pt/90% Times LT Std Bold,serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Subscription Rights for Common Shares</b></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0.2pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 10%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->


<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Bold,serif; margin: 1.6pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt/normal Times LT Std Roman; margin: 0 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
Fun</i>d Advent Convertible and Income Fund (the &#8220;Fund&#8221;) is a diversified, closed-end management investment company.</span></p>

<p style="font: 10pt/normal Times LT Std Roman; margin: 5.95pt 5.95pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investment
Objective.</i> The Fund&#8217;s investment objective is to provide total return through a combination of capital appreciation and current
income. There can be no assurance that the Fund will achieve its investment objective, and you could lose some or all of your investment.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6.15pt 13.2pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investment
Strategy. </i>Under normal market conditions, the Fund invests at least 80% of its Managed Assets (as defined in this Prospectus) in
a diversified portfolio of convertible securities and non-convertible income producing securities. Under normal market conditions, the
Fund will invest at least 30% of its Managed Assets in convertible securities and may invest up to 70% of its Managed Assets in non-convertible
income securities. The Fund may invest without limitation in foreign securities. The Fund also uses a strategy of writing (selling) covered
call options on up to 25% of the securities held in the portfolio, thus generating option writing premiums. &#8220;Managed Assets&#8221;
means the total assets of the Fund, including assets attributable to the Fund&#8217;s use of leverage, minus the sum of its accrued liabilities
(other than liabilities incurred for the purpose of creating leverage).</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Offering.
</i>The Fund may offer, from time to time, up to $150,000,000 aggregate initial offering price of common shares of beneficial interest,
par value $0.001 per share (&#8220;common shares&#8221;), and subscription rights to purchase Common Shares (&#8220;Rights,&#8221; and
collectively with the common shares, &#8220;Securities&#8221;) in one or more offerings in amounts, at prices and on terms set forth
in one or more supplements to this Prospectus (each a &#8220;Prospectus Supplement&#8221;). You should read this Prospectus and any related
Prospectus Supplement carefully before you decide to invest in the Securities.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may offer Securities (1) directly to one or more purchasers, (2) through agents that the Fund may designate from time to time or
(3) to or through underwriters or dealers. The Prospectus Supplement relating to a particular offering of Securities will identify any
agents or underwriters involved in the sale of Securities, and will set forth any applicable purchase price, fee, commission or discount
arrangement between the Fund and agents or underwriters or among underwriters or the basis upon which such amount may be calculated.
The Fund may not sell Securities through agents, underwriters or dealers without delivery of this Prospectus and a Prospectus Supplement.
See &#8220;Plan of Distribution.&#8221;</span></p>

<p style="font: bold 10pt/91% Times LT Std; margin: 5.7pt 30.6pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
in the Fund&#8217;s Securities involves certain risks. Shares of closed-end funds listed for trading on a securities exchange
frequently trade at a discount from net asset value. An investment in the Fund <span style="letter-spacing: -0.25pt">is subject to
investment risk, including the possible loss of the entire principal amount that you invest. The Fund utilizes leverage, which is
subject to numerous risks. See &#8220;Risks&#8221; beginning on page 23 of this Prospectus and &#8220;Risks&#8221; in the
Fund&#8217;s most recent Annual Report on Form N-CSR and in any of the Fund&#8217;s other filings with the Securities and Exchange
Commission (&#8220;SEC&#8221;) incorporated herein by reference. You should carefully consider these risks together with all of the
other information contained in this Prospectus before making a decision to purchase the Fund&#8217;s Securities.</span></span></p>

<p style="font: bold 10pt Times LT Std; margin: 5pt 0 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the SEC nor any state securities commission has approved or disapproved of these securities or determined if this Prospectus is truthful
or complete. Any representation to the contrary is a criminal offense.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 5pt 0 0 6pt; text-indent: 0.25in"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 10%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 0 0 6pt; text-indent: 0.25in"></p>

<p style="font: 10pt Times LT Std Roman; margin: 9.9pt 2.9pt 0 17.85pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospectus
dated September 12, <span style="letter-spacing: -0.2pt">2024</span></span></p>


<!-- Field: Page; Sequence: 32 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 11.65pt 0 9pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Adviser.
</i>Advent Capital Management, LLC (&#8220;Advent&#8221; or the &#8220;Adviser&#8221;) serves as the investment adviser to the Fund and
is responsible for the day-to-day management of the Fund&#8217;s portfolio of securities, which includes buying and selling securities
for the Fund.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 9pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common
Shares.</i> The Fund&#8217;s outstanding common shares are, and the common shares offered by this Prospectus will be, subject to notice
of issuance, listed on the New York Stock Exchange (&#8220;NYSE&#8221;) under the symbol &#8220;AVK.&#8221; As of August 23, 2024, the
net asset value of the Fund&#8217;s common shares was $12.36 per share and the last reported sale price for the Fund&#8217;s common shares
on the NYSE was $12.69 per share, representing a premium to net asset value of 2.67%. See &#8220;Market and Net Asset Value Information.&#8221;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 7.8pt 0 9pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distributions.
</i>The Fund intends to pay substantially all of its net investment income to Common Shareholders through monthly distributions. In addition,
the Fund intends to distribute any net long-term capital gains to Common Shareholders at least annually. The Fund expects that distributions
paid on the Common Shares will consist primarily of (i) investment company taxable income, which includes, among other things, ordinary
income, net short-term capital gain and income from certain hedging and interest rate transactions, (ii) net capital gain (which is the
excess of net long-term capital gain over net short-term capital loss), and/or (iii) return of capital. Distributions paid by the Fund
for any particular month may be comprised of more or less than the amount of net investment income from that monthly period. As a result,
all or a portion of a distribution may be deemed a return of capital (which is in effect a partial return of the amount a Common Shareholder
invested in the Fund) up to the amount of the Common Shareholder&#8217;s tax basis in their Common Shares, which would reduce such tax
basis. The Fund&#8217;s distributions have historically included, and may in the future include, a significant portion of return of capital.
For the fiscal year ended October 31, 2023, the Fund&#8217;s distributions were comprised of approximately 28.04% ordinary income and
71.96% return of capital. Accordingly, shareholders should not assume that the source of a distribution from the Fund is net income or
profit, and the Fund&#8217;s distributions should not be used as a measure of performance or confused with yield or income. Return of
capital is the return of a portion of the shareholder&#8217;s original investment up to the amount of the Common Shareholder&#8217;s
tax basis in their Common Shares, which would reduce such tax basis. Although a return of capital may not be taxable, it will generally
increase the Common Shareholder&#8217;s potential gain or reduce the Common Shareholder&#8217;s potential loss on any subsequent sale
or other disposition of Common Shares, which may increase taxes payable by a Common Shareholder or reduce a Common Shareholder&#8217;s
loss deduction in connection with such sale or other disposition. Common Shareholders should not assume that the source of a distribution
from the Fund is net income or profit, and Common Shareholders who receive distributions that include return of capital should not assume
that such return of capital is derived from the Fund&#8217;s investments.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0.4in 0 9pt; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Leverage.
</i>As part of its investment strategy, the Fund utilizes leverage to finance the purchase of additional securities that provide increased
income and potentially greater appreciation potential to common shareholders than could be achieved from a portfolio that is not leveraged.
The Fund may utilize leverage up to the limits imposed by the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;).
Under the 1940 Act, the Fund may utilize leverage in the form of indebtedness in an aggregate amount up to 33 1 / 3% of the Fund&#8217;s
Managed Assets (including the proceeds of such leverage) immediately after incurring such indebtedness. Under the 1940 Act, the Fund
may utilize leverage in the form of preferred shares in an aggregate amount of up to 50% of the Fund&#8217;s total assets (including
the proceeds of such leverage) immediately after such issuance. The Fund may also invest in reverse repurchase agreements to the maximum
extent permitted by the SEC and/or SEC staff rules, guidance or <span style="letter-spacing: -0.1pt">positions.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 7.05pt 0 9pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund has entered into a senior secured credit agreement dated December 15, 2017, as amended from time to time through the date hereof,
with a financial institution (the &#8220;Credit Agreement&#8221;) pursuant to which the Fund may borrow up to $158 million. As of April
30, 2024, outstanding borrowings under the Credit Agreement were approximately $157 million, which represented approximately 21.5% of
the Fund&#8217;s Managed Assets as of such date. In addition, as of April 30, 2024, the Fund had reverse repurchase agreements outstanding
representing leverage equal to approximately 21.5% of the Fund&#8217;s Managed Assets as of such date. As of April 30, 2024, the Fund&#8217;s
total financial leverage, through indebtedness under the Credit Agreement and reverse repurchase agreements, represented approximately
43.0% of the Fund&#8217;s Managed Assets.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 9pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Fund may engage in certain derivatives transactions that have economic characteristics similar to leverage to the extent
permitted by the SEC and/or SEC staff rules, guidance or positions.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 9pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Roman; text-align: center; margin-top: 6pt; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii&#160;</span></p>


<!-- Field: Page; Sequence: 33 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
use of leverage is a speculative technique that involves special risks. There can be no assurance that the Fund&#8217;s leveraging strategy
will be successful. See &#8220;Use of Leverage&#8221; in this Prospectus and &#8220;Investment Objective, Policies and Principal Risks&#8212;Principal
Risks&#8212;Leverage Risk&#8221; in the Fund&#8217;s Annual Report.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 2.9pt 0 17.9pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* <span style="letter-spacing: -0.5pt">*</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this Prospectus and the documents incorporated herein by reference, which contain important information about the Fund that
you should know before deciding whether to invest, and retain it for future reference. A Statement of Additional Information, dated September
12, 2024, containing additional information about the Fund, has been filed with the SEC and is incorporated by reference in its entirety
into this Prospectus.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 18.45pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s Securities do not represent a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured
depository institution and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other
government agency.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
permitted by regulations adopted by the SEC, paper copies of the Fund&#8217;s annual and semi-annual shareholder reports will no longer
be sent by mail, unless you specifically request paper copies of the reports from the Fund or from your financial intermediary, such
as a broker-dealer or bank. Instead, the reports will be made available on the Fund&#8217;s website (www.guggenheiminvestments.com/cef/fund/avk),
and you will be notified by mail each time a report is posted and provided with a website link to access the report.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may elect to receive all future reports in paper free of charge. If you own these shares through a financial intermediary, such as a
broker-dealer or bank, you may contact your financial intermediary to request that you continue to receive paper copies of your shareholder
reports. If you invest directly with the Fund, you can inform the Fund that you wish to continue receiving paper copies of your shareholder
reports by calling (800) 345-7999. Your election to receive reports in paper will apply to all funds held with the fund complex if you
invest directly with the Fund or to all funds held in your account if you invest through your financial intermediary.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Roman; text-align: center; margin-top: 6pt; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii&#160;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Bold,serif; margin: 5pt 12.05pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF <span style="letter-spacing: -0.1pt">CONTENTS</span></b></span></p>

<p style="font: bold 10pt Times LT Std; margin: 10pt 5.9pt 0 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Page</span></span></p>



<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 11pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 90%; text-align: left; padding-top: 3.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT
    THIS PROSPECTUS </span></td>
    <td style="width: 10%; text-align: right; padding-top: 3.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE
    YOU CAN FIND MORE INFORMATION </span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INCORPORATION
    BY REFERENCE</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS
    SUMMARY</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY
    OF FUND EXPENSES</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL
    HIGHLIGHTS</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
    FUND</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE
    OF PROCEEDS</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MARKET
    AND NET ASSET VALUE INFORMATION</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INVESTMENT
    OBJECTIVE AND POLICIES</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
    FUND&#8217;S INVESTMENTS</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE
    OF LEVERAGE</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISKS
    </span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MANAGEMENT
    OF THE FUND</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NET
    ASSET VALUE</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DISTRIBUTIONS
    </span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIVIDEND
    REINVESTMENT PLAN</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
    OF CAPITAL STRUCTURE</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
    OF SUBSCRIPTION RIGHTS THAT MAY BE ISSUED</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANTI-TAKEOVER
    PROVISIONS IN THE FUND&#8217;S GOVERNING DOCUMENTS</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTAIN
    PROVISIONS OF DELAWARE LAW, THE DECLARATION OF TRUST AND BY-LAWS</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLOSED-END
    FUND STRUCTURE</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TAX
    MATTERS</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN
    OF DISTRIBUTION</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SERVICING
    AGENT, TRANSFER AGENT, CUSTODIAN AND ADMINISTRATOR</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL
    MATTERS</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INDEPENDENT
    REGISTERED PUBLIC ACCOUNTING FIRM</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FISCAL
    YEAR END AND REPORTS TO SHAREHOLDERS</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRIVACY
    PRINCIPLES OF THE FUND</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td></tr>
  <tr style="font: 10pt Times LT Std Roman; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0.5pt; padding-bottom: 0pt; padding-left: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
    OF CONTENTS OF STATEMENT OF ADDITIONAL INFORMATION</span></td>
    <td style="text-align: right; padding-top: 0.5pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td></tr>
</table>
<p style="font: 11pt Times LT Std Roman; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 11pt Times LT Std Roman; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv&#160;</span></p>


<!-- Field: Page; Sequence: 35 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 17.9pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT
THIS <span style="letter-spacing: -0.1pt">PROSPECTUS</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Prospectus is part of a registration statement on Form N-2 that the Fund filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;)
using a &#8220;shelf&#8221; registration process. Under this process, the Fund may offer, from time to time, up to $150,000,000 aggregate
initial offering price of Securities in one or more offerings in amounts, at prices and on terms set forth in one or more Prospectus
Supplements. The Prospectus Supplement may also add, update or change information contained in this Prospectus. You should carefully
read this Prospectus and any accompanying Prospectus Supplement, together with the additional information described under the heading
&#8220;Where You Can Find More Information.&#8221;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 7.8pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Prospectus, any accompanying Prospectus Supplement and the Statement of Additional Information, contain (or will contain) or incorporate
(or will incorporate) by reference forward-looking statements, within the meaning of the federal securities laws, that involve risks
and uncertainties. These statements describe the Fund&#8217;s plans, strategies, and goals and the Fund&#8217;s beliefs and assumptions
concerning future economic and other conditions and the outlook for the Fund, based on currently available information. In this Prospectus
and any accompanying Prospectus Supplement, words such as &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;objectives,&#8221;
&#8220;goals,&#8221; &#8220;future,&#8221; &#8220;intends,&#8221; &#8220;seeks,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;could,&#8221;
&#8220;should,&#8221; and similar expressions, and the negative of such terms, are used in an effort to identify forward-looking statements,
although some forward-looking statements may be expressed differently. By their nature, all forward-looking statements involve risks
and uncertainties, and actual results could differ materially from those contemplated by any forward looking statements. Although the
Fund believes that the expectations expressed in these forward-looking statements are (or will be) reasonable, actual results could differ
materially from those projected or assumed in these forward-looking statements. The Fund&#8217;s future financial condition and results
of operations, as well as any forward-looking statements, are subject to change and are subject to inherent risks and uncertainties,
such as those disclosed in the &#8220;Risks&#8221; sections of this Prospectus and the Fund&#8217;s most recent Annual Report, which
describe certain currently known risk factors that could cause actual results to differ materially from the Fund&#8217;s expectations,
and, if applicable, additional risk considerations described in an accompanying Prospectus Supplement. The Fund urges you to review carefully
that section for a more detailed discussion of the risks associated with an investment in the Fund&#8217;s securities. All forward-looking
statements contained or incorporated by reference in this Prospectus and any accompanying Prospectus Supplement are made as of the date
of this Prospectus and any accompanying Prospectus Supplement. The Fund does not intend, and undertakes no obligation, to update any
forward-looking statement. The Fund is not entitled to the safe harbor for forward-looking statements pursuant to Section 27A of the
Securities Act of 1933 (the &#8220;Securities Act&#8221;).</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on the information contained or incorporated by reference in this Prospectus and any accompanying Prospectus Supplement.
The Fund has not authorized any other person to provide you with different information. If anyone provides you with different or inconsistent
information, you should not rely on it. The Fund is not making an offer to sell these securities in any jurisdiction where the offer
or sale is not permitted. You should not assume that the information in this Prospectus and any accompanying Prospectus Supplement is
accurate as of any date other than the date of this Prospectus and any accompanying Prospectus Supplement. The Fund&#8217;s business,
financial condition and results of operations may have changed since that date. The Fund will amend this Prospectus and any accompanying
Prospectus Supplement if, during the period that this Prospectus and any accompanying Prospectus Supplement is required to be delivered,
there are any subsequent material changes.</span></p>


<!-- Field: Page; Sequence: 36; Options: NewSection -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHERE
YOU CAN FIND MORE <span style="letter-spacing: -0.1pt">INFORMATION</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is subject to the informational requirements of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and the 1940
Act and in accordance therewith files, or will file, reports and other information with the SEC. Reports, proxy statements and other
information filed by the Fund with the SEC pursuant to the informational requirements of the Exchange Act and the 1940 Act can be inspected
and copied at the public reference facilities maintained by the SEC, 100 F Street, N.E., Washington, D.C. 20549. The SEC maintains a
web site at www.sec. gov containing reports, proxy and information statements and other information regarding registrants, including
the Fund, that file electronically with the SEC</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 6.5pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Prospectus constitutes part of a Registration Statement filed by the Fund with the SEC under the Securities Act, and the 1940 Act. This
Prospectus omits certain of the information contained in the Registration Statement, and reference is hereby made to the Registration
Statement and related exhibits for further information with respect to the Fund and the common shares offered hereby. Any statements
contained herein concerning the provisions of any document are not necessarily complete, and, in each instance, reference is made to
the copy of such document filed as an exhibit to the Registration Statement or otherwise filed with the SEC. Each such statement is qualified
in its entirety by such reference. The complete Registration Statement may be obtained from the SEC upon payment of the fee prescribed
by its rules and regulations or free of charge through the SEC&#8217;s website (www.sec.gov).</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.2pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund will provide without charge to each person, including any beneficial owner, to whom this Prospectus is delivered, upon written or
oral request, a copy of any and all of the information that has been incorporated by reference in this Prospectus or any accompanying
Prospectus Supplement. You may request such information by calling (800) 345-7999 or by writing to Guggenheim Funds Distributors, LLC
at 227 West Monroe Street, 7th Floor, Chicago, Illinois, 60606, or you may obtain a copy (and other information regarding the Fund) from
the SEC&#8217;s website (www.sec.gov). Free copies of the Fund&#8217;s Prospectus, Statement of Additional
Information and any incorporated information will also be available from the Fund&#8217;s website at www.guggenheiminvestments.com/cef/
fund/avk. Information contained on the Fund&#8217;s website is not incorporated by reference into this Prospectus or any Prospectus Supplement
and should not be considered to be part of this Prospectus or any Prospectus Supplement.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">INCORPORATION
BY REFERENCE</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Prospectus is part of a registration statement that the Fund has filed with the SEC. The Fund is permitted to &#8220;incorporate by reference&#8221;
the information that it files with the SEC, which means that the Fund can disclose important information to you by referring you to those
documents. The information incorporated by reference is an important part of this Prospectus, and later information that the Fund files
with the SEC will automatically update and supersede this information.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 10.85pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
documents listed below, and any reports and other documents subsequently filed by the Fund with the SEC pursuant to Rule 30(b)(2) under
the 1940 Act and Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offering, and any reports and
other documents subsequently filed by the Fund with the SEC pursuant to Rule 30(b)(2) under the 1940 Act and Sections 13(a), 13(c), 14
or 15(d) of the Exchange Act after the date of the initial registration statement and prior to the effectiveness of the registration
statement, are incorporated by reference into this Prospectus and deemed to be part of this Prospectus from the date of the filing of
such reports and documents:</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 17.95pt"/><td style="width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Fund&#8217;s Statement of Additional Information, dated September 12, 2024, filed with this
                                            Prospectus <span style="letter-spacing: -0.1pt">(&#8220;SAI&#8221;);</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 17.95pt"/><td style="width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 27.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Fund&#8217;s Annual Report on Form<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm"> N-CSR</a> for the fiscal year ended October 31, 2023, filed
                                            with the SEC on December 29, 2023 (&#8220;Annual Report&#8221;);</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 17.95pt"/><td style="width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Fund&#8217;s Semi-Annual Report on Form <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126824000124/gug87515avk-ncsr.htm">N-CSRS</a> for the period ended April 30, 2024, filed
                                            with the SEC on July 3, 2024 (&#8220;Semi-Annual Report&#8221;);</span></td></tr></table>


<!-- Field: Page; Sequence: 37 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 3.9pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 13.75pt"/><td style="width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 31.55pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            financial highlights contained within the Fund&#8217;s Annual Report on Form <a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180419000003/gug75351-ncsr.htm">N-CSR</a> for the
                                            fiscal year ended October 31, 2018, filed with the SEC on January 4, 2019;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 13.75pt"/><td style="width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 11.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Fund&#8217;s definitive proxy statement on <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">Schedule 14A</a> for its 2024 annual meeting of shareholders,
                                            filed with the SEC on August 2, 2024 (&#8220;Proxy Statement&#8221;); and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 13.75pt"/><td style="width: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 29.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Fund&#8217;s description of common shares contained in its Registration Statement on <a href="https://www.sec.gov/Archives/edgar/data/1219120/000095017203001191/s426975.txt">Form 8-A</a> (File No. 001- 31663) filed with the SEC on April 10, 2003.</span></td></tr></table>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 22.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
obtain copies of these filings, see &#8220;Where You Can Find More <span style="letter-spacing: -0.1pt">Information.&#8221;</span></span></p>


<!-- Field: Page; Sequence: 38 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 4.5pt 12.05pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="letter-spacing: -0.1pt">PROSPECTUS
SUMMARY</span></span></p>

<p style="font: bold 10pt Times LT Std; margin: 4.5pt 12.05pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 4.5pt 12.05pt 0 15pt; text-align: center"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The <span style="letter-spacing: -0.2pt">Fund</span></b></span></td>
  <td style="width: 80%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advent Convertible and Income Fund
  is a diversified, closed-end management investment company registered under the 1940 Act. The Fund was organized as a Delaware statutory
  trust on February 18, 2003. The common shares commenced trading on the NYSE on April 29, 2003. The Fund's principal office is located
  at 888 Seventh Ave., 31st Floor, New York, New York 10019, and its telephone number is (212) 482-1600.</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Offering</b></span></td>
  <td><p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
      Fund may offer, from time to time, up to $150,000,000 aggregate initial offering price of Securities, including common shares and
      Rights, in one or more offerings in amounts, at prices and on terms set forth in one or more Prospectus Supplements. You should
      read this Prospectus and any related Prospectus Supplement carefully before you decide to invest in the Securities.</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may offer Securities (1) directly to one or more purchasers, (2)	through agents that the Fund may designate from time to time
or (3) to or through underwriters or dealers. The Prospectus Supplement relating to a particular offering of Securities will identify
any agents or underwriters involved in the sale of Securities, and will set forth any applicable purchase price, fee, commission or discount
arrangement between the Fund and agents or underwriters or among underwriters or the basis upon which such amount may be calculated.
The Fund may not sell Securities through agents, underwriters or dealers without delivery of this Prospectus and a Prospectus Supplement.
See &#8220;Plan of Distribution.&#8221;</span></p>
</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Proceeds	</b></span></td>
  <td><p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
      Fund registered $150,000,000 aggregate initial offering price of Securities pursuant to the registration statement of which this
      Prospectus is a part. Unless otherwise specified in a Prospectus Supplement, the Fund intends to invest the net proceeds of an
      offering of Securities in accordance with its investment objective and policies as stated in this Prospectus. It is currently anticipated
      that the Fund will be able to invest substantially all of the net proceeds of an offering of Securities in accordance with its
      investment objective and policies within three months after the completion of such offering. Pending the full investment of the
      proceeds of an offering, it is anticipated that all or a portion of the proceeds will be invested in U.S. Government securities
      or high grade, short-term money market instruments, which have returns substantially lower than those the Fund anticipates earning
      once it has fully invested the proceeds of an offering in accordance with its investment objective. A delay in the anticipated
      use of proceeds could lower returns and reduce the Fund&#8217;s distribution to common shareholders.</span></p>
</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Objective and Policies</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under normal market conditions, the Fund invests at least
  80% of its Managed Assets (as defined in this Prospectus) in a diversified portfolio of convertible securities and non-convertible
  income producing securities. Under normal market conditions, the Fund will invest at least 30% of its Managed Assets in convertible
  securities and may invest up to 70% of its Managed Assets in non-convertible income securities. The Fund may invest without limitation
  in foreign</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="width: 80%"><p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">securities.
                         The Fund also uses a strategy of writing (selling) covered call options on up to 25% of the securities held
                         in the portfolio, thus generating option writing premiums.</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;Investment Objective and Policies&#8221; and &#8220;The Fund&#8217;s Investments&#8221; in this Prospectus.</span></p>
</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks</b></span></td>
  <td><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See &#8220;Risks&#8221;
      in this Prospectus and the information contained under the heading &#8220;Investment Objective, Policies and Principal Risks&#8212;
      Principal Risks&#8221; in the Fund&#8217;s Annual Report. Investors should consider the specific risk factors and special considerations
      associated with investing in the Fund. An investment in the Fund is subject to investment risk, including the possible loss of
      your entire investment. A Prospectus Supplement relating to an offering of the Fund&#8217;s securities may identify additional
      risk associated with such offering.</span></p>
      <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Leverage</b></span></td>
  <td><p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
      part of its investment strategy, the Fund utilizes leverage to finance the purchase of additional securities that provide increased
      income and potentially greater appreciation potential to common shareholders than could be achieved from a portfolio that is not
      leveraged. The Fund may utilize leverage up to the limits imposed by the Investment Company Act of 1940, as amended (the &#8220;1940
      Act&#8221;). Under the 1940 Act, the Fund may utilize leverage in the form of indebtedness in an aggregate amount up to 33 1 /
      3% of the Fund&#8217;s Managed Assets (including the proceeds of such leverage) immediately after incurring such indebtedness.
      Under the 1940 Act, the Fund may utilize leverage in the form of preferred shares in an aggregate amount of up to 50% of the Fund&#8217;s
      total assets (including the proceeds of such leverage) immediately after such issuance. The Fund may also invest in reverse repurchase
      agreements to the maximum extent permitted by the SEC and/or SEC staff rules, guidance or positions.</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund has entered into a senior secured credit agreement dated December 15, 2017, as amended from time to time through the date hereof,
with a financial institution (the &#8220;Credit Agreement&#8221;) pursuant to which the Fund may borrow up to $158 million. As of April
30, 2024, outstanding borrowings under the Credit Agreement were approximately $157 million, which represented approximately 21.5% of
the Fund&#8217;s Managed Assets as of such date. In addition, as of April 30, 2024, the Fund had reverse repurchase agreements outstanding
representing leverage equal to approximately 21.5% of the Fund&#8217;s Managed Assets as of such date. As of April 30, 2024, the Fund&#8217;s
total financial leverage, through indebtedness under the Credit Agreement and reverse repurchase agreements, represented approximately
43.0% of the Fund&#8217;s Managed Assets.</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Fund may engage in certain derivatives transactions that have economic characteristics similar to leverage to the extent
permitted by the SEC and/or SEC staff rules, guidance or positions.</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
use of leverage is a speculative technique that involves special risks. There can be no assurance that the Fund&#8217;s leveraging strategy
will be successful. See &#8220;Use of Leverage&#8221; in this Prospectus and &#8220;Investment Objective, Policies and Principal Risks&#8212;Principal
Risks&#8212;Leverage Risk&#8221; in the Fund&#8217;s Annual Report.</span></p>
</td></tr>
</table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Management of the Fund</b></span></td>
  <td style="width: 80%"><p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advent
                         is responsible for the daily management of the Fund&#8217;s portfolio of investments, which includes buying
                         and selling securities for the Fund, as well as investment research. Advent is a registered investment adviser,
                         based in New York, which specializes in convertible and high-yield securities for institutional and individual
                         investors. The firm was established by Tracy V. Maitland, a former Director in the Convertible Securities sales
                         and trading division of Merrill Lynch. Advent&#8217;s investment discipline emphasizes capital structure research,
                         encompassing equity fundamentals as well as credit research, with a focus on cash flow and asset values while
                         seeking to maximize total return. As of May 31, 2024 Advent managed more than $7.8 billion in assets.</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Adviser receives an annual fee from the Fund based on the average value of the Fund&#8217;s Managed Assets. If the average value of the
Fund&#8217;s Managed Assets (calculated monthly) is greater than $250 million, the fee will be a maximum amount equal to 0.54% of the
average value of the Fund&#8217;s Managed Assets.</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fee paid to the Adviser is calculated on the basis of the Fund&#8217;s Managed Assets, including proceeds from leverage, so the fees
paid to the Adviser will be higher when leverage is utilized. The Fund bears the portion of the management fee attributable to assets
purchased with the proceeds of leverage and therefore common shareholders effectively bear the entire management fee.</span></p>
</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Distributions</b></span></td>
  <td><p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
      Fund intends to pay substantially all of its net investment income to Common Shareholders through monthly distributions. In addition,
      the Fund intends to distribute any net long-term capital gains to Common Shareholders at least annually. The Fund expects that
      distributions paid on the Common Shares will consist primarily of (i) investment company taxable income, which includes, among
      other things, ordinary income, net short-term capital gain and income from certain hedging and interest rate transactions, (ii)
      net capital gain (which is the excess of net long-term capital gain over net short-term capital loss), and/or (iii) return of capital.
      Distributions paid by the Fund for any particular month may be comprised of more or less than the amount of net investment income
      from that monthly period. As a result, all or a portion of a distribution may be deemed a return of capital (which is in effect
      a partial return of the amount a Common Shareholder invested in the Fund) up to the amount of the Common Shareholder&#8217;s tax
      basis in their Common Shares, which would reduce such tax basis.</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Fund&#8217;s distributions have historically included, and may in the future include, a significant portion of return of capital. For
the fiscal year ended October 31, 2023, the Fund&#8217;s distributions were comprised of approximately 28.04% ordinary income and 71.96%
return of capital.</b> Accordingly, shareholders should not assume that the source of a distribution from the Fund is net income or profit,
and the Fund&#8217;s distributions should not be used as a measure of performance or confused with yield or income. Return of capital
is the return of a portion of the shareholder&#8217;s original investment up to the amount of the Common Shareholder&#8217;s tax basis
in their Common Shares, which would reduce such tax basis. Although a return of</span></p>
</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="width: 80%"><p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">capital
                         may not be taxable, it will generally increase the Common Shareholder&#8217;s potential gain or reduce the Common
                         Shareholder&#8217;s potential loss on any subsequent sale or other disposition of Common Shares, which may increase
                         taxes payable by a Common Shareholder or reduce a Common Shareholder&#8217;s loss deduction in connection with
                         such sale or other disposition. Common Shareholders should not assume that the source of a distribution from
                         the Fund is net income or profit, and Common Shareholders who receive distributions that include return of capital
                         should not assume that such return of capital is derived from the Fund&#8217;s investments.</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternatively,
the Fund may also distribute less than its net investment income in a particular period. The undistributed net investment income may
be available to supplement future common share distributions. Undistributed net investment income is included in the Common Shares&#8217;
net asset value, and, correspondingly, distributions from net investment income will reduce the Common Shares&#8217; net asset value.</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
each distribution that does not consist solely of net investment income, the Fund will issue a notice to shareholders that will provide
estimated information regarding the amount and composition of the distribution. The amounts and sources of distributions reported in
each notice will be estimated, are likely to change over time and are not provided for tax reporting purposes. The final determination
of such amounts will be made and reported to shareholders after the end of the calendar year when the Fund determines its earnings and
profits for the year. The actual amounts and sources of the amounts for accounting and tax reporting purposes will depend upon the Fund&#8217;s
investment experience during its full fiscal year and may be subject to changes based on tax regulations. The Fund will send each shareholder
a Form 1099-DIV for the calendar year that will tell shareholders how to report distributions for federal income tax purposes.</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s distribution rate is not constant and the amount of distributions, when and if declared by the Fund&#8217;s Board of Trustees,
is subject to change based on the performance of the Fund.</span></p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&#8220;Distributions&#8221; in this Prospectus.</span></p>
</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Listing and Symbol</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s currently outstanding common shares
  are, and common shares offered by this Prospectus will be, listed on the NYSE under the symbol &#8220;AVK.&#8221;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-Takeover Provisions in the</b></span></p>
      <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund&#8217;s Governing Documents</b></span></p></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund presently has provisions in its Governing Documents
  which could have the effect of limiting, in each case, (i) the ability of other entities or persons to acquire control of the Fund,
  (ii) the Fund&#8217;s freedom to engage in certain transactions or (iii) the ability of the Fund&#8217;s Board of Trustees or shareholders
  to amend the Governing Documents or effectuate changes in the Fund&#8217;s management. See &#8220;Anti-Takeover Provisions in the Fund&#8217;s
  Governing Documents&#8221; in this Prospectus.</span></td></tr>
</table>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="width: 80%"><p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                         addition, as a Delaware statutory trust, the Fund is subject to the control share acquisition statute (the &#8220;Control
                         Share Statute&#8221;) contained in Subchapter III of the Delaware Statutory Trust Act (the &#8220;DSTA&#8221;),
                         which became automatically applicable to listed closed- end funds, such as the Fund, upon its effective date
                         of August 1, 2022 (the &#8220;Effective Date&#8221;). The Control Share Statute provides that an acquirer of
                         shares above a series of voting power thresholds has no voting rights under the DSTA or the governing documents
                         of the Fund with respect to shares acquired in excess of that threshold (i.e., the &#8220;control shares&#8221;)
                         unless approved by shareholders. See &#8220;Certain Provisions of Delaware Law, the Declaration of Trust and
                         By-Laws&#8212;Delaware Control Share Statute.</span></p>
</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tax Matters</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund has elected to be treated and intends to continue
  to qualify each year as a regulated investment company (&#8220;RIC&#8221;) under subchapter M of the Internal Revenue Code of 1986,
  as amended (the &#8220;Code&#8221;). See &#8220;Tax Matters.&#8221;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Administrator</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MUFG Investor Services (US), LLC serves as the Fund&#8217;s
  Administrator. Pursuant to an administration agreement with the Fund, MUFG provides certain administrative, bookkeeping and accounting
  services to the Fund.</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Servicing Agent</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guggenheim Funds Distributors, LLC acts as servicing
  agent to the Fund. The Servicing Agent is located at 227 West Monroe Street, Chicago, IL 60606. Pursuant to a servicing agreement with
  the Fund, the Servicing Agent provides the Fund a variety of services, including (i) replying to requests for information concerning
  the Fund from shareholders or prospective shareholders, brokers or the public; (ii) aiding in the secondary market support of the Fund
  through regular written and oral communications with the Fund&#8217;s NYSE designated market maker, the closed-end fund analyst community
  and various information providers specializing in the dissemination of closed-end fund information; (iii) coordinating and overseeing
  activities of the Fund&#8217;s administrator; (iv) developing and maintaining a website for the Fund and (v) overseeing, in consultation
  with, and as agreed by, Advent matters relating to the conduct and administration of meetings of the Board of Trustees and committees
  thereof.</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Custodian</b></span></td>
  <td><p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
      securities owned by the Fund and all cash, including proceeds from the sale of securities in the Fund&#8217;s investment portfolio,
      are held by The Bank of New York Mellon, as custodian (the &#8220;Custodian&#8221;). The Custodian is responsible for holding all
      securities, other investments and cash, receiving and paying for securities purchased, delivering against payment securities sold,
      receiving and collecting income from investments, making all payments covering expenses and performing other administrative duties,
      all as directed by authorized persons.</span></p>
</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer Agent</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computershare Trust Company, N.A. serves as the Fund&#8217;s
  transfer agent.</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="font: bold 10pt Times LT Std; margin: 4.5pt 12.05pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt"></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 15.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<p style="font: bold 10pt Times LT Std; margin: 5pt 17.9pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY
OF FUND <span style="letter-spacing: -0.1pt">EXPENSES</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table contains information about the costs and expenses that common shareholders will bear directly or indirectly. The table
is based on the capital structure of the Fund as of April 30, 2024 (except as noted below). The purpose of the table and the example
below is to help you understand the fees and expenses that you, as a common shareholder, would bear directly or indirectly.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Shareholder
Transaction Expenses</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="width: 80%">Sales load paid by common shareholders (as a percentage of offering
price)</td>
  <td style="text-align: center; width: 20%">&#8212;%<sup>(1)</sup></td></tr>
<tr style="vertical-align: top; text-align: left; background-color: White">
  <td>Offering expenses borne by the Fund (as a percentage of offering
price)</td>
  <td style="text-align: center">&#8212;%<sup>(1)</sup></td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td>Dividend Reinvestment Plan fees</td>
  <td style="text-align: center">None<sup>(2)</sup></td></tr>
</table>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="text-align: left; padding-bottom: 1pt; width: 80%; vertical-align: bottom"><b>Annual Expenses</b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="border-bottom: Black 1pt solid; text-align: center; width: 20%"><p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
                                            a Percentage of Net Assets Attributable to Common Shares</b></span></p>
</td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management fee<sup>(3)</sup></span></td>
  <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.95%</span></td></tr>
<tr style="vertical-align: top; text-align: left; background-color: White">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest Expenses<sup>(4)</sup></span></td>
  <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.21%</span></td></tr>
<tr style="vertical-align: top; text-align: left; background-color: rgb(204,238,255)">
  <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Expenses<sup>(5)</sup></span></td>
  <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.83%</span></td></tr>
<tr style="vertical-align: top; text-align: left; background-color: White">
  <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total annual expenses</span></td>
  <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.99%</span></td></tr>
</table>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"></p>

<p style="font: 10pt Times LT Std Roman; margin: 6.6pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times LT Std Roman; margin: 6.6pt 0 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 10%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times LT Std Roman; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt/91% Times LT Std Roman; width: 100%; margin-top: 7.6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 6pt"/><td style="width: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt; line-height: 91%"><sup>(1)</sup></span></td><td style="text-align: justify; padding-right: 19.85pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            common shares are sold to or through underwriters, a prospectus or prospectus supplement
                                            will set forth any applicable sales load and the estimated offering expenses borne by the
                                            Fund.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt/91% Times LT Std Roman; width: 100%; margin-top: 4.95pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 6pt"/><td style="width: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt; line-height: 91%"><sup>(2)</sup></span></td><td style="text-align: justify; padding-right: 28.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
                                            shareholders will incur brokerage charges if they direct Computershare Trust Company, N.A.,
                                            as Plan Agent for the common shareholders, to sell their common shares held in a dividend
                                            reinvestment <span style="letter-spacing: -0.1pt">account.</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt/91% Times LT Std Roman; width: 100%; margin-top: 4.85pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 6pt"/><td style="width: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt; line-height: 91%"><sup>(3)</sup></span></td><td style="padding-right: 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Fund pays the Adviser an annual management fee, payable monthly in arrears, in an amount
                                            equal to 0.54% of the Fund&#8217;s average daily Managed Assets. Common shareholders bear
                                            the portion of the investment advisory fee attributable to the assets purchased with the
                                            proceeds of leverage, which means that common shareholders effectively bear the entire management
                                            fee. The contractual management fee rate of 0.54% of the Fund&#8217;s Managed Assets represents
                                            an effective management fee rate of 0.95% of net assets attributable to common shares, assuming
                                            leverage of 43.0% of the Fund&#8217;s Managed Assets (the Fund&#8217;s outstanding leverage
                                            as of April 30, 2024).</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt/91% Times LT Std Roman; width: 100%; margin-top: 4.75pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 6pt"/><td style="width: 36pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt; line-height: 91%"><sup>(4)</sup></span></td><td style="padding-right: 14.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            interest payments on borrowed funds and interest expense on reverse repurchase agreements.
                                            Interest payments on borrowed funds is based upon the Fund&#8217;s outstanding borrowings
                                            under the Credit Agreement as of April 30, 2024, in an amount equal to 21.5% of the Fund&#8217;s
                                            Managed Assets, at an annual interest rate cost to the Fund of 5.97% (the weighted average
                                            interest rate paid by the Fund during the six months ended April 30, 2024). Interest expenses
                                            on reverse repurchase agreements is based on the Fund&#8217;s outstanding reverse repurchase
                                            agreements as of April 30, 2024, representing 21.5% of the Fund&#8217;s Managed Assets at
                                            an annual interest rate cost to the Fund of 4.80% (the weighted average interest rate cost
                                            incurred by the Fund during the six months ended April 30, 2024). The actual amount of interest
                                            expense incurred by the Fund will vary over time in accordance with the amount of borrowings
                                            and reverse repurchase agreements and variations in market interest rates.</span></td></tr></table>

<p style="font: 10pt Times LT Std Roman; margin: 3.9pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.25pt"><sup>(5)</sup></span><sup><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></sup><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;
&#160;&#160;&#160;&#160; &#8239;&#8239;&#8239;&#8220;Other Expenses&#8221; are based on estimated amounts for the six months ended April 30, <span style="letter-spacing: -0.1pt">2024.</span></span></p>


<!-- Field: Page; Sequence: 44 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 0 0 7.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Example</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 12.4pt 0 7.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following example illustrates the expenses that you would pay on a $1,000 investment in common shares, assuming (1) total annual
expenses of 5.99% of net assets attributable to common shares, and (2) a 5% annual return. The example assumes that the estimated
Total Annual Expenses set forth in the Annual Expenses table are accurate and that all dividends and distributions are reinvested at
net asset value per common share. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate
of return may be greater or less than the hypothetical 5% return shown in the example.</span></p>

<p style="font: 6pt Times LT Std Roman; margin: 0.25pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times LT Std Roman; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; width: 25%; padding-top: 0.5pt; padding-right: 0.55in; text-align: right; line-height: 8.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1
    <span style="letter-spacing: -0.2pt">Year</span></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 25%; padding-top: 0.5pt; padding-left: 0.95pt; text-align: center; line-height: 8.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3
    <span style="letter-spacing: -0.2pt">Years</span></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 25%; padding-top: 0.5pt; padding-left: 1.25pt; text-align: center; line-height: 8.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5
    <span style="letter-spacing: -0.2pt">Years</span></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 25%; padding-top: 0.5pt; padding-left: 37.45pt; text-align: center; line-height: 8.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt"><b>10
    </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.4pt">Years</span></b></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-top: 0.9pt; padding-right: 45.5pt; text-align: right; line-height: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.25pt">$60</span></td>
    <td style="padding-top: 0.9pt; padding-left: 0.95pt; text-align: center; line-height: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">$177</span></td>
    <td style="padding-top: 0.9pt; padding-left: 1.25pt; text-align: center; line-height: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">$292</span></td>
    <td style="padding-top: 0.9pt; padding-left: 37.5pt; text-align: center; line-height: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">$570</span></td></tr>
  </table>
<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 19.55pt 0 7.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Example should not be considered a representation of future expenses or returns. Actual expenses may be higher or lower than those assumed.
Moreover, the Fund&#8217;s actual rate of return may be higher or lower than the hypothetical 5% return shown in the example.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 14.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">FINANCIAL
HIGHLIGHTS</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 7.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial highlights table is intended to help you understand the Fund&#8217;s financial performance for the periods presented.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 23.7pt 0 7.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial highlights for the six-month period ended April 30, 2024 are incorporated by reference to the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126824000124/gug87515avk-ncsr.htm">Semi-Annual Report</a>
to Shareholders to the period ended April 30, 2024, as contained in the Fund&#8217;s Form N-CSRS filed with the SEC on July 3, 2024.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 38.65pt 0 7.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial highlights for the fiscal years ended October 31, 2023, 2022, 2021, 2020 and 2019 are incorporated by reference to the
Fund&#8217;s Annual Report to shareholders for the year ended October 31, 2023, as contained in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Form
N-CSR</a> filed with the SEC on December 29, 2023, and has been audited by PricewaterhouseCoopers LLP, independent registered public
accounting firm for the Fund. The report of PricewaterhouseCoopers LLP is included in the Fund&#8217;s Annual Report to shareholders
for the year ended October 31, 2023, as contained in the Registrant&#8217;s Form N-CSR filed with the SEC on December 29, 2023, and
is incorporated herein by reference.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 7.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial highlights for the fiscal years ended October 31, 2018, 2017, 2016, 2015 and 2014 are incorporated by reference to the Fund&#8217;s
Annual Report to shareholders for the year ended October 31, 2018, as contained in the Registrant&#8217;s Form <a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180419000003/gug75351-ncsr.htm">N-CSR</a> filed with the SEC
on January 4, 2019.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Bold,serif; margin: 0 14.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SENIOR
<span style="letter-spacing: -0.1pt">SECURITIES</span></b></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 7.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information about the Fund&#8217;s outstanding senior securities as of the end of each fiscal set forth below.
The information in this table for the fiscal years ended October 31, 2023, 2022, 2021, 2020 and 2019 has been audited by PricewaterhouseCoopers
LLP, independent registered public accounting firm for the Fund. The report of PricewaterhouseCoopers LLP is included in the Fund&#8217;s
Annual Report to shareholders for the year ended October 31, 2023, as contained in the Registrant&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Form N-CSR</a> filed with the SEC
on December 29, 2023, and is incorporated herein by reference.</span></p>


<!-- Field: Page; Sequence: 45 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Senior
Securities Representing <span style="letter-spacing: -0.1pt">Indebtedness</span></span></p>

<p style="font: 9.5pt Times LT Std Bold,serif; margin: 0.15pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times LT Std Roman; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: #81837D 1pt solid; width: 27%; padding-top: 9.45pt; padding-left: 2pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt"><b>Fiscal
    Year</b></span><b> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">Ended</span></b></td>
    <td style="border-bottom: #81837D 1pt solid; width: 39%; padding-right: 27pt; padding-left: 60.9pt; text-indent: 27.75pt; text-align: left; line-height: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt"><b>Principal
    </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount Outstanding</span></b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)(2)</sup></span></td>
    <td style="border-bottom: #81837D 1pt solid; width: 34%"><p style="font: 8.5pt/9.6pt Times LT Std Bold,serif; margin: 0.45pt 0 0 6.3pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Asset
                                            <span style="letter-spacing: -0.1pt">Coverage</span></b></span></p>
    <p style="font: 8.5pt/7.8pt Times LT Std Bold,serif; margin: 0 0 0 6.3pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Per
    $1,000 of Principal <span style="letter-spacing: -0.1pt">Amount</span></b></span></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 2.15pt; padding-left: 2pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, <span style="letter-spacing: -0.2pt">2023</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 2.15pt; padding-right: 48.2pt; text-align: right; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$173,000,000</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 2.15pt; padding-left: 6.3pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$3,159</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 2pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, <span style="letter-spacing: -0.2pt">2022</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-right: 48.2pt; text-align: right; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$173,000,000</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 6.3pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$3,480</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 2pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, <span style="letter-spacing: -0.2pt">2021</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-right: 48.2pt; text-align: right; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$168,000,000</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 6.3pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$5,139</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 2pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, <span style="letter-spacing: -0.2pt">2020</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-right: 48.2pt; text-align: right; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$168,000,000</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 6.3pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$4,300</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 2pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, <span style="letter-spacing: -0.2pt">2019</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-right: 48.2pt; text-align: right; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$210,000,000</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 6.3pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$3,686</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 2pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, <span style="letter-spacing: -0.2pt">2018</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-right: 48.2pt; text-align: right; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$235,000,000</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 6.3pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$3,381</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 2pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, <span style="letter-spacing: -0.2pt">2017</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-right: 48.2pt; text-align: right; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$150,000,000</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 6.3pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$3,356</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 2pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, <span style="letter-spacing: -0.2pt">2016</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-right: 48.2pt; text-align: right; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$170,000,000</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 6.3pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$3,256</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 2pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, <span style="letter-spacing: -0.2pt">2015</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-right: 48.2pt; text-align: right; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$170,000,000</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 6.3pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$3,374</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 2pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, <span style="letter-spacing: -0.2pt">2014</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-right: 48.2pt; text-align: right; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$170,000,000</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.35pt; padding-left: 6.3pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$3,635</span></td></tr>
  </table>
<table cellpadding="0" cellspacing="0" style="font: 11pt/87% Times LT Std Roman; width: 100%; margin-top: 8.75pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 6.05pt"/><td style="width: 35.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt"><sup>(1)</sup></span></td><td style="padding-right: 25.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
                                            amount outstanding represents the principal amount owed by the Fund to lenders under credit
                                            facility arrangements in place at the time.</span></td></tr></table>

<p style="font: 11pt Times LT Std Roman; margin: 1.95pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.25pt"><sup>(2)</sup></span><sup><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;</span></sup><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;
&#8239;&#8239;&#8239;&#8239;For each fiscal year listed above, the Fund also had outstanding leverage through reverse repurchase <span style="letter-spacing: -0.1pt">agreements.</span></span></p>


<!-- Field: Page; Sequence: 46 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
<span style="letter-spacing: -0.2pt">FUND</span></span></p>

<p style="font: 10pt/97% Times LT Std Roman; margin: 5.9pt 9.05pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advent
Convertible and Income Fund is a diversified, closed-end management investment company registered under the 1940 Act. The Fund was organized
as a Delaware statutory trust on February 18, 2003. The common shares commenced trading on the NYSE on April 29, 2003. The Fund&#8217;s
principal office is located at 888 Seventh Ave., 31st Floor, New York, New York 10019, and its telephone number is (212) 482-1600.</span></p>

<p style="font: 10pt/97% Times LT Std Roman; margin: 4.95pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advent
Capital Management, LLC serves as the Fund&#8217;s investment adviser and is responsible for the management of the Fund.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 2.05pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0.05pt 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE
OF <span style="letter-spacing: -0.1pt">PROCEEDS</span></span></p>

<p style="font: 10pt/97% Times LT Std Roman; margin: 5.9pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund registered $150,000,000 aggregate initial offering price of Securities pursuant to the registration statement of which this Prospectus
is a part. Unless otherwise specified in a Prospectus Supplement, the Fund intends to invest the net proceeds of an offering of Securities
in accordance with its investment objective and policies as stated in this Prospectus. It is currently anticipated that the Fund will
be able to invest substantially all of the net proceeds of an offering of Securities in accordance with its investment objective and
policies within three months after the completion of such offering. Pending the full investment of the proceeds of an offering, it is
anticipated that all or a portion of the proceeds will be invested in U.S. Government securities or high grade, short-term money market
instruments, which have returns substantially lower than those the Fund anticipates earning once it has fully invested the proceeds of
an offering in accordance with its investment objective. A delay in the anticipated use of proceeds could lower returns and reduce the
Fund&#8217;s distribution to common shareholders.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 1.95pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">MARKET
AND NET ASSET VALUE INFORMATION</span></p>

<p style="font: 10pt/97% Times LT Std Roman; margin: 5.95pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s currently outstanding common shares are, and the common shares offered pursuant to this Prospectus Supplement and the accompanying
Prospectus will be, subject to notice of issuance, listed on the NYSE. The common shares commenced trading on the NYSE on April 29, 2003.</span></p>

<p style="font: 10pt/97% Times LT Std Roman; margin: 4.95pt 7.8pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s common shares have traded both at a premium and at a discount to the Fund&#8217;s net asset value per share. There can be
no assurance that the common shares will trade at a premium or discount to net asset value after the offering. Shares of closed-end investment
companies frequently trade at a discount to net asset value. The Fund&#8217;s net asset value will be reduced immediately following an
offering of the common shares due to the costs of such offering, which will be borne entirely by the Fund. The sale of common shares
by the Fund (or the perception that such sales may occur) may have an adverse effect on prices of common shares in the secondary market.
An increase in the number of common shares available for sale may result in downward pressure on the market price for common shares.
See &#8220;Risks&#8212;Market Discount Risk&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual Report</a>, which is incorporated by reference <span style="letter-spacing: -0.1pt">herein.</span></span></p>

<p style="font: 3.5pt Times LT Std Roman; margin: 0.35pt 0 0.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times LT Std Roman; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="5" style="padding-right: 14pt; padding-left: 261.4pt; text-align: center; line-height: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corresponding
    Net Asset Value Per</b></span></td>
    <td colspan="2" style="padding-left: 14.1pt; text-align: center; line-height: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corresponding
    Premium/ (Discount) as a Percentage of</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: #81837D 1pt solid; padding-top: 0.45pt; padding-left: 47.85pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
    <span style="letter-spacing: -0.1pt">Price</span></b></span></td>
    <td colspan="2" style="border-bottom: #81837D 1pt solid; padding-top: 0.45pt; padding-left: 34.5pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    <span style="letter-spacing: -0.1pt">Share</span></b></span></td>
    <td colspan="2" style="border-bottom: #81837D 1pt solid; padding-top: 0.45pt; padding-left: 38.6pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
    Asset <span style="letter-spacing: -0.1pt">Value</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-bottom: #81837D 1pt solid; width: 21%; padding-top: 0.3pt; padding-left: 2pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
    Quarter <span style="letter-spacing: -0.1pt">Ended</span></b></span></td>
    <td style="border-bottom: #81837D 1pt solid; width: 13%; padding-top: 0.15pt; padding-right: 3.2pt; padding-left: 3.15pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt"><b>High</b></span></td>
    <td style="border-top: #81837D 1pt solid; border-bottom: #81837D 1pt solid; width: 13%; padding-top: 0.15pt; padding-right: 0.15pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.25pt"><b>Low</b></span></td>
    <td style="border-bottom: #81837D 1pt solid; width: 13%; padding-top: 0.15pt; padding-right: 0.05pt; padding-left: 3.2pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt"><b>High</b></span></td>
    <td style="border-bottom: #81837D 1pt solid; width: 12%; padding-top: 0.15pt; padding-left: 4.75pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.25pt"><b>Low</b></span></td>
    <td style="border-bottom: #81837D 1pt solid; width: 14%; padding-top: 0.15pt; padding-left: 23.55pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt"><b>High</b></span></td>
    <td style="border-bottom: #81837D 1pt solid; width: 14%; padding-top: 0.15pt; padding-right: 4.7pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.25pt"><b>Low</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 2pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    31, <span style="letter-spacing: -0.2pt">2024</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 2.9pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$12.85</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 0.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$11.58</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 3.1pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$12.28</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 1pt; padding-left: 4.75pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$12.06</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 24.1pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">4.64%</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 20pt; text-align: right; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">3.98%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 2pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    30, <span style="letter-spacing: -0.2pt">2024</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 2.9pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$12.10</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 0.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$11.23</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 3.1pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$12.59</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 1pt; padding-left: 4.75pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$11.95</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 22.7pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">3.89%</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 21.5pt; text-align: right; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">6.03%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 2pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, <span style="letter-spacing: -0.2pt">2024</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 2.9pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$11.71</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 0.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$9.64</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 3.1pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$12.39</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 1pt; padding-left: 4.75pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$10.86</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 22.7pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">5.49%</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 19.35pt; text-align: right; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">11.23%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 2pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, <span style="letter-spacing: -0.2pt">2023</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 2.9pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$11.96</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 0.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$9.27</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 3.1pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$12.79</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 1pt; padding-left: 4.75pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$10.81</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 22.7pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">6.49%</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 19.35pt; text-align: right; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">14.25%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 2pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    31, <span style="letter-spacing: -0.2pt">2023</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 2.9pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$11.96</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 0.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$11.01</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 3.1pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$12.89</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 1pt; padding-left: 4.75pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$11.99</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 22.7pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">7.21%</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 20pt; text-align: right; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">8.17%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 2pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    30, <span style="letter-spacing: -0.2pt">2023</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 2.9pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$13.13</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 0.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$11.06</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 3.1pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$13.60</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 1pt; padding-left: 4.75pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$11.90</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 22.7pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">3.46%</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 20pt; text-align: right; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">7.06%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.2pt; padding-left: 2pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, <span style="letter-spacing: -0.2pt">2023</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.2pt; padding-right: 2.9pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$12.57</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.2pt; padding-right: 0.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$10.81</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.2pt; padding-right: 3.1pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$13.23</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.2pt; padding-right: 1pt; padding-left: 4.75pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$12.22</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.2pt; padding-left: 22.7pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">4.99%</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.2pt; padding-right: 19.35pt; text-align: right; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">11.54%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 2pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, <span style="letter-spacing: -0.2pt">2022</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 2.9pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$14.70</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 0.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$10.43</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 3.1pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$14.15</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 1pt; padding-left: 4.75pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$11.73</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 24.1pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">3.89%</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 19.35pt; text-align: right; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">11.08%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 2pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    31, <span style="letter-spacing: -0.2pt">2022</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 2.9pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$14.53</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 0.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$11.75</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 3.1pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$15.08</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 1pt; padding-left: 4.75pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$12.38</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 22.7pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">3.65%</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 20pt; text-align: right; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">5.09%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 2pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    30, <span style="letter-spacing: -0.2pt">2022</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 2.9pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$16.87</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 0.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$14.18</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 3.1pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$16.73</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 1pt; padding-left: 4.75pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$14.99</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 24.1pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">0.84%</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 20pt; text-align: right; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">5.40%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 2pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, <span style="letter-spacing: -0.2pt">2022</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 2.9pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$19.39</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 0.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$15.59</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 3.1pt; padding-left: 3.15pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$20.31</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 1pt; padding-left: 4.75pt; text-align: center; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$16.62</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-left: 22.7pt; text-align: left; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">4.53%</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 1.15pt; padding-right: 20pt; text-align: right; line-height: 9.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span style="letter-spacing: -0.1pt">6.20%</span></span></td></tr>
  </table>
<p style="font: 10pt/97% Times LT Std Roman; margin: 9.35pt 13.2pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of August 23, 2024, 34,600,881 common shares were outstanding. The last reported sales price, net asset value per share and percentage
premium to net asset value per share on August 23, 2024 was $12.69, $12.36 and 2.67%, respectively. The Fund cannot predict whether its
common shares will trade in the future at a premium to or discount from net asset value, or the level of any premium or discount. Shares
of closed-end investment companies frequently trade at a discount from net asset value.</span></p>


<!-- Field: Page; Sequence: 47 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 2.95pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INVESTMENT
OBJECTIVE AND <span style="letter-spacing: -0.1pt">POLICIES</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 5.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the headings &#8220;Investment Objective, Policies and Principal Risks&#8212;Investment Objective and Policies,&#8221;
&#8220;About the Fund Manager&#8212;Investment Philosophy&#8221; and &#8220;About the Fund Manager&#8212; Investment Process&#8221; in
the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual Report</a> is incorporated herein by reference.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 2.95pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
FUND&#8217;S <span style="letter-spacing: -0.1pt">INVESTMENTS</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 32.85pt 0 5.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s investment portfolio may consist of investments in the following types of securities. There is no guarantee that the fund
will buy all of the types of securities or use all of the investment techniques that are described herein.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 11.2pt 0 5.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Convertible
and Non-Convertible Securities Allocation</i>. Under normal market conditions, the Fund invests at least 80% of its Managed Assets (as
defined in this Prospectus) in a diversified portfolio of convertible securities and non-convertible income producing securities. Under
normal market conditions, the Fund will invest at least 30% of its Managed Assets in convertible securities and may invest up to 70%
of its Managed Assets in non-convertible income securities. The Fund may invest without limitation in convertible securities.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 10.85pt 0 23.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Convertible
Securities</span>. A convertible security is a bond, debenture, note, stock or other similar security that may be converted into or
exchanged for a prescribed amount of common stock or other equity security of the same or a different issuer within a particular
period of time at a specified price or formula. A convertible security may also be structured so that it is convertible at the
option of the holder or the issuer, or subject to mandatory conversion. Before conversion, convertible securities have
characteristics similar to nonconvertible debt securities in that they ordinarily provide a stream of income with generally higher
yields than those of common stock of the same or similar issuers. Convertible securities are senior in rank to common stock in a
corporation&#8217;s capital structure and, therefore, generally entail less risk than the corporation&#8217;s common stock, although
the extent to which such risk is reduced depends in large measure upon the degree to which the convertible security sells above its
value as a fixed income security.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 9.05pt 0 23.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund believes that the characteristics of convertible securities make them appropriate investments for an investment company seeking
a high level of total return on its assets. These characteristics include the potential for capital appreciation if the value of the
underlying common stock increases, the relatively high yield received from dividend or interest payments as compared to common stock
dividends and decreased risks of decline in value, relative to the underlying common stock due to their fixed income nature. As a result
of the conversion feature, however, the interest rate or dividend preference on a convertible security is generally less than would be
the case if the securities were not convertible. During periods of rising interest rates, it is possible that the potential for capital
gain on a convertible security may be less than that of a common stock equivalent if the yield on the convertible security is at a level
that causes it to sell at a discount.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 17.2pt 0 23.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Every
convertible security may be valued, on a theoretical basis, as if it did not have a conversion privilege. This theoretical value is determined
by the yield it provides in comparison with the yields of other securities of comparable character and quality that do not have a conversion
privilege. This theoretical value, which may change with prevailing interest rates, the credit rating of the issuer and other pertinent
factors, often referred to as the &#8220;investment value,&#8221; represents the security&#8217;s theoretical price support level.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13pt 0 23.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Conversion
value&#8221; is the amount a convertible security would be worth in market value if it were to be exchanged for the underlying equity
security pursuant to its conversion privilege. Conversion value fluctuates directly with the price of the underlying equity security,
usually common stock. If, because of low prices for the common stock, the conversion value is substantially below the investment value,
the price of the <span style="letter-spacing: -0.1pt">convertible security is governed principally by the factors described in the preceding
paragraph. If the conversion value rises near or above its investment value, the price of the convertible security generally will rise
above its investment value and, in addition, will sell at some premium over its conversion value. This premium represents the price investors
are willing to pay for the privilege of purchasing a fixed-income security with a possibility of capital appreciation due to the conversion
privilege. Accordingly, the conversion value of a convertible security is subject to equity risk, that is, the risk that the price of
an equity security will fall due to general market and economic conditions, perceptions regarding the industry in which the issuer participates
or the issuing</span></span></p>


<!-- Field: Page; Sequence: 48 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 0 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">company&#8217;s
particular circumstances. If the appreciation potential of a convertible security is not realized, its conversion value premium may not
be recovered.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Non-Convertible
Income Securities</span>. The Fund may also invest in income securities other than convertible securities that are expected to periodically
accrue or generate income for their holders. Such income securities include (i) fixed income securities such as bonds, debentures, notes,
preferred stock, short-term discounted Treasury Bills or certain securities of the U.S. government sponsored instrumentalities, as well
as money market mutual funds that invest in those securities, which, in the absence of an applicable exemptive order, will not be affiliated
with the Adviser, and (ii) common and preferred stocks of issuers that have historically paid periodic dividends. Fixed income securities
obligate the issuer to pay to the holder of the security a specified return, which may be either fixed or reset periodically in accordance
with the terms of the security. Fixed income securities generally are senior to an issuer&#8217;s common stock and their holders generally
are entitled to receive amounts due before any distributions are made to common stockholders. Common stocks, on the other hand, generally
do not obligate an issuer to make periodic distributions to holders.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 15.65pt 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market value of fixed income securities, especially those that provide a fixed rate of return, may be expected to rise and fall
inversely with interest rates and in general is affected by the credit rating of the issuer, the issuer&#8217;s performance and
perceptions of the issuer in the market place. The market value of callable or redeemable fixed income securities may also be
affected by the issuer&#8217;s call and redemption rights. In addition, it is possible that the issuer of fixed income securities
may not be able to meet its interest or principal obligations to holders. Further, holders of non-convertible fixed income
securities do not participate in any capital appreciation of the issuer.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 6pt 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may also invest in obligations of government sponsored instrumentalities. Unlike non-U.S. government securities, obligations of
certain agencies and instrumentalities of the U.S. government, such as the Government National Mortgage Association, are supported by
the &#8220;full faith and credit&#8221; of the U.S. government; others, such as those of the Export-Import Bank of the U.S., are supported
by the right of the issuer to borrow from the U.S. Treasury; others, such as those of the Federal National Mortgage Association, are
supported by the discretionary authority of the U.S. government to purchase the agency&#8217;s obligations; and still others, such as
those of the Student Loan Marketing Association, are supported only by the credit of the instrumentality. No assurance can be given that
the U.S. government would provide financial support to U.S. government sponsored instrumentalities if it is not obligated to do so by
law. Although the Fund may invest in all types of obligations of agencies and instrumentalities of the U.S. government, the Fund currently
intends to invest only in obligations that are supported by the &#8220;full faith and credit&#8221; of the U.S. government.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 7pt 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund also may invest in common stock of issuers that have historically paid periodic dividends or otherwise made distributions to common
stockholders. Unlike fixed income securities, dividend payments generally are not guaranteed and so may be discontinued by the issuer
at its discretion or because of the issuer&#8217;s inability to satisfy its liabilities. Further, an issuer&#8217;s history of paying
dividends does not guarantee that it will continue to pay dividends in the future. In addition to dividends, under certain circumstances
the holders of common stock may benefit from the capital appreciation of the issuer.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 8.2pt 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
stocks represent the residual ownership interest in the issuer and holders of common stock are entitled to the income and increase in
the value of the assets and business of the issuer after all of its debt obligations and obligations to preferred shareholders are satisfied.
Common stocks generally have voting rights.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
stocks fluctuate in price in response to many factors including historical and prospective earnings of the issuer, the value of its assets,
general economic conditions, interest rates, investor perceptions and market <span style="letter-spacing: -0.1pt">liquidity.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 9.05pt 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Synthetic
Convertible Securities</span>. The Fund may also invest in &#8220;synthetic&#8221; convertible securities, which, for purposes of its investment
policies, the Fund considers to be convertible securities. A synthetic convertible security may be created by the Fund or by a third
party by combining separate securities that possess the two principal characteristics of a traditional convertible security: an income
producing component and a convertible component. Synthetic convertible securities differ from convertible securities whose conversion
privilege may be evidenced by warrants attached to the security or acquired as part of a unit with the security. The income-producing
component is achieved by investing in non-convertible, income-producing securities such</span></p>


<!-- Field: Page; Sequence: 49 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 10.85pt 0 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
bonds, preferred stocks and money market instruments. The convertible component is achieved by investing in securities or instruments
such as warrants or options to buy common stock at a certain exercise price, or options on a stock index. Unlike a traditional convertible
security, which is a single security having a single market value, a synthetic convertible comprises two or more separate securities,
each with its own market value. Because the &#8220;market value&#8221; of a synthetic convertible security is the sum of the values of
its income producing component and its convertible component, the value of a synthetic convertible security may respond differently to
market fluctuations than a traditional convertible security. The Fund also may purchase synthetic convertible securities created by other
parties, including convertible structured notes. Convertible structured notes are income-producing debentures linked to equity. Convertible
structured notes have the attributes of a convertible security; however, the issuer of the convertible note (typically an investment
bank), rather than the issuer of the underlying common stock into which the note is convertible, assumes credit risk associated with
the underlying investment and the Fund in turn assumes credit risk associated with the issuer of the convertible note.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Covered
Call Option Strategy</i>. The Fund may use a strategy of writing (selling) covered call options on the securities held in the portfolio,
thus generating option writing premiums. The objective of this strategy is to generate current gains from option premiums to enhance
distributions payable to common shareholders. The Fund may write (sell) covered call options on up to 25% of the securities held in its
portfolio.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 9.05pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Options</i>.
An option on a security is a contract that gives the holder of the option, in return for a premium, the right to buy from (in the case
of a call) or sell to (in the case of a put) the writer of the option the security underlying the option at a specified exercise or &#8220;strike&#8221;
price. The writer of an option on a security has the obligation upon exercise of the option to deliver the underlying security upon payment
of the exercise price or to pay the exercise price upon delivery of the underlying security. Certain options, known as &#8220;American
style&#8221; options may be exercised at any time during the term of the option. Other options, known as &#8220;European style&#8221;
options, may be exercised only on the expiration date of the option.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 18.45pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an option written by the Fund expires unexercised, the Fund realizes on the expiration date a capital gain equal to the premium received
by the Fund at the time the option was written. If an option purchased by the Fund expires unexercised, the Fund realizes a capital loss
equal to the premium paid. Prior to the earlier of exercise or expiration, an exchange-traded option may be closed out by an offsetting
purchase or sale of an option of the same series (type, underlying security, exercise price and expiration). There can be no assurance,
however, that a closing purchase or sale transaction can be effected when the Fund desires. The Fund may sell put or call options it
has previously purchased, which could result in a net gain or loss depending on whether the amount realized on the sale is more or less
than the premium and other transaction costs paid on the put or call option when purchased. The Fund will realize a capital gain from
a closing purchase transaction if the cost of the closing option is less than the premium received from writing the option, or, if it
is more, the Fund will realize a capital loss. If the premium received from a closing sale transaction is more than the premium paid
to purchase the option, the Fund will realize a capital gain or, if it is less, the Fund will realize a capital loss. Net gains from
the Fund&#8217;s option strategy will be short-term capital gains which, for U.S. federal income tax purposes, will constitute net investment
company taxable <span style="letter-spacing: -0.1pt">income.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 10.85pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
part of its strategy, the Fund may not sell &#8220;naked&#8221; call options on individual securities, (<i>i.e., </i>options representing
more shares of the stock than are held in the portfolio). A call option written by the Fund on a security is &#8220;covered&#8221; if
the Fund owns the security or instrument underlying the call or has an absolute and immediate right to acquire that security or instrument
without additional cash consideration (or, if additional cash consideration is required, cash or other assets determined to be liquid
by the Adviser (in accordance with procedures established by the Board of Trustees) in such amount are segregated by the Fund&#8217;s
custodian) upon conversion or exchange of other securities held by the Fund. A call option is also covered if the Fund holds a call on
the same security as the call written where the exercise price of the call held is (i) equal to or less than the exercise price of the
call written, or (ii) greater than the exercise price of the call written, provided the difference is maintained by the Fund in segregated
assets determined to be liquid by the Adviser as described above.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Put
options are contracts that give the holder of the option, in return for a premium, the right to sell to the writer of the option the
security underlying the option at a specified exercise price at a specific time or times during the term of the option. These strategies
may produce a considerably higher return than the Fund&#8217;s primary strategy of covered call writing, but involve a higher degree
of risk and potential volatility.</span></p>


<!-- Field: Page; Sequence: 50 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund will write (sell) put options on individual securities only if the put option is &#8220;covered.&#8221; A put option written by
the Fund on a security is &#8220;covered&#8221; if the Fund segregates or earmarks assets determined to be liquid by the Adviser, as
described above, equal to the exercise price. A put option is also covered if the Fund holds a put on the same security as the put written
where the exercise price of the put held is (i) equal to or greater than the exercise price of the put written, or (ii) less than the
exercise price of the put written, provided the difference is maintained by the Fund in segregated or earmarked assets determined to
be liquid by the Adviser, as described above.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 30.75pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may sell put and call options on indices of securities. Options on an index differ from options on securities because (i) the
exercise of an index option requires cash payments and does not involve the <span style="letter-spacing: -0.1pt">actual purchase or
sale of securities, (ii) the holder of an index option has the right to receive cash upon exercise of the option if the level of the
index upon which the option is based is greater, in the case of a call, or less, in the case of a put, than the exercise price of
the option and (iii) index options reflect price-fluctuations in a group of securities or segments of the securities market rather
than price fluctuations in a single security.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Illiquid
Securities</i>. The Fund may invest no more than 20% of its Managed Assets in illiquid securities. Illiquid securities include
securities legally restricted as to resale, such as commercial paper issued pursuant to Section <span style="letter-spacing: -0.2pt">4(a)
(2) of the Securities Act and securities eligible for resale pursuant to Rule 144A thereunder. Section 4(a)(2) and Rule 144A
securities may, however, be treated as liquid by the Adviser pursuant to procedures adopted by the Board of Trustees, which require
consideration of factors such as trading activity, availability of market quotations and number of dealers willing to purchase the
security. If the Fund invests in Rule 144A securities, the level of portfolio illiquidity may be increased to the extent that
eligible buyers become uninterested in purchasing such securities.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 10.85pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
may be difficult to sell such securities at a price representing the fair value until such time as such securities may be sold publicly.
Where registration is required, a considerable period may elapse between a decision to sell the securities and the time when it would
be permitted to sell. Thus, the Fund may not be able to obtain as favorable a price as that prevailing at the time of the decision to
sell. The Fund may also acquire securities through private placements under which it may agree to contractual restrictions on the resale
of such securities. Such restrictions might prevent their sale at a time when such sale would otherwise be desirable.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described below, the Fund may invest a portion of its assets in privately offered convertible securities or similar instruments that
may be illiquid.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
Securities</i>. The Fund may invest without limitation in foreign securities. Investing in foreign securities may provide increased diversification
by adding securities from various foreign countries (i) that offer different investment opportunities, (ii) that generally are affected
by different economic trends and (iii) whose stock markets may not be correlated with U.S. markets. At the same time, these opportunities
and trends involve risks that may not be encountered in U.S. investments.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 29.05pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following considerations comprise both risks and opportunities not typically associated with investing in U.S. securities:
fluctuations in exchange rates of foreign currencies; possible imposition of exchange <span style="letter-spacing: -0.1pt">control
regulations or currency restrictions that would prevent cash from being brought back to the United States; less public information
with respect to issuers of securities; less government supervision of stock exchanges, securities brokers and issuers of securities;
lack of uniform accounting, auditing and financial reporting standards; lack of uniform settlement periods and trading practices;
less liquidity and frequently greater price volatility in foreign markets than in the United States; possible imposition of foreign
taxes; the possibility of expropriation or confiscatory taxation, seizure or nationalization of foreign bank deposits or other
assets; the adoption of foreign government restrictions and other adverse political, social or diplomatic developments that could
affect investment; difficulty in obtaining or enforcing a court judgment abroad; sometimes less advantageous legal, operational and
financial protections applicable to foreign sub-custodial arrangements; and the historically lower level of responsiveness of
foreign management to shareholder concerns (such as dividends and return on investment).</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may purchase sponsored American Depository Receipts (&#8220;ADRs&#8221;) or U.S. dollar denominated securities of foreign issuers.
ADRs are receipts issued by U.S. banks or trust companies in respect of securities of foreign issuers held on deposit for use in the
U.S. securities markets.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 32.85pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
risks described above for foreign securities, including the risks of nationalization and expropriation of assets, are typically increased
to the extent that the Fund invests in companies headquartered in developing, or emerging market, countries. Investments in securities
of companies headquartered in such countries may <span style="letter-spacing: -0.25pt">be</span></span></p>


<!-- Field: Page; Sequence: 51 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 24.85pt 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">considered
speculative and subject to certain special risks. The political and economic structures in many of these countries may be in their infancy
and developing rapidly, and such countries may lack the social, political and economic characteristics of more developed countries. Certain
of these countries have in the past failed to recognize private property rights and have at times nationalized and expropriated the assets
of private companies. Some countries have inhibited the conversion of their currency to another. The currencies of certain emerging market
countries have experienced devaluation relative to the U.S. dollar, and future devaluations may adversely affect the value of the Fund&#8217;s
assets denominated in such currencies. Some emerging market countries have experienced substantial rates of inflation for many years.
Continued inflation may adversely affect the economies and securities markets of such countries. In addition, unanticipated political
or social developments may affect the value of the Fund&#8217;s investments in these countries and the availability of the Fund of additional
investments in these countries. The small size, limited trading volume and relative inexperience of the securities markets in these countries
may make the Fund&#8217;s investments in such countries illiquid and more volatile than investments in more developed countries, and
the Fund may be required to establish special custodial or other arrangements before making investments in these countries. There may
be little financial or accounting information available with respect to companies located in these countries, and it may be difficult
as a result to assess the value or prospects of an investment in such companies.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Equity
Securities</i>. Equity securities, such as common stock, generally represent an ownership interest in a company. The Fund may invest
up to 20% of its Managed Assets in non-convertible equity securities.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.2pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lower
Grade Securities</i>. The Fund may invest a significant portion of its assets in securities rated below investment grade, such as those
rated Ba or lower by Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) and BB or lower by Standard &amp; Poor&#8217;s
(&#8220;S&amp;P&#8221;) or securities comparably rated by other rating agencies or in unrated securities determined by Advent to be of
comparable quality. Lower grade securities are commonly referred to as &#8220;junk bonds.&#8221; Both the convertible securities and
the income-producing securities in which the Fund will invest may be lower grade securities.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 16.6pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prices
of lower grade securities are more sensitive to negative developments, such as a decline in the issuer&#8217;s revenues or a general
economic downturn, than are the prices of higher grade securities. Lower grade securities tend to be less liquid than investment grade
securities. The market value of lower grade securities may be more volatile than the market value of investment grade securities and
generally tends to reflect the market&#8217;s perception of the creditworthiness of the issuer and short-term market developments to
a greater extent than investment grade securities, which primarily reflect fluctuations in general levels of interest rates.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ratings
are relative and subjective, and not absolute standards of quality. Securities ratings are based largely on the issuer&#8217;s historical
financial condition and the rating agencies&#8217; analysis at the time of rating. Consequently, the rating assigned to any particular
security is not necessarily a reflection of the issuer&#8217;s current financial condition.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 9.1pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may purchase securities of companies that are experiencing significant financial or business difficulties, including companies
involved in bankruptcy or other reorganization and liquidation proceedings. Although such investments may result in significant
financial returns to the Fund, they involve a substantial degree of risk. The level of analytical sophistication, both financial and
legal, necessary for successful investments in issuers experiencing significant business and financial difficulties is unusually
high. There can be no assurance that the Fund will correctly evaluate the value of the assets collateralizing its investments or the
prospects for a successful reorganization or similar action. In any reorganization or liquidation proceeding relating to a portfolio
investment, the Fund may lose all or part of its investment or may be required to accept collateral with a value less than the
amount of the Fund&#8217;s initial investment.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a part of its investments in lower grade securities, the Fund may invest in the securities of issuers in <span style="letter-spacing: -0.1pt">default.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 12.4pt 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
investing in the securities of issuers in default, the Fund bears the risk that these issuers will not continue to honor their obligations
or emerge from bankruptcy protection or that the value of these securities will not otherwise <span style="letter-spacing: -0.1pt">appreciate.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.6pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to using statistical rating agencies and other sources, the Adviser will also perform its own analysis of issuers in seeking
investments that it believes to be underrated (and thus higher yielding) in light of the financial condition of the issuer. Its analysis
of issuers may include, among other things, current and anticipated cash flow and borrowing requirements, value of assets in relation
to historical cost, strength of management, responsiveness</span></p>


<!-- Field: Page; Sequence: 52 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 19.7pt 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
business conditions, credit standing and current anticipated results of operations. In selecting investments for the Fund, the Adviser
may also consider general business conditions, anticipated changes in interest rates and the outlook for specific industries.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
to its purchase by the Fund, an issue of securities may cease to be rated or its rating may be <span style="letter-spacing: -0.1pt">reduced.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 5.95pt 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, it is possible that statistical rating agencies might change their ratings of a particular issue to reflect subsequent events
on a timely basis. Moreover, such ratings do not assess the risk of a decline in market value. None of these events will require the
sale of the securities by the Fund, although the Adviser will consider these events in determining whether the Fund should continue to
hold the securities.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for lower grade and comparable unrated securities has at various times, particularly during times of economic recession, experienced
substantial reductions in market value and liquidity. Past recessions have adversely affected the value of such securities as well as
the ability of certain issuers of such securities to repay principal and pay interest thereon or to refinance such securities. The market
for those securities could react in a similar fashion in the event of any future economic recession.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Preferred
Stock</i>. The Fund may invest in preferred stock. The preferred stock in which the Fund typically will invest will be convertible securities.
Preferred shares are equity securities, but they have many characteristics of fixed income securities, such as a fixed dividend payment
rate and/or a liquidity preference over the issuer&#8217;s common shares. However, because preferred stocks are equity securities, they
may be more susceptible to risks traditionally associated with equity investments than the Fund&#8217;s fixed income securities.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 10.85pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Private
Securities</i>. The Fund may invest up to 15% of its Managed Assets in privately offered convertible securities, privately offered non-convertible
income securities and any attached or related privately offered warrants or equity-linked securities (collectively, &#8220;private securities&#8221;),
which may include securities of private companies and privately issued securities of public companies. Advent does not expect to invest
more than 2.5% of the Fund&#8217;s Managed Assets in any single private security at the time of investment. The Fund invests primarily
in private securities to seek to enhance the Fund&#8217;s current income. Therefore, the Fund will invest in a private security only
if the expected yield on such security at the time of investment exceeds the yield of specified public convertible and high yield bond
benchmarks (currently the ICE BofAML All U.S. Convertibles Index and ICE BofAML US High Yield Total Return Index). The Fund is not required
to dispose of private securities in the event that relative yields change after the time of investment. Any private securities investments
will increase the percentage of <span style="letter-spacing: -0.25pt">the Fund&#8217;s assets invested in illiquid securities. In order
to provide for further diversification, Advent intends to limit the number of private securities transactions the Fund makes in any given
year and deploy the Fund&#8217;s overall allocation to private securities over the course of several years.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 14.5pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Derivative
Transactions</i>. The Fund may purchase and sell derivative instruments such as exchange-listed and over-the-counter put and call options
on securities, financial futures, equity, fixed-income and interest rate indices, and other financial instruments, purchase and sell
financial futures contracts and options thereon, enter into various interest rate transactions such as swaps, caps, floors or collars
and enter into various currency transactions such as currency forward contracts, currency futures contracts, currency swaps or options
on currency or currency futures or credit transactions and credit default swaps. The Fund also may purchase derivative instruments that
combine features of these instruments and purchase securities for delayed settlement. See &#8220;The Fund&#8217;s Investments&#8212;
Derivatives&#8221; in the Statement of Additional Information.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Investment Companies</i>. The Fund may invest in the securities of other investment companies to the extent that such investments
are consistent with the Fund&#8217;s investment objective and policies and permissible under the 1940 Act. The Fund may invest in
mutual funds, closed-end funds and exchange-traded funds. Under the 1940 Act, the Fund generally may invest only up to 10% of its
total assets in the aggregate in shares of other investment companies and only up to 5% of its total assets in any one investment
company, provided the investment does not represent more than 3% of the voting stock of the acquired investment company at the time
such shares are purchased. However, pursuant to certain exemptions set forth in the 1940 Act, the Fund may invest in excess of this
limitation provided that certain conditions are met. Investments in other investment companies involve operating expenses and fees
at the other investment company level that are in addition to the expenses and fees borne by the Fund and are borne indirectly by
common shareholders. For purposes of the Fund&#8217;s policy of investing at least 80% of its Managed Assets in convertible
securities and other income producing securities, the Fund will include the</span></p>


<!-- Field: Page; Sequence: 53 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 12.4pt 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">value
of its investments in other investment companies that invest primarily in convertible securities and/or other income producing securities.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Defensive
and Temporary Investments</i>. Under unusual market or economic conditions or for temporary defensive purposes, the Fund may invest
up to 100% of its total assets in securities issued or guaranteed by the U.S. government or its instrumentalities or agencies,
certificates of deposit, bankers&#8217; acceptances and other bank obligations, commercial paper rated in the highest category by a
nationally recognized statistical rating organization or other fixed income securities deemed by the Adviser to be consistent with a
defensive posture, or may hold cash, including money market funds.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 19.7pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Repurchase
Agreements</i>. The Fund may enter into repurchase agreements with broker-dealers, member banks of the Federal Reserve System and
other financial institutions. Repurchase agreements may be seen as loans by the Fund collateralized by underlying debt securities.
Under the terms of a typical repurchase agreement, the Fund would acquire an underlying debt obligation for a relatively short
period (usually not more than one week) subject to an obligation of the seller to repurchase, and the Fund to resell, the obligation
at an agreed price and time. This arrangement results in a fixed rate of return to the Fund that is not subject to market
fluctuations during the holding period. The Fund bears a risk of loss in the event that the other party to a repurchase agreement
defaults on its obligations and the Fund is delayed in or prevented from exercising its rights to dispose of the collateral
securities, including the risk of a possible decline in the value of the underlying securities during the period in which it seeks
to assert these rights. The Adviser, acting under the supervision of the Board of Trustees, reviews the creditworthiness of those
banks and dealers with which the Fund enters into repurchase agreements to evaluate these risks, and monitors on an ongoing basis
the value of the securities subject to repurchase agreements to ensure that the value is maintained at the required level. The Fund
will not enter into repurchase agreements with the Adviser or any of its <span style="letter-spacing: -0.1pt">affiliates.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.15pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Lending
of Portfolio Securities</i>. The Fund may lend portfolio securities to registered broker-dealers or other institutional investors
deemed by the Adviser to be of good standing under agreements which require that the loans be secured continuously by collateral in
cash, cash equivalents or U.S. Treasury bills maintained on a current basis at an amount at least equal to the market value of the
securities loaned. The Fund continues to receive the equivalent of the interest or dividends paid by the issuer on the securities
loaned as well as the benefit of an increase and the detriment of any decrease in the market value of the securities loaned and
would also receive compensation based on investment of the collateral. The Fund would not, however, have the right to vote any
securities having voting rights during the existence of the loan, but would call the loan in anticipation of an important vote to be
taken among holders of the securities or of the giving or withholding of consent on a material matter affecting the investment. As
with other extensions of credit, there are risks of delay in recovery or even loss of rights in the collateral should the borrower
of the securities fail financially. At no time would the value of the securities loaned exceed 35% of the value of the Fund&#8217;s
total assets.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 9.05pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Portfolio
Turnover Rate</i>. Portfolio turnover rate is not considered a limiting factor in the execution of investment decisions for the Fund.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 17.9pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE
OF <span style="letter-spacing: -0.1pt">LEVERAGE</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 9.85pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may utilize leverage up to the limits imposed by the 1940 Act. Under the 1940 Act, the Fund may utilize financial leverage in
the form of indebtedness in an aggregate amount up to 33 1/3% of the Fund&#8217;s Managed Assets (including the proceeds of such
leverage) immediately after incurring such indebtedness. Under the 1940 Act, the Fund may utilize leverage in the form of preferred
shares in an aggregate amount of up to 50% of the Fund&#8217;s total assets (including the proceeds of such leverage) immediately
after such issuance. The Fund may also invest in reverse repurchase agreements to the maximum extent permitted by the SEC and/or SEC
staff rules, guidance or positions. In addition, the Fund may engage in certain derivatives transactions that have economic
characteristics similar to leverage to the extent permitted by the SEC and/or SEC staff rules, guidance or positions.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Borrowings</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is authorized to borrow or issue debt securities for financial leveraging purposes and for temporary purposes such as the settlement
of transactions. The Fund may utilize indebtedness to the maximum extent permitted under the 1940 Act. Under the 1940 Act, a fund generally
is not permitted to issue commercial paper or notes or</span></p>


<!-- Field: Page; Sequence: 54 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 5.95pt 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">engage
in other borrowings unless, immediately after the borrowing, the fund would have asset coverage (as defined in the 1940 Act) of at least
300%, <i>i.e., </i>the value of the fund&#8217;s total assets less liabilities other than the principal amount represented by commercial
paper, notes or other borrowings, is at least 300% of such principal amount. In addition, other than with respect to privately arranged
borrowings, the Fund is not permitted to declare any cash dividend or other distribution on the common shares unless, at the time of
such declaration, the value of the Fund&#8217;s total assets, less liabilities other than the principal amount represented by borrowings,
is at least 300% of such principal amount after deducting the amount of such dividend or other distribution. If the Fund borrows, the
Fund intends, to the extent possible, to prepay all or a portion of the principal amount of any outstanding commercial paper, notes or
other borrowings to the extent necessary to maintain the required asset coverage.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 9.85pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of any such borrowings may require a Fund to pay a fee to maintain a line of credit, such as a commitment fee, or to maintain
minimum average balances with a lender. Any such requirements would increase the cost of such borrowings over the stated interest
rate. Such lenders would have the right to receive interest on <span style="letter-spacing: -0.25pt">and repayment of principal of
any such borrowings, which right will be senior to those of the common shareholders. Any such borrowings may contain provisions
limiting certain activities of the Fund, including the payment of dividends to common shareholders in certain
circumstances.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 23.05pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
types of borrowings subject the Fund to covenants in credit agreements relating to asset coverage and portfolio composition
requirements. Certain borrowings also may subject the Fund to certain restrictions on investments imposed by guidelines of one or
more rating agencies, which may issue ratings for such <span style="letter-spacing: -0.1pt">borrowings. </span>Such guidelines may
impose asset coverage or portfolio composition requirements that are more stringent than those imposed by the 1940 Act.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
1940 Act grants to the holders of senior securities representing indebtedness, other than with respect to privately arranged borrowings,
certain voting rights in the event of default in the payment of interest on or repayment of principal. Failure to maintain certain asset
coverage requirements under the 1940 Act could result in an event of default and entitle the debt holders to elect a majority of the
Board of Trustees.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Credit
Agreement. </i>The Fund has entered into a senior secured credit agreement, dated December 15, 2017, as amended from time to time through
the date hereof, between the Fund and Soci&#233;t&#233; G&#233;n&#233;rale, New York Branch (the &#8220;Credit Agreement&#8221;).
Under the terms of the Credit Agreement, the Fund may borrow up to the following <span style="letter-spacing: -0.1pt">amounts:</span></span></p>


<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 10%"/><td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.88% fixed rate 5-year maturity (December 15, 2025)</span></td>
                                                                                                                                                    <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$19,000,000</span></td></tr></table>


																		    <table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 10%"/><td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SOFR + 0.95% floating rate</span></td>
                                                                                                                                                    <td style="width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$139,000,000</span></td></tr></table>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
undrawn commitment fee of 0.30% per annum is charged on the difference between the $139,000,000 floating rate loan commitment and the
amount borrowed. In the event that the Fund terminates a credit agreement prior to the contractually agreed-upon date, the Fund may be
charged a breakage fee by the counterparty to compensate for the early termination.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 7.8pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s borrowings under the Credit Agreement are collateralized by portfolio assets. The Credit Agreement includes usual and customary
covenants. These covenants impose on the Fund asset coverage requirements, collateral requirements, investment strategy requirements,
and certain financial obligations. These covenants place limits or restrictions on the Fund&#8217;s ability to (i) enter into additional
indebtedness with a party other than Soci&#233;t&#233; G&#233;n&#233;rale, (ii) change its fundamental investment policies, or
(iii) pledge to any other party, other than to the counterparty, securities owned or held by the Fund over which the counterparty has
a lien. In addition, the Fund is required to deliver financial information to the counterparty within established deadlines, maintain
an asset coverage ratio (as defined in Section 18(g) of the 1940 Act) of at least 300%, comply with the rules of the stock exchange on
which its shares are listed, and maintain its classification as a &#8220;closed-end management investment company&#8221; as defined in
the 1940 Act.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of April 30, 2024, there was $157 million outstanding in connection with the Credit Agreement. The average daily amount of borrowings
under the credit agreement during the six months ended April 30, 2024 was $160,868,132, with a related weighted average interest rate
of 5.97%. The maximum amount outstanding during the six months ended April 30, 2024 was $173,000,000.</span></p>


<!-- Field: Page; Sequence: 55 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 0 0 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reverse
Repurchase <span style="letter-spacing: -0.1pt">Agreements</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 17.5pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
a reverse repurchase agreement, the Fund sells a portfolio instrument to another party, such as a bank or broker-dealer, in return for
cash. At the same time, the Fund agrees to repurchase the instrument at an agreed- upon time and price, which reflects an interest payment.
Such agreements have the economic effect of borrowings. Proceeds of the sale will be invested in additional instruments for the Fund,
and the income from these investments will generate income for the Fund. If such income does not exceed the income, capital appreciation
and gain or loss that would have been realized on the securities sold as part of the reverse repurchase transaction, the use of this
technique will diminish the investment performance of the Fund compared with what the performance would have been without the use of
reverse repurchase transactions. With respect to any reverse repurchase agreement, the Fund&#8217;s Managed Assets shall include any
proceeds from the sale of an asset of the Fund to a counterparty in such a transaction, in addition to the value of the underlying asset
as of the relevant measuring date.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reverse
repurchase agreements involve the risks that the interest income earned on the investment of the proceeds will be less than the interest
expense and expenses associated with the repurchase agreement, that the market value of the securities sold by the Fund may decline below
the price at which the Fund is obligated to repurchase such securities and that the securities may not be returned to the Fund. There
is no assurance that reverse repurchase agreements can be successfully employed. In connection with reverse repurchase agreements, the
Fund will also be subject to counterparty risk with respect to the purchaser of the securities. If the broker/dealer to whom the Fund
sells securities becomes insolvent, the Fund&#8217;s right to purchase or repurchase securities may be restricted.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the six months ended April 30, 2024, the average daily balance for which reverse repurchase agreements were outstanding amounted to $157,000,000
(exclusive of interest payable), with a related weighted average interest rate of 4.80%. As of April 30, 2024, there were $157,021,361
(inclusive of interest payable) in reverse repurchase agreements outstanding.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 19.7pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
18f-4 under the 1940 Act (the &#8220;Derivatives Rule&#8221;) permits the Fund to enter into derivatives transactions and certain other
transactions notwithstanding the restrictions on the issuance of &#8220;senior securities&#8221; under Section 18 of the 1940 Act. The
Derivatives Rule requires registered investment companies that enter into derivatives transactions and certain other transactions that
create future payment or delivery obligations to, among other things, (i) comply with a value-at-risk leverage limit, and (ii) adopt
and implement a derivatives risk management program. The Fund has elected to treat reverse repurchase agreements as derivatives for purposes
of complying with Rule 18f-4.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
<span style="letter-spacing: -0.1pt">Shares</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 11.9pt 0 6pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s Declaration of Trust (as defined herein) provides that the Board of Trustees may authorize and issue preferred shares with
rights as determined by the Board of Trustees, by action of the Board of Trustees without prior approval of common shareholders.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 9.05pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
shareholders have no preemptive right to purchase any preferred shares that might be issued. Any such preferred share offering would
be subject to the limits imposed by the 1940 Act. Any preferred shares issued by the Fund would have special voting rights and a liquidation
preference over the common shares. Issuance of preferred shares would constitute leverage and would entail special risks to the common
shareholders.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 1940 Act, the Fund may not issue preferred shares unless, immediately after such issuance, it has an &#8220;asset coverage&#8221;
of at least 200% of the liquidation value of the outstanding preferred shares (<i>i.e., </i>such liquidation value may not exceed 50%
of the value of the Fund&#8217;s total assets). For these purposes, &#8220;asset coverage&#8221; means the ratio of (i) total assets
less all liabilities and indebtedness not represented by &#8220;senior securities&#8221; to (ii) the amount of &#8220;senior securities
representing indebtedness&#8221; plus the &#8220;involuntary liquidation preference&#8221; of the preferred shares. &#8220;Senior security&#8221;
generally means any bond, note, or similar security evidencing indebtedness and any class of shares having priority over any other class
as to distribution of assets or payment of dividends. &#8220;Senior security representing indebtedness&#8221; means any &#8220;senior
security&#8221; other than equity shares. The &#8220;involuntary liquidation preference&#8221; of the preferred shares is the amount
that holders of preferred shares would be entitled to receive in the event of an involuntary liquidation of the Fund in preference to
the common shares.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 22.65pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
preferred shares are outstanding, two of the Fund&#8217;s Trustees will be elected by the holders of preferred shares, voting separately
as a class. The remaining Trustees of the Fund will be elected by common shareholders and preferred shareholders voting together as a
single class. In the unlikely event the Fund failed to pay <span style="letter-spacing: -0.1pt">dividends</span></span></p>


<!-- Field: Page; Sequence: 56 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 20.95pt 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
preferred shares for two years, preferred shareholders would be entitled to elect a majority of the Trustees of the Fund.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.15pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is not permitted to declare any dividend (except a dividend payable in common shares), or to declare any other distribution on the
common shares, or to purchase any common shares, unless the preferred shares have at the time of the declaration of any such dividend
or other distribution, or at the time of any such purchase of common shares, an asset coverage of at least 200% after deducting the amount
of such dividend, distribution or purchase price.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Fund may be subject to certain restrictions imposed by guidelines of one or more rating agencies that may issue ratings
for preferred shares issued by the Fund. These guidelines may impose asset coverage or portfolio composition requirements that are more
stringent than those imposed on the Fund by the 1940 Act.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
preferred shares are issued, the terms of any preferred shares issued are expected to include asset coverage maintenance provisions which
will require the redemption of the preferred shares in the event of non-compliance by the Fund and may also prohibit dividends and other
distributions on the common shares in such circumstances. In order to meet redemption requirements, the Fund may have to liquidate portfolio
securities. Such liquidations and redemptions would cause the Fund to incur related transaction costs and could result in capital losses
to the Fund. Prohibitions on dividends and other distributions on the common shares could impair the Fund&#8217;s ability to qualify
as a regulated investment company under the Code.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Derivatives</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may engage in certain derivatives transactions that have economic characteristics similar to <span style="letter-spacing: -0.1pt">leverage.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 21.75pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent the terms of such transactions obligate the Fund to make payments, the Fund earmarks or segregates cash or liquid securities
in an amount at least equal to the current value of the amount then payable by the Fund under the terms of such transactions or otherwise
cover such transactions in accordance with applicable interpretations of the staff of the SEC. To the extent the terms of such transactions
obligate the Fund to deliver particular securities to extinguish the Fund&#8217;s obligations under such transactions, the Fund may &#8220;cover&#8221;
its obligations under such transactions by either (i) owning the securities or collateral underlying such transactions or (ii) having
an absolute and immediate right to acquire such securities or collateral without additional cash consideration (or, if additional cash
consideration is required, having earmarked or segregated cash or liquid securities). Such segregation or cover is intended to provide
the Fund with available assets to satisfy its obligations under such transactions. As a result of such segregation or cover, the Fund&#8217;s
obligations under such transactions will not be considered senior securities representing indebtedness for purposes of the 1940 Act,
or included in calculating the aggregate amount of the Fund&#8217;s financial leverage.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 11.15pt 0 8.95pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule
18f-4 under the 1940 Act, the Derivatives Rule, permits the Fund to enter into derivatives transactions and certain other transactions
notwithstanding the restrictions on the issuance of &#8220;senior securities&#8221; under Section 18 of the 1940 Act. The Fund has adopted
a derivatives risk management program which includes value-at-risk modeling, stress tests, backtests, and additional disclosures to the
SEC in compliance with Rule 18f-4 under the 1940 Act. The requirements of the rule and the Fund&#8217;s derivatives risk management program
may restrict the Fund&#8217;s ability to engage in certain derivatives transactions and/or increase the cost of such transactions, which
could adversely affect the performance of the Fund.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effects
of <span style="letter-spacing: -0.1pt">Leverage</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 11pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
that the Fund utilizes leverage representing approximately 43.0% of the Fund&#8217;s Managed Assets (the Fund&#8217;s outstanding leverage
as of April 30, 2024) and that the Fund will bear expenses relating to that leverage at an average annual rate of 5.38%, the income generated
by the Fund&#8217;s portfolio (net of estimated expenses) must exceed 2.32% in order to cover the expenses specifically related to the
Fund&#8217;s estimated use of leverage. Of course, these numbers are merely estimates used for illustration. Actual leverage expenses
will vary frequently and may be significantly higher or lower than the rate estimated above.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 22.2pt 0 8.95pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table is furnished in response to requirements of the SEC. It is designed to illustrate the effect of leverage on common share
total return, assuming investment portfolio total returns (comprised of income and changes in the value of securities held in the Fund&#8217;s
portfolio) of (10)%, (5)%, 0%, 5% and 10%. These assumed investment portfolio returns are hypothetical figures and are not necessarily
indicative of the investment <span style="letter-spacing: -0.1pt">portfolio</span></span></p>


<!-- Field: Page; Sequence: 57 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 16.6pt 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">returns
experienced or expected to be experienced by the Fund. The table further reflects the use of leverage representing 43.0% of the Fund&#8217;s
total managed assets and the Fund&#8217;s currently projected annual leverage expense of 5.38%.</span></p>

<p style="font: 4.5pt Times LT Std Roman; margin: 0.4pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times LT Std Roman; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-top: #81837D 1pt solid; border-bottom: #81837D 1pt solid; width: 49%; padding-top: 0.05pt; padding-left: 24pt; text-align: left; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed
    Portfolio Total Return (net of <span style="letter-spacing: -0.1pt">expenses)</span></span></td>
    <td style="border-top: #81837D 1pt solid; border-bottom: #81837D 1pt solid; width: 11%; padding-top: 0.05pt; padding-left: 2.25pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">(10.00)%</span></td>
    <td style="border-top: #81837D 1pt solid; border-bottom: #81837D 1pt solid; width: 11%; padding-top: 0.05pt; padding-right: 2.2pt; padding-left: 4.3pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">(5.00)%</span></td>
    <td style="border-top: #81837D 1pt solid; border-bottom: #81837D 1pt solid; width: 11%; padding-top: 0.05pt; padding-right: 2.95pt; padding-left: 5.75pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">0.00%</span></td>
    <td style="border-top: #81837D 1pt solid; border-bottom: #81837D 1pt solid; width: 10%; padding-top: 0.05pt; padding-left: 2.1pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">5.00%</span></td>
    <td style="border-top: #81837D 1pt solid; border-bottom: #81837D 1pt solid; width: 8%; padding-top: 0.05pt; padding-right: 1.9pt; text-align: right; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">10.00%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.05pt; padding-left: 24pt; text-align: left; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Common
    Share Total Return</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.05pt; padding-left: 2.25pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">(21.63)%</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.05pt; padding-right: 4.3pt; padding-left: 2.1pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">(12.85)%</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.05pt; padding-right: 5.75pt; padding-left: 2.8pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">(4.07)%</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.05pt; padding-left: 2.1pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">4.71%</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.05pt; padding-right: 1.9pt; text-align: right; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">13.49%</span></td></tr>
  </table>
<p style="font: 10pt Times LT Std Roman; margin: 9.25pt 8.95pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Share Total Return is composed of two elements: the common share distributions paid by the Fund (the amount of which is largely determined
by the net investment income of the Fund) and gains or losses on the value of the securities the Fund owns. As required by SEC rules,
the table assumes that the Fund is more likely to suffer capital losses than to enjoy capital appreciation. For example, a total return
of 0% assumes that the tax-exempt interest the Fund receives on its investments is entirely offset by losses in the value of those securities.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 17.9pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">RISKS</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 22.65pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the heading &#8220;Investment Objective, Policies and Principal Risks&#8212;Principal Risks&#8221; in the
Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual Report</a> is incorporated herein by reference. Investors should consider the specific risk factors and special considerations
associated with investing in the Fund. An investment in the Fund is subject to investment risk, including the possible loss of your entire
investment. A Prospectus Supplement relating to an offering of the Fund&#8217;s securities may identify additional risk associated with
such offering.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distribution
<span style="letter-spacing: -0.2pt">Risk</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 9.85pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s net investment income can vary significantly over time; however, the Fund seeks to maintain a more stable monthly distribution
per share. The distributions paid by the Fund for any particular month may be more or less than the amount of net investment income for
that monthly period. The Fund may distribute more than the entire amount of the net investment income earned in a particular period,
in which case all or a portion of a distribution may be a return of capital. <b>The Fund&#8217;s distributions have historically included,
and may in the future include, a significant portion of return of capital. For the fiscal year ended October 31, 2023, the Fund&#8217;s
distributions were comprised of approximately 28.04% ordinary income and 71.96% return of capital. </b>Accordingly, shareholders should
not assume that the source of a distribution from the Fund is net income or profit, and the Fund&#8217;s distributions should not be
used as a measure of performance or confused with yield or income.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 16.8pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Return
of capital is the return of a portion of the shareholder&#8217;s original investment up to the amount of the Common Shareholder&#8217;s
tax basis in their Common Shares, which would reduce such tax basis. Although a return of capital may not be taxable, it will generally
increase the Common Shareholder&#8217;s potential gain or reduce the Common Shareholder&#8217;s potential loss on any subsequent sale
or other disposition of Common Shares. In any given year, there can be no guarantee the Fund&#8217;s investment returns will exceed the
amount of distributions which may increase taxes payable by a Common Shareholder or reduce a Common Shareholder&#8217;s loss deduction
in connection with such sale or other disposition. To the extent the amount of distributions paid to shareholders in cash exceeds the
total net investment returns of the Fund, the assets of the Fund will decline, which may have the effect of increasing the Fund&#8217;s
expense ratio. In addition, in order to make such distributions, the Fund may have to sell a portion of its investment portfolio at a
time when independent investment judgment might not dictate such action.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
Associated with Offerings of Additional Common <span style="letter-spacing: -0.1pt">Shares</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 10.85pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
voting power of current common shareholders will be diluted to the extent that current common shareholders do not purchase common shares
in any future offerings of common shares or do not purchase sufficient common shares to maintain their percentage interest. If the Fund
is unable to invest the proceeds of such offering as intended, the Fund&#8217;s per common share distribution may decrease and the Fund
may not participate in market advances to the same extent as if such proceeds were fully invested as planned.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
Risks of <span style="letter-spacing: -0.1pt">Rights</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are additional risks associated with an offering of Rights. Shareholders who do not exercise their Rights may, at the completion of such
an offering, own a smaller proportional interest in the Fund than if they exercised their Rights. As a result of such an offering, a
shareholder may experience dilution in net asset value per share if the subscription price per share is below the net asset value per
share on the expiration date. If the subscription price</span></p>


<!-- Field: Page; Sequence: 58 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 6.55pt 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per
share is below the net asset value per share of the Fund&#8217;s common shares on the expiration date, a shareholder will experience
an immediate dilution of the aggregate net asset value of such shareholder&#8217;s common shares if the shareholder does not participate
in such an offering and the shareholder will experience a reduction in the net asset value per share of such shareholder&#8217;s common
shares whether or not the shareholder participates in such an offering. Such a reduction in net asset value per share may have the effect
of reducing market price of the common share. The Fund cannot state precisely the extent of this dilution (if any) if the shareholder
does not exercise such shareholder&#8217;s Rights because the Fund does not know what the net asset value per share will be when the
offer expires or what proportion of the Rights will be exercised. If the subscription price is substantially less than the then current
net asset value per common share at the expiration of a rights offering, such dilution could be substantial. Any such dilution or accretion
will depend upon whether (i) such shareholders participate in the Rights offering and (ii) the Fund&#8217;s net asset value per common
share is above or below the subscription price on the expiration date of the Rights offering. In addition to the economic dilution described
above, if a common shareholder does not exercise all of their rights, the common shareholder will incur voting dilution as a result of
this rights offering. This voting dilution will occur because the common shareholder will own a smaller proportionate interest in the
Fund after the rights offering than prior to the rights offering. There is a risk that changes in market conditions may result in the
underlying common shares purchasable upon exercise of the subscription rights being less attractive to investors at the conclusion of
the subscription period. This may reduce or eliminate the value of the subscription rights. If investors exercise only a portion of the
rights, the number of common shares issued may be reduced, and the common shares may trade at less favorable prices than larger offerings
for similar securities. Subscription rights issued by the Fund may be transferable or non-transferable rights. In a non-transferable
rights offering, common shareholders who do not wish to exercise their rights will be unable to sell their rights. In a transferrable
rights offering, the Fund will use its best efforts to ensure an adequate trading market for the rights; however, investors may find
that there is no market to sell rights they do not wish to exercise.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">MANAGEMENT
OF THE</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">FUND</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Trustees</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s business and affairs are managed under the direction of the Board of Trustees, which has overall responsibility for monitoring
and overseeing the Fund&#8217;s management and operations. The Board of Trustees consists of eight members, seven of whom are not considered
&#8220;interested persons&#8221; of the Fund (as that term is defined in the 1940 Act) (the &#8220;Independent Trustees&#8221;). The
Trustees are subject to removal or replacement in accordance with Delaware law and the Declaration of Trust.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Trustees, including a majority of the Independent Trustees, oversees and monitors the Fund&#8217;s investment performance. The
Board will review, on an annual basis, the Investment Advisory Agreement to determine, among other things, whether the fees payable thereunder
are reasonable in light of the services provided.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Adviser</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to an investment advisory agreement between the Fund and Advent (the &#8220;Investment Advisory Agreement&#8221;), Advent is responsible
for the daily management of the Fund&#8217;s portfolio of investments, which includes buying and selling securities for the Fund, as
well as investment research. Advent is a registered investment adviser, based in New York, which specializes in convertible and high-yield
securities for institutional and individual investors. The firm was established by Tracy V. Maitland, a former Director in the Convertible
Securities sales and trading division of Merrill Lynch. Advent&#8217;s investment discipline emphasizes capital structure research, encompassing
equity fundamentals as well as credit research, with a focus on cash flow and asset values while seeking to maximize total return. Advent
is located at 888 Seventh Avenue, 31st Floor, New York, New York 10019. As of May 31, 2024, Advent managed approximately $7.8 billion
in assets.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Adviser receives an annual fee from the Fund based on the average value of the Fund&#8217;s Managed <span style="letter-spacing: -0.1pt">Assets.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
annual fee will be determined as <span style="letter-spacing: -0.1pt">follows:</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(a)</span></td><td style="padding-right: 11.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the average value of the Fund&#8217;s Managed Assets (calculated monthly) is greater than
                                            $250 million, the fee will be a maximum amount equal to 0.54% of the average value of the
                                            Fund&#8217;s Managed Assets.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(b)</span></td><td style="padding-right: 14.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the average value of the Fund&#8217;s Managed Assets (calculated monthly) is $250 million
                                            or less, the fee will be a maximum amount equal to 0.55% of the average value of the Fund&#8217;s
                                            Managed Assets.</span></td></tr></table>


<!-- Field: Page; Sequence: 59 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 13.25pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, subject to the approval of the Fund&#8217;s Board of Trustees, a pro rata portion of the salaries, bonuses, health insurance,
retirement benefits and similar employment costs for the time spent on Fund operations (other than the provision of services required
under the Investment Advisory Agreement) of all personnel employed by the Adviser who devote substantial time to Fund operations may
be reimbursed by the Fund to the Adviser. For the year ended October 31, 2023, the Adviser was not reimbursed by the Fund for these items.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portfolio
<span style="letter-spacing: -0.1pt">Management</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under &#8220;Item 8. Portfolio Managers of Closed-End Management Investment Companies&#8221; of the Fund&#8217;s
<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual Report</a> is incorporated herein by reference. Additional information about the portfolio managers&#8217; compensation, other accounts
managed by the portfolio managers, and other information is provided in the SAI.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 17.9pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">NET
ASSET VALUE</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.2pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s net asset value is determined as of the close of regular session trading (normally 4:00 p.m. Eastern Time) on each day the
NYSE is open for business. The Fund&#8217;s net asset value is calculated by taking the market value of the Fund&#8217;s total assets,
including interest or dividends accrued but not yet collected, less all liabilities, and dividing by the total number of common shares
outstanding. The result, rounded to the nearest cent, is the net asset value.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Trustees of the Fund (the &#8220;Board&#8221;) has adopted policies and procedures for the valuation of the Fund&#8217;s investments
(the &#8220;Valuation Procedures&#8221;). The U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) adopted Rule 2a-5 under
the 1940 Act (&#8220;Rule 2a-5&#8221;) which establishes requirements for determining fair value in good faith and became effective September
8, 2022. Rule 2a-5 also defines &#8220;readily available market quotations&#8221; for purposes of the 1940 Act and establishes requirements
for determining whether a fund must fair value a security in good faith.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Rule 2a-5, the Board has designated the Investment Adviser as the valuation designee to perform fair valuation determinations for
the Fund with respect to all Fund investments and other assets. As the Fund&#8217;s valuation designee pursuant to Rule 2a-5, the Investment
Adviser has adopted separate procedures (the &#8220;Valuation Designee Procedures&#8221;) reasonably designed to prevent violations of
the requirements of Rule 2a-5 and Rule 31a-4. The Investment Adviser, in its role as valuation designee, utilizes a valuation committee
(the &#8220;Valuation Committee&#8221;), in the fair value of the Fund&#8217;s securities and/or other assets.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 30.6pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuations
of the Fund&#8217;s securities and other assets are supplied primarily by pricing service providers appointed pursuant to the processes
set forth in the Valuation Procedures. The Investment Adviser, consistent with the monitoring and review responsibilities set forth in
the Valuation Procedures, regularly reviews the appropriateness of the inputs, methods, models and assumptions employed by the pricing
service provider.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the pricing service provider cannot or does not provide a valuation for a particular investment or such valuation is deemed unreliable,
such investment is fair valued by the Investment Adviser.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 22.45pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
listed on an exchange or on an over-the-counter market will be valued at the last reported sale price on the primary exchange or market
on which they are traded; provided, however, that securities listed on the National Association of Securities Dealers Automated Quotations
(&#8220;NASDAQ&#8221;) National Market system will be valued at the NASDAQ official closing price, which may not necessarily represent
the last sale price.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
securities that are traded on an exchange or on the over-the-counter (&#8220;OTC&#8221;) market and for which there are no transactions
on a given day are valued at the mean of the closing bid and asked prices.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Open-end
investment companies are valued at their net asset value (&#8220;NAV&#8221;) as of the close of business, on the valuation date. Exchange-traded
funds and closed-end investment companies are generally valued at the last quoted sale price.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 19.7pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
trading in foreign securities markets is substantially completed each day at various times prior to the close of the New York Stock Exchange
(&#8220;NYSE&#8221;). The values of foreign securities are determined as of the close of such foreign markets or the close of the NYSE,
if earlier. All investments quoted in foreign currencies are valued in U.S. dollars on the basis of the foreign currency exchange rates
prevailing at the close of U.S. business</span></p>


<!-- Field: Page; Sequence: 60 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at
4:00 p.m. Investments in foreign securities may involve risks not present in domestic investments. The Valuation Committee will determine
the current value of such foreign securities by taking into consideration certain factors which may include those discussed above, as
well as the following factors, among others: the value of the securities traded on other foreign markets, ADR trading, closed-end fund
trading, foreign currency exchange activity, and the trading prices of financial products that are tied to foreign securities. In addition,
under the Valuation Procedures, the Valuation Committee is authorized to use prices and other information supplied by a third-party pricing
vendor in valuing foreign securities.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 8.2pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercial
paper and discount notes are valued based on prices provided by independent pricing services or, if not available or if the
Investment Adviser considers that price to not represent fair value, by dealers using the mean of the closing bid and asked prices
for such securities or, if such prices are not available, at prices for securities of comparable maturity, quality and type. If
sufficient market activity is limited or does not exist, the pricing services or dealers may utilize proprietary valuation models
which may, for example, consider market characteristics such as benchmark yield curves, option adjusted spreads, credit spreads,
estimated default rates, coupon rates, anticipated timing of principal repayments, underlying collateral, or other unique security
features in order to estimate relevant cash flows, which are then discounted to calculate a security&#8217;s fair value. Commercial
paper and discount notes with remaining maturities of 60 days or less at the time of valuation are valued at amortized cost, unless
the Investment Adviser concludes that amortized cost does not represent the fair value of the applicable asset in which case it will
be valued using an independent pricing service. Commercial paper and discount notes which have a term-to- maturity greater than 60
days from the date of purchase are valued at their current market quotations until maturity or disposition. Convertible securities
are valued in the same manner as debt securities.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 38.65pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase
agreements are generally valued at amortized cost, provided such amounts approximate market value.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset-back
securities (&#8220;ABS&#8221;) and other structured finance securities are generally valued using a pricing service provider.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Typically,
loans are valued using information provided by an independent third-party pricing service which uses broker quotes, among other inputs.
If the pricing service cannot or does not provide a valuation for a particular loan, or such valuation is deemed unreliable, such investment
is valued based on a quote from a broker-dealer or is fair valued by the Investment Adviser.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange-traded
options are valued at the closing price, or if not traded that day at the mean of the bid and ask prices on the principal exchange on
which they are traded.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward
foreign currency exchange contracts are valued daily based on the applicable exchange rate of the underlying currency.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments
for which market quotations are not readily available are fair valued as determined in good faith by the Investment Adviser. Valuations
in accordance with these methods are intended to reflect each security&#8217;s (or asset&#8217;s or liability&#8217;s) &#8220;fair value.&#8221;
Each such determination is based on a consideration of all relevant factors, which are likely to vary from one pricing context to another.
Examples of such factors may include, but are not limited <span style="letter-spacing: -0.25pt">to market prices; sale prices; broker
quotes; and models which derive prices based on inputs such as prices of securities with comparable maturities and characteristics, or
based on inputs such as anticipated cash flows or collateral, spread over U.S. Treasury securities, and other information analysis.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">DISTRIBUTIONS</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 11.3pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund intends to pay substantially all of its net investment income to Common Shareholders through monthly distributions. In addition,
the Fund intends to distribute any net long-term capital gains to Common Shareholders at least annually. The Fund expects that distributions
paid on the Common Shares will consist primarily of (i) investment company taxable income, which includes, among other things, ordinary
income, net short-term capital gain and income from certain hedging and interest rate transactions, (ii) net capital gain (which is the
excess of net long-term capital gain over net short-term capital loss), and/or (iii) return of capital.</span></p>


<!-- Field: Page; Sequence: 61 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s net investment income can vary significantly over time; however, the Fund seeks to maintain a more stable monthly distribution
per share. The distributions paid by the Fund for any particular month may be more or less than the amount of net investment income for
that monthly period.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
any given year, there can be no guarantee the Fund&#8217;s investment returns will exceed the amount of distributions. The Fund may distribute
more than the entire amount of the net investment income earned in a particular period, in which case all or a portion of a distribution
may be a return of capital. Return of capital is the return of a portion of the shareholder&#8217;s original investment up to the amount
of the Common Shareholder&#8217;s tax basis in their Common Shares, which would reduce such tax basis. Although a return of capital may
not be taxable, it will generally increase the Common Shareholder&#8217;s potential gain or reduce the Common Shareholder&#8217;s potential
loss on any subsequent sale or other disposition of Common Shares which may increase taxes payable by a Common Shareholder or reduce
a Common Shareholder&#8217;s loss deduction in connection with such sale or other disposition. <b>The Fund&#8217;s distributions have
historically included, and may in the future include, a significant portion of return of capital. For the fiscal year ended October 31,
2023, the Fund&#8217;s distributions were comprised of approximately 28.04% ordinary income and 71.96% return of capital.</b> Accordingly,
shareholders should not assume that the source of a distribution from the Fund is net income or profit, and the Fund&#8217;s distributions
should not be used as a measure of performance or confused with yield or income. Although a return of capital may not be taxable, it
will generally increase the common shareholder&#8217;s potential gain, or reduce the common shareholder&#8217;s potential loss, on any
subsequent sale or other disposition of common shares. Common shareholders should not assume that the source of a distribution from the
Fund is net income or profit, and common shareholders who receive distributions that include return of capital should not assume that
such return of capital is derived from the Fund&#8217;s <span style="letter-spacing: -0.1pt">investments.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternatively,
the Fund may also distribute less than its net investment income in a particular period. The undistributed net investment income may
be available to supplement future common share distributions. Undistributed net investment income is included in the Common Shares&#8217;
net asset value, and, correspondingly, distributions from net investment income will reduce the Common Shares&#8217; net asset value.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.6pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
each distribution that does not consist solely of net investment income, the Fund will issue a notice to shareholders that will provide
estimated information regarding the amount and composition of the distribution. The amounts and sources of distributions reported in
each notice will be estimated, are likely to change over time and are not provided for tax reporting purposes. The final determination
of such amounts will be made and reported to shareholders after the end of the calendar year when the Fund determines its earnings and
profits for the year. The actual amounts and sources of the amounts for accounting and tax reporting purposes will depend upon the Fund&#8217;s
investment experience during its full fiscal year and may be subject to changes based on tax regulations. The Fund will send each shareholder
a Form 1099-DIV for the calendar year that will tell shareholders how to report distributions for federal income tax purposes.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s distribution rate is not constant and the amount of distributions, when and if declared by the Fund&#8217;s Board of Trustees,
is subject to change based on the performance of the Fund. The Fund reserves the right to change its distribution policy and the basis
for establishing the rate of distributions at any time and may do so without prior notice to Common Shareholders.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of future distributions is subject to approval by the Fund&#8217;s Board of Trustees, as well as meeting the covenants of any outstanding
Indebtedness or preferred shares and the asset coverage requirements of the 1940 Act.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
distributions the Fund has paid since April 30, 2024 are as <span style="letter-spacing: -0.1pt">follows:</span></span></p>

<p style="font: 4.5pt Times LT Std Roman; margin: 0.15pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times LT Std Roman; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: #81837D 1pt solid; width: 24%; padding-top: 0.85pt; padding-left: 12pt; text-align: left; line-height: 7.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Payment
    <span style="letter-spacing: -0.2pt">Date</span></b></span></td>
    <td style="border-bottom: #81837D 1pt solid; width: 31%; padding-top: 0.45pt; padding-left: 6.05pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Record
    <span style="letter-spacing: -0.2pt">Date</span></b></span></td>
    <td style="border-bottom: #81837D 1pt solid; width: 45%; padding-top: 0.45pt; padding-right: 4.8pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Distribution
    per Common <span style="letter-spacing: -0.2pt">Share</span></b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.95pt; padding-left: 12pt; text-align: left; line-height: 7.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    31, <span style="letter-spacing: -0.2pt">2024</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.05pt; padding-left: 6.05pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    15, <span style="letter-spacing: -0.2pt">2024</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.05pt; padding-right: 4.8pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$0.1172</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.95pt; padding-left: 12pt; text-align: left; line-height: 7.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    28, <span style="letter-spacing: -0.2pt">2024</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.05pt; padding-left: 6.05pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    3, <span style="letter-spacing: -0.2pt">2024</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.05pt; padding-right: 4.8pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$0.1172</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.95pt; padding-left: 12pt; text-align: left; line-height: 7.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    31, <span style="letter-spacing: -0.2pt">2024</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.05pt; padding-left: 6.05pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    1, <span style="letter-spacing: -0.2pt">2024</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.05pt; padding-right: 4.8pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$0.1172</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.95pt; padding-left: 12pt; text-align: left; line-height: 7.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    30, <span style="letter-spacing: -0.2pt">2024</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.05pt; padding-left: 6.05pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August
    1, <span style="letter-spacing: -0.2pt">2024</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.05pt; padding-right: 4.8pt; text-align: center; line-height: 8.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">$0.1172</span></td></tr>
  </table>

<!-- Field: Page; Sequence: 62 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIVIDEND
REINVESTMENT <span style="letter-spacing: -0.2pt">PLAN</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained under the heading &#8220;Dividend Reinvestment Plan&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual Report</a> is incorporated herein
by reference.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">DESCRIPTION
OF CAPITAL STRUCTURE</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 18.45pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is a statutory trust organized under the laws of the state of Delaware. The following is a brief description of the terms of the
common shares, indebtedness and preferred shares which may be issued by the Fund. This description does not purport to be complete and
is qualified by reference to the Fund&#8217;s Agreement and Declaration of Trust (the &#8220;Declaration of Trust&#8221;) and By-Laws
(collectively, the &#8220;Governing Documents&#8221;).</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
<span style="letter-spacing: -0.1pt">Shares</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0 26.95pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Declaration of Trust, the Fund is authorized to issue unlimited common shares, par value </span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 16.05pt 0 8.95pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$0.001
per share. Each common share has one vote and, when issued and paid for in accordance with the terms of this offering, will be fully
paid and non-assessable. All common shares are equal as to dividends, assets and voting privileges and have no conversion, preemptive
or other subscription rights.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s currently outstanding common shares are, and common shares offered by this Prospectus will be, listed on the NYSE under
the symbol &#8220;AVK.&#8221;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 26.95pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund will not issue certificates for common <span style="letter-spacing: -0.1pt">shares.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 9.05pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Issuance
of Additional Common Shares</i>. Any additional offerings of common shares will require approval by the Board of Trustees. The provisions
of the 1940 Act, including Section 23(b) of the 1940 Act, generally require that the public offering price (less underwriting commissions
and discounts) of common shares sold by a closed-end investment company must equal or exceed the net asset value of such company&#8217;s
common shares (calculated within 48 hours of the pricing of such offering), except, in pertinent part, (i) with the consent of a majority
of its common shareholders; or (ii) in connection with an offering to the holders of one or more classes of its capital stock.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.9pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may, from time to time, seek the consent of common shareholders to permit the issuance and sale by the Fund of common shares at
a price below the Fund&#8217;s then-current net asset value, subject to certain conditions. If such consent is obtained, the Fund may,
contemporaneous with and in no event more than one year following the receipt of such consent, sell common shares at price below net
asset value in accordance with any conditions adopted in connection with the giving of such consent. Additional information regarding
any consent of common shareholders obtained by the Fund and the applicable conditions imposed on the issuance and sale by the Fund of
common shares at a price below net asset value will be disclosed in the Prospectus Supplement relating to any such offering of common
shares at a price below net asset value. Until such consent of common shareholders, if any, is obtained, the Fund may not sell common
shares at a price below net asset value. Because the Fund&#8217;s advisory fee is based upon average Managed Assets, the Adviser&#8217;s
interest in recommending the issuance and sale of common shares at a price below net asset value may conflict with the interests of the
Fund and its common shareholders.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may also issue and sell common shares at a price below the Fund&#8217;s then-current net asset value in connection with an offering
to the holders of its common shares pursuant to the issuance of subscription rights. See &#8220;Description of Subscription Rights.&#8221;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
<span style="letter-spacing: -0.1pt">Shares</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 9.05pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s Declaration of Trust provides that the Board of Trustees may authorize and issue preferred shares with rights as determined
by the Board of Trustees, by action of the Board of Trustees without prior approval of the holders of the common shares.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
shareholders have no preemptive right to purchase any preferred shares that might be issued. Any such preferred share offering would
be subject to the limits imposed by the 1940 Act. Any preferred shares issued by the Fund would have special voting rights and a liquidation
preference over the common shares. Issuance of preferred shares would constitute leverage and would entail special risks to the common
shareholders.</span></p>


<!-- Field: Page; Sequence: 63 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 1940 Act, the Fund may not issue preferred shares unless, immediately after such issuance, it has an &#8220;asset coverage&#8221;
of at least 200% of the liquidation value of the outstanding preferred shares (<i>i.e., </i>such liquidation value may not exceed 50%
of the value of the Fund&#8217;s total assets). For these purposes, &#8220;asset coverage&#8221; means the ratio of (i) total assets
less all liabilities and indebtedness not represented by &#8220;senior securities&#8221; to (ii) the amount of &#8220;senior securities
representing indebtedness&#8221; plus the &#8220;involuntary liquidation preference&#8221; of the preferred shares. &#8220;Senior security&#8221;
generally means any bond, note, or similar security evidencing indebtedness and any class of shares having priority over any other class
as to distribution of assets or payment of dividends. &#8220;Senior security representing indebtedness&#8221; means any &#8220;senior
security&#8221; other than equity shares. The &#8220;involuntary liquidation preference&#8221; of the preferred shares is the amount
that holders of preferred shares would be entitled to receive in the event of an involuntary liquidation of the Fund in preference to
the common shares.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 9.05pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
preferred shares are outstanding, two of the Fund&#8217;s Trustees will be elected by the holders of preferred shares, voting separately
as a class. The remaining Trustees of the Fund will be elected by common shareholders and preferred shares voting together as a single
class. In the unlikely event the Fund failed to pay dividends on preferred shares for two years, preferred shares would be entitled to
elect a majority of the Trustees of the Fund.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 10.85pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is not permitted to declare any dividend (except a dividend payable in common shares), or to declare any other distribution on the
common shares, or to purchase any common shares, unless the preferred shares have at the time of the declaration of any such dividend
or other distribution, or at the time of any such purchase of common shares, an asset coverage of at least 200% after deducting the amount
of such dividend, distribution or purchase price. In addition, the Fund may be subject to certain restrictions imposed by guidelines
of one or more rating agencies that may issue ratings for preferred shares issued by the Fund. These guidelines may impose asset coverage
or portfolio composition requirements that are more stringent than those imposed on the Fund by the 1940 Act.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Indebtedness</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 7.8pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is authorized to borrow or issue debt securities for financial leveraging purposes and for temporary purposes such as the settlement
of transactions. The Fund may utilize indebtedness to the maximum extent permitted under the 1940 Act. Under the 1940 Act, a fund generally
is not permitted to issue commercial paper or notes or engage in other borrowings unless, immediately after the borrowing, the fund would
have asset coverage (as defined in the 1940 Act) of at least 300%, <i>i.e., </i>the value of the fund&#8217;s total assets less liabilities
other than the principal amount represented by commercial paper, notes or other borrowings, is at least 300% of such principal amount.
In addition, other than with respect to privately arranged borrowings, the Fund is not permitted to declare any cash dividend or other
distribution on the common shares unless, at the time of such declaration, the value of the Fund&#8217;s total assets, less liabilities
other than the principal amount represented by borrowings, is at least 300% of such principal amount after deducting the amount of such
dividend or other distribution. If the Fund borrows, the Fund intends, to the extent possible, to prepay all or a portion of the principal
amount of any outstanding commercial paper, notes or other borrowings to the extent necessary to maintain the required asset coverage.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.45pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms of any such borrowings may require the Fund to pay a fee to maintain a line of credit, such as a commitment fee, or to
maintain minimum average balances with a lender. Any such requirements would increase the cost of such borrowings over the stated
interest rate. Such lenders would have the right to receive interest on <span style="letter-spacing: -0.25pt">and repayment of
principal of any such borrowings, which right will be senior to those of the common shareholders. Any such borrowings may contain
provisions limiting certain activities of the Fund, including the payment of dividends to common shareholders in certain
circumstances.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 26pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
types of borrowings subject the Fund to covenants in credit agreements relating to asset coverage and portfolio composition
requirements. Certain borrowings also may subject the Fund to certain restrictions on investments imposed by guidelines of one or
more rating agencies, which may issue ratings for such <span style="letter-spacing: -0.1pt">borrowings. Such guidelines may impose
asset coverage or portfolio composition requirements that are more stringent than those imposed by the 1940 Act.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
1940 Act grants to the holders of senior securities representing indebtedness, other than with respect to privately arranged borrowings,
certain voting rights in the event of default in the payment of interest on or repayment of principal. Failure to maintain certain asset
coverage requirements under the 1940 Act could result in an event of default and entitle the debt holders to elect a majority of the
Board of Trustees.</span></p>


<!-- Field: Page; Sequence: 64 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Capitalization</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following information regarding the Fund&#8217;s authorized shares is as of April 30, <span style="letter-spacing: -0.1pt">2024:</span></span></p>

<p style="font: 4.5pt Times LT Std Roman; margin: 0.15pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Times LT Std Roman; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: #81837D 1pt solid; text-align: center; width: 24%; vertical-align: bottom"><p style="font: 8.5pt Times LT Std Roman; margin: 8.2pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 8.5pt/8.4pt Times LT Std Bold,serif; margin: 0.05pt 0 0 3.85pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of <span style="letter-spacing: -0.1pt">Class</span></b></span></p></td>
    <td style="border-bottom: #81837D 1pt solid; text-align: center; width: 25%; vertical-align: bottom"><p style="font: 8.5pt Times LT Std Roman; margin: 8.2pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 8.5pt/8.4pt Times LT Std Bold,serif; margin: 0.05pt 0 0 6.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt"><b>Amount
    Authorized</b></span></p></td>
    <td style="border-bottom: #81837D 1pt solid; vertical-align: bottom; width: 27%; padding-top: 8.8pt; padding-right: 18.7pt; padding-left: 26.2pt; text-indent: -5.85pt; text-align: center; line-height: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
    Held by Fund for its own Account</b></span></td>
    <td style="border-bottom: #81837D 1pt solid; vertical-align: bottom; width: 24%; padding-right: 19.7pt; padding-left: 18.85pt; text-align: center; line-height: 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount
    Outstanding <span style="letter-spacing: -0.1pt">Exclusive of Amounts </span>held by Fund</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.15pt; padding-left: 3.85pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    <span style="letter-spacing: -0.1pt">Shares</span></span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.15pt; padding-left: 6.35pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Unlimited</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.15pt; padding-left: 1.55pt; text-align: center; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">None</span></td>
    <td style="border-bottom: #81837D 1pt solid; padding-top: 0.15pt; padding-left: 38.65pt; text-align: left; line-height: 8.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">34,593,769</span></td></tr>
  </table>
<p style="font: 10pt Times LT Std Roman; margin: 6.3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">DESCRIPTION
OF SUBSCRIPTION RIGHTS THAT MAY BE ISSUED</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may issue subscription rights to holders of common shares to purchase additional common shares. Subscription rights may or may not
be transferable by the person purchasing or receiving the subscription rights. In connection with a subscription rights offering to holders
of common shares, the Fund would distribute certificates evidencing the subscription rights and a Prospectus Supplement to our common
shareholders as of the record date that we set for determining the shareholders eligible to receive subscription rights in such subscription
rights offering. For complete terms of the subscription rights, please refer to the actual terms of such subscription rights which will
be set forth in the subscription rights agreement or subscription certificate relating to such subscription rights and described in the
Prospectus Supplement.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.2pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund generally may not issue and sell common shares at a public offering price (less underwriting commissions and discounts) less than
the net asset value of the Fund&#8217;s common shares (calculated within 48 hours of the pricing of such offering). However, pursuant
to Section 23(b) of the 1940 Act, the Fund may issue and sell common shares at a public offering price less than the net asset value
of the Fund&#8217;s common shares in connection with the issuance of subscription rights to holders of common shares to purchase additional
common shares. See &#8220;Description of Capital Structure.&#8221;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
applicable Prospectus Supplement, which would accompany this Prospectus, would describe the following terms of subscription rights in
respect of which this Prospectus is being delivered:</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 9.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            period of time the offering would remain open (which will be open a minimum number of days
                                            such that all record holders would be eligible to participate in the offering and will not
                                            be open longer than 120 days);</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            title of such subscription <span style="letter-spacing: -0.1pt">rights;</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            exercise price for such subscription rights (or method of calculation <span style="letter-spacing: -0.1pt">thereof);</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of such subscription rights issued in respect of each <span style="letter-spacing: -0.1pt">share;</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of rights required to purchase a single <span style="letter-spacing: -0.1pt">share;</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 16.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            extent to which such subscription rights are transferable and the market on which they may
                                            be traded if they are transferable;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 26.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">if
                                            applicable, a discussion of certain U.S. federal income tax considerations applicable to
                                            the issuance or exercise of such subscription rights;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 16.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            date on which the right to exercise such subscription rights will commence, and the date
                                            on which such right will expire (subject to any extension);</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 54.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            extent to which such subscription rights include an over-subscription privilege with respect
                                            to unsubscribed securities and the terms of such over-subscription privilege;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            termination right the Fund may have in connection with such subscription rights <span style="letter-spacing: -0.1pt">offering;</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            expected trading market, if any, for rights; <span style="letter-spacing: -0.25pt">and</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 45.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            other terms of such subscription rights, including exercise, settlement and other procedures
                                            and limitations relating to the transfer and exercise of such subscription rights.</span></td></tr></table>


<!-- Field: Page; Sequence: 65 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise
of Subscription <span style="letter-spacing: -0.1pt">Rights</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 30.6pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
subscription right would entitle the holder of the subscription right to purchase for cash such number of shares at such exercise price
as in each case is set forth in, or is determinable as set forth in, the Prospectus Supplement relating to the subscription rights offered
thereby. Subscription rights would be exercisable at any time up to the close of business on the expiration date for such subscription
rights set forth in the Prospectus Supplement. After the close of business on the expiration date, all unexercised subscription rights
would become void.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
expiration of the rights offering and the receipt of payment and the subscription rights certificate properly completed and duly executed
at the corporate trust office of the subscription rights agent or any other office indicated in the Prospectus Supplement, the Fund would
issue, as soon as practicable, the shares purchased as a result of such exercise. To the extent permissible under applicable law, the
Fund may determine to offer any unsubscribed offered securities directly to persons other than shareholders, to or through agents, underwriters
or dealers or through a combination of such methods, as set forth in the applicable Prospectus Supplement.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transferable
Rights <span style="letter-spacing: -0.1pt">Offering</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 19.2pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
rights issued by the Fund may be transferrable. The distribution to shareholders of transferable rights, which may themselves have intrinsic
value, also will afford non-participating shareholders the potential of receiving cash payment upon the sale of the rights, receipt of
which may be viewed as partial compensation for any dilution of their interests that may occur as a result of the rights offering. In
a transferrable rights offering, management of the Fund will use its best efforts to ensure an adequate trading market in the rights
for use by shareholders who do not exercise such rights. However, there can be no assurance that a market for transferable rights will
develop or, if such a market does develop, what the price of the transferable rights will be. In a transferrable rights offering to purchase
common shares at a price below net asset value, the subscription ratio will not be less than 1-for-3, that is the holders of common shares
of record on the record date of the rights offering will receive one right for each outstanding common share owned on the record date
and the rights will entitle their holders to purchase one new common share for every three rights held (provided that any common shareholder
who owns fewer than three common shares as of the record date may subscribe for one full common share). Assuming the exercise of all
rights, such a rights offering would result in an approximately 33 1/3% increase in the Fund&#8217;s common shares outstanding.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 17.85pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">ANTI-TAKEOVER
PROVISIONS IN THE FUND&#8217;S GOVERNING DOCUMENTS</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.2pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund presently has provisions in its Governing Documents which could have the effect of limiting, in each case, (i) the ability of other
entities or persons to acquire control of the Fund, (ii) the Fund&#8217;s freedom to engage in certain transactions or (iii) the ability
of the Fund&#8217;s Board of Trustees or shareholders to amend the Governing Documents or effectuate changes in the Fund&#8217;s management.
These provisions of the Governing Documents of the Fund may be regarded as &#8220;anti-takeover&#8221; provisions. The Board of Trustees
is divided into three classes, with the terms of one class expiring at each annual meeting of shareholders. At each annual meeting, one
class of Trustees is elected to a three-year term. This provision could delay for up to two years the replacement of a majority of the
Board of Trustees. A Trustee may be removed from office for cause by the action of a majority of the remaining Trustees followed by a
vote of the holders of at least 75% of the shares then entitled to vote for the election of the respective Trustee.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Declaration of Trust requires the affirmative vote of a majority of the Board of Trustees followed by the affirmative vote of the holders
of at least 75% of the outstanding shares of each affected class or series of the Fund, voting separately as a class or series, to approve,
adopt or authorize certain transactions with 5% or greater holders of a class or series of shares and their associates, unless the transaction
has been approved by at least 80% of the Board of Trustees, in which case &#8220;a majority of the outstanding voting securities&#8221;
(as defined in the 1940 Act) of the Fund shall be required. For purposes of these provisions, a 5% or greater holder of a class or series
of shares (a &#8220;Principal Shareholder&#8221;) refers to any person who, whether directly or indirectly and whether alone or together
<span style="letter-spacing: -0.2pt">with its affiliates and associates, beneficially owns 5% or more of the outstanding shares of any
class or series of shares of beneficial interest of the Fund.</span></span></p>


<!-- Field: Page; Sequence: 66 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 0 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
5% holder transactions subject to these special approval requirements <span style="letter-spacing: -0.2pt">are:</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            merger or consolidation of the Fund or any subsidiary of the Fund with or into any Principal
                                            <span style="letter-spacing: -0.1pt">Shareholder;</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 17.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            issuance of any securities of the Fund to any Principal Shareholder for cash (other than
                                            pursuant to any automatic dividend reinvestment plan);</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 9.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            sale, lease or exchange of all or any substantial part of the assets of the Fund to any Principal
                                            Shareholder, except assets having an aggregate fair market value of less than $1,000,000,
                                            aggregating for the purpose of such computation all assets sold, leased or exchanged in any
                                            series of similar transactions within a twelve-month period; or</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 17.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            sale, lease or exchange to the Fund or any subsidiary thereof, in exchange for securities
                                            of the Fund, of any assets of any Principal Shareholder, except assets having an aggregate
                                            fair market value of less than</span></td></tr></table>

<p style="font: 10pt Times LT Std Roman; margin: 0 13.2pt 0 44.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,000,000,
aggregating for the purposes of such computation all assets sold, leased or exchanged in any series of similar transactions within a
twelve-month period.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 10.85pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purposes of calculating &#8220;a majority of the outstanding voting securities&#8221; under the Declaration of Trust, each class
and series of the Fund shall vote together as a single class, except to the extent required by the 1940 Act or the Declaration of Trust
with respect to any class or series of shares. If a separate vote is required, the applicable proportion of shares of the class or series,
voting as a separate class or series, also will be required. A &#8220;majority of the outstanding voting securities&#8221; means the
lesser of (i) 67% or more of the Fund&#8217;s voting securities present at a meeting, if the holders of more than 50% of the Fund&#8217;s
outstanding voting securities are present or represented by proxy; or (ii) more than 50% of the Fund&#8217;s outstanding voting securities.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Trustees has determined that provisions with respect to the Board and shareholder voting requirements described above, which
voting requirements are greater than the minimum requirements under Delaware law or the 1940 Act, are in the best interest of shareholders
generally. Reference should be made to the Declaration of Trust on file with the SEC for the full text of these provisions. See &#8220;Where
You Can Find More <span style="letter-spacing: -0.1pt">Information.&#8221;</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as a Delaware statutory trust, the Fund is subject to the Control Share Statute contained in Subchapter III of the DSTA, which
became automatically applicable to listed closed-end funds, such as the Fund, upon its Effective Date of August 1, 2022. The Control
Share Statute provides that an acquirer of shares above a series of voting power thresholds has no voting rights under the DSTA or the
governing documents of the Fund with respect to shares acquired in excess of that threshold (<i>i.e.,</i> the &#8220;control shares&#8221;)
unless approved by shareholders. See &#8220;Certain Provisions of Delaware Law, the Declaration of Trust and By-Laws&#8212;Delaware Control
Share Statute.&#8221;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 0 0 28.35pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">CERTAIN
PROVISIONS OF DELAWARE LAW, THE DECLARATION OF TRUST AND BY-LAWS</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Classified
Board of <span style="letter-spacing: -0.1pt">Trustees</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 22.35pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Trustees is divided into three classes of trustees serving staggered three-year terms. Upon expiration of their current terms,
Trustees of each class will be elected to serve for three-year terms and until their successors are duly elected and qualified or the
Fund terminates, and each year one class of Trustees will be elected by the shareholders. A classified board may render a change in control
of the Fund or removal of the Fund&#8217;s incumbent management more difficult. The Fund believes, however, that the longer time required
to elect a majority of a classified Board of Trustees will help to ensure the continuity and stability of its management and policies.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election
of <span style="letter-spacing: -0.1pt">Trustees</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s Declaration of Trust provides that the affirmative vote of the holders of a majority of the shares entitled to vote and
present or represented by proxy will be required to elect a Trustee.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Trustees; Vacancies; <span style="letter-spacing: -0.1pt">Removal</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 7.8pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s Declaration of Trust provides that the number of Trustees will be set by the Board of Trustees. The Fund&#8217;s Declaration
of Trust provides that a majority of the Fund&#8217;s Trustees then in office may at any time increase or decrease the number of Trustees
provided there will be at least two Trustees. The Trustees&#8217; power of appointment is subject to Section 16(a) of the 1940 Act. Whenever
a vacancy in the number of Trustees will occur, until such</span></p>


<!-- Field: Page; Sequence: 67 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 18.45pt 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">vacancy
is filled as provided, the Trustees in office, regardless of their number, will have all the powers granted to the Trustees and will
discharge all the duties imposed upon the Trustees by the Declaration of Trust.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Action
by <span style="letter-spacing: -0.1pt">Shareholders</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 13.2pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder
action can be taken only at an annual or special meeting of shareholders or by written consent in lieu of a meeting.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance
Notice Provisions for Shareholder Nominations and Shareholder <span style="letter-spacing: -0.1pt">Proposals</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 13.2pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s By-laws provide that with respect to an annual meeting of shareholders, nominations of persons for election to the Board
of Trustees and the proposal of business to be considered by shareholders may be made only (1) pursuant to the Fund&#8217;s notice of
the meeting, (2) by the Board of Trustees or (3) by a shareholder of record who individually or in the aggregate, holds at least 3% of
the shares entitled to vote, has held such shares continuously for one year, continuously holds such shares through and including the
time of the annual meeting, and has complied with the advance notice procedures of the By-laws. With respect to special meetings of shareholders,
only the business specified in the Fund&#8217;s notice of the meeting may be brought before the meeting. Nominations of persons for election
to the Board of Trustees at a special meeting may be made only (1) pursuant to the Fund&#8217;s notice of the meeting, (2) by the Board
of Trustees or (3) by a shareholder of record who individually or in the aggregate, holds at least 3% of the shares entitled to vote,
has held such shares continuously for one year, continuously holds such shares through and including the time of the annual meeting,
and has complied with the advance notice procedures of the By-laws.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calling
of Special Meetings of <span style="letter-spacing: -0.1pt">Shareholders</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 15.1pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s By-laws provide that special meetings of shareholders may be called at any time by the President or the majority of Trustees
of the Fund. By following certain procedures, a special meeting of shareholders will also be called by any Trustee of the Fund upon the
written request of the shareholders entitled to cast not less than a majority of all the votes entitled to be cast at such meeting.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
Provisions of the Declaration of Trust and By-<span style="letter-spacing: -0.2pt">Laws</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 10.85pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Declaration of Trust provides that the Trustees shall owe to the Fund and its Shareholders the same fiduciary duties as owed by directors
of corporations to such corporations and their stockholders under the Delaware General Corporation Law.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 16.1pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Declaration of Trust, the Trustees and officers of the Fund are entitled to indemnification under certain circumstances against liabilities
and expenses in connection with any action, suit or other proceeding in which he or she may be involved while acting as a trustee or
officer of the Fund except with respect to any matter as to which he or she shall not have acted in good faith in the reasonable belief
that his or her action was in the <span style="letter-spacing: -0.2pt">best interest of the Fund or, in the case of any criminal proceeding,
as to which he or she shall have had reasonable cause to believe that the conduct was unlawful, provided, however, that no indemnitee
shall be indemnified hereunder against any liability to any person or any expense of such indemnitee arising by reason of (i) willful
misfeasance, (ii) bad faith, (iii) gross negligence, or (iv) reckless disregard of the duties involved in the conduct of his position.
Subject to any limitations provided by the 1940 Act, the Fund has the power and authority to indemnify and provide for the advance payment
of expenses to employees, agents and other persons providing services to the Fund or serving in any capacity at the request of the Fund
to the full extent corporations organized under the Delaware General Corporation Law may indemnify or provide for the advance payment
of expenses for such persons, provided that such indemnification has been approved by a majority of the Trustees.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the By-Laws, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or
proceeding brought on behalf of the Trust, (ii) any action asserting a claim of breach of a fiduciary duty owed by any trustee, officer,
or employee of the Trust to the Trust or its Shareholders, (iii) any action asserting a claim against the Trust or any trustee, officer,
or employee of the Trust arising pursuant to any provision of the Delaware Statutory Trust Act or the Trust&#8217;s Declaration or By-Laws,
or (iv) any action asserting a claim against the Trust or any trustee, officer, or employee of the Trust governed by the internal affairs
doctrine of the State of Delaware; provided, however, that, in the event that the Court of Chancery of the State of Delaware lacks jurisdiction
over any such action or proceeding, the sole and exclusive forum for such action or proceeding shall be another state or federal court
located within the State of Delaware. The foregoing exclusive form provision does not apply to any claim under the U.S. federal securities
laws. The exclusive forum provision may require a</span></p>


<!-- Field: Page; Sequence: 68 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 0 0 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shareholders
to have to bring a claim subject to the exclusive forum provision in forum that such shareholder may consider to be less convenient and/or
less favorable than other forums in which a shareholder may otherwise seek to bring such claim.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware
Control Share <span style="letter-spacing: -0.1pt">Statute</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 7.8pt 0 9pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
the Fund is organized as a Delaware statutory trust it is subject to the Control Share Statute contained in Subchapter III of the DSTA,
which became automatically applicable to listed closed-end funds, such as the Fund, upon its Effective Date of August 1, 2022.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.2pt 0 9pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Control Share Statute provides for a series of voting power thresholds above which shares are considered control shares. These thresholds
are:</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 27pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10%
                                            or more, but less than 15% of all voting <span style="letter-spacing: -0.1pt">power;</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 27pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15%
                                            or more, but less than 20% of all voting <span style="letter-spacing: -0.1pt">power;</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 27pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20%
                                            or more, but less than 25% of all voting <span style="letter-spacing: -0.1pt">power;</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 27pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25%
                                            or more, but less than 30% of all voting <span style="letter-spacing: -0.1pt">power;</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 27pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30%
                                            or more, but less than a majority of all voting power; <span style="letter-spacing: -0.35pt">or</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 27pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            majority or more of all voting <span style="letter-spacing: -0.1pt">power.</span></span></td></tr></table>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 9pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
power is defined by the Control Share Statute as the power to directly or indirectly exercise or direct the exercise of the voting power
of Fund shares in the election of Trustees. Whether a voting power threshold is met is determined by aggregating the holdings of the
acquirer as well as those of its &#8220;associates,&#8221; as defined by the Control Share Statute.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 20pt 0 9pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
a threshold is reached, an acquirer has no voting rights under the DSTA or the governing documents of the Fund with respect to shares
acquired in excess of that threshold (<i>i.e.,</i> the &#8220;control shares&#8221;) unless approved by shareholders. Approval by shareholders
requires the affirmative vote of two-thirds of all votes entitled to be cast on the matter, excluding shares held by the acquirer and
its associates as well as shares held by certain insiders of a Fund. The Control Share Statute provides procedures for an acquirer to
request a shareholder meeting for the purpose of considering whether voting rights shall be accorded to control shares. Further approval
by a Fund&#8217;s shareholders would be required with respect to additional acquisitions of control shares above the next applicable
threshold level.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 9pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Control Share Statute effectively allows non-interested shareholders to evaluate the intentions and plans of an acquiring person above
each threshold level.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 18.45pt 0 9pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternatively,
the Board of Trustees is permitted, but not obligated, to exempt specific acquisitions or classes of acquisitions of control shares,
either in advance or retroactively. The Board of Trustees has considered the Control Share Statute. As of the date hereof, the Board
of Trustees has not received notice of the occurrence of a control share acquisition nor has been requested to exempt any acquisition.
Therefore, the Board of Trustees has not determined whether the application of the Control Share Statute to an acquisition of Fund shares
is in the best interest of the Fund and its shareholders and has not exempted, and has no present intention to exempt, any acquisition
or class of acquisitions.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 7.05pt 0 9pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Board of Trustees receives a notice of a control share acquisition and/or a request to exempt any acquisition, it will consider whether
the application of the Control Share Statute or the granting of such an exemption would be in the best interest of the Fund and its shareholders.
The Fund should not be viewed as a vehicle for trading purposes. It is designed primarily for risk-tolerant long-term investors.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 35.35pt 0 9pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Control Share Statute does not retroactively apply to acquisitions of shares that occurred prior to the Effective Date. However, such
shares will be aggregated with any shares acquired after the Effective Date for purposes of determining whether a voting power threshold
is exceeded, resulting in the newly acquired shares constituting control shares.</span></p>


<!-- Field: Page; Sequence: 69 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 28.2pt 0 6pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Control Share Statute requires shareholders to disclose to the Fund any control share acquisition within 10 days of such acquisition
and, upon request, to provide any information that the Board of Trustees reasonably believes is necessary or desirable to determine whether
a control share acquisition has occurred.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
uncertainty around the general application under the 1940 Act of state control share statutes exists as a result of recent federal and
state court decisions that have found that certain control share by-laws and the opting in to state control share statutes violated the
1940 Act. Additionally, in some circumstances uncertainty may also exist in how to enforce the control share restrictions contained in
state control share statutes against beneficial owners who hold their shares through financial intermediaries. The Board has considered
the Control Share Statute and the uncertainty around the general application under the 1940 Act of state control share statutes and enforcement
of statute control share statutes. The Board intends to continue to monitor developments relating to the Control Share Statute and state
control share statutes generally.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 20.4pt 0 6pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing is only a summary of certain aspects of the Control Share Statute. Shareholders should consult their own legal counsel to determine
the application of the Control Share Statute with respect to their shares of the Fund and any subsequent acquisitions of shares.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 2.95pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CLOSED-END
FUND <span style="letter-spacing: -0.1pt">STRUCTURE</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closed-end
funds differ from open-end management investment companies (commonly referred to as &#8220;mutual funds&#8221;) in that closed-end funds
generally list their shares for trading on a securities exchange and do not redeem their shares at the option of the shareholder. By
comparison, mutual funds issue securities redeemable at net asset value at the option of the shareholder and typically engage in a continuous
offering of their shares. Mutual funds are subject to continuous asset in-flows and out-flows that can complicate portfolio management,
whereas closed-end funds generally can stay more fully invested in securities consistent with the closed-end fund&#8217;s investment
objective and policies. In addition, in comparison to open-end funds, closed-end funds have greater flexibility in their ability to make
certain types of investments, including investments in illiquid securities.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 19.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
shares of closed-end funds listed for trading on a securities exchange frequently trade at a discount from net asset value, but in some
cases trade at a premium. The market price may be affected by trading volume of the shares, general market and economic conditions and
other factors beyond the control of the closed-end fund. The foregoing factors may result in the market price of the common shares being
greater than, less than or equal to net asset value. The Board of Trustees has reviewed the structure of the Fund in light of its investment
objective and policies and has determined that the closed-end structure is in the best interests of the shareholders. Investors should
assume, therefore, that it is unlikely that the Board of Trustees would vote to convert the Fund to an open-end management investment
company.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repurchase
of Common <span style="letter-spacing: -0.1pt">Shares</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Trustees will review periodically the trading range and activity of the Fund&#8217;s shares with respect to its net asset value
and the Board of Trustees may take certain actions to seek to reduce or eliminate any such discount. Such actions may include open market
repurchases or tender offers for the common shares at net asset value. There can be no assurance that the Board of Trustees will decide
to undertake any of these actions or that, if undertaken, such actions would result in the common shares trading at a price equal to
or close to net asset value per common share.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
to Open-End <span style="letter-spacing: -0.2pt">Fund</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 20.05pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
convert the Fund to an open-end management investment company, the Declaration of Trust requires the affirmative vote of a majority of
the Board of Trustees followed by the affirmative vote of the holders of at least 75% of the outstanding shares of each affected class
or series of shares of the Fund, voting separately as a class or series, unless such action has been approved by at least 80% of the
Board of Trustees, in which case &#8220;a majority of the outstanding voting securities&#8221; (as defined in the 1940 Act) of the Fund
shall be required. The foregoing vote would satisfy a separate requirement in the 1940 Act that any conversion of the Fund to an open-end
<span style="letter-spacing: -0.1pt">management investment company be approved by the shareholders. If approved in the foregoing manner,
conversion of the Fund to an open-end management investment company could not occur until 90 days after the shareholders&#8217; meeting
at which such conversion was approved and would require at least 30 days&#8217; prior notice to all shareholders.</span></span></p>


<!-- Field: Page; Sequence: 70 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of conversion, the common shares would cease to be listed on the NYSE or other national securities exchange or market system.
If the Fund were converted to an open-end management investment company, it is likely that new common shares would be sold at net asset
value plus a sales load. Shareholders of an open-end management investment company may require the company to redeem their shares at
any time (except in certain circumstances as authorized by or under the 1940 Act) at their net asset value, less such redemption charge,
if any, as might be in effect at the time of a redemption. In the event of conversion, the Fund would expect to pay all such redemption
requests in cash, but would intend to reserve the right to pay redemption requests in a combination of cash or securities. If such partial
payment in securities were made, investors could incur brokerage costs in converting such securities to cash.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 18.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Trustees has reviewed the structure of the Fund in light of its investment objective and policies and has determined that the
closed-end structure is in the best interests of the shareholders. Any conversion to an open-end management investment company would
require material changes to the Fund&#8217;s investment strategy, including with respect to the use of leverage and investment in illiquid
securities, which may adversely impact the Fund&#8217;s ability to achieve its investment objective. Investors should assume, therefore,
that it is unlikely that the Board of Trustees would vote to convert the Fund to an open-end management investment company.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.25pt">TAX
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">MATTERS</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of certain U.S. federal income tax considerations generally applicable to the Fund and U.S. Shareholders (as
defined below) and Non-U.S. Shareholders (as defined below) that acquire common shares (collectively, the &#8220;Shareholders&#8221;
that acquire &#8220;Shares&#8221;) and that hold such shares as capital assets within the meaning of the Code (generally, property
held for investment). A more complete discussion of the tax rules applicable to the Fund and its Shareholders can be found in the
SAI that is incorporated by reference into this Prospectus. This summary does not discuss the consequences of an investment in the
Rights. The tax consequences of such an investment will be discussed in a relevant Prospectus Supplement. The discussion is based
upon the Code, Treasury Regulations, judicial authorities, published positions of the Internal Revenue Service (the
&#8220;IRS&#8221;) and other applicable authorities, all as in effect on the date hereof and all of which are subject to change or
differing interpretations (possibly with retroactive effect). This summary does not address all of the potential U.S. federal income
tax consequences that may be applicable to the Fund or to all categories of investors, some of which may be subject to special tax
rules. No ruling has been or will be sought from the IRS regarding any matter discussed herein. No assurance can be given that the
IRS would not assert, or that a court would not sustain, a position contrary to any of the tax aspects set forth below. This summary
of U.S. federal income tax consequences is for general information only. <b>Prospective investors should consult their tax advisors
as to the U.S. federal income tax consequences of acquiring, holding and disposing of common shares of the Fund, as well as the
effects of state, local and non-U.S. tax <span style="letter-spacing: -0.1pt">laws.</span></b></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this summary, the term &#8220;U.S. Shareholder&#8221; means a beneficial owner of common shares that, for U.S. federal income
tax purposes, is one of the following:</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">1.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            individual who is a citizen or resident of the United <span style="letter-spacing: -0.1pt">States;</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">2.</span></td><td style="padding-right: 23.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            corporation or other entity taxable as a corporation created in or organized under the laws
                                            of the United States, any state thereof or the District of Columbia;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">3.</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            estate the income of which is subject to U.S. federal income taxation regardless of its source;
                                            <span style="letter-spacing: -0.25pt">or</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">4.</span></td><td style="text-align: justify; padding-right: 6.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            trust (x) if a U.S. court is able to exercise primary supervision over the administration
                                            of such trust and one or more U.S. persons have the authority to control all substantial
                                            decisions of such trust or (y) that has a valid election in effect under applicable U.S.
                                            Treasury regulations to be treated as a U.S. person.</span></td></tr></table>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a partnership (including any other entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds common
shares, the U.S. federal income tax treatment of a partner in such partnership generally will depend upon the status of the partner and
the activities of the partnership. Partners of partnerships that hold common shares should consult their tax advisors.</span></p>


<!-- Field: Page; Sequence: 71 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxation
of the <span style="letter-spacing: -0.2pt">Fund</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 21.75pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund has elected to be treated, and intends to qualify annually, as a RIC under Subchapter M of the Code. Accordingly, the Fund must,
among other things, meet certain income, asset diversification and distribution <span style="letter-spacing: -0.1pt">requirements:</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 24pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(i)</span></td><td style="padding-right: 15.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Fund must derive in each taxable year at least 90% of its gross income from the following
                                            sources: (a) dividends, interest (including tax-exempt interest), payments with respect to
                                            certain securities loans, and gains from the sale or other disposition of stock, securities
                                            or foreign currencies, or other income (including gain from options, futures and forward
                                            contracts) derived with respect to its business of investing in such stock, securities or
                                            foreign currencies; and (b) net income derived from interests in &#8220;qualified publicly
                                            traded partnerships&#8221; (as defined in the Code). Generally, a qualified publicly traded
                                            partnership includes a
partnership the interests of which are traded on an established securities market or readily tradable on a secondary market (or the substantial
equivalent thereof) and that derives less than 90% of its gross income from the items described in (a) above.</span></td></tr></table>



<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 24pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt">(ii)</span></td><td style="padding-right: 14.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Fund must diversify its holdings so that, at the end of each quarter of each taxable year,
                                            (a) at least 50% of the market value of the Fund&#8217;s total assets is represented by cash
                                            and cash items, including receivables,</span></td></tr></table>

<p style="font: 10pt Times LT Std Roman; margin: 0 9.05pt 0 42pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Government securities, the securities of other RICs and other securities, with such other securities limited, in respect of any one issuer,
to an amount not greater than 5% of the value of the Fund&#8217;s total assets and not more than 10% of the outstanding voting securities
of such issuer and (b) not more than 25% of the market value of the Fund&#8217;s total assets is invested in the securities (other than
U.S. Government securities and the securities of other RICs) of (I) any one issuer, (II) any two or more issuers that the Fund controls
and that are determined to be engaged in the same business or similar or related trades or businesses or (III) any one or more &#8220;qualified
publicly traded partnerships&#8221; (as defined in the Code).</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 24.85pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
long as the Fund qualifies as a RIC, the Fund generally will not be subject to U.S. federal income tax on income and gains that the Fund
distributes to its shareholders; provided that it distributes each taxable year at least 90% of the sum of (i) the Fund&#8217;s investment
company taxable income (which includes, among other items, dividends, interest, the excess of any net short-term capital gain over net
long-term capital loss, and other <span style="letter-spacing: -0.1pt">taxable income, other than any net capital gain (defined below),
reduced by deductible expenses) determined without regard to the deduction for dividends paid and (ii) the Fund&#8217;s net tax-exempt
interest (the excess of its gross tax-exempt interest over certain disallowed deductions) (the &#8220;Annual Distribution Requirement&#8221;).
The Fund intends to distribute substantially all of such income each year. The Fund will be subject to income tax at regular corporate
rates on any taxable income or gains that it does not distribute to its shareholders.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 15.25pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund will either distribute or retain for reinvestment all or part of its net capital gain (which consists of the excess of its net long-term
capital gain over its net short-term capital loss). If any such gain is retained, the Fund will be subject to U.S. federal income tax
a regular corporate rates on such retained amount. In that event, the Fund may report the retained amount as undistributed capital gain
in a notice to its Shareholders, each of whom (i) will be required to include in income for U.S. federal income tax purposes as long-term
capital gain its share of such undistributed amounts, (ii) will be entitled to credit its proportionate share of the tax paid by the
Fund against its U.S. federal income tax liability and to claim refunds to the extent that the credit exceeds such liability and (iii)
will increase its basis in its shares by the amount of undistributed capital gain included in such Shareholder&#8217;s gross income net
of the tax deemed paid by such Shareholder under clause (ii).</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 19.2pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Code imposes a 4% nondeductible excise tax on the Fund to the extent the Fund does not distribute by the end of any calendar year at
least the sum of (i) 98% of its ordinary income (not taking into account any capital gain or loss) for the calendar year and (ii) 98.2%
of its capital gain in excess of its capital loss (adjusted for certain ordinary losses) for a one-year period generally ending on October
31 of the calendar year (unless an election is made to use the Fund&#8217;s fiscal year) (the &#8220;Excise Tax Avoidance Requirement&#8221;).
In addition, the minimum amounts that must be distributed in any year to avoid the excise tax will be increased or decreased to reflect
any under-distribution or over-distribution, as the case may be, from the previous year. For purposes of the excise tax, the Fund will
be deemed to have distributed any income on which it paid U.S. federal income tax in the taxable year ending within the calendar year.
While the Fund intends to distribute any income and capital gain in the manner necessary to minimize imposition of the 4% nondeductible
excise tax, there can be no assurance that sufficient amounts of the Fund&#8217;s taxable income and capital gain will be distributed
to entirely avoid the imposition of the excise tax. <span style="letter-spacing: -0.25pt">In</span></span></p>


<!-- Field: Page; Sequence: 72 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 13.2pt 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
event, the Fund will be liable for the excise tax only on the amount by which it does not meet the foregoing distribution requirement.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
for any taxable year the Fund does not qualify as a RIC, all of its taxable income (including its net capital gain) will be subject to
tax at regular corporate rates without any deduction for distributions to Shareholders, and such distributions will be taxable to the
Shareholders as ordinary dividends to the extent of the Fund&#8217;s current and accumulated earnings and profits. Such dividends, however,
would be eligible (i) to be treated as qualified dividend income in the case of non-corporate U.S. Shareholders and (ii) for the dividends-received
deduction in the case of U.S. Shareholders taxed as corporations, in each case provided that certain holding period and other requirements
are met. The Fund could be required to recognize unrealized gains, pay taxes and make distributions (which could be subject to interest
charges) before requalifying for taxation as a RIC. The remainder of this discussion assumes that the Fund qualifies as a RIC.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxation
of the Fund&#8217;s <span style="letter-spacing: -0.1pt">Investments</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
of the Fund&#8217;s investment practices are subject to special and complex U.S. federal income tax provisions that may, among other
things, (i) disallow, suspend or otherwise limit the allowance of certain losses or deductions, (ii) convert lower taxed long-term capital
gains or &#8220;qualified dividend income&#8221; into higher taxed short-term capital gains or ordinary income, (iii) convert an ordinary
loss or a deduction into a capital loss (the deductibility of which is more limited), (iv) cause the Fund to recognize income or gain
without a corresponding receipt of cash, (v) adversely affect the time as to when a purchase or sale of stock or securities is deemed
to occur, (vi) adversely alter the characterization of certain complex financial transactions and (vii) produce income that will not
be &#8220;qualified&#8221; income for purposes of the 90% gross income requirement described above. These U.S. federal income tax provisions
could therefore affect the amount, timing and character of distributions to Shareholders. The Fund intends to structure and monitor its
transactions and may make certain tax elections and may be required to dispose of securities to mitigate the effect of these provisions
and prevent disqualification of the Fund as a RIC (which may adversely affect the net after-tax return to the Fund).</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Fund acquires shares in a &#8220;passive foreign investment company&#8221; (a &#8220;PFIC&#8221;), the Fund may be subject <span style="letter-spacing: -0.25pt">to</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 15.5pt 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
federal income tax on a portion of any &#8220;excess distribution&#8221; or gain from the disposition of such shares even if such income
is distributed as a taxable dividend by the Fund to Shareholders. Additional charges in the nature <span style="letter-spacing: -0.25pt">of
interest may be imposed on the Fund in respect of deferred taxes arising from such distributions or gains. If the Fund invests in a PFIC
and elects to treat the PFIC as a &#8220;qualified electing fund&#8221; (a &#8220;QEF&#8221;) under the Code, in lieu of the foregoing
requirements, the Fund will be required to include in income each year a portion of the ordinary earnings and net capital gain of the
QEF, even if such income is not distributed to the Fund. The Fund&#8217;s ability to make this election will depend on factors beyond
the Fund&#8217;s control. Alternatively, the Fund can elect to mark to market at the end of each taxable year the Fund&#8217;s shares
in a PFIC; in this case, the Fund will recognize as ordinary income any increase in the value of such shares, and as ordinary loss any
decrease in such value to the extent it does not exceed prior increases included in income. Under either election, the Fund may be required
to recognize in a year income in excess of the Fund&#8217;s distributions from PFICs and the Fund&#8217;s proceeds from dispositions
of PFIC stock during that year, and such income will nevertheless be subject to the Annual Distribution Requirement and will be taken
into account for purposes of the 4% excise tax.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 15.35pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Fund holds directly or indirectly 10% or more of the shares in a foreign corporation that is treated as a &#8220;controlled foreign
corporation&#8221; (a &#8220;CFC&#8221;), the Fund may be treated as receiving a deemed distribution (taxable as ordinary income) each
year from such foreign corporation in an amount equal to the Fund&#8217;s pro rata share of the corporation&#8217;s income for the taxable
year (including both ordinary earnings and capital gains), whether or not the corporation makes an actual distribution during such year.
In general, a foreign corporation will be classified as a CFC if more than 50% of the shares of the corporation, measured by reference
to combined voting power or value, is owned (directly, indirectly or by attribution) by U.S. shareholders. A U.S. shareholder, for this
purpose, is any U.S. person that possesses (directly, indirectly or by attribution) 10% or more of the combined voting power or value
of all classes of shares of a corporation. If the Fund is treated as receiving a deemed distribution from a CFC, the Fund will be required
to include such distribution in its investment company taxable income regardless of whether the Fund receives any actual distributions
from such CFC, and the Fund must distribute such income to satisfy the Annual Distribution Requirement and the Excise Tax Avoidance Requirement.</span></p>


<!-- Field: Page; Sequence: 73 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxation
of U.S. <span style="letter-spacing: -0.1pt">Shareholders</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 13.6pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distributions</i>.
Distributions paid to U.S. Shareholders by the Fund from its net capital gains (which is the excess of net long-term capital gain over
net short-term capital loss) if any, that the Fund properly reports as capital gains dividends (&#8220;capital gain dividends&#8221;)
are taxable as long-term capital gains, regardless of how long a U.S. Shareholder has held its shares. All other dividends paid to U.S.
Shareholders by the Fund (including dividends from short-term capital gains) from its current or accumulated earnings and profits (&#8220;ordinary
income dividends&#8221;) are generally subject to tax as ordinary income.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the case of corporate U.S. Shareholders, properly reported ordinary income dividends paid by the Fund generally will be eligible for
the dividends received deduction to the extent that the Fund&#8217;s income consists of dividend income from U.S. corporations and certain
holding period requirements are satisfied by both the Fund and the corporate U.S. Shareholders. In the case of individuals, any properly
reported ordinary income dividend that you receive from the Fund will generally be eligible for taxation at the rates applicable to long-term
capital gains to the extent that (i) the ordinary income dividend is attributable to &#8220;qualified dividend income&#8221; (<i>i.e.,
</i>generally dividends paid by U.S. corporations and certain qualified foreign corporations) received by the Fund, (ii) the Fund satisfies
certain holding period and other requirements with respect to the stock on which such qualified dividend income was paid and (iii) you
satisfy certain holding period and other requirements with respect to your Shares. Qualified dividend income eligible for these special
rules are not actually treated as capital gains, however, and thus will not be included in the computation of your net capital gain and
generally cannot be used to offset any capital losses. In general, you may include as qualified dividend income only that portion of
the dividends that may be and are so reported by the Fund as qualified dividend income. Dividend income from PFICs and, in general, dividend
income from real estate investment trusts (&#8220;REITs&#8221;) is not eligible for the reduced rate for qualified dividend income and
is taxed as ordinary income. Due to the nature of the Fund&#8217;s investments, the Fund does not expect that a significant portion of
its distributions will be eligible for the dividends received deduction or for the reduced rates applicable to qualified dividend income.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 9.85pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Treasury regulations, for taxable years beginning before January 1, 2026, properly reported dividends paid by the Fund that are attributable
to the Fund&#8217;s &#8220;qualified REIT dividends&#8221; (generally, ordinary income dividends paid by a REIT, not including capital
gain dividends or dividends treated as qualified dividend income) may be eligible for the 20% deduction described in Section 199A of
the Code in the case of non-corporate U.S. Shareholders; provided that certain holding period and other requirements are met by the Shareholder
and the Fund. There can be no assurance as to what portion, if any, of our distributions will qualify for such deduction. Subject to
any future regulatory guidance to the contrary, any distribution attributable to income from the Fund&#8217;s investments in publicly
traded partnerships, if any, will not qualify for the 20% deduction that could be available to a non-<span style="letter-spacing: -0.1pt">corporate
U.S. Shareholder were the Shareholder to own such partnership interests directly.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
distributions you receive that are in excess of the Fund&#8217;s current and accumulated earnings and profits will be treated as a tax-deferred
return of capital to the extent of your adjusted tax basis in your shares, and thereafter as capital gain from the sale of shares. The
amount of any Fund distribution that is treated as a return of capital will reduce your adjusted tax basis in your shares, thereby increasing
your potential gain, or reducing your potential loss, on any subsequent sale or other disposition of your shares.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 18.45pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends
and other taxable distributions are taxable to you even if they are reinvested in additional Shares of the Fund. Dividends and other
distributions paid by the Fund are generally treated as received by you at the time the dividend or distribution is made. If, however,
the Fund pays you a dividend in January that was declared in the previous October, November or December and you were the U.S. Shareholder
of record on a specified date in one of such months, then such dividend will be treated for U.S. federal income tax purposes as being
paid by the Fund and received by you on December 31 of the year in which the dividend was declared.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund will send you information after the end of each year setting forth the amount and tax status of any distributions paid to you by
the Fund.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.2pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sale
of Shares</i>. Except in the case of a redemption (the consequences of which are described in the SAI under &#8220;Tax Matters&#8221;),
the sale or other disposition of common shares of the Fund will generally result in capital gain or loss to you and will be long-term
capital gain or loss if you have held such shares for more than one year. Any loss upon the sale or other disposition of shares held
for six months or less will be treated as long-term capital loss to the extent of any capital gain dividends received (including amounts
credited as an undistributed capital gain)</span></p>


<!-- Field: Page; Sequence: 74 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 0.25in 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">by
you with respect to such shares. Any loss you recognize on a sale or other disposition of common shares will be disallowed if you acquire
other common shares (whether through the automatic reinvestment of dividends or otherwise) within a 61-day period beginning 30 days before
and ending 30 days after your sale or exchange of the shares. In such case, your tax basis in the shares acquired will be adjusted to
reflect the disallowed loss.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
U.S. federal income tax law taxes both long-term and short-term capital gain of corporations at the rates applicable to ordinary income.
For non-corporate taxpayers, short-term capital gain is currently taxed at rates applicable to ordinary income, while long-term capital
gain generally is taxed at reduced maximum rates. The deductibility of capital losses is subject to limitations under the Code.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Medicare
Tax</i>. Certain U.S. Shareholders who are individuals, estates or trusts and whose income exceeds certain thresholds will be required
to pay a 3.8% Medicare tax on all or a part of their &#8220;net investment income,&#8221; which includes dividends received from the
Fund and capital gains from the sale or other disposition of Fund common shares.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxation
of Non-U.S. <span style="letter-spacing: -0.1pt">Shareholders</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion only applies to Non-U.S. Shareholders. A &#8220;Non-U.S. Shareholder&#8221; is a holder, other than a partnership
(or other entity or arrangement treated as a partnership for U.S. federal income tax purposes), that is not a U.S. Shareholder for U.S.
federal income tax purposes. Whether an investment in Fund shares is appropriate for a Non-U.S. Shareholder will depend upon that Non-U.S.
Shareholder&#8217;s particular circumstances. An investment in shares by a Non-U.S. Shareholder may have adverse tax consequences. Non-U.S.
Shareholders should consult their tax advisors before investing in Fund shares.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 7.8pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
of ordinary income dividends to Non-U.S. Shareholders, subject to the discussion below, will generally be subject to withholding of U.S.
federal tax at a 30% rate (or lower rate provided by an applicable treaty) to the extent of the Fund&#8217;s current and accumulated
earnings and profits. Actual or deemed distributions of the Fund&#8217;s net capital gain to a Non-U.S. Shareholder, and gain recognized
by a Non-U.S. Shareholder upon the sale of Fund shares, generally will not be subject to U.S. federal withholding tax and will not be
subject to U.S. federal income tax. Different tax consequences may result if the Non-U.S. Shareholder is engaged in a trade or business
in the United States or, in the case of an individual, is present in the United States for 183 days or more during a taxable year and
certain other conditions are met. Special certification requirements apply to a shareholder that is a foreign partnership or a foreign
Fund, and such entities are urged to consult their tax advisors.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
U.S. source withholding taxes will be imposed on dividends paid by RICs to Non-U.S. Shareholders to the extent the dividends are properly
reported as &#8220;interest related dividends&#8221; or &#8220;short-term capital gain dividends.&#8221; Under this exemption, interest
related dividends and short-term capital gain dividends generally represent distributions of interest or short-term capital gain that
would not have been subject to U.S. withholding tax at the source if they had been received directly by a Non-U.S. Shareholder, and that
satisfy certain other requirements. No assurance can be given as to the portion of the Fund&#8217;s dividends that will constitute interest
related or short-term capital gain dividends.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 18.45pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Fund distributes its net capital gains in the form of deemed rather than actual distributions (which the Fund may do in the future),
a Non-U.S. Shareholder will be entitled to a U.S. federal income tax credit or tax refund equal to the Non-U.S. Shareholder&#8217;s allocable
share of the tax that the Fund pays on the capital gains deemed to have been distributed. In order to obtain the refund, the Non-U.S.
Shareholder must obtain a U.S. taxpayer identification number and file a U.S. federal income tax return even if the Non-U.S. Shareholder
is not otherwise required to obtain a U.S. taxpayer identification number or file a federal income tax return. For a Non-U.S.
Shareholder, distributions (both actual and deemed) and gains realized upon the sale of shares that are in each case effectively connected
with a U.S. trade or business (or, where an applicable treaty applies, are attributable to a permanent establishment in the United States)
will generally be subject to U.S. federal income tax at the rates applicable to U.S. persons and for a corporate Non-U.S. Shareholder
may, under certain circumstances, be subject to an additional &#8220;branch profits tax&#8221; at a 30% rate (or at a lower rate if provided
for by an applicable tax treaty). Accordingly, investment in shares may not be appropriate for certain Non-U.S. Shareholders.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
provisions of the Code referred to as &#8220;FATCA&#8221; require withholding at a rate of 30% on dividends in respect of shares held
by or through certain foreign financial institutions (including investment funds), unless such institution enters into an agreement with
the Treasury to report, on an annual basis, information with respect to</span></p>


<!-- Field: Page; Sequence: 75 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">interests
in, and accounts maintained by, the institution to the extent such interests or accounts are held by <span style="letter-spacing: -0.1pt">certain</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 16.6pt 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
persons and by certain non-U.S. entities that are wholly or partially owned by U.S. persons and to withhold on certain payments. Accordingly,
the entity through which shares are held will affect the determination of whether such withholding is required. Similarly, dividends
in respect of shares held by an investor that is a non-financial non-U.S. entity that does not qualify under certain exemptions will
be subject to withholding at a rate of 30%, unless such entity either (i) certifies to the applicable withholding agent that such entity
does not have any &#8220;substantial United States owners&#8221; or (ii) provides certain information regarding the entity&#8217;s &#8220;substantial
United States owners,&#8221; which the applicable withholding agent will in turn provide to the Secretary of the Treasury. An intergovernmental
agreement between the United States and an applicable foreign country, or future Treasury regulations or other guidance, may modify these
requirements. The Fund will not pay any additional amounts to Non-U.S. Shareholders in respect of any amounts withheld. Non-U.S. Shareholders
are encouraged to consult their tax advisors regarding the possible implications of the legislation on their investment in shares.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing is a general and abbreviated summary of the provisions of the Code and the Treasury regulations in effect as they directly
govern the taxation of the Fund and its U.S. Shareholders and <span style="letter-spacing: -0.2pt">Non-U.S. Shareholders. These provisions
are subject to change by legislative or administrative action, and any such change may be retroactive. A more complete discussion of
the tax rules applicable to the Fund, its U.S. Shareholders and Non-U.S. Shareholders can be found in the SAI that is incorporated by
reference into this Prospectus. Shareholders are urged to consult their tax advisers regarding specific questions as to U.S. federal,
state, local and foreign income or other taxes.</span></span></p>


<!-- Field: Page; Sequence: 76 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN
OF <span style="letter-spacing: -0.1pt">DISTRIBUTION</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may offer up to $150,000,000 in aggregate initial offering price of common shares or Rights from time to time under this Prospectus
and any related Prospectus Supplement (1) directly to one or more purchases, including existing shareholders in a Rights offering; (2)
through agents; (3) through underwriters; (4) through dealers; or (5) pursuant to the Fund&#8217;s dividend reinvestment plan. Each Prospectus
Supplement relating to an offering of securities will state the terms of the offering, including:</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            names of any agents, underwriters or <span style="letter-spacing: -0.1pt">dealers;</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            sales loads or other items constituting underwriters&#8217; <span style="letter-spacing: -0.1pt">compensation;</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            discounts, commissions, or fees allowed or paid to dealers or <span style="letter-spacing: -0.1pt">agents;</span></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 6.15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            public offering or purchase price of the offered Securities and the net proceeds the Fund
                                            will receive from the sale; and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 26.95pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
                                            securities exchange on which the offered Securities may be <span style="letter-spacing: -0.1pt">listed.</span></span></td></tr></table>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Direct
<span style="letter-spacing: -0.1pt">Sales</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 30.6pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may sell Securities directly to, and solicit offers from, institutional investors or others who may be deemed to be underwriters
as defined in the Securities Act for any resales of the securities. In this case, no underwriters or agents would be involved. The Fund
may use electronic media, including the Internet, to sell offered securities directly. The Fund will describe the terms of any of those
sales in a Prospectus Supplement.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
<span style="letter-spacing: -0.1pt">Agents</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may offer Securities through agents that the Fund may designate. The Fund will name any agent involved in the offer and sale and
describe any commissions payable by the Fund in the Prospectus Supplement. Unless otherwise indicated in the Prospectus Supplement, the
agents will be acting on a best efforts basis for the period of their appointment.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
<span style="letter-spacing: -0.1pt">Underwriters</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 21.75pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may offer and sell Securities from time to time to one or more underwriters who would purchase the Securities as principal for resale
to the public, either on a firm commitment or best efforts basis. If the Fund sells Securities to underwriters, the Fund will execute
an underwriting agreement with them at the time of the sale and will name them in the Prospectus Supplement. In connection with these
sales, the underwriters may be deemed to have received compensation from the Fund in the form of underwriting discounts and commissions.
The underwriters also may receive commissions from purchasers of Securities for whom they may act as agent. Unless otherwise stated in
the Prospectus Supplement, the underwriters will not be obligated to purchase the Securities unless the conditions set forth in the underwriting
agreement are satisfied, and if the underwriters purchase any of the Securities, they will be required to purchase all of the offered
Securities. The underwriters may sell the offered Securities to or through dealers, and those dealers may receive discounts, concessions
or commissions from the underwriters as well as from the purchasers for whom they may act as agent. Any public offering price and any
discounts or concessions allowed or reallowed or paid to dealers may be changed from time to time.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 14.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with an offering of common shares, if a Prospectus Supplement so indicates, the Fund may grant the underwriters an option
to purchase additional common shares at the public offering price, less the underwriting discounts and commissions, within 45 days from
the date of the Prospectus Supplement, to cover any <span style="letter-spacing: -0.1pt">overallotments.</span></span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
<span style="letter-spacing: -0.1pt">Dealers</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may offer and sell Securities from time to time to one or more dealers who would purchase the Securities as principal. The dealers
then may resell the offered Securities to the public at fixed or varying prices to be determined by those dealers at the time of resale.
The Fund will set forth the names of the dealers and the terms of the transaction in the Prospectus Supplement.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
<span style="letter-spacing: -0.1pt">Information</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agents,
underwriters, or dealers participating in an offering of Securities may be deemed to be underwriters, and any discounts and commission
received by them and any profit realized by them on resale of the offered</span></p>


<!-- Field: Page; Sequence: 77 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 4pt 13.2pt 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
for whom they act as agent, may be deemed to be underwriting discounts and commissions under the Securities Act.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may offer to sell Securities either at a fixed price or at prices that may vary, at market prices prevailing at the time of sale,
at prices related to prevailing market prices or at negotiated prices.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 18.45pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
facilitate an offering of Securities in an underwritten transaction and in accordance with industry practice, the underwriters may engage
in transactions that stabilize, maintain, or otherwise affect the market price of the Securities. Those transactions may include overallotment,
entering stabilizing bids, effecting syndicate covering transactions, and reclaiming selling concessions allowed to an underwriter or
a dealer.</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 24pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 62.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            overallotment in connection with an offering creates a short position in the Securities for
                                            the underwriter&#8217;s own account.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 24pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 20.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
                                            underwriter may place a stabilizing bid to purchase the Securities for the purpose of pegging,
                                            fixing, or maintaining the price of the Securities.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 24pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 14.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriters
                                            may engage in syndicate covering transactions to cover overallotments or to stabilize the
                                            price of the Securities by bidding for, and purchasing, Securities in the open market in
                                            order to reduce a short position created in connection with the offering.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 11pt Times LT Std Roman; width: 100%; margin-top: 6pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 24pt"/><td style="width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="padding-right: 13.85pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            managing underwriter may impose a penalty bid on a syndicate member to reclaim a selling
                                            concession in connection with an offering when the Securities originally sold by the syndicate
                                            member is purchased in syndicate covering transactions or otherwise.</span></td></tr></table>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
of these activities may stabilize or maintain the market price of the Securities above independent market levels. The underwriters are
not required to engage in these activities, and may end any of these activities at any <span style="letter-spacing: -0.1pt">time.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 30.6pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with any Rights offering, the Fund may also enter into a standby underwriting arrangement with one or more underwriters pursuant
to which the underwriter(s) will purchase common shares remaining unsubscribed for after the Rights offering.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
underwriters to whom the offered Securities are sold for offering and sale may make a market in the offered Securities, but the underwriters
will not be obligated to do so and may discontinue any market-making at any time without notice. There can be no assurance that there
will be a liquid trading market for the offered Securities.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 5.95pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
agreements entered into with the Fund, underwriters and agents may be entitled to indemnification by the Fund and the Adviser against
certain civil liabilities, including liabilities under the Securities Act, or to contribution for payments the underwriters or agents
may be required to make.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.2pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters, agents, and their affiliates may engage in financial or other business transactions with the Fund in the ordinary course
of business.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a requirement of the Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) the maximum compensation to be received by
any FINRA member or independent broker-dealer in connection with an offering of the Fund&#8217;s securities may not be greater than eight
percent (8%) of the gross proceeds received by the Fund for the sale of any securities being registered pursuant to SEC Rule 415 under
the Securities Act.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.2pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent permitted under the 1940 Act and the rules and regulations promulgated thereunder, the underwriters may from time to time
act as brokers or dealers and receive fees in connection with the execution of portfolio transactions on behalf of the Fund after the
underwriters have ceased to be underwriters and, subject to certain restrictions, each may act as a broker while it is an underwriter.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 13.2pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Prospectus and accompanying Prospectus Supplement in electronic form may be made available on the websites maintained by underwriters.
The underwriters may agree to allocate a number of Securities for sale to their online brokerage account holders. Such allocations of
Securities for internet distributions will be made on the same basis as other allocations. In addition, Securities may be sold by the
underwriters to securities dealers who resell Securities to online brokerage account holders.</span></p>


<!-- Field: Page; Sequence: 78 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">SERVICING
AGENT, TRANSFER AGENT, CUSTODIAN AND ADMINISTRATOR</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Servicing
Agent</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 8.65pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guggenheim
Funds Distributors, LLC acts as servicing agent to the Fund. The Servicing Agent is located at 227 West Monroe Street, Chicago, IL 60606.
Pursuant to a servicing agreement with the Fund, the Servicing Agent provides the Fund a variety of services, including (i) replying
to requests for information concerning the Fund from shareholders or prospective shareholders, brokers or the public; (ii) aiding in
the secondary market support of the Fund through regular written and oral communications with the Fund&#8217;s NYSE designated market
maker, the closed- end fund analyst community and various information providers specializing in the dissemination of closed-end fund
information; (iii) coordinating and overseeing activities of the Fund&#8217;s administrator; (iv) developing and maintaining a website
for the Fund and (v) overseeing, in consultation with, and as agreed by, Advent matters relating to the conduct and administration of
meetings of the Board and committees thereof.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Transfer
Agent</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computershare
Trust Company, N.A. serves as the Fund&#8217;s transfer agent. Computershare Trust Company, N.A. is located at P.O. Box 30170, College
Station, TX 77842.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Custodian</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
securities owned by the Fund and all cash, including proceeds from the sale of securities in the Fund&#8217;s investment portfolio, are
held by The Bank of New York Mellon, 101 Barclay Street, New York, New York 10286, as custodian (the &#8220;Custodian&#8221;). The Custodian
is responsible for holding all securities, other investments and cash, receiving and paying for securities purchased, delivering against
payment securities sold, receiving and collecting income from investments, making all payments covering expenses and performing other
administrative duties, all as directed by authorized persons. The Custodian does not exercise any supervisory function in such matters
as purchase and sale of portfolio securities, payment of dividends or payment of expenses.</span></p>

<p style="font: bold 10pt Times LT Std; margin: 6pt 0 0 8.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">Administrator</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 5.95pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MUFG
Investor Services (US), LLC serves as the Fund&#8217;s Administrator. Pursuant to an administration agreement with the Fund, MUFG provides
certain administrative, bookkeeping and accounting services to the Fund. MUFG is located at 805 King Farm Boulevard, Rockville, Maryland
20850.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL
<span style="letter-spacing: -0.1pt">MATTERS</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
legal matters will be passed on for the Fund by Skadden, Arps, Slate, Meagher &amp; Flom LLP, Chicago, Illinois, in connection with the
offering of the common shares.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">INDEPENDENT
REGISTERED PUBLIC ACCOUNTING</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">FIRM</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PricewaterhouseCoopers
LLP, 300 Madison Avenue, New York, New York 10017, is the independent registered public accounting firm of the Fund. The independent
registered public accounting firm is expected to render an opinion annually on the financial statements and financial highlights of the
Fund.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 3pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times LT Std; margin: 0 12.1pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FISCAL
YEAR END AND REPORTS TO <span style="letter-spacing: -0.1pt">SHAREHOLDERS</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 26.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund&#8217;s fiscal year end is October <span style="letter-spacing: -0.25pt">31.</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
soon as practicable after the end of each calendar year, the Fund will furnish to common shareholders a statement on Form 1099-DIV identifying
the sources of the distributions paid by the Fund to common shareholders for tax purposes.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 8.95pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Fund will prepare and transmit to common shareholders a semi-annual report and annual report within 60 days after the close
of the period for which the report is being made, or as otherwise required by the 1940 <span style="letter-spacing: -0.2pt">Act.</span></span></p>


<!-- Field: Page; Sequence: 79 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 2.95pt 0 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">PRIVACY
PRINCIPLES OF THE</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.2pt">FUND</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 12.4pt 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund is committed to maintaining the privacy of its shareholders and to safeguarding their non-public personal information. The following
information is provided to help you understand what personal information the Fund collects, how the Fund protects that information and
why, in certain cases, the Fund may share information with select other parties.</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
the Fund does not receive any non-public personal information relating to its shareholders, although certain non-public personal information
of its shareholders may become available to the Fund. The Fund does not disclose any non-public personal information about its shareholders
or former shareholders to anyone, except as permitted by law or as is necessary in order to service shareholder accounts (for example,
to a transfer agent or third-party administrator).</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 6pt 0 0 6pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund restricts access to non-public personal information about its shareholders to employees of the Fund&#8217;s Adviser and its affiliates
with a legitimate business need for the information. The Fund maintains physical, electronic and procedural safeguards designed to protect
the non-public personal information of its shareholders.</span></p>


<!-- Field: Page; Sequence: 80 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times LT Std; margin: 5pt 12.05pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TABLE
OF CONTENTS OF STATEMENT OF ADDITIONAL <span style="letter-spacing: -0.1pt">INFORMATION</span></span></p>

<p style="font: bold 10pt Times LT Std; margin: 5pt 12.05pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="letter-spacing: -0.1pt">&#160;</span></span></p>
<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 87%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><span style="text-decoration: underline">Page</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">The Fund	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-2</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Investment Objective and Policies	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-2</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Investment Restrictions	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-13</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Management of the Fund	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-15</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Portfolio Transactions	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-18</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Tax Matters 	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-18</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">General Information	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-25</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Financial Statements	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-27</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Appendix&#160;A: Description of Securities Ratings	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">A-1</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Appendix&#160;B: Proxy Voting Policies and Procedures	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">B-1</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 81 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0"></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 17.85pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
page intentionally left <span style="letter-spacing: -0.1pt">blank</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 17.85pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="letter-spacing: -0.1pt">&#160;</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 17.85pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="letter-spacing: -0.1pt">&#160;</span></span></p>


<!-- Field: Page; Sequence: 82 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 12.05pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
page intentionally left <span style="letter-spacing: -0.1pt">blank</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 12.05pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="letter-spacing: -0.1pt">&#160;</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 12.05pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="letter-spacing: -0.1pt">&#160;</span></span></p>


<!-- Field: Page; Sequence: 83 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 17.85pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
page intentionally left <span style="letter-spacing: -0.1pt">blank</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 17.85pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="letter-spacing: -0.1pt">&#160;</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 17.85pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="letter-spacing: -0.1pt">&#160;</span></span></p>


<!-- Field: Page; Sequence: 84 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 12.05pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
page intentionally left <span style="letter-spacing: -0.1pt">blank</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 12.05pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="letter-spacing: -0.1pt">&#160;</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 12.05pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="letter-spacing: -0.1pt">&#160;</span></span></p>


<!-- Field: Page; Sequence: 85 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times LT Std Roman; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0"></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 17.85pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
page intentionally left <span style="letter-spacing: -0.1pt">blank</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 17.85pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="letter-spacing: -0.1pt">&#160;</span></span></p>

<p style="font: 10pt Times LT Std Roman; margin: 0 17.85pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="letter-spacing: -0.1pt">&#160;</span></span></p>


<!-- Field: Page; Sequence: 86 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 18pt Times LT Std Roman; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 18pt Times LT Std Roman; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 18pt Times LT Std Roman; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt">&#160;</span></p>

<p style="font: 18pt Times LT Std Bold,serif; margin: 0 12.05pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt; letter-spacing: -0.1pt"><b>$150,000,000</b></span></p>

<p style="font: 18pt Times LT Std Bold,serif; margin: 8.4pt 12.05pt 0 15pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt"><b>ADVENT
CONVERTIBLE AND INCOME <span style="letter-spacing: -0.2pt">FUND</span></b></span></p>

<p style="font: 18pt Times LT Std Bold,serif; margin: 2.35pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt"><b>&#160;</b></span></p>

<p style="font: 14pt/106% Times LT Std Bold,serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>Common
Shares</b></span></p>

<p style="font: 14pt/106% Times LT Std Bold,serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>Subscription
Rights for Common Shares</b></span></p>

<p style="font: 14pt/106% Times LT Std Bold,serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>&#160;</b></span></p>

<p style="font: 14pt/106% Times LT Std Bold,serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 10%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 14pt/106% Times LT Std Bold,serif; text-align: center; margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 87 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="text-align: center">&#160;</p>

<p style="text-align: center">&#160;</p>


<p style="text-align: center">&#160;</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">ADVENT CONVERTIBLE AND INCOME FUND</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">__________________________<br/>
Statement of Additional Information</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Advent Convertible and Income Fund (the &#8220;Fund&#8221;)
is a diversified, closed-end management investment company.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s investment objective is to provide
total return through a combination of capital appreciation and current income. There can be no assurance that the Fund will achieve its
investment objective, and you could lose some or all of your investment.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">This Statement of Additional Information (&#8220;SAI&#8221;)
is not a Prospectus, but should be read in conjunction with the Prospectus for the Fund dated September 12, 2024, and any related supplement to
the Prospectus (each a &#8220;Prospectus Supplement&#8221;). Investors should obtain and read the Prospectus and any related Prospectus
Supplement prior to purchasing Common Shares. A copy of the Prospectus and any related Prospectus Supplement may be obtained, without
charge, by calling the Fund at (800) 345-7999.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Prospectus, any accompanying Prospectus Supplement
and this SAI omit certain of the information contained in the registration statement filed with the Securities and Exchange Commission
(the &#8220;SEC&#8221;). The registration statement may be obtained from the SEC upon payment of the fee prescribed, or inspected at the
SEC&#8217;s office or via its website (www.sec.gov) at no charge. Capitalized terms used but not defined herein have the meanings ascribed
to them in the Prospectus.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">TABLE OF CONTENTS</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 87%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><span style="text-decoration: underline">Page</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">The Fund	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-2</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Investment Objective and Policies	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-2</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Investment Restrictions	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-13</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Management of the Fund	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-15</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Portfolio Transactions	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-18</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Tax Matters 	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-18</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">General Information	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-25</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Financial Statements	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">S-27</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Appendix&#160;A: Description of Securities Ratings	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">A-1</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Appendix&#160;B: Proxy Voting Policies and Procedures	</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">B-1</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">This Statement of Additional Information
is dated September 12, 2024.</p>


<!-- Field: Page; Sequence: 89 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">THE FUND</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund is a diversified, closed-end management
investment company organized as a Delaware statutory trust.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">THE FUND&#8217;S INVESTMENTS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The following information supplements the discussion
of the Fund&#8217;s investments and techniques that are described in the Prospectus. The Fund may make the following investments, among
others, some of which are part of its principal investment strategies and some of which are not. The principal risks of the Fund&#8217;s
principal investment strategies are discussed in the Prospectus. The Fund may not buy all of the types of securities or use all of the
investment techniques that are described.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Derivatives</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may, but is not required to, use various
derivatives transactions for hedging and risk management purposes, to facilitate portfolio management and to earn income or enhance total
return. The use of derivatives transactions to earn income or enhance total return may be particularly speculative. Derivatives are financial
instruments the value of which is derived from a reference instrument. The Fund may engage in a variety of derivatives transactions, including
options, swaps, swaptions, futures contracts, options on futures contracts, forward currency contracts and options on forward currency
contracts. The Fund may purchase and sell exchange-listed, centrally cleared and off-exchange derivatives. If a derivative is centrally
cleared, a central clearing entity stands between the two parties to the trade as counterparty to each. The Fund may utilize derivatives
that reference one or more securities, indices, commodities, currencies or interest rates. In addition, the Fund may utilize new techniques,
transactions, instruments or strategies that are developed or permitted as regulatory changes occur. Derivatives may allow the Fund to
increase or decrease the level of risk to which the Fund is exposed more quickly and efficiently than transactions in other types of instruments.
If the Fund invests in a derivative for speculative purposes, the Fund will be fully exposed to the risks of loss of that derivative,
which may sometimes be greater than the derivative&#8217;s cost. The use of derivatives may involve substantial economic leverage and
consequently substantial volatility.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">There is no assurance that these derivative strategies
will be available at any time, that the Adviser will determine to use them for the Fund or, if used, that the strategies will be successful.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>Options.</i> An option on a security is a contract that gives the
holder of the option, in return for a premium, the right to buy from (in the case of a call) or sell to (in the case of a put) the writer
of the option the security underlying the option at a specified exercise or &#8220;strike&#8221; price. The writer of an option on a security
has the obligation upon exercise of the option to deliver the underlying security upon payment of the exercise price or to pay the exercise
price upon delivery of the underlying security. Certain options, known as &#8220;American style&#8221; options may be exercised at any
time during the term of the option. Other options, known as &#8220;European style&#8221; options, may be exercised only on the expiration
date of the option.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">If an option written by the Fund expires unexercised, the Fund realizes
on the expiration date a capital gain equal to the premium received by the Fund at the time the option was written. If an option purchased
by the Fund expires unexercised, the Fund realizes a capital loss equal to the premium paid. Prior to the earlier of exercise or expiration,
an exchange-traded option may be closed out by an offsetting purchase or sale of an option of the same series (type, underlying security,
exercise price and expiration). There can be no assurance, however, that a closing purchase or sale transaction can be effected when the
Fund desires. The Fund may sell put or call options it has previously purchased, which could result in a net gain or loss depending on
whether the amount realized on the sale is more or less than the premium and other transaction costs paid on the put or call option when
purchased. The Fund will realize a capital gain from a closing purchase transaction if the cost of the closing option is less than the
premium received from writing the option, or, if it is more, the Fund will realize a capital loss. If the premium received from a closing
sale transaction is more than the premium paid to purchase the option, the Fund will realize a capital gain or, if it is less, the Fund
will realize a capital loss. Net gains from the Fund&#8217;s option strategy will be short-term capital gains which, for U.S. federal
income tax purposes, will constitute net investment company taxable income.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">As part of its strategy, the Fund may not sell &#8220;naked&#8221; call
options on individual securities, (<i>i.e.</i>, options representing more shares of the stock than are held in the portfolio). A call
option written by the Fund on a security is &#8220;covered&#8221; if the Fund owns the security or instrument underlying the call or has
an absolute and immediate right to acquire that</p>


<!-- Field: Page; Sequence: 90; Options: NewSection; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">security or instrument without additional cash consideration (or, if
additional cash consideration is required, cash or other assets determined to be liquid by the Adviser (in accordance with procedures
established by the Board of Trustees) in such amount are segregated by the Fund&#8217;s custodian) upon conversion or exchange of other
securities held by the Fund. A call option is also covered if the Fund holds a call on the same security as the call written where the
exercise price of the call held is (i) equal to or less than the exercise price of the call written, or (ii) greater than the exercise
price of the call written, provided the difference is maintained by the Fund in segregated assets determined to be liquid by the Adviser
as described above.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Put options are contracts that give the holder of the option, in return
for a premium, the right to sell to the writer of the option the security underlying the option at a specified exercise price at a specific
time or times during the term of the option. These strategies may produce a considerably higher return than the Fund&#8217;s primary strategy
of covered call writing, but involve a higher degree of risk and potential volatility.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund will write (sell) put options on individual securities only
if the put option is &#8220;covered.&#8221; A put option written by the Fund on a security is &#8220;covered&#8221; if the Fund segregates
or earmarks assets determined to be liquid by the Adviser, as described above, equal to the exercise price. A put option is also covered
if the Fund holds a put on the same security as the put written where the exercise price of the put held is (i) equal to or greater than
the exercise price of the put written, or (ii) less than the exercise price of the put written, provided the difference is maintained
by the Fund in segregated or earmarked assets determined to be liquid by the Adviser, as described above.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may sell put and call options on indices
of securities. Options on an index differ from options on securities because (i) the exercise of an index option requires cash payments
and does not involve the actual purchase or sale of securities, (ii) the holder of an index option has the right to receive cash upon
exercise of the option if the level of the index upon which the option is based is greater, in the case of a call, or less, in the case
of a put, than the exercise price of the option and (iii) index options reflect price-fluctuations in a group of securities or segments
of the securities market rather than price fluctuations in a single security.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Futures and Options on Futures</i>. The Fund may
buy, sell and write futures contracts that relate to: interest rates, credit instruments and related indices, volatility indices, credit-linked
notes and individual stocks and stock indices.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">A futures contract is an agreement between two parties
to buy and sell a security, index or interest rate (each a &#8220;financial instrument&#8221;) for a set price on a future date. Certain
futures contracts, such as futures contracts relating to individual securities, call for making or taking delivery of the underlying financial
instrument. However, these contracts generally are closed out before delivery by entering into an offsetting purchase or sale of a matching
futures contract (same exchange, underlying financial instrument, and delivery month). Other futures contracts, such as futures contracts
on interest rates and indices, do not call for making or taking delivery of the underlying financial instrument, but rather are agreements
pursuant to which two parties agree to take or make delivery of an amount of cash equal to the difference between the value of the financial
instrument at the close of the last trading day of the contract and the price at which the contract was originally written. These contracts
also may be settled by entering into an offsetting futures contract.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Unlike when the Fund purchases or sells a security,
no price is paid or received by the Fund upon the purchase or sale of a futures contract. Initially, the Fund will be required to deposit
with the futures broker, known as a futures commission merchant (&#8220;FCM&#8221;), an amount of cash or securities equal to a varying
specified percentage of the contract amount. This amount is known as initial margin. The margin deposit is intended to ensure completion
of the contract. Minimum initial margin requirements are established by the futures exchanges and may be revised. In addition, FCMs may
establish margin deposit requirements that are higher than the exchange minimums. Cash held in the margin account generally is not income
producing. However, coupon-bearing securities, such as Treasury securities, held in margin accounts generally will earn income. Subsequent
payments to and from the FCM, called variation margin, will be made on a daily basis as the price of the underlying financial instrument
fluctuates, making the futures contract more or less valuable, a process known as marking the contract to market. Changes in variation
margin are recorded by the Fund as unrealized gains or losses. At any time prior to expiration of the futures contract, the Fund may elect
to close the position by taking an opposite position that will operate to terminate its position in the futures contract. A final determination
of variation margin is then made, additional cash is required to be paid by or released to the Fund, and the Fund realizes a gain or loss.
In the event of the bankruptcy or insolvency of an FCM that holds margin on behalf of the Fund, the Fund may be entitled to the return
of margin owed to it only in</p>


<!-- Field: Page; Sequence: 91; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">proportion to the amount received by the FCM&#8217;s other customers,
potentially resulting in losses to the Fund. Futures transactions also involve brokerage costs.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund also may buy and write options on the futures
contracts in which it may invest (&#8220;futures options&#8221;) and may buy or write straddles, which consist of a call and a put option
on the same futures contract. A futures option gives the purchaser of such option the right, in return for the premium paid, to assume
a long position (call) or short position (put) in a futures contract at a specified exercise price at any time during the period of the
option. Upon exercise of a call futures option, the purchaser acquires a long position in the futures contract and the writer is assigned
the opposite short position. Upon the exercise of a put futures option, the opposite is true.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Interest Rate Futures Contracts and Options Thereon</i>.
The Fund may purchase or sell interest rate futures contracts to take advantage of or to protect the Fund against fluctuations in interest
rates affecting the value of debt securities which the Fund holds or intends to acquire. For example, if interest rates are expected to
increase, the Fund might sell futures contracts on debt securities, the values of which historically have a high degree of positive correlation
to the values of the Fund&#8217;s portfolio securities. Such a sale would have an effect similar to selling an equivalent value of the
Fund&#8217;s portfolio securities. If interest rates increase, the value of the Fund&#8217;s portfolio securities will decline, but the
value of the futures contracts to the Fund will increase at approximately an equivalent rate thereby keeping the net asset value of the
Fund from declining as much as it otherwise would have. The Fund could accomplish similar results by selling debt securities with longer
maturities and investing in debt securities with shorter maturities when interest rates are expected to increase. However, since the futures
market may be more liquid than the cash market, the use of futures contracts as a risk management technique allows the Fund to maintain
a defensive position without having to sell its portfolio securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Similarly, the Fund may purchase interest rate futures
contracts when it is expected that interest rates may decline. The purchase of futures contracts for this purpose constitutes a hedge
against increases in the price of debt securities (caused by declining interest rates) which the Fund intends to acquire. Since fluctuations
in the value of appropriately selected futures contracts should approximate that of the debt securities that will be purchased, the Fund
can take advantage of the anticipated rise in the cost of the debt securities without actually buying them. Subsequently, the Fund can
make its intended purchase of the debt securities in the cash market and liquidate its futures position.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The purchase of a call option on a futures contract
is similar in some respects to the purchase of a call option on an individual security. Depending on the pricing of the option compared
to either the price of the futures contract upon which it is based or the price of the underlying debt securities, it may or may not be
less risky than ownership of the futures contract or underlying debt securities. As with the purchase of futures contracts, when the Fund
is not fully invested it may purchase a call option on a futures contract to hedge against a market advance due to declining interest
rates.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The purchase of a put option on a futures contract
is similar to the purchase of protective put options on portfolio securities. The Fund will purchase a put option on a futures contract
to hedge the Fund&#8217;s portfolio against the risk of rising interest rates and a consequent reduction in the value of portfolio securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The writing of a call option on a futures contract
constitutes a partial hedge against declining prices of the securities which are deliverable upon exercise of the futures contract. If
the futures price at expiration of the option is below the exercise price, the Fund will retain the full amount of the option premium
which provides a partial hedge against any decline that may have occurred in the Fund&#8217;s portfolio holdings. The writing of a put
option on a futures contract constitutes a partial hedge against increasing prices of the securities that are deliverable upon exercise
of the futures contract. If the futures price at expiration of the option is higher than the exercise price, the Fund will retain the
full amount of the option premium, which provides a partial hedge against any increase in the price of debt securities that the Fund intends
to purchase. If a put or call option the Fund has written is exercised, the Fund will incur a loss which will be reduced by the amount
of the premium it received. Depending on the degree of correlation between changes in the value of its portfolio securities and changes
in the value of its futures positions, the Fund&#8217;s losses from options on futures it has written may to some extent be reduced or
increased by changes in the value of its portfolio securities.</p>


<!-- Field: Page; Sequence: 92; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Currency Futures and Options Thereon</i>. Generally,
foreign currency futures contracts and options thereon are similar to the interest rate futures contracts and options thereon discussed
previously. By entering into currency futures and options thereon, the Fund will seek to establish the rate at which it will be entitled
to exchange U.S. dollars for another currency at a future time. By selling currency futures, the Fund will seek to establish the number
of dollars it will receive at delivery for a certain amount of a foreign currency. In this way, whenever the Fund anticipates a decline
in the value of a foreign currency against the U.S. dollar, the Fund can attempt to &#8220;lock in&#8221; the U.S. dollar value of some
or all of the securities held in its portfolio that are denominated in that currency. By purchasing currency futures, the Fund can establish
the number of dollars it will be required to pay for a specified amount of a foreign currency in a future month. Thus, if the Fund intends
to buy securities in the future and expects the U.S. dollar to decline against the relevant foreign currency during the period before
the purchase is effected, the Fund can attempt to &#8220;lock in&#8221; the price in U.S. dollars of the securities it intends to acquire.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The purchase of options on currency futures will
allow the Fund, for the price of the premium and related transaction costs it must pay for the option, to decide whether or not to buy
(in the case of a call option) or to sell (in the case of a put option) a futures contract at a specified price at any time during the
period before the option expires. If the Adviser, in purchasing an option, has been correct in its judgment concerning the direction in
which the price of a foreign currency would move against the U.S. dollar, the Fund may exercise the option and thereby take a futures
position to hedge against the risk it had correctly anticipated or close out the option position at a gain that will offset, to some extent,
currency exchange losses otherwise suffered by the Fund. If exchange rates move in a way the Fund did not anticipate, however, the Fund
will have incurred the expense of the option without obtaining the expected benefit; any such movement in exchange rates may also thereby
reduce rather than enhance the Fund&#8217;s profits on its underlying securities transactions.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Securities Index Futures Contracts and Options
Thereon</i>. Purchases or sales of securities index futures contracts are used for hedging purposes to attempt to protect the Fund&#8217;s
current or intended investments from broad fluctuations in stock or bond prices. For example, the Fund may sell securities index futures
contracts in anticipation of or during a market decline to attempt to offset the decrease in market value of the Fund&#8217;s securities
portfolio that might otherwise result. If such decline occurs, the loss in value of portfolio securities may be offset, in whole or part,
by gains on the futures position. When the Fund is not fully invested in the securities market and anticipates a significant market advance,
it may purchase securities index futures contracts in order to gain rapid market exposure that may, in part or entirely, offset increases
in the cost of securities that the Fund intends to purchase. As such purchases are made, the corresponding positions in securities index
futures contracts will be closed out. The Fund may write put and call options on securities index futures contracts for hedging purposes.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Swaps</i>. Swap agreements are two party contracts
entered into primarily by institutional investors for periods ranging from a few weeks to more than one year. In a standard &#8220;swap&#8221;
transaction, two parties agree to exchange the returns (or differentials in rates of return) earned or realized on particular predetermined
investments or instruments. The gross returns to be exchanged or &#8220;swapped&#8221; between the parties are calculated with respect
to a &#8220;notional amount&#8221; (<i>i.e.</i>, the dollar amount invested at a particular interest rate, in a particular foreign currency,
or in a &#8220;basket&#8221; of securities representing a particular index). The &#8220;notional amount&#8221; of the swap agreement is
only a basis on which to calculate the obligations that the parties to a swap agreement have agreed to exchange. The Fund&#8217;s obligations
(or rights) under a swap agreement generally will be equal only to the &#8220;net amount&#8221; to be paid or received under the agreement
based on the relative values of the positions held by each party to the agreement. The Fund&#8217;s obligations under a swap agreement
will be accrued daily (offset against any amounts owing to the Fund) and any accrued but unpaid net amounts owed to a swap counterparty
will be covered by marking as segregated liquid, unencumbered assets.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Credit Default Swaps</i>. The Fund may enter into
credit default swap agreements and similar agreements. Among other purposes, credit default swaps provide investment exposure to changes
in credit spreads and relative interest rates. The credit default swap agreement or similar instrument may have as reference obligations
one or more securities that are not currently held by the Fund (including a &#8220;basket&#8221; of securities representing an index).
The protection &#8220;buyer&#8221; in a credit default contract may be obligated to pay the protection &#8220;seller&#8221; an upfront
payment or a periodic stream of payments over the term of the contract provided generally that no credit event on a reference obligation
has occurred. If a credit event occurs, the seller generally must pay the buyer the &#8220;par value&#8221; (full notional value) of the
swap in exchange for an equal face amount of deliverable obligations of the reference entity described in the swap, or the seller may
be required to deliver the related net cash amount, if the swap is cash settled.</p>


<!-- Field: Page; Sequence: 93; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">The Fund may be either the buyer or seller in the transaction. If the
Fund is a buyer and no credit event occurs, the Fund recovers nothing if the swap is held through its termination date. However, if a
credit event occurs, the Fund may elect to receive the full notional value of the swap in exchange for delivery of an equal face amount
of deliverable obligations of the reference entity that may have little or no value. As a seller, the Fund generally receives an upfront
payment or a fixed rate of income throughout the term of the swap, which typically is between six months and three years; provided that
there is no credit event. If a credit event occurs, generally the seller must pay the buyer the full notional value of the swap in exchange
for an equal face amount of deliverable obligations of the reference entity that may have little or no value.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Total Return Swaps</i>. The Fund may enter into
total return swaps. Total return swaps are used as substitutes for owning a particular physical security, or the securities comprising
a given market index, or to obtain exposure in markets where no physical securities are available such as an interest rate index. Total
return refers to the payment (or receipt) of the total return on the security, index or other instrument underlying the swap, which is
then exchanged for the receipt (or payment) of a floating interest rate. Total return swaps provide the Fund with the additional flexibility
of gaining exposure to a particular security or index by using the most cost-effective vehicle available. Total return swaps provide the
Fund with the opportunity to actively manage the cash maintained by the Fund as a result of not having to purchase the actual securities
or other instruments underlying the swap. The cash backing total return swaps is actively managed to seek to earn a return in excess of
the floating rate paid on the swap.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Interest Rate Swaps</i>. Interest rate swaps involve
the exchange by the Fund with another party of respective commitments to pay or receive interest (<i>e.g.</i>, an exchange of fixed rate
payments for floating rate payments).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Currency Swaps</i>. Currency swaps involve the
exchange of the two parties&#8217; respective commitments to pay or receive fluctuations with respect to a notional amount of two different
currencies (<i>e.g.</i>, an exchange of payments with respect to fluctuations in the value of the U.S. dollar relative to the Japanese
yen).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Swaptions</i>. The Fund may enter into &#8220;swaptions,&#8221;
which are options on swap agreements. A swaption is a contract that gives a counterparty the right (but not the obligation) to enter into
a new swap agreement or to shorten, extend, cancel or otherwise modify an existing swap agreement, at some designated future time on specified
terms. The Fund may write (sell) and purchase put and call swaptions. Depending on the terms of the particular option agreement, the Fund
generally will incur a greater degree of risk when it writes a swaption than it will incur when it purchases a swaption. When the Fund
purchases a swaption, it risks losing only the amount of the premium it has paid should it decide to let the option expire unexercised.
When the Fund writes a swaption, upon exercise of the option the Fund will become obligated according to the terms of the underlying agreement.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Credit-Linked Securities</i>. Credit-linked securities
are issued by a limited purpose trust or other vehicle that, in turn, invests in a derivative or basket of derivatives, such as credit
default swaps, interest rate swaps and other securities, in order to provide exposure to certain fixed income markets. Like an investment
in a bond, investments in these credit-linked securities represent the right to receive periodic income payments (in the form of distributions)
and payment of principal at the end of the term of the security. However, these payments are conditioned on the issuer&#8217;s receipt
of payments from, and the issuer&#8217;s potential obligations to, the counterparties to the derivatives and other securities in which
the issuer invests. For instance, the issuer may sell one or more credit default swaps, under which the issuer would receive a stream
of payments over the term of the swap agreements provided that no event of default has occurred with respect to the referenced debt obligation
upon which the swap is based. If a default occurs, the stream of payments may stop and the issuer would be obligated to pay the counterparty
the par (or other agreed-upon value) of the referenced debt obligation. This, in turn, would reduce the amount of income and principal
that the Fund would receive. The Fund&#8217;s investments in these instruments are indirectly subject to the risks associated with derivatives,
including, among others, counterparty risk, credit risk and leverage risk. There may be no established trading market for these securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Limitations on the Purchase and Sale of Futures
Contracts, Certain Options, and Swaps</i>. Pursuant to amendments by the Commodity Futures Trading Commission (&#8220;CFTC&#8221;) to
Rule&#160;4.5 under the Commodity Exchange Act (&#8220;CEA&#8221;), the Adviser has filed a notice of exemption from registration as a
&#8220;commodity pool operator&#8221; with respect to the Fund. The Fund and the Adviser are therefore not subject to registration or
regulation as a commodity pool operator under the CEA. In addition, certain trading restrictions are applicable to the Fund as a result
of this status.</p>


<!-- Field: Page; Sequence: 94; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">These trading restrictions permit the Fund to engage in &#8220;commodity
interest&#8221; transactions (generally, transactions in futures, certain options, certain currency transactions, and certain types of
swaps) that include (i) &#8220;bona fide hedging&#8221; transactions, as that term is defined and interpreted by the CFTC and its staff,
without regard to the percentage of the Fund&#8217;s assets committed to margin and options premiums and (ii) non-bona fide hedging transactions;
provided that the Fund does not enter into such non-bona fide hedging transactions if, immediately thereafter, either (a) the sum of the
amount of initial margin deposits on the Fund&#8217;s existing futures positions or swaps positions and option or swaption premiums would
exceed 5% of the market value of the Fund&#8217;s liquidating value, after taking into account unrealized profits and unrealized losses
on any such transactions, or (b) the aggregate net notional value of the Fund&#8217;s commodity interest transactions would not exceed
100% of the market value of the Fund&#8217;s liquidating value, after taking into account unrealized profits and unrealized losses on
any such transactions. In addition to meeting one of the foregoing trading limitations, the Fund may not market itself as a commodity
pool or otherwise as a vehicle for trading in the futures, options or swaps markets. Therefore, in order to claim the Rule&#160;4.5 exemption,
the Fund is limited in its ability to invest in commodity futures, options, and certain types of swaps (including securities futures,
broad based stock index futures, and financial futures contracts). If the Adviser was required to register as a commodity pool operator
with respect to the Fund, compliance with additional registration and regulatory requirements would increase Fund expenses. Other potentially
adverse regulatory initiatives could also develop.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Special Risk Considerations Relating to Futures
and Options Thereon</i>. The Fund&#8217;s ability to establish and close out positions in futures contracts and options thereon will be
subject to the development and maintenance of liquid markets. Although the Fund generally will purchase or sell only those futures contracts
and options thereon for which there appears to be a liquid market, there is no assurance that a liquid market on an exchange will exist
for any particular futures contract or option thereon at any particular time. In the event no liquid market exists for a particular futures
contract or option thereon in which the Fund maintains a position, it will not be possible to effect a closing transaction in that contract
or to do so at a satisfactory price and the Fund would have to either make or take delivery under the futures contract or, in the case
of a written option, wait to sell the underlying securities until the option expires or is exercised or, in the case of a purchased option,
exercise the option. In the case of a futures contract or an option thereon which the Fund has written and which the Fund is unable to
close, the Fund would be required to maintain margin deposits on the futures contract or option thereon and to make variation margin payments
until the contract is closed.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Successful use of futures contracts and options thereon
and forward contracts by the Fund is subject to the ability of the Adviser to predict correctly movements in the direction of interest
and foreign currency rates. If the Adviser&#8217;s expectations are not met, the Fund will be in a worse position than if a hedging strategy
had not been pursued. For example, if the Fund has hedged against the possibility of an increase in interest rates that would adversely
affect the price of securities in its portfolio and the price of such securities increases instead, the Fund will lose part or all of
the benefit of the increased value of its securities because it will have offsetting losses in its futures positions. In addition, in
such situations, if the Fund has insufficient cash to meet daily variation margin requirements, it may have to sell securities to meet
the requirements. These sales may be, but will not necessarily be, at increased prices which reflect the rising market. The Fund may have
to sell securities at a time when it is disadvantageous to do so.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Additional Risks of Foreign Options, Futures Contracts,
Options on Futures Contracts and Forward Contracts</i>. Options, futures contracts and options thereon and forward contracts on securities
and currencies may be traded on foreign exchanges. Such transactions may not be regulated as effectively as similar transactions in the
United States, may not involve a clearing mechanism and related guarantees, and are subject to the risk of governmental actions affecting
trading in, or the prices of, foreign securities. The value of such positions also could be adversely affected by (i) other complex foreign
political, legal and economic factors, (ii) lesser availability than in the U.S. of data on which to make trading decisions, (iii) delays
in the Fund&#8217;s ability to act upon economic events occurring in the foreign markets during non-business hours in the United States,
(iv) the imposition of different exercise and settlement terms and procedures and margin requirements than in the United States and (v)
lesser trading volume.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Exchanges on which options, futures and options on
futures are traded may impose limits on the positions that the Fund may take in certain circumstances.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><i>1940 Act Considerations. </i>To the extent the terms of such transactions
obligate the Fund to make payments, the Fund earmarks or segregates cash or liquid securities in an amount at least equal to the current
value of the amount then</p>


<!-- Field: Page; Sequence: 95; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">payable by the Fund under the terms of such transactions or otherwise
cover such transactions in accordance with applicable interpretations of the staff of the SEC. To the extent the terms of such transactions
obligate the Fund to deliver particular securities to extinguish the Fund&#8217;s obligations under such transactions, the Fund may &#8220;cover&#8221;
its obligations under such transactions by either (i) owning the securities or collateral underlying such transactions or (ii) having
an absolute and immediate right to acquire such securities or collateral without additional cash consideration (or, if additional cash
consideration is required, having earmarked or segregated cash or liquid securities). Such segregation or cover is intended to provide
the Fund with available assets to satisfy its obligations under such transactions. As a result of such segregation or cover, the Fund&#8217;s
obligations under such transactions will not be considered senior securities representing indebtedness for purposes of the 1940 Act, or
included in calculating the aggregate amount of the Fund&#8217;s financial leverage.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Rule&#160;18f-4 under the 1940 Act, the Derivatives
Rule, permits the Fund to enter into derivatives transactions and certain other transactions notwithstanding the restrictions on the issuance
of &#8220;senior securities&#8221; under Section&#160;18 of the 1940 Act. The Fund has adopted a derivatives risk management program which
includes value-at-risk modeling, stress tests, backtests, and additional disclosures to the SEC in compliance with Rule&#160;18f-4 under
the 1940 Act. The requirements of the rule and the Fund&#8217;s derivatives risk management program may restrict the Fund&#8217;s ability
to engage in certain derivatives transactions and/or increase the cost of such transactions, which could adversely affect the performance
of the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Synthetic Investments</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">As an alternative to holding investments directly,
the Fund may also obtain investment exposure to investments in which the Fund may invest directly through the use of derivative instruments.
The Fund may utilize swaps, options, forwards, notional principal contracts or other derivative instruments to replicate, modify or replace
the economic attributes associated with an investment in which the Fund may invest directly. To the extent that the Fund invests in synthetic
investments with economic characteristics similar to convertible securities or other income producing securities investments, the value
of such investments will be counted for purposes of the Fund&#8217;s policy of investing at least 80% of its Managed Assets in convertible
securities or other income producing securities investments.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Contingent Convertible Securities</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">One type of convertible security in which the Fund
may invest is contingent convertible securities, sometimes referred to as &#8220;CoCos.&#8221; CoCos are a form of hybrid debt security
issued by banking institutions that are intended to either automatically convert into equity or have their principal written down upon
the occurrence of certain &#8220;trigger events,&#8221; which may include a decline in the issuer&#8217;s capital below a specified threshold
level, increase in the issuer&#8217;s risk weighted assets, the share price of the issuer falling to a particular level for a certain
period of time and certain regulatory events. CoCos&#8217; unique equity conversion or principal write-down features are tailored to the
issuing banking institution and its regulatory requirements.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">CoCos are a newer form of instrument and the regulatory
environment for these instruments continues to evolve. Because the market for such securities is evolving, it is uncertain how the larger
market for CoCos would react to a trigger event, coupon cancellation, write-down of par value or coupon suspension (as described below)
applicable to a single issuer. Following conversion of a CoCo, because the common stock of the issuer may not pay a dividend, investors
in such securities could experience reduced yields or no yields at all.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Loss Absorption Risk</i>. CoCos have fully discretionary
coupons. This means coupons can potentially be cancelled at the banking institution&#8217;s discretion or at the request of the relevant
regulatory authority in order to help the bank absorb losses. The liquidation value of a CoCo may be adjusted downward to below the original
par value or written off entirely under certain circumstances. The write-down of the security&#8217;s par value may occur automatically
and would not entitle holders to institute bankruptcy proceedings against the issuer. In addition, an automatic write-down could result
in a reduced income rate if the dividend or interest payment associated with the security is based on the security&#8217;s par value.
Coupon payments may also be subject to approval by the issuer&#8217;s regulator and may be suspended in the event there are insufficient
distributable reserves. Due to uncertainty surrounding coupon payments, CoCos may be volatile and their price may decline rapidly in the
event that coupon payments are suspended.</p>


<!-- Field: Page; Sequence: 96; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Subordinated Instruments</i>. CoCos will, in the
majority of circumstances, be issued in the form of subordinated debt instruments in order to provide the appropriate regulatory capital
treatment prior to a conversion. Accordingly, in the event of liquidation, dissolution or winding-up of an issuer prior to a conversion
having occurred, the rights and claims of the holders of the CoCos, such as the Fund, against the issuer in respect of or arising under
the terms of the CoCos shall generally rank junior to the claims of all holders of unsubordinated obligations of the issuer. In addition,
if the CoCos are converted into the issuer&#8217;s underlying equity securities following a conversion event (<i>i.e.</i>, a &#8220;trigger&#8221;),
each holder will be subordinated due to their conversion from being the holder of a debt instrument to being the holder of an equity instrument.
Such conversion may be automatic.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><i>Unpredictable Market Value Fluctuate</i>. The
value of CoCos is unpredictable and will be influenced by many factors including, without limitation: (i) the creditworthiness of the
issuer and/or fluctuations in such issuer&#8217;s applicable capital ratios; (ii) supply and demand for the CoCos; (iii) general market
conditions and available liquidity; and (iv) economic, financial and political events that affect the issuer, its particular market or
the financial markets in general.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Stressed, Distressed and Defaulted Investments</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may invest in debt securities and other
instruments of companies undergoing, or that have recently completed, bankruptcies, reorganizations, insolvencies, liquidations or other
fundamental changes or similar proceedings or other stressed issuers. In any investment opportunity involving any such type of special
situation, there exists the risk that the contemplated transaction either will be unsuccessful, will take considerable time or will result
in a distribution of cash or new securities, the value of which will be less than the purchase price to the Fund of the securities or
other financial instruments in respect of which such distribution is received. Similarly, if an anticipated transaction does not in fact
occur, the Fund may be required to sell its investment at a loss. The consummation of such transactions can be prevented or delayed by
a variety of factors, including, but not limited to, (i) intervention of a regulatory agency; (ii) market conditions resulting in material
changes in securities prices; (iii) compliance with any applicable bankruptcy, insolvency or securities laws; and (iv) the inability to
obtain adequate financing. Because there is substantial uncertainty concerning the outcome of transactions involving financially troubled
companies in which the Fund may invest, there is a potential risk of loss by the Fund of its entire investment in such companies.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may invest in debt securities and other
instruments that are in default or at risk of being in default as to the repayment of principal and/or interest at the time of acquisition
by the Fund. The repayment of defaulted obligations is subject to significant uncertainties. Defaulted obligations might be repaid only
after lengthy bankruptcy or other reorganization proceedings, during which the issuer might not make any interest or other payments.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Distressed and defaulted instruments generally present
the same risks as investment in below investment grade instruments. However, in most cases, these risks are of a greater magnitude because
of the uncertainties of investing in an issuer undergoing financial distress. Distressed instruments present a risk of loss of principal
value, including potentially a total loss of value. Distressed instruments may be highly illiquid and the prices at which they may be
sold may represent a substantial discount to what the Adviser believes to be their ultimate value.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Short-Term Fixed Income Securities</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">For temporary defensive purposes or to keep cash
on hand fully invested, the Fund may invest up to 100% of its Managed Assets in cash equivalents and short-term fixed income securities.
Short-term fixed income investments are defined to include, without limitation, the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(1)</td><td>U.S. government securities, including bills, notes and bonds differing as to maturity and rates of interest that are either issued
or guaranteed by the U.S. Treasury or by U.S. government agencies or instrumentalities. U.S. government securities include securities
issued by (a) the Federal Housing Administration, Farmers Home Administration, Export-Import Bank of the United States, Small Business
Administration and Government National Mortgage Association, whose securities are supported by the full faith and credit of the United
States; (b) the Federal Home Loan Banks, Federal Intermediate Credit Banks and Tennessee Valley Authority, whose securities are supported
by the right of the agency to borrow from the U.S. Treasury; (c) the Federal National</td></tr></table>


<!-- Field: Page; Sequence: 97; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 1in">Mortgage Association, whose securities are supported by the
discretionary authority of the U.S. government to purchase certain obligations of the agency or instrumentality; and (d) the Student Loan
Marketing Association, whose securities are supported only by its credit. While the U.S. government provides financial support to such
U.S. government-sponsored agencies or instrumentalities, no assurance can be given that it always will do so since it is not so obligated
by law. The U.S. government, its agencies and instrumentalities do not guarantee the market value of their securities. Consequently, the
value of such securities may fluctuate.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(2)</td><td>Certificates of deposit issued against funds deposited in a bank or a savings and loan association. Such certificates are for a definite
period of time, earn a specified rate of return and are normally negotiable. The issuer of a certificate of deposit agrees to pay the
amount deposited plus interest to the bearer of the certificate on the date specified thereon. Certificates of deposit purchased by the
Fund may not be fully insured by the Federal Deposit Insurance Corporation.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(3)</td><td>Repurchase agreements.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(4)</td><td>Commercial paper, which consists of short-term unsecured promissory notes, including variable rate master demand notes issued by corporations
to finance their current operations. Master demand notes are direct lending arrangements between the Fund and a corporation. There is
no secondary market for such notes. However, they are redeemable by the Fund at any time. The Adviser will consider the financial condition
of the corporation (<i>e.g.</i>, earning power, cash flow and other liquidity ratios) and will continuously monitor the corporation&#8217;s
ability to meet all of its financial obligations, because the Fund&#8217;s liquidity might be impaired if the corporation were unable
to pay principal and interest on demand. Investments in commercial paper will be limited to commercial paper rated in the two highest
categories by a major rating agency or are unrated but determined to be of comparable quality by the Adviser and which mature within one
year of the date of purchase or carry a variable or floating rate of interest.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Short Sales</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may make short sales of securities. A short
sale is a transaction in which the Fund sells a security it does not own in anticipation that the market price of that security will decline.
The Fund may make short sales to hedge positions, for duration and risk management, in order to maintain portfolio flexibility or to enhance
income or gain.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">When the Fund makes a short sale, it must borrow
the security sold short and deliver it to the broker-dealer through which it made the short sale as collateral for its obligation to deliver
the security upon conclusion of the sale. The Fund may have to pay a fee to borrow particular securities and is often obligated to pay
over any payments received on such borrowed securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s obligation to replace the borrowed
security will be secured by collateral deposited with the broker-dealer, usually cash, U.S. government securities or other liquid securities.
The Fund will also be required to designate on its books and records similar collateral with its custodian to the extent, if any, necessary
so that the aggregate collateral value is at all times at least equal to the current market value of the security sold short. Depending
on arrangements made with the broker-dealer from which it borrowed the security regarding payment over of any payments received by the
Fund on such security, the Fund may not receive any payments (including interest) on its collateral deposited with such broker-dealer.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">If the price of the security sold short increases
between the time of the short sale and the time the Fund replaces the borrowed security, the Fund will incur a loss; conversely, if the
price declines, the Fund will realize a gain. Any gain will be decreased, and any loss increased, by the transaction costs described above.
Although the Fund&#8217;s gain is limited to the price at which it sold the security short, its potential loss is theoretically unlimited.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund will not make a short sale if, after giving
effect to such sale, the market value of all securities sold short exceeds 25% of the value of its Managed Assets or the Fund&#8217;s
aggregate short sales of a particular class of securities exceeds 25% of the outstanding securities of that class. The Fund may also make
short sales &#8220;against the box&#8221;</p>


<!-- Field: Page; Sequence: 98; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">without respect to such limitations. In this type of short sale, at
the time of the sale, the Fund owns or has the immediate and unconditional right to acquire at no additional cost the identical security.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>When Issued, Delayed Delivery Securities And Forward
Commitments</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may enter into forward commitments for the
purchase or sale of securities. The Fund may enter into transactions on a &#8220;when issued&#8221; or &#8220;delayed delivery&#8221;
basis, in excess of customary settlement periods for the type of security involved. In some cases, a forward commitment may be conditioned
upon the occurrence of a subsequent event, such as approval and consummation of a merger, corporate reorganization or debt restructuring
(<i>i.e.</i>, a when, as and if issued security). When such transactions are negotiated, the price is fixed at the time of the commitment,
with payment and delivery taking place in the future, generally a month or more after the date of the commitment. While it will only enter
into a forward commitment with the intention of actually acquiring the security, the Fund may sell the security before the settlement
date if it is deemed advisable. Securities purchased under a forward commitment are subject to market fluctuation, and generally no interest
(or dividends) accrues to the Fund prior to the settlement date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Securities purchased on a when-issued or delayed
delivery basis may expose the Fund to counterparty risk of default as well as the risk that securities may experience fluctuations in
value prior to their actual delivery. The Fund generally will not accrue income with respect to a when-issued or delayed delivery security
prior to its stated delivery date. Purchasing securities on a when-issued or delayed delivery basis can involve the additional risk that
the price or yield available in the market when the delivery takes place may not be as favorable as that obtained in the transaction itself.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Pay-In-Kind Securities</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may invest pay-in-kind, or &#8220;PIK,&#8221;
securities. PIK securities are securities which pay interest through the issuance of additional debt or equity securities. Similar to
zero coupon obligations, PIK securities also carry additional risk as holders of these types of securities realize no cash until the cash
payment date unless a portion of such securities is sold and, if the issuer defaults, the Fund may obtain no return at all on its investment.
The market price of PIK securities is affected by interest rate changes to a greater extent, and therefore tends to be more volatile,
than that of securities which pay interest in cash. Additionally, current U.S. federal tax law requires the holder of certain PIK securities
to accrue income with respect to these securities prior to the receipt of cash payments. To maintain its qualification as a regulated
investment company and avoid liability for U.S. federal income and excise taxes, the Fund may be required to distribute income accrued
with respect to these securities and may have to dispose of portfolio securities under disadvantageous circumstances in order to generate
cash to satisfy these distribution requirements.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Zero Coupon Bonds</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may invest in zero dividend preferred securities
and zero coupon bonds. These are instruments that typically do not pay interest either for the entire life of the obligation or for an
initial period after the issuance of the obligation. When held to its redemption or maturity, a holder receives the par value (or the
accreted value) of the zero (rate) coupon security, which generates a return equal to the difference between the purchase price and its
redemption or maturity value. A zero dividend preferred security or a zero coupon security is normally issued and traded at a deep discount
from face value. This original issue discount (&#8220;OID&#8221;) approximates the total amount of interest the security will accrue and
compound prior to its redemption or maturity. Because these securities and other OID instruments do not pay cash dividends or interest
at regular intervals, the instruments&#8217; ongoing accruals require ongoing judgments concerning the collectability of stated par value
of the instrument at its redemption or maturity, as well as the value of any associated collateral. As a result, these securities may
be subject to greater value fluctuations and less liquidity in the event of adverse market conditions than comparably rated securities
that pay cash on a current basis. Because zero dividend preferred securities and zero coupon bonds, and OID instruments generally, allow
an issuer to delay the need to generate cash to meet current dividend or interest payments (unless there is a prescribed accumulated funding
of the payment), they may involve greater payment and credit risk than dividend or coupon securities that pay dividends or interest currently
or in cash. In order to maintain its status as a regulated investment company (&#8220;RIC&#8221;), the Fund generally will be required
to distribute dividends to shareholders representing the income of these instruments as it accrues, even though the Fund will not receive
all of the income</p>


<!-- Field: Page; Sequence: 99; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">on a current basis or in cash. Thus, the Fund may have to sell other
investments, including when it may not be advisable to do so, and use the cash proceeds to make income distributions to its shareholders.
For accounting purposes, these cash distributions to shareholders will not treated as a return of capital.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Exchange-Traded Notes</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Exchange-traded notes (&#8220;ETNs&#8221;) are a
type of senior, unsecured, unsubordinated debt security issued by financial institutions that combines both aspects of bonds and ETFs.
An ETN&#8217;s returns are based on the performance of a market index minus fees and expenses. Similar to ETFs, ETNs are listed on an
exchange and traded in the secondary market. However, unlike an ETF, an ETN can be held until the ETN&#8217;s maturity, at which time
the issuer will pay a return linked to the performance of the market index to which the ETN is linked minus certain fees. Unlike regular
bonds, ETNs do not make periodic interest payments and principal is not protected. ETNs are subject to credit risk and the value of an
ETN may drop due to a downgrade in the issuer&#8217;s credit rating, despite the underlying market benchmark or strategy remaining unchanged.
The value of an ETN may also be influenced by time to maturity, level of supply and demand for the ETN, volatility and lack of liquidity
in underlying assets, changes in the applicable interest rates, changes in the issuer&#8217;s credit rating, and economic, legal, political
or geographic events that affect the referenced underlying asset. When the Fund invests in ETNs it will bear its proportionate share of
any fees and expenses borne by the ETN. The Fund&#8217;s decision to sell its ETN holdings may be limited by the availability of a secondary
market. In addition, although an ETN may be listed on an exchange, the issuer may not be required to maintain the listing and there can
be no assurance that a secondary market will exist for an ETN.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">ETNs are also subject to tax risk. No assurance can
be given that the Internal Revenue Service (&#8220;IRS&#8221;) will accept, or a court will uphold, how the Fund characterizes and treats
ETN investments for tax purposes. Further, the IRS and Congress have considered proposals that would change the timing and character of
income and gains from ETNs.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">An ETN that is tied to a specific market benchmark
or strategy may not be able to replicate and maintain exactly the composition and relative weighting of securities, commodities or other
components in the applicable market benchmark or strategy. Some ETNs that use leverage can, at times, be relatively illiquid, and thus
they may be difficult to purchase or sell at a fair price. Leveraged ETNs are subject to the same risk as other instruments that use leverage
in any form.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The market value of ETN shares may differ from their
market benchmark or strategy. This difference in price may be due to the fact that the supply and demand in the market for ETN shares
at any point in time is not always identical to the supply and demand in the market for the securities, commodities or other components
underlying the market benchmark or strategy that the ETN seeks to track. As a result, there may be times when an ETN share trades at a
premium or discount to its market benchmark or strategy.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Depositary Receipts</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s investments in non-U.S. issuers
may include investment in depositary receipts, including American Depositary Receipts (&#8220;ADRs&#8221;), European Depositary Receipts
(&#8220;EDRs&#8221;) and Global Depositary Receipts (&#8220;GDRs&#8221;). U.S. dollar-denominated ADRs, which are traded in the United
States on exchanges in off exchange markets, are issued by domestic banks. ADRs represent the right to receive securities of foreign issuers
deposited in a domestic bank or a correspondent bank. ADRs do not eliminate all the risk inherent in investing in the securities of foreign
issuers. However, by investing in ADRs rather than directly in foreign issuers&#8217; stock, the Fund can avoid currency risks during
the settlement period for either purchases or sales. In general, there is a large, liquid market in the United States for many ADRs. The
information available for ADRs is subject to the accounting, auditing and financial reporting standards of the domestic market or exchange
on which they are traded, which standards are more uniform and more exacting than those to which many foreign issuers may be subject.
The Fund also may invest in EDRs, GDRs and in other similar instruments representing securities of foreign companies. EDRs and GDRs are
securities that are typically issued by foreign banks or foreign trust companies, although U.S. banks or U.S. trust companies may issue
them. EDRs and GDRs are structured similarly to the arrangements of ADRs. EDRs, in bearer form, are designed for use in European securities
markets and are not necessarily denominated in the currency of the underlying security.</p>


<!-- Field: Page; Sequence: 100; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Certain depositary receipts, typically those denominated
as unsponsored, require the holders thereof to bear most of the costs of the facilities while issuers of sponsored facilities normally
pay more of the costs thereof. The depository of an unsponsored facility frequently is under no obligation to distribute shareholder communications
received from the issuer of the deposited securities or to pass through the voting rights to facility holders in respect to the deposited
securities, whereas the depository of a sponsored facility typically distributes shareholder communications and passes through voting
rights.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Warrants and Rights</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may invest in warrants or rights that entitle
the holder to buy equity securities at a specific price for a specific period of time. The Fund may acquire warrants for equity securities
and debt securities that are acquired as units with debt securities. Warrants are securities permitting, but not obligating, their holder
to subscribe to other securities. Warrants do not carry with them the right to dividends or voting rights with respect to the securities
that they entitle their holder to purchase, and they do not represent any rights in the assets of the issuer. As a result, warrants may
be considered more speculative than certain other types of investments. In addition, the value of a warrant does not necessarily change
with the value of the underlying securities and a warrant ceases to have value if it is not exercised prior to its expiration date.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Collateralized Loan Obligations</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund&#8217;s investments in non-convertible income securities may
include investments in collateralized loan obligation (&#8220;CLO&#8221;) securities. A CLO vehicle generally is an entity that is formed
to hold a portfolio consisting principally (typically, 80% or more of its assets) of loan obligations. The loan obligations within the
CLO vehicle are limited to loans which meet established credit criteria and are subject to concentration limitations in order to limit
a CLO vehicle&#8217;s exposure to a single credit. The transaction documents relating to the issuance of CLO securities impose eligibility
criteria on the assets of the CLO, restrict the ability of the CLO&#8217;s investment manager to trade investments and impose certain
portfolio-wide asset quality requirements.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">A CLO issues various classes or &#8220;tranches&#8221; of securities.
Each tranche has different payment characteristics and different credit ratings. These tranches are generally categorized as senior, mezzanine,
or subordinated/equity, according to their degree of risk. The key feature of the CLO structure is the prioritization of the cash flows
from a pool of securities among the several tranches of the CLO. As interest payments are received, the CLO makes contractual interest
payments to each tranche of debt based on its seniority. If there are funds remaining after each tranche of debt receives its contractual
interest rate and the CLO meets or exceeds required collateral coverage levels (or other similar covenants), the remaining funds may be
paid to the subordinated tranche (often referred to as the &#8220;residual&#8221; or &#8220;equity&#8221; tranche). The contractual provisions
setting out this order of payments are set out in detail in the relevant CLO&#8217;s indenture. These provisions are referred to as the
&#8220;priority of payments&#8221; or the &#8220;waterfall&#8221; and determine the terms of payment of any other obligations that may
be required to be paid ahead of payments of interest and principal on the securities issued by a CLO. In addition, for payments to be
made to each tranche, after the most senior tranche of debt, there are various tests that must be complied with, which are different for
each CLO. CLO securities are generally limited recourse obligations of the CLO payable solely from the underlying assets of the CLO or
the proceeds thereof. Consequently, holders of CLO securities must rely solely on distributions on the underlying assets or proceeds thereof
for payment in respect thereof. The cash flows generated by the underlying obligations held in a CLO&#8217;s portfolio will generally
determine the interest payments on CLO securities. Payments to holders of CLO securities are made in sequential order of priority. CLO
securities may have floating interest rates or fixed interest rates. The rated tranches of CLO securities are generally assigned credit
ratings by one or more nationally recognized statistical rating organizations.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Fund currently intends to invest in the rated debt tranches of CLOs
and does not currently intend to invest in the subordinated (or &#8220;residual&#8221; or &#8220;equity&#8221;) tranche.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">&#160;</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">INVESTMENT RESTRICTIONS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund operates under the following restrictions
that constitute fundamental policies that, except as otherwise noted, cannot be changed without the affirmative vote of the holders of
a majority of the outstanding voting</p>


<!-- Field: Page; Sequence: 101; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">securities of the Fund voting together as a single class, which is
defined by the 1940 Act as the lesser of (i) 67% or more of the Fund&#8217;s voting securities present at a meeting, if the holders of
more than 50% of the Fund&#8217;s outstanding voting securities are present or represented by proxy; or (ii) more than 50% of the Fund&#8217;s
outstanding voting securities. These restrictions provide that the Fund shall not:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(1)</td><td>invest 25% or more of the value of its Managed Assets in any one industry; provided that this limitation does not apply to government
securities;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(2)</td><td>with respect to 75% of its Managed Assets, invest more than 5% of the value of its Managed Assets in the securities of any single
issuer or purchase more than 10% of the outstanding voting securities of any one issuer;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(3)</td><td>issue senior securities or borrow money other than as permitted by the Investment Company Act of 1940 (the &#8220;1940 Act&#8221;),
or pledge its assets other than to secure such issuances or in connection with Strategic Transactions and other investment strategies;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(4)</td><td>make loans of money or property to any person, except through loans of portfolio securities, the purchase of convertible securities
and non-convertible income securities consistent with the Fund&#8217;s investment objective and policies or the entry into repurchase
agreements;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(5)</td><td>underwrite the securities of other issuers, except to the extent that in connection with the disposition of portfolio securities or
the sale of its own securities the Fund may be deemed to be an underwriter;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(6)</td><td>purchase or sell real estate, except that the Fund may invest in securities of companies that deal in real estate or are engaged in
the real estate business, including real estate investment trusts, and securities secured by real estate or interests therein and the
Fund may hold and sell real estate or mortgages on real estate acquired through default, liquidation or other distributions of an interest
in real estate as a result of the Fund&#8217;s ownership of such securities; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">(7)</td><td>purchase or sell commodities or commodity contracts for any purposes except as, and to the extent, permitted by applicable law without
the Fund becoming subject to registration with the Commodity Futures Trading Commission as a commodity pool.</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Currently, under the 1940 Act, the Fund generally
is not permitted to engage in borrowings unless immediately after a borrowing the value of the Fund&#8217;s total assets less liabilities
(other than the borrowing) is at least 300% of the principal amount of the borrowing (<i>i.e.</i>, the principal amount may not exceed
33 <span style="background-color: white"><sup>1&#160;</sup>/<sub>&#160;3</sub></span>% of the Fund&#8217;s total assets). In addition,
the Fund is not permitted to declare any cash dividend or other distribution on common shares unless, at the time of declaration, the
value of the Fund&#8217;s total assets, less liabilities other than borrowings, is at least 300% of the principal amount of its borrowing.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Currently, under the 1940 Act, the Fund may generally
not lend money or property to any person, directly or indirectly, if the person controls or is under common control with the Fund, except
for a loan from the Fund to a company that owns all of the outstanding securities of the Fund, except directors&#8217; and qualifying
shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">For purposes of the foregoing, &#8220;majority of
the outstanding,&#8221; when used with respect to particular shares of the Fund (whether voting together as a single class or voting as
separate classes), means (i) 67% or more of such shares present at a meeting, if the holders of more than 50% of such shares are present
or represented by proxy, or (ii) more than 50% of such shares, whichever is less.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Unless otherwise indicated, all limitations applicable
to the Fund&#8217;s investments apply only at the time a transaction is entered into.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Currently, under the 1940 Act, a &#8220;senior security&#8221;
does not include any promissory note or evidence of indebtedness where the loan is for temporary purposes only and in an amount not exceeding
5% of the value of the total assets of</p>


<!-- Field: Page; Sequence: 102; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">the issuer at the time the loan is made. A loan is presumed to be for
temporary purposes if it is repaid within sixty days and is not extended or renewed.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund would be deemed to &#8220;concentrate&#8221;
in a particular industry if it invested 25% or more of its total assets in that industry. The Fund&#8217;s industry concentration policy
does not preclude it from focusing investments in issuers in a group of related industrial sectors (such as different types of utilities).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Currently, to the extent the Fund covers its commitment
under a reverse repurchase agreement, derivative instrument or other borrowing instrument by the segregation of liquid assets, equal in
value to the amount of the Fund&#8217;s commitment, or by entering into offsetting transactions or by owning other positions covering
its obligations, the instrument will not be considered a &#8220;senior security&#8221; for purposes of the asset coverage requirements
otherwise applicable to borrowings by the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund interprets its policies with respect to
borrowing and lending to permit such activities as may be lawful for the Fund, to the full extent permitted by the 1940 Act or by exemption
from the provisions of the 1940 Act under an exemptive order of the SEC.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">MANAGEMENT OF THE FUND</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Board of Trustees</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">The information contained under the heading &#8220;Other Information&#8212;Trustees&#8221;
in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual Report</a>
is incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Trustee Qualifications</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The information contained under the heading &#8220;The
Proposal: To Elect Trustees&#8212;Trustee Experiences, Qualifications, and Skills&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">Proxy
Statement</a> is incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Executive Officers</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The information contained under the heading &#8220;Other
Information&#8212;Officers&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual
Report</a> is incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Board Leadership Structure</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The information contained under the heading &#8220;The
Proposal: To Elect Trustees&#8212;Board Leadership Structure&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">Proxy
Statement</a> is incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Board Committees</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The information contained under the headings
&#8220;The Proposal: To Elect Trustees&#8212;Board Committees&#8221; and "The Proposal: To Elect Trustees&#8212;Board Meetings" in
the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">Proxy Statement</a> is
incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>Board&#8217;s Role in Risk Oversight</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 10pt; text-indent: 0in">The information contained under the heading
&#8220;The Proposal: To Elect Trustees&#8212;Board&#8217;s Role in Risk Oversight&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">Proxy
Statement</a> is incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Remuneration of Trustees and Officers</b></p>


<!-- Field: Page; Sequence: 103; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The information contained under the heading &#8220;The
Proposal: To Elect Trustees&#8212;Trustee Compensation&#8221; in the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">Proxy
Statement</a> is incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Trustee Share Ownership</b>&#160;</p>



<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">The information contained under the heading &#8220;The Proposal: To
Elect Trustees&#8212;Trustee and Officer Beneficial Ownership of Securities&#8221; in the Fund&#8217;s Proxy Statement is incorporated
herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Indemnification of Officers and Trustees; Limitations on Liability</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s Declaration of Trust and By-Laws
(collectively, the &#8220;Governing Documents&#8221;) provide that the Fund will indemnify its Trustees and officers and may indemnify
its employees or agents against liabilities and expenses incurred in connection with litigation in which they may be involved because
of their positions with the Fund, to the fullest extent permitted by law. However, nothing in the Governing Documents protects or indemnifies
a Trustee, officer, employee or agent of the Fund against any liability to which such person would otherwise be subject in the event of
such person&#8217;s willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of his
or her position.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Adviser</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Pursuant to an investment advisory agreement between the Fund and the
Adviser (the &#8220;Investment Advisory Agreement&#8221;), the Fund pays the Adviser a management fee, payable monthly.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">Under the terms of the Investment Advisory Agreement, the Adviser is
responsible for the day-to-day management of the Fund&#8217;s portfolio of investments, which includes buying and selling securities for
the Fund, as well as investment research.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Investment Advisory Agreement had an initial term of two years and
thereafter remains in effect from year to year if approved annually (i) by the Board of Trustees or by the holders of a majority of the
Fund&#8217;s outstanding voting securities and (ii) by a majority of the Trustees who are not &#8220;interested persons&#8221; (as defined
in the 1940 Act)</p>


<!-- Field: Page; Sequence: 104; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">of the Fund or the Adviser, by vote cast in person at a meeting called
for the purpose of voting on such approval. The Investment Advisory Agreement terminates automatically on its assignment and may be terminated
without penalty on 60 days written notice at the option of either party thereto or by a vote of a majority of the Fund&#8217;s outstanding
shares, which is defined by the 1940 Act as the lesser of (i) 67% or more of the Fund&#8217;s voting securities present at a meeting,
if the holders of more than 50% of the Fund&#8217;s outstanding voting securities are present or represented by proxy; or (ii) more than
50% of the Fund&#8217;s outstanding voting securities.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The Investment Advisory Agreement provides that, in the absence of willful
misfeasance, bad faith, gross negligence or reckless disregard for its obligations and duties thereunder, Advent is not liable for any
error or judgment or mistake of law or for any loss suffered by the Fund. Pursuant to the Investment Advisory Agreement, Advent has granted
the right to use the name &#8220;Advent&#8221; in the name of the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0">The table below sets forth information about the total management fees
paid by the Fund to Advent.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0"><b>Advisory Fees Paid to Advent</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 22%; padding-right: 4.3pt; padding-left: 4.3pt">
    <p style="border-bottom: Black 0.5pt solid; font: 9pt Times New Roman, Times, Serif; margin: 0"><b>For the Fiscal Year Ended</b></p></td>
    <td style="width: 31%; padding-right: 4.3pt; padding-left: 4.3pt; text-align: center">&#160;</td>
    <td style="width: 47%; padding-right: 4.3pt; padding-left: 4.3pt">
    <p style="border-bottom: Black 0.5pt solid; font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Paid to Advent</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 4.3pt; padding-left: 4.3pt; text-align: center"><span style="font-size: 9pt">October&#160;31, 2023</span></td>
    <td style="padding-right: 4.3pt; padding-left: 4.3pt">&#160;</td>
    <td rowspan="3" style="padding-right: 4.3pt; padding-left: 4.3pt">
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">$4,197,461</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">$4,716,909</p>
    <p style="font: 9pt Times New Roman, Times, Serif; margin: 0; text-align: center">$5,434,775</p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 4.3pt; padding-left: 4.3pt; text-align: center"><span style="font-size: 9pt">October&#160;31, 2022</span></td>
    <td style="padding-right: 4.3pt; padding-left: 4.3pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 4.3pt; padding-left: 4.3pt; text-align: center"><span style="font-size: 9pt">October&#160;31, 2021</span></td>
    <td style="padding-right: 4.3pt; padding-left: 4.3pt">&#160;</td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>&#160;</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Portfolio Managers</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The information contained under &#8220;Item&#160;8.
Portfolio Managers of Closed-End Management Investment Companies&#8221; of the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual
Report</a> is incorporated herein by reference.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Fund Administration Agreement</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Fund administration services are provided to the
Fund by MUFG Investor Services (US), LLC (&#8220;MUFG&#8221;), pursuant to a fund administration agreement between the Fund and MUFG.
The Fund pays MUFG a contractual fund administration fee for these services, payable monthly at the annual rate set forth as a percentage
of the average daily Managed Assets of the Fund in the table below.</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td colspan="2" style="padding-top: 1pt; padding-bottom: 1pt"><b><span style="text-decoration: underline">Fund Administration Fee</span></b></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">&#160;</td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; width: 67%; padding-top: 1pt; padding-bottom: 1pt"><b>Managed Assets</b></td>
    <td style="border-bottom: Black 1pt solid; width: 25%; padding-top: 1pt; padding-bottom: 1pt"><b>Rate</b></td>
    <td style="width: 8%; padding-top: 1pt; padding-bottom: 1pt">&#160;</td></tr>
  <tr>
    <td style="padding-top: 1pt; padding-bottom: 1pt">First $200,000,000</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">0.0275%</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-top: 1pt; padding-bottom: 1pt">Next $300,000,000</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">0.0200%</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">&#160;</td></tr>
  <tr>
    <td style="padding-top: 1pt; padding-bottom: 1pt">Next $500,000,000</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">0.0150%</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="padding-top: 1pt; padding-bottom: 1pt">Over $1,000,000,000</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">0.0100%</td>
    <td style="padding-top: 1pt; padding-bottom: 1pt">&#160;</td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Servicing Agreement</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Pursuant to a Servicing Agreement between the Fund
and Guggenheim Funds Distributors, LLC (&#8220;GFD&#8221;) (the &#8220;GFD Servicing Agreement&#8221;), the Fund pays GFD a servicing
fee of 0.21% of the average value of the Fund&#8217;s Managed Assets, payable monthly.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Under the terms of the GFD Servicing Agreement, GFD
provides the Fund a variety of services, including (i) replying to requests for information concerning the Fund from shareholders or prospective
shareholders, brokers or the public; (ii) aiding in the secondary market support of the Fund through regular written and oral communications
with the Fund&#8217;s NYSE designated market maker, the closed-end fund analyst community and various information providers specializing
in the dissemination of closed-end fund information; (iii) coordinating and overseeing activities of the Fund&#8217;s administrator; (iv)
developing and maintaining a website for the Fund and (v) overseeing, in</p>


<!-- Field: Page; Sequence: 105; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">consultation with, and as agreed by, Advent matters relating to the
conduct and administration of meetings of the Board and committees thereof.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The GFD Servicing Agreement remains in effect from
year to year if approved annually by the Board of Trustees.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The GFD Servicing Agreement is terminable (a) by
the Fund, without penalty, on thirty (30) days&#8217; written notice, by a vote of a majority of the Fund&#8217;s Board of Trustees, or
(b) on sixty (60) days&#8217; written notice by GFD. The GFD Servicing Agreement shall automatically terminate in the event of its assignment
as the term is defined in the 1940 Act. In addition, either party to the GFD Servicing Agreement may also terminate the GFD Servicing
Agreement in the event the other party has materially breached the GFD Servicing Agreement in the event that the breach is not cured within
ten (10) days after receipt by the breaching party of written notice of the breach.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The GFD Servicing Agreement provides that, in the
absence of willful misconduct, bad faith, gross negligence or reckless disregard for its obligations and duties thereunder, GFD is not
liable for any error or judgment or mistake of law or for any loss suffered by the Fund.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">PORTFOLIO TRANSACTIONS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Subject to policies established by the Board of Trustees,
the Adviser is responsible for placing purchase and sale orders and the allocation of brokerage on behalf of the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Adviser will employ a variety of criteria in
selecting brokers to execute trades for the account of the Fund, and will, at all times, seek best execution of such trades. The Adviser
is responsible for selecting the broker or dealer used in each investment transaction for the Fund. When a transaction is effected on
an exchange, the Adviser seeks to use brokers whose commissions it considers to be fair and reasonable without necessarily determining
that the lowest possible commissions are paid in all circumstances. The Adviser also considers the relative creditworthiness of counterparties,
including brokers and dealers, when choosing a broker or dealer as counterparty in respect of investment transactions.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Adviser does not currently utilize &#8220;soft-dollar&#8221;
arrangements, pursuant to which brokers provide research services to the Adviser in return for allocating brokerage transactions. However,
the Adviser may from time to time receive or be offered research services from brokers at no stated cost or requirement to execute transactions,
and may trade with such brokers.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>Commissions Paid</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 10pt">The Fund paid approximately the following commissions to brokers
during the fiscal years shown:</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><b>Fiscal Year Ended October&#160;31:</b></span></td>
    <td style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b><span style="text-decoration: underline">All Brokers</span></b></span></td>
    <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b><span style="text-decoration: underline">Affiliated Brokers</span></b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">2023</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$191,572</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$0</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">2022</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$613,105</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$0</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">2021</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$236,222</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">$0</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 72%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt"><b>Fiscal Year Ended October&#160;31, 2023 Percentages:</b></span></td>
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Commissions with affiliate to total Transactions:</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">0%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-size: 9pt">Value of Brokerage Transactions with affiliate to total transactions:</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt">0%</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">During the fiscal period ended October&#160;31, 2023,
the Fund paid $191,572 in brokerage commissions on transactions totaling $648,072,562 to brokers selected primarily on the basis of research
services provided to the Adviser.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">TAX MATTERS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">This section and the discussion in the Prospectus
(see &#8220;Tax Matters&#8221;) provide a summary of certain U.S. federal income tax considerations generally applicable to the Fund,
U.S. Shareholders (as defined in the Prospectus) and Non-U.S. Shareholders (as defined in the Prospectus) that acquire common shares (collectively,
the &#8220;Shareholders&#8221;) and that hold such shares as capital assets within the meaning of the Internal Revenue Code of 1986, as
amended</p>


<!-- Field: Page; Sequence: 106; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">(the &#8220;Code&#8221;) (generally, property held for investment).
This summary does not discuss the consequences of an investment in the Rights. The tax consequences of such an investment will be discussed
in a relevant Prospectus Supplement. The discussion is based upon the Code, U.S. Treasury Regulations, judicial authorities, published
positions of the IRS and other applicable authorities, all as in effect on the date hereof and all of which are subject to change or differing
interpretations (possibly with retroactive effect). This summary does not address all of the potential U.S. federal income tax consequences
that may be applicable to the Fund or to all categories of investors, some of which may be subject to special tax rules. No ruling has
been or will be sought from the IRS regarding any matter discussed herein. No assurance can be given that the IRS would not assert, or
that a court would not sustain, a position contrary to any of the tax aspects set forth below. <b>Prospective investors should consult
their tax advisors as to the U.S. federal income tax consequences of acquiring, holding and disposing of common shares, as well as the
effects of state, local and non-U.S. tax laws.</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Taxation of the Fund</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund has elected to be treated, and intends to
qualify each year, as a RIC under Subchapter M of the Code. Accordingly, the Fund must, among other things, (i) derive in each taxable
year at least 90% of its gross income from (a) dividends, interest (including tax-exempt interest), payments with respect to certain securities
loans, and gains from the sale or other disposition of stock, securities or foreign currencies, or other income (including gain from options,
futures and forward contracts) derived with respect to its business of investing in such stock, securities or foreign currencies and (b)
net income derived from interests in &#8220;qualified publicly traded partnerships&#8221; (as defined in the Code); and (ii) diversify
its holdings so that, at the end of each quarter of each taxable year (a) at least 50% of the market value of the Fund&#8217;s total assets
is represented by cash and cash items, U.S. government securities, the securities of other RICs and other securities, with such other
securities limited, in respect of any one issuer, to an amount not greater than 5% of the value of the Fund&#8217;s total assets and not
more than 10% of the outstanding voting securities of such issuer and (b) not more than 25% of the market value of the Fund&#8217;s total
assets is invested in the securities (other than U.S. government securities and the securities of other RICs) of (I) any one issuer, (II)
any two or more issuers that the Fund controls and that are determined to be engaged in the same business or similar or related trades
or businesses or (III) any one or more &#8220;qualified publicly traded partnerships.&#8221; Generally, a qualified publicly traded partnership
includes a partnership the interests of which are traded on an established securities market or readily tradable on a secondary market
(or the substantial equivalent thereof) and that derives less than 90% of its gross income from the items described in (i)(a) above.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">As long as the Fund qualifies as a RIC, the Fund
generally will not be subject to U.S. federal income tax on income and gains that the Fund distributes to its shareholders; provided that
it distributes each taxable year at least 90% of the sum of (i) the Fund&#8217;s investment company taxable income (which includes, among
other items, dividends, interest, the excess of any net short-term capital gain over net long-term capital loss, and other taxable income,
other than any net capital gain (defined below), reduced by deductible expenses) determined without regard to the deduction for dividends
and distributions paid and (ii) the Fund&#8217;s net tax-exempt interest (the excess of its gross tax-exempt interest over certain disallowed
deductions) (the &#8220;Annual Distribution Requirement&#8221;). The Fund intends to distribute substantially all of such income each
year. The Fund will be subject to income tax at regular corporate rates on any taxable income or gains that it does not distribute to
its shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Code imposes a 4% nondeductible excise tax on
the Fund to the extent the Fund does not distribute by the end of any calendar year at least the sum of (i) 98% of its ordinary income
(not taking into account any capital gain or loss) for the calendar year and (ii) 98.2% of its capital gain in excess of its capital loss
(adjusted for certain ordinary losses) for a one-year period generally ending on October&#160;31 of the calendar year (unless an election
is made to use the Fund&#8217;s taxable year) (the &#8220;Excise Tax Avoidance Requirements&#8221;). In addition, the minimum amounts
that must be distributed in any year to avoid the excise tax will be increased or decreased to reflect any under-distribution or over-distribution,
as the case may be, from the previous year. For purposes of the excise tax, the Fund will be deemed to have distributed any income on
which it paid U.S. federal income tax in the taxable year ending within the calendar year. While the Fund intends to distribute any income
and capital gain in the manner necessary to minimize imposition of the 4% nondeductible excise tax, there can be no assurance that sufficient
amounts of the Fund&#8217;s taxable income and capital gain will be distributed to avoid entirely the imposition of the excise tax. In
that event, the Fund will be liable for the excise tax only on the amount by which it does not meet the foregoing distribution requirement.</p>


<!-- Field: Page; Sequence: 107; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">If for any taxable year the Fund does not qualify
as a RIC, all of its taxable income (including its net capital gain, which consists of the excess of its net long-term capital gain over
its net short-term capital loss) will be subject to tax at regular corporate rates without any deduction for distributions to its shareholders,
and such distributions will be taxable to the Shareholders as ordinary dividends to the extent of the Fund&#8217;s current and accumulated
earnings and profits. Such dividends, however, would be eligible (i) to be treated as &#8220;qualified dividend income&#8221; in the case
of Shareholders taxed as individuals and (ii) for the dividends received deduction in the case of corporate Shareholders, subject, in
each case, to certain holding period and other requirements. To qualify again to be taxed as a RIC in a subsequent year, the Fund would
generally be required to distribute to its shareholders its earnings and profits attributable to non-RIC years. If the Fund fails to qualify
as a RIC for a period greater than two taxable years, the Fund may be required to recognize and pay tax on any net built-in gains with
respect to certain of its assets (<i>i.e.</i>, the excess of the aggregate gains, including items of income, over aggregate losses that
would have been realized with respect to such assets if the Fund had been liquidated) or, alternatively, to elect to be subject to taxation
on such built-in gain recognized for a period of five years, in order to qualify as a RIC in a subsequent year. The remainder of this
discussion assumes that the Fund qualifies as a RIC.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Taxation of the Fund&#8217;s Investments</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Certain of the Fund&#8217;s investment practices
are subject to special and complex U.S. federal income tax provisions (including mark-to-market, constructive sale, straddle, wash sale,
short sale and other rules) that may, among other things, (i) disallow, suspend or otherwise limit the allowance of certain losses or
deductions, including the dividends received deduction, (ii) convert lower taxed long-term capital gains or &#8220;qualified dividend
income&#8221; into higher taxed short-term capital gains or ordinary income, (iii) convert ordinary loss or a deduction into capital loss
(the deductibility of which is more limited), (iv) cause the Fund to recognize income or gain without a corresponding receipt of cash,
(v) adversely affect the time as to when a purchase or sale of stock or securities is deemed to occur, (vi) adversely alter the characterization
of certain complex financial transactions and (vii) produce income that will not be &#8220;qualified&#8221; income for purposes of the
90% annual gross income requirement described above. These U.S. federal income tax provisions could therefore affect the amount, timing
and character of distributions to Shareholders. The Fund intends to monitor its transactions and may make certain tax elections and may
be required to dispose of securities to mitigate the effect of these provisions and prevent disqualification of the Fund as a RIC. Additionally,
the Fund may be required to limit its activities in derivative instruments in order to enable the Fund to maintain its RIC status.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">If the Fund acquires shares in a &#8220;passive foreign
investment company&#8221; (a &#8220;PFIC&#8221;), the Fund may be subject to U.S. federal income tax on a portion of any &#8220;excess
distribution&#8221; or gain from the disposition of such shares even if such income is distributed as a taxable dividend by the Fund to
Shareholders. Additional charges in the nature of interest may be imposed on the Fund in respect of deferred taxes arising from such distributions
or gains. If the Fund invests in a PFIC and elects to treat the PFIC as a &#8220;qualified electing fund&#8221; under the Code (a &#8220;QEF&#8221;),
in lieu of the foregoing requirements, the Fund will be required to include in income each year a portion of the ordinary earnings and
net capital gain of the QEF, even if such income is not distributed to the Fund. Alternatively, the Fund can elect to mark to market at
the end of each taxable year the Fund&#8217;s shares in a PFIC; in this case, the Fund will recognize as ordinary income any increase
in the value of such shares, and as ordinary loss any decrease in such value to the extent it does not exceed prior increases included
in income. The Fund&#8217;s ability to make either election will depend on factors beyond the Fund&#8217;s control. Under either election,
the Fund may be required to recognize in a year income in excess of the Fund&#8217;s distributions from PFICs and the Fund&#8217;s proceeds
from dispositions of PFIC stock during that year, and such income will nevertheless be subject to the Annual Distribution Requirement
and will be taken into account for purposes of the 4% excise tax.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">If the Fund holds 10% or more of the shares in a
foreign corporation that is treated as a controlled foreign corporation (&#8220;CFC&#8221;), the Fund may be treated as receiving a deemed
distribution (taxable as ordinary income) each year from such foreign corporation in an amount equal to the Fund&#8217;s pro rata share
of the corporation&#8217;s income for the taxable year (including both ordinary earnings and capital gains), whether or not the corporation
makes an actual distribution during such year. In general, a foreign corporation will be classified as a CFC if more than 50% of the shares
of the corporation, measured by reference to combined voting power or value, is owned (directly, indirectly or by attribution) by U.S.
shareholders. A U.S. shareholder, for this purpose, is any U.S. person that possesses (directly, indirectly or by attribution) 10% or
more of the combined voting power or value of all classes of shares of a corporation. If the Fund is treated as receiving a deemed distribution
from a CFC, the Fund will be required to</p>


<!-- Field: Page; Sequence: 108; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">include such distribution in its investment company taxable income
regardless of whether the Fund receives any actual distributions from such CFC, and the Fund must distribute such income to satisfy the
Annual Distribution Requirement and the Excise Tax Avoidance Requirement.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Certain types of income received by the Fund from
REITs, real estate mortgage investment conduits (&#8220;REMICs&#8221;), taxable mortgage pools or other investments may cause the Fund
to designate some or all of its distributions as &#8220;excess inclusion income.&#8221; To Shareholders such excess inclusion income will
(i) constitute taxable income, as &#8220;unrelated business taxable income&#8221; (&#8220;UBTI&#8221;) for those Shareholders who would
otherwise be tax-exempt such as individual retirement accounts, 401(k) accounts, Keogh plans, pension plans and certain charitable entities,
(ii) not be offset against net operating losses for tax purposes, (iii) not be eligible for reduced U.S. withholding for Non-U.S. Shareholders
even from tax treaty countries and (iv) cause the Fund to be subject to tax if certain &#8220;disqualified organizations,&#8221; as defined
by the Code (which includes charitable remainder trusts), are Shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may invest a portion of its net assets in
below investment grade securities, commonly known as &#8220;junk&#8221; securities. Investments in these types of securities may present
special tax issues for the Fund. U.S. federal income tax rules are not entirely clear about issues such as when the Fund may cease to
accrue interest, original issue discount or market discount, when and to what extent deductions may be taken for bad debts or worthless
securities, how payments received on obligations in default should be allocated between principal and income and whether exchanges of
debt instruments in a bankruptcy or workout context are taxable. The Fund intends to address these and other issues, to the extent necessary,
in order to seek to ensure that the Fund distributes sufficient income to preserve its status as a RIC and does not become subject to
U.S. federal income or excise tax.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Certain credit securities acquired by the Fund may
be treated as credit securities that were originally issued at a discount. Generally, the amount of the original issue discount is treated
as interest income and is included in taxable income (and, to the extent allocable to the Fund, is required to be distributed by the Fund
in order to qualify as a RIC or avoid income or excise taxes on undistributed income) over the term of the security, even though payment
of that amount is not received until a later time, usually when the debt instrument matures. If the Fund purchases a debt instrument on
a secondary market at a price lower than its adjusted issue price, the excess of the adjusted issue price over the purchase price is &#8220;market
discount.&#8221; Unless the Fund makes an election to accrue market discount on a current basis, generally, any gain realized on the disposition
of, and any partial payment of principal on, a debt instrument having market discount is treated as ordinary income to the extent the
gain, or principal payment, does not exceed the &#8220;accrued market discount&#8221; on the debt instrument. Market discount generally
accrues in equal daily installments.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund may invest in preferred securities or other
securities the U.S. federal income tax treatment of which may not be clear or may be subject to recharacterization by the IRS. To the
extent the tax treatment of such securities or the income from such securities differs from the tax treatment expected by the Fund, it
could affect the timing or character of income recognized by the Fund, requiring the Fund to purchase or sell securities, or otherwise
change its portfolio, in order to comply with the tax rules applicable to RICs under the Code.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Gain or loss on the sales of securities by the Fund
will generally be long-term capital gain or loss if the securities have been held by the Fund for more than one year. Gain or loss on
the sale of securities held for one year or less will be short-term capital gain or loss.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Because the Fund may invest in foreign securities,
its income from such securities may be subject to non-U.S. taxes. The Fund does not expect to be eligible to elect to &#8220;pass through&#8221;
to Shareholders of the Fund the ability to use the foreign tax deduction or foreign tax credit allocable to it for foreign taxes paid
by the Fund with respect to qualifying taxes.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Income from options on individual stocks written
by the Fund will not be recognized by the Fund for tax purposes until an option is exercised, lapses or is subject to a &#8220;closing
transaction&#8221; (as defined by applicable regulations) pursuant to which the Fund&#8217;s obligations with respect to the option are
otherwise terminated. If the option lapses without exercise or is otherwise subject to a closing transaction, the premiums received by
the Fund from the writing of such options will generally be characterized as short-term capital gain. If an option written by the Fund
is exercised, the Fund will generally recognize gain or loss depending on the exercise price of the option, the option premium, and the
Fund&#8217;s tax basis in the security underlying the option. The character of any gain or loss on the sale</p>


<!-- Field: Page; Sequence: 109; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">of the underlying security as short-term or long-term capital gain
or loss will depend on the holding period of the Fund in the underlying security. In general, distributions received by U.S. Shareholders
of the Fund that are attributable to short-term capital gains recognized by the Fund from option writing activities of the Fund will be
taxed to such U.S. Shareholders as ordinary income and will not be eligible for the reduced tax rate applicable to qualified dividend
income.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Options on indices of securities and sectors of securities
that qualify as &#8220;section&#160;1256 contracts&#8221; will generally be &#8220;marked-to-market&#8221; for U.S. federal income tax
purposes. As a result, the Fund will generally recognize gain or loss on the last day of each taxable year equal to the difference between
the value of the option on that date and the adjusted basis of the option. The adjusted basis of the option will consequently be increased
by such gain or decreased by such loss. Any gain or loss with respect to options on indices and sectors that qualify as &#8220;section&#160;1256
contracts&#8221; will be treated as short-term capital gain or loss to the extent of 40% of such gain or loss and long-term capital gain
or loss to the extent of 60% of such gain or loss. Because the mark-to-market rules may cause the Fund to recognize gain in advance of
the receipt of cash, the Fund may be required to dispose of investments in order to meet its distribution requirements. &#8220;Mark-to-market&#8221;
losses may be suspended or otherwise limited if such losses are part of a straddle or similar transaction.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Taxation of U.S. Shareholders</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund will either distribute or retain for reinvestment
all or part of its net capital gain. If any such gain is retained, the Fund will be subject to regular corporate income tax on such retained
amount. In that event, the Fund may designate the retained amount as undistributed capital gain in a notice to its Shareholders, each
of whom, if subject to U.S. federal income tax on long-term capital gains, (i) would be required to include in income for U.S. federal
income tax purposes as long-term capital gain its share of such undistributed amounts, (ii) would be entitled to credit its proportionate
share of the tax paid by the Fund against its U.S. federal income tax liability and to claim refunds to the extent that the credit exceeds
such liability and (iii) would increase its basis in its shares by the amount of undistributed capital gain included in such Shareholder&#8217;s
gross income net of the tax deemed paid by such Shareholder under clause&#160;(ii).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Distributions paid to you by the Fund from its net
capital gains, if any, that the Fund properly reports as capital gains dividends (&#8220;capital gain dividends&#8221;) are taxable as
long-term capital gains, regardless of how long you have held your shares. All other dividends paid to you by the Fund (including dividends
from net short-term capital gains) from its current or accumulated earnings and profits (&#8220;ordinary income dividends&#8221;) are
generally subject to tax as ordinary income. Capital gain dividends are not eligible for the dividends received deduction.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Properly reported ordinary income dividends received
by corporate Shareholders generally will be eligible for the dividends received deduction to the extent that the Fund&#8217;s income consists
of dividend income from U.S. corporations and certain holding period and other requirements are satisfied by both the Fund and the corporate
U.S. Shareholders. In the case of U.S. Shareholders who are individuals, any properly reported ordinary income dividends that you receive
from the Fund will generally be eligible for taxation at the rates applicable to long-term capital gains to the extent that (i) the ordinary
income dividend is attributable to &#8220;qualified dividend income&#8221; (<i>i.e.</i>, generally dividends paid by U.S. corporations
and certain qualified foreign corporations) received by the Fund, (ii) the Fund satisfies certain holding period and other requirements
with respect to the stock on which such qualified dividend income was paid and (iii) you satisfy certain holding period and other requirements
with respect to your shares. Dividend income from PFICs and, in general, dividend income from REITs is not eligible for the reduced rate
for qualified dividend income and is taxed as ordinary income. In addition, for dividends to be eligible for the dividends received deduction
or for reduced rates applicable to individuals, the Fund cannot have an option to sell or be under a contractual obligation to sell (pursuant
to a short sale or otherwise) substantially identical stock or securities. Qualified dividend income eligible for these special rules
is not actually treated as capital gains, however, and thus will not be included in the computation of your net capital gain and generally
cannot be used to offset any capital losses. Due to the nature of the Fund&#8217;s investments, the Fund does not expect that a significant
portion of its distributions will be eligible for the dividends received deduction or for the reduced rates applicable to qualified dividend
income.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Under Treasury regulations, for taxable years beginning
before January 1, 2026, properly reported dividends paid by the Fund that are attributable to the Fund&#8217;s &#8220;qualified REIT dividends&#8221;
(generally, ordinary income dividends paid</p>


<!-- Field: Page; Sequence: 110; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">by a REIT, not including capital gain dividends or dividends treated
as qualified dividend income) may be eligible for the 20% deduction described in Section&#160;199A of the Code in the case of non-corporate
U.S. Shareholders; provided that certain holding period and other requirements are met by the Shareholder and the Fund. There can be no
assurance as to what portion, if any, of our distributions will qualify for such deduction. Subject to any future regulatory guidance
to the contrary, any distribution attributable to income from the Fund&#8217;s investments in publicly traded partnerships, if any, will
not qualify for the 20% deduction that could be available to a non-corporate U.S. Shareholder were the Shareholder to own such partnership
interests directly.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Any distributions you receive that are in excess
of the Fund&#8217;s current and accumulated earnings and profits will be treated as a tax-deferred return of capital to the extent of
your adjusted tax basis in your shares, and thereafter as capital gain from the sale of shares (assuming such shares are held as a capital
asset). The amount of any Fund distribution that is treated as a return of capital will reduce your adjusted tax basis in your shares,
thereby increasing your potential gain or reducing your potential loss on any subsequent sale or other disposition of your shares. In
determining the extent to which a distribution will be treated as being made from the Fund&#8217;s earnings and profits, earnings and
profits will be allocated on a pro rata basis first to distributions with respect to the Fund&#8217;s preferred shares, if any, and then
to the Fund&#8217;s common shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">U.S. Shareholders may be entitled to offset their
capital gain dividends with capital losses. The Code contains a number of statutory provisions affecting when capital losses may be offset
against capital gain, and limiting the use of losses from certain investments and activities. Accordingly, Shareholders that have capital
losses are urged to consult their tax advisers.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The IRS currently requires a RIC that has two or
more classes of shares outstanding to designate to each such class proportionate amounts of each type of its income (<i>e.g.</i>, ordinary
income, capital gain dividends, qualified dividend income) for each tax year based upon the percentage of total dividends distributed
to each class for such year.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Dividends and other taxable distributions are taxable
to you even though they are reinvested in additional shares of the Fund. Dividends and other distributions paid by the Fund are generally
treated under the Code as received by you at the time the dividend or distribution is made. If, however, the Fund pays you a dividend
in January that was declared in the previous October, November or December and you were the shareholder of record on a specified date
in one of such months, then such dividend will be treated for U.S. federal income tax purposes as being paid by the Fund and received
by you on December&#160;31 of the year in which the dividend was declared. In addition, certain other distributions made after the close
of the Fund&#8217;s taxable year may be &#8220;spilled back&#8221; and treated as paid by the Fund (except for purposes of the 4% nondeductible
excise tax) during such taxable year. In such case, you will be treated as having received such dividends in the taxable year in which
the distributions were actually made.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The price of shares purchased at any time may reflect
the amount of a forthcoming distribution. Those purchasing shares just prior to the record date of a distribution will receive a distribution
which will be taxable to them even as described above though economically it represents in part a return of invested capital.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund will send you information after the end
of each year setting forth the amount and tax status of any distributions paid to you by the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Except in the case of a redemption, the sale or other
disposition of common shares (including in connection with a termination of the Fund) will generally result in capital gain or loss to
you and will be long-term capital gain or loss if you have held such shares for more than one year at the time of sale. Any loss upon
the sale or other disposition of shares held for six months or less will be treated as long-term capital loss to the extent of any capital
gain dividends received (including amounts credited as an undistributed capital gain dividend) by you with respect to such shares. Any
loss you recognize on a sale or other disposition of shares will be disallowed if you acquire other shares (whether through the automatic
reinvestment of dividends or otherwise) within a 61-day period beginning 30 days before and ending 30 days after your sale or exchange
of shares. In such case, your tax basis in the shares acquired will be adjusted to reflect the disallowed loss.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">In general, a redemption of shares should be treated as a sale or exchange
of such shares under section&#160;302 of the Code, if the distribution of cash (a) is &#8220;substantially disproportionate&#8221; with
respect to the Shareholder, (b) results in a &#8220;complete redemption&#8221; of the Shareholder&#8217;s interest, or (c) is &#8220;not
essentially equivalent to a dividend&#8221; with</p>


<!-- Field: Page; Sequence: 111; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">respect to the Shareholder. A &#8220;substantially disproportionate&#8221;
distribution generally requires a reduction of at least 20% in the Shareholder&#8217;s proportionate interest in the Fund and also requires
the Shareholder to own less than 50% of the voting power of all classes entitled to vote immediately after the redemption. A &#8220;complete
redemption&#8221; of a Shareholder&#8217;s interest generally requires that all common shares and preferred shares of the Fund owned by
such Shareholder be disposed of. A distribution &#8220;not essentially equivalent to a dividend&#8221; requires that there be a &#8220;meaningful
reduction&#8221; in the Shareholder&#8217;s proportionate interest in the Fund, which should result if the Shareholder has a minimal interest
in the Fund, exercises no control over Fund affairs and suffers a reduction in his proportionate interest in the Fund. In determining
whether any of these tests has been met, any common shares and preferred shares actually owned, as well as shares considered to be owned
by the Shareholder by reason of certain constructive ownership rules set forth in section&#160;318 of the Code, generally must be taken
into account.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">If the redemption of your shares meets any of these three tests for
&#8220;sale or exchange&#8221; treatment, you will recognize gain or loss equal to the difference between the amount of cash and the fair
market value of other property received pursuant to the transaction and the adjusted tax basis of the sold shares. If none of the tests
described above are met, you may be treated as having received, in whole or in part, a dividend, return of capital or capital gain, depending
on (i) whether there are sufficient earnings and profits to support a dividend and (ii) your tax basis in the relevant shares. The tax
basis in the sold shares will be transferred to any remaining shares held by you in the Fund. In addition, if the redemption of shares
is treated as a &#8220;dividend&#8221; to a shareholder, a constructive dividend under certain provisions of the Code may result to a
non-selling Shareholder whose proportionate interest in the earnings and assets of the Fund has been increased as a result of such transaction.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Adjusted cost basis information for covered securities,
which generally include shares of a RIC, must be reported to the IRS and to taxpayers. Shareholders should contact their financial intermediaries
with respect to reporting of cost basis and available elections for their accounts.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Current U.S. federal income tax law taxes both long-term
and short-term capital gain of corporations at the rates applicable to ordinary income. For non-corporate taxpayers, short-term capital
gain is currently taxed at rates applicable to ordinary income while long-term capital gain generally is taxed at reduced maximum rates.
The deductibility of capital losses is subject to limitations under the Code.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Certain U.S. Shareholders who are individuals, estates
or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare tax on all or a part of their &#8220;net
investment income,&#8221; which includes dividends received from the Fund and capital gains from the sale or other disposition of common
shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Ordinary income dividends, capital gain dividends,
and gain on the disposition of shares also may be subject to state, local or foreign taxes. Shareholders are urged to consult their tax
advisers regarding specific questions about U.S. federal (including the application of the alternative minimum tax rules), state, local
or foreign tax consequences to them of investing in the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Taxation of Non-U.S. Shareholders</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The following discussion only applies to Non-U.S.
Shareholders. Whether an investment in Fund shares is appropriate for a Non-U.S. Shareholder will depend upon that Non-U.S. Shareholder&#8217;s
particular circumstances. An investment in shares by a Non-U.S. Shareholder may have adverse tax consequences. Non-U.S. Shareholders should
consult their tax advisors before investing in our shares.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">A Non-U.S. Shareholder generally will be subject
to U.S. federal withholding tax at the rate of 30% (or possibly a lower rate provided by an applicable tax treaty) on ordinary income
dividends (except as discussed below). In general, U.S. federal withholding tax and U.S. federal income tax will not apply to any gain
or income realized by a Non-U.S. Shareholder in respect of any distribution of net capital gain (including amounts credited as an undistributed
capital gain dividend) or upon the sale or other disposition of shares of the Fund. Different tax consequences may result if the Non-U.S.
Shareholder is engaged in a trade or business in the United States or, in the case of an individual, is present in the United States for
183 days or more during a taxable year and certain other conditions are met.</p>


<!-- Field: Page; Sequence: 112; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Dividends properly reported by the Fund are generally
exempt from U.S. federal withholding tax where they (i) are paid in respect of the Fund&#8217;s &#8220;qualified net interest income&#8221;
(generally, the Fund&#8217;s U.S.-source interest income, other than certain contingent interest and interest from obligations of a corporation
or partnership in which the Fund is at least a 10% shareholder, reduced by expenses that are allocable to such income) or (ii) are paid
in respect of the Fund&#8217;s &#8220;qualified short-term capital gains&#8221; (generally, the excess of the Fund&#8217;s net short-term
capital gain over the Fund&#8217;s long-term capital loss for such taxable year). Depending on its circumstances, the Fund may report
all, some or none of its potentially eligible dividends as such qualified net interest income or as qualified short-term capital gains,
and/or treat such dividends, in whole or in part, as ineligible for this exemption from withholding. In order to qualify for this exemption
from withholding, a Non-U.S. Shareholder needs to comply with applicable certification requirements relating to its non-U.S. status (including,
in general, furnishing an IRS Form&#160;W-8BEN, W-8BEN-E or substitute Form). In the case of shares held through an intermediary, the
intermediary may withhold even if the Fund reports the payment as qualified net interest income or qualified short-term capital gain.
Non-U.S. Shareholders should contact their intermediaries with respect to the application of these rules to their accounts. There can
be no assurance as to what portion of the Fund&#8217;s distributions will qualify for favorable treatment as qualified net interest income
or qualified short-term capital gains.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">If the Fund distributes its net capital gains in
the form of deemed rather than actual distributions, a Non-U.S. Shareholder will be entitled to a U.S. federal income tax credit or tax
refund equal to the Non-U.S. Shareholder&#8217;s allocable share of the tax that the Fund pays on the capital gains deemed to have been
distributed. In order to obtain the refund, the Non-U.S. Shareholder must obtain a U.S. taxpayer identification number and file a federal
income tax return even if the Non-U.S. Shareholder is not otherwise required to obtain a U.S. taxpayer identification number or file a
federal income tax return. For a Non-U.S. Shareholder, distributions (both actual and deemed), and gains realized upon the sale of shares
that are effectively connected with a U.S. trade or business (or, where an applicable treaty applies, are attributable to a permanent
establishment in the United States) will generally be subject to U.S. federal income tax at the rates applicable to U.S. persons and for
a corporate Non-U.S. Shareholder may, under certain circumstances, be subject to an additional &#8220;branch profits tax&#8221; at a 30%
rate (or at a lower rate if provided for by an applicable tax treaty). Accordingly, investment in shares may not be appropriate for certain
Non-U.S. Shareholders.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">In addition, withholding at a rate of 30% is required
on dividends in respect of shares held by or through certain foreign financial institutions (including investment funds), unless such
institution enters into an agreement with the Secretary of the Treasury to report, on an annual basis, information with respect to interests
in, and accounts maintained by, the institution to the extent such interests or accounts are held by certain U.S. persons and by certain
non-U.S. entities that are wholly or partially owned by U.S. persons and to withhold on certain payments. Accordingly, the entity through
which shares are held will affect the determination of whether such withholding is required. Similarly, dividends in respect of shares
held by an investor that is a non-financial non-U.S. entity that does not qualify under certain exemptions will be subject to withholding
at a rate of 30%, unless such entity either (i) certifies to the applicable withholding agent that such entity does not have any &#8220;substantial
United States owners&#8221; or (ii) provides certain information regarding the entity&#8217;s &#8220;substantial United States owners,&#8221;
which the applicable withholding agent will in turn provide to the Secretary of the Treasury. The Fund will not pay any additional amounts
to Shareholders in respect of any amounts withheld. An intergovernmental agreement between the United States and an applicable foreign
country, or future Treasury regulations or other guidance, may modify these requirements. Shareholders are encouraged to consult their
tax advisors regarding the possible implications of the legislation on their investment in our shares.</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">GENERAL INFORMATION</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Proxy Voting Policy and Procedures and Proxy Voting Record</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Adviser will be responsible for voting proxies
on securities held in the Fund&#8217;s portfolio. The Adviser&#8217;s Proxy Voting Policy and Procedures are included as Appendix&#160;B
to this Statement of Additional Information.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Information on how the Fund voted proxies relating
to portfolio securities during the most recent twelve-month period ended October&#160;31 will be available without charge, upon request,
by calling (800) 345-7999 or by visiting the Fund&#8217;s website at www.guggenheiminvestments.com/cef/fund/avk. This information is also
available on the SEC&#8217;s website at www.sec.gov.</p>


<!-- Field: Page; Sequence: 113; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Principal Shareholders</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">As of the date of this SAI, to the knowledge of the
Fund, no person beneficially owned more than 5% of the voting securities of any class of equity securities of the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Independent Registered Public Accounting Firm</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">PricewaterhouseCoopers LLP, 300 Madison Avenue, New
York, New York 10017, is the independent registered public accounting firm of the Fund. The independent registered public accounting firm
is expected to render an opinion annually on the financial statements and financial highlights of the Fund.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s audited financial statements
and financial highlights appearing in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Annual
Report</a> to shareholders for the fiscal year ended October&#160;31, 2023, including accompanying notes thereto and the report of PricewaterhouseCoopers
LLP thereon, have been incorporated by reference in this SAI in reliance upon the report of such firm given upon their authority as experts
in accounting and auditing.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Codes of Ethics</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund and the Adviser each have adopted its own
code of ethics. The codes of ethics sets forth restrictions on the trading activities of Trustees/directors, officers and employees of
the Fund, the Adviser and their affiliates, as applicable. The codes of ethics of the Fund and the Adviser are on file with the SEC and
can be reviewed and copied at the SEC&#8217;s Public Reference Room in Washington, D.C. Information on the operation of the Public Reference
Room may be obtained by calling the SEC at (202) 551-8090. The codes of ethics are also available on the EDGAR Database on the SEC&#8217;s
Internet site at www.sec.gov, and copies of the code of ethics may be obtained, after paying a duplicating fee, by electronic request
at the following email address: publicinfo@sec.gov, or by writing the SEC&#8217;s Public Reference Section, Washington, D.C. 20549-0102.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Where You Can Find More Information</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund is subject to the informational requirements
of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and the 1940 Act and in accordance therewith files, or will file,
reports and other information with the SEC. Reports, proxy statements and other information filed by the Fund with the SEC pursuant to
the informational requirements of the Exchange&#160;Act and the 1940 Act can be inspected and copied at the public reference facilities
maintained by the SEC, 100&#160;F&#160;Street, N.E., Washington,&#160;D.C. 20549. The SEC maintains a web site at www.sec.gov containing
reports, proxy and information statements and other information regarding registrants, including the Fund, that file electronically with
the SEC.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">This Statement of Additional Information constitutes
part of a Registration Statement filed by the Fund with the SEC under the Securities Act, and the 1940 Act. This Statement of Additional
Information omits certain of the information contained in the Registration Statement, and reference is hereby made to the Registration
Statement and related exhibits for further information with respect to the Fund and the Securities offered hereby. Any statements contained
herein concerning the provisions of any document are not necessarily complete, and, in each instance, reference is made to the copy of
such document filed as an exhibit to the Registration Statement or otherwise filed with the SEC. Each such statement is qualified in its
entirety by such reference. The complete Registration Statement may be obtained from the SEC upon payment of the fee prescribed by its
rules and regulations or free of charge through the SEC&#8217;s website (www.sec.gov).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><span style="background-color: white">The Fund will
provide without charge to each person, including any beneficial owner, to whom this SAI is delivered, upon written or oral request, a
copy of any and all of the information that has been incorporated by reference in this SAI, the Prospectus or any accompanying Prospectus
Supplement. You may request such information </span>by calling (800) 345-7999 or by writing to Guggenheim Funds Distributors, LLC at 227
West Monroe Street, 7<sup>th</sup> Floor, Chicago, Illinois 60606, or you may obtain a copy (and other information regarding the Fund)
from the SEC&#8217;s website (www.sec.gov). Free copies of the Fund&#8217;s Prospectus, SAI and any incorporated information will also
be available from the Fund&#8217;s website www.guggenheiminvestments.com/cef/fund/avk. <span style="background-color: white">Information
contained</span></p>


<!-- Field: Page; Sequence: 114; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0">on the Fund&#8217;s website is not incorporated by reference into this
SAI, the Prospectus or any Prospectus Supplement and should not be considered to be part of this SAI, the Prospectus or any Prospectus
Supplement.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in"><b>Incorporation by Reference</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">This Statement of Additional Information
is part of a registration statement that the Fund has filed with the SEC. The Fund is permitted to &#8220;incorporate by reference&#8221;
the information that it files with the SEC, which means that the Fund can disclose important information to you by referring you to those
documents. The information incorporated by reference is an important part of this Prospectus, and later information that the Fund files
with the SEC will automatically update and supersede this information. </span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0"><span style="background-color: white">The documents listed below, and
any reports and other documents subsequently filed with the SEC pursuant to Rule&#160;30(b)(2) under the 1940 Act and Sections&#160;13(a),
13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offering, are incorporated by reference into this Prospectus and
deemed to be part of this Prospectus from the date of the filing of such reports and documents:</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the Fund&#8217;s
                                            Statement of Additional Information, dated September 12, 2024, filed with this Prospectus (&#8220;SAI&#8221;);</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            Fund&#8217;s Annual Report on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Form&#160;N-CSR</a>
                                            for the fiscal year ended October&#160;31, 2023, filed with the SEC on December&#160;29,
                                            2023 (&#8220;Annual Report&#8221;);</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            Fund&#8217;s Semi-Annual Report on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126824000124/gug87515avk-ncsr.htm">Form
                                            N-CSRS</a> for the period ended April 30, 2024, filed with the SEC on July 3, 2024 (&#8220;Semi-Annual
                                            Report&#8221;);</span><span style="background-color: white"> </span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            financial highlights contained within the Fund&#8217;s Annual Report on <a href="https://www.sec.gov/Archives/edgar/data/1219120/000089180419000003/gug75351-ncsr.htm">Form
                                            N-CSR</a> for the fiscal year ended October 31, 2018, filed with the SEC on January 4, 2019;</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            Fund&#8217;s definitive proxy statement on <a href="https://www.sec.gov/Archives/edgar/data/1219120/000182126824000183/gug87836avk.htm">Schedule&#160;14A</a> for its 2024 annual meeting
                                            of shareholders, filed with the SEC on August&#160;2, 2024 (&#8220;Proxy Statement&#8221;);
                                            and</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><span style="background-color: white">the
                                            Fund&#8217;s description of common shares contained in its Registration Statement on <a href="https://www.sec.gov/Archives/edgar/data/1219120/000095017203001191/s426975.txt">Form&#160;8-A</a>
                                            (File No.&#160;001-31663) filed with the SEC on April&#160;10, 2003.</span></td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in"><span style="background-color: white">To obtain
copies of these filings, see &#8220;General Information&#8212;Where You Can Find More Information.&#8221;</span></p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">FINANCIAL STATEMENTS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s audited financial statements and
financial highlights appearing in the Fund&#8217;s Annual Report to shareholders for the year ended October&#160;31, 2023, including accompanying
notes thereto and the report of PricewaterhouseCoopers LLP thereon, as contained in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126823000222/gugg86657.htm">Form&#160;N-CSR</a> filed with the SEC
on December&#160;29, 2023, are incorporated by reference in this Statement of Additional Information.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">The Fund&#8217;s unaudited financial statements and
financial highlights appearing in the Fund&#8217;s Semi-Annual Report to shareholders for the period ended April 30, 2024, including accompanying
notes thereto, as contained in the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1219120/000182126824000124/gug87515avk-ncsr.htm">Form&#160;N-CSRS</a> filed with the SEC on July 3, are incorporated by reference in this Statement
of Additional Information.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0in">Shareholder reports are available upon request and
without charge by calling (800) 345-7999 or by writing to Guggenheim Funds Distributors, LLC at 227 West Monroe Street, 7<sup>th</sup>
Floor, Chicago, Illinois 60606.</p>


<!-- Field: Page; Sequence: 115; Value: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">Appendix&#160;A</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">DESCRIPTION OF SECURITIES RATINGS</p>

<p style="font: 9pt/10.8pt Times New Roman, Times, Serif; margin: 11.85pt 0 0"><b><span style="text-decoration: underline">Moody&#8217;s Investors Service Inc.</span></b></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.9pt 0.05in 0 0">A brief description of the applicable Moody&#8217;s
Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) rating symbols and their meanings (as published by Moody&#8217;s) follows:</p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 11.85pt 0 0"><b>Global Rating Scales</b></p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 12.35pt 0 0">Ratings assigned on Moody&#8217;s global long-term and
short-term rating scales are forward-looking opinions of the relative credit risks of financial obligations issued by non-financial corporates,
financial institutions, structured finance vehicles, project finance vehicles, and public sector entities. Long-term ratings are assigned
to issuers or obligations with an original maturity of one year or more and reflect both on the likelihood of a default on contractually
promised payments and the expected financial loss suffered in the event of default. Short-term ratings are assigned to obligations with
an original maturity of thirteen months or less and reflect both on the likelihood of a default on contractually promised payments.</p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 0.4pt 0 0; text-indent: 0.5in"><span style="letter-spacing: 0.05pt">&#160;</span></p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 0.4pt 0 0"><span style="letter-spacing: 0.05pt">Moody&#8217;s differentiates
structured finance ratings from fundamental ratings (<i>i.e.</i>, ratings on nonfinancial corporate, financial institution, and public
sector entities) on the global long-term scale by adding (sf) to all structured finance ratings. The addition of (sf) to structured finance
ratings should eliminate any presumption that such ratings and fundamental ratings at the same letter grade level will behave the same.
The (sf) indicator for structured finance security ratings indicates that otherwise similarly rated structured finance and fundamental
securities may have different risk characteristics. Through its current methodologies, however, Moody&#8217;s aspire to achieve broad
expected equivalence in structured finance and fundamental rating performance when measured over a long period of time.</span></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.85pt 0 0"><b>Global Long-Term Rating Scale</b></p>



<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.15pt 0 0">Aaa&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Obligations rated Aaa are judged to be of the highest quality, subject to the lowest level of credit risk.</p>

<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.15pt 0 0">Aa&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Obligations rated Aa are judged to be of high quality
and are subject to very low credit risk.</p>

<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.1pt 0 0">A&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Obligations
rated A are judged to be upper-medium grade and are subject to low credit risk.</p>

<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.1pt 0 0">Baa&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Obligations rated Baa are judged to be medium-grade
and subject to moderate credit risk and as such may possess certain speculative characteristics.</p>



<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.1pt 0 0">Ba&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Obligations rated Ba are judged to be speculative
and are subject to substantial credit risk.</p>

<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.15pt 0 0">B&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Obligations
rated B are considered speculative and are subject to high credit risk.</p>

<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.1pt 0 0"><span style="letter-spacing: -0.05pt">Caa&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Obligations
rated Caa are judged to be of poor standing and are subject to very high credit risk.</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 0.5in">Ca</td><td style="padding-right: 0.15in">Obligations rated Ca are highly speculative and are likely in, or very near, default, with some prospect
of recovery of principal and interest.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 11.8pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">C</td><td style="padding-right: 0.25in">Obligations rated C are the lowest-rated class of bonds and are typically in default, with little prospect
for recovery of principal or interest.</td></tr></table>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.2pt 0 0">Note: Moody&#8217;s appends numerical modifiers 1, 2, and
3 to each generic rating classification from Aa through Caa. The modifier 1 indicates that the obligation ranks in the higher end of its
generic rating category; the modifier 2 indicates a mid-range ranking; and the modifier 3 indicates a ranking in the lower end of that
generic rating</p>


<!-- Field: Page; Sequence: 116; Section: Appendix A; Options: NewSection -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.2pt 0 0">category. Additionally, a &#8220;(hyb)&#8221; indicator
is appended to all ratings of hybrid securities issued by banks, insurers, finance companies, and securities firms.*</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.2pt 0 0">* <i>By their terms, hybrid securities allow for the omission
of scheduled dividends, interest, or principal payments, which can potentially result in impairment if such an omission occurs. Hybrid
securities may also be subject to contractually allowable write-downs of principal that could result in impairment. Together with the
hybrid indicator, the long-term obligation rating assigned to a hybrid security is an expression of the relative credit risk associated
with that security.</i></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.85pt 0 0"><b>Medium-Term Note Program Ratings</b></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.95pt 0.25in 0 0">Moody&#8217;s assigns provisional ratings to medium-term
note (MTN) programs and definitive ratings to the individual debt securities issued from them (referred to as drawdowns or notes).</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.1pt 0 0; text-align: justify">MTN program ratings are intended to
reflect the ratings likely to be assigned to drawdowns issued from the program with the specified priority of claim (<i>e.g.</i>, senior
or subordinated). To capture the contingent nature of a program rating, Moody&#8217;s assigns provisional ratings to MTN programs. A provisional
rating is denoted by a (P) in front of the rating and is defined elsewhere in this document.</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.1pt 0 0"><span style="letter-spacing: -0.05pt">The rating assigned
to a drawdown from a rated MTN or bank/deposit note program is definitive in nature, and may differ from the program rating if the drawdown
is exposed to additional credit risks besides the issuer&#8217;s </span>default, such as links to the defaults of other issuers, or has
other structural features that warrant a different rating. In some circumstances, no rating may be assigned to a drawdown.</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.05pt 0.3in 0 0">Moody&#8217;s encourages market participants to contact
Moody&#8217;s Ratings Desks or visit www.moodys.com directly if they have questions regarding ratings for specific notes issued under
a medium-term note program. Unrated notes issued under an MTN program may be assigned an NR (not rated) symbol.</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.95pt 0 0"><b>Global Short-Term Rating Scale</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">P-1&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ratings of Prime-1 reflect a superior ability to repay short-term obligations.</p>



<p style="font: 9pt/11.35pt Times New Roman, Times, Serif; margin: 12.15pt 0 0"><span style="letter-spacing: -0.05pt">P-2&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ratings of
Prime-2 reflect a strong ability to repay short-term obligations.</span></p>

<p style="font: 9pt/11.35pt Times New Roman, Times, Serif; margin: 12.15pt 0 0"><span style="letter-spacing: -0.05pt">P-3&#160;&#160;&#160;&#160;&#160;&#160;&#160;Ratings of
Prime-3 reflect an acceptable ability to repay short-term obligations.</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">NP&#160;&#160;&#160;&#160;&#160;&#160;&#160;Issuers (or supporting institutions)
rated Not Prime do not fall within any of the Prime rating categories.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12pt 0 0"><b><span style="text-decoration: underline">Standard &amp; Poor&#8217;s </span></b></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.2pt 0 0">A brief description of the applicable Standard &amp; Poor&#8217;s
rating symbols and their meanings (as published by S&amp;P Global Ratings) follows:</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.9pt 0 0"><b>Issue Credit Ratings Definitions</b></p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 12.4pt 0.1in 0 0"><span style="letter-spacing: -0.1pt">An S&amp;P Global
Ratings issue credit rating is a forward-looking opinion about the creditworthiness of an obligor with respect to a specific financial
obligation, a specific class of financial obligations, or a specific financial program (including ratings on medium-term note programs
and commercial paper programs). It takes into consideration the creditworthiness of guarantors, insurers, or other forms of credit enhancement
on the obligation and takes into account the currency in which the obligation is denominated. The opinion reflects S&amp;P Global Ratings&#8217;
view of the obligor&#8217;s capacity and willingness to meet its financial commitments as they come due, and this opinion may assess terms,
such as collateral security and subordination, which could affect ultimate payment in the event of default.</span></p>


<!-- Field: Page; Sequence: 117; Section: Appendix A -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 12.4pt 0.1in 0 0">Issue credit ratings can be either long-term or short-term.
Short-term issue credit ratings are generally assigned to those obligations considered short-term in the relevant market, typically with
an original maturity of no more than 365 days. Short-term issue credit ratings are also used to indicate the creditworthiness of an obligor
with respect to put features on long-term obligations. S&amp;P Global Ratings would typically assign a long-term issue credit rating to
an obligation with an original maturity of greater than 365 days. However, the ratings S&amp;P Global Ratings assigns to certain instruments
may diverge from these guidelines based on market practices. Medium-term notes are assigned long-term ratings.</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.85pt 0 0"><b>Long-Term Issue Credit Ratings</b></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.95pt 0.6in 0 0">Issue credit ratings are based, in varying degrees,
on S&amp;P Global Ratings&#8217; analysis of the following considerations:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.55pt Times New Roman, Times, Serif; width: 100%; margin-top: 11.95pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td style="padding-right: 0.05in">The likelihood of payment&#8212;the capacity and willingness of the obligor to meet its financial commitment
on an obligation in accordance with the terms of the obligation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/12.55pt Times New Roman, Times, Serif; width: 100%; margin-top: 10.95pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td>The nature of and provisions of the financial obligation, and the promise we impute; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Symbol">&#183;</span></td><td style="padding-right: 0.45in">The protection afforded by, and relative position of, the obligation in the event of a bankruptcy, reorganization,
or other arrangement under the laws of bankruptcy and other laws affecting creditors&#8217; rights.</td></tr></table>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 12.15pt 0 0">An issue rating is an assessment of default risk but may
incorporate an assessment of relative seniority or ultimate recovery in the event of default. Junior obligations are typically rated lower
than senior obligations, to reflect lower priority in bankruptcy, as noted above. (Such differentiation may apply when an entity has both
senior and subordinated obligations, secured and unsecured obligations, or operating company and holding company obligations.)</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">AAA</td><td style="padding-right: 0.1in">An obligation rated &#8216;AAA&#8217; has the highest rating assigned by S&amp;P Global Ratings. The
obligor&#8217;s capacity to meet its financial commitments on the obligation is extremely strong.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">AA</td><td style="padding-right: 0.2in">An obligation rated &#8216;AA&#8217; differs from the highest-rated obligations only to a small degree.
The obligor&#8217;s capacity to meet its financial commitments on the obligation is very strong.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.4pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">A</td><td style="padding-right: 0.2in">An obligation rated &#8216;A&#8217; is somewhat more susceptible to the adverse effects of changes in
circumstances and economic conditions than obligations in higher-rated categories. However, the obligor&#8217;s capacity to meet its financial
commitments on the obligation is still strong.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.4pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><span style="letter-spacing: -0.05pt">BBB</span></td><td style="padding-right: 0.2in"><span style="letter-spacing: -0.05pt">An obligation rated &#8216;BBB&#8217; exhibits adequate protection
parameters. However, adverse economic conditions or changing circumstances are more likely to lead to a weakened capacity of the obligor
to meet its</span> financial commitments on the obligation.</td></tr></table>

<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 12.15pt 0 0">BB, B, CCC, CC, and C</p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 12.05pt 0 0 0.5in">Obligations rated &#8216;BB&#8217;, &#8216;B&#8217;,
&#8216;CCC&#8217;, &#8216;CC&#8217;, and &#8216;C&#8217; are regarded as having significant speculative characteristics. &#8216;BB&#8217;
indicates the least degree of speculation and &#8216;C&#8217; the highest. While such obligations will likely have some quality and protective
characteristics, these may be outweighed by large uncertainties or major exposures to adverse conditions.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">BB</td><td>An obligation rated &#8216;BB&#8217; is less vulnerable to nonpayment than other speculative issues. However, it faces major ongoing
uncertainties or exposure to adverse business, financial, or economic conditions which could lead to the obligor&#8217;s inadequate capacity
to meet its financial commitments on the obligation.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">B</td><td style="padding-right: 0.1in">An obligation rated &#8216;B&#8217; is more vulnerable to nonpayment than obligations rated &#8216;BB&#8217;,
but the obligor currently has the capacity to meet its financial commitments on the obligation. Adverse business,</td></tr></table>


<!-- Field: Page; Sequence: 118; Section: Appendix A -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.05pt 0.1in 0 0.5in">financial, or economic conditions will likely
impair the obligor&#8217;s capacity or willingness to meet its financial commitments on the obligation.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.1pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">CCC</td><td style="padding-right: 0.15in">An obligation rated &#8216;CCC&#8217; is currently vulnerable to nonpayment, and is dependent upon favorable
business, financial, and economic conditions for the obligor to meet its financial commitments on the obligation. In the event of adverse
business, financial, or economic conditions, the obligor is not likely to have the capacity to meet its financial commitments on the obligation.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 11.8pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">CC</td><td style="padding-right: 0.15in">An obligation rated &#8216;CC&#8217; is currently highly vulnerable to nonpayment. The &#8216;CC&#8217;
rating is used when a default has not yet occurred but S&amp;P Global Ratings expects default to be a virtual certainty, regardless of
the anticipated time to default.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">C</td><td>An obligation rated &#8216;C&#8217; is currently highly vulnerable to nonpayment, and the obligation is expected to have lower relative
seniority or lower ultimate recovery compared to obligations that are rated higher.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.15pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">D</td><td>An obligation rated &#8216;D&#8217; is in default or in breach of an imputed promise. For non-hybrid capital instruments, the &#8216;D&#8217;
rating category is used when payments on an obligation are not made on the date due, unless S&amp;P Global Ratings believes that such
payments will be made within the next five business days in the absence of a stated grace period or within the earlier of the stated grace
period or 30 calendar days. The &#8216;D&#8217; rating also will be used upon the filing of a bankruptcy petition or the taking of similar
action and where default on an obligation is a virtual certainty, for example due to automatic stay provisions. A rating on an obligation
is lowered to &#8216;D&#8217; if it is subject to a distressed debt restructuring.</td></tr></table>

<p style="font: 9pt/11.4pt Times New Roman, Times, Serif; margin: 11.9pt 0 0">Plus (+) or minus (-)</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12pt 0.25in 0 0.5in">The ratings from &#8216;AA&#8217; to &#8216;CCC&#8217;
may be modified by the addition of a plus (+) or minus (-) sign to show relative standing within the major rating categories.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.05pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">NR</td><td style="padding-right: 0.25in">NR indicates that a rating has not been assigned or is no longer assigned.</td></tr></table>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 11.9pt 0 0"><b>Short-Term Issue Credit Ratings</b></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.45pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.2pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">A-1</td><td style="padding-right: 0.25in">A short-term obligation rated &#8216;A-1&#8217; is rated in the highest category by S&amp;P Global Ratings.
The obligor&#8217;s capacity to meet its financial commitments on the obligation is strong. Within this category, certain obligations
are designated with a plus sign (+). This indicates that the obligor&#8217;s capacity to meet its financial commitments on these obligations
is extremely strong.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.45pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.2pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">A-2</td><td style="padding-right: 0.25in">A short-term obligation rated &#8216;A-2&#8217; is somewhat more susceptible to the adverse effects
of changes in circumstances and economic conditions than obligations in higher rating categories. However, the obligor&#8217;s capacity
to meet its financial commitments on the obligation is satisfactory.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.1pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">A-3</td><td style="padding-right: 0.05in">A short-term obligation rated &#8216;A-3&#8217; exhibits adequate protection parameters. However, adverse
economic conditions or changing circumstances are more likely to lead to a weakened capacity of the obligor to meet its financial commitments
on the obligation.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 11.8pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><span style="letter-spacing: -0.05pt">B</span></td><td style="padding-right: 0.1in"><span style="letter-spacing: -0.05pt">A short-term obligation rated &#8216;B&#8217; is regarded as vulnerable
and has significant speculative characteristics. The obligor currently has the capacity to meet its financial commitments; however, it
faces major ongoing uncertainties which could lead to the obligor&#8217;s inadequate capacity to meet its financial commitments.</span></td></tr></table>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12pt 0 0">C&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A short-term obligation
rated &#8216;C&#8217; is currently vulnerable to nonpayment and is dependent upon favorable</p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 0.05pt 0.45in 0 0.5in">business, financial, and economic conditions
for the obligor to meet its financial commitment on the obligation.</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/11.5pt Times New Roman, Times, Serif; width: 100%; margin-top: 12.15pt; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">D</td><td style="padding-right: 0.1in">A short-term obligation rated &#8216;D&#8217; is in default or in breach of an imputed promise. For non-hybrid
capital instruments, the &#8216;D&#8217; rating category is used when payments on an obligation are not made on the date</td></tr></table>


<!-- Field: Page; Sequence: 119; Section: Appendix A -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.15pt 0.1in 0 0.5in">due, unless S&amp;P Global Ratings believes that
such payments will be made within any stated grace period. However, any stated grace period longer than five business days will be treated
as five business days. The &#8216;D&#8217; rating also will be used upon the filing of a bankruptcy petition or the taking of a similar
action and where default on an obligation is a virtual certainty, for example due to automatic stay provisions. A rating on an obligation
is lowered to &#8216;D&#8217; if it is subject to a distressed debt restructuring.</p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 11.65pt 0 0"><b>SPUR (Standard &amp; Poor&#8217;s Underlying Rating)</b></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.25pt 0.05in 0 0">A SPUR is an opinion about the stand-alone capacity
of an obligor to pay debt service on a credit-enhanced debt issue, without giving effect to the enhancement that applies to it. These
ratings are published only at the request of the debt issuer or obligor with the designation SPUR to distinguish them from the credit-enhanced
rating that applies to the debt issue. S&amp;P Global Ratings maintains surveillance of an issue with a published SPUR.</p>

<p style="font: 9pt/11.45pt Times New Roman, Times, Serif; margin: 11.9pt 0 0"><b>Dual Ratings</b></p>

<p style="font: 9pt/11.5pt Times New Roman, Times, Serif; margin: 12.1pt 0.05in 0 0">Dual ratings may be assigned to debt issues that
have a put option or demand feature. The first component of the rating addresses the likelihood of repayment of principal and interest
as due, and the second component of the rating addresses only the demand feature. The first component of the rating can relate to either
a short-term or long-term transaction and accordingly use either short-term or long-term rating symbols. The second component of the rating
relates to the put option and is assigned a short-term rating symbol (for example, &#8216;AAA/A-1+&#8217; or &#8216;A-1+/A-1&#8217;).
With U.S. municipal short-term demand debt, the U.S. municipal short-term note rating symbols are used for the first component of the
rating (for example, &#8216;SP-1+/A-1+&#8217;).<br/>
<br/>
</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0"><b><span style="text-decoration: underline">Fitch&#160;Ratings</span></b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 0"><b>Long-Term Credit Ratings </b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 0">Rated entities in a number of sectors, including financial and non-financial
corporations, sovereigns, insurance companies and certain sectors within public finance, are generally assigned Issuer Default Ratings
(&#8220;IDRs&#8221;). IDRs are also assigned to certain entities or enterprises in global infrastructure, project finance and public finance.
IDRs opine on an entity&#8217;s relative vulnerability to default (including by way of a distressed debt exchange) on financial obligations.
The threshold default risk addressed by the IDR is generally that of the financial obligations whose non-payment would best reflect the
uncured failure of that entity. As such, IDRs also address relative vulnerability to bankruptcy, administrative receivership or similar
concepts.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">In aggregate, IDRs provide an ordinal ranking of issuers based on
the agency&#8217;s view of their relative vulnerability to default, rather than a prediction of a specific percentage likelihood of default.</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding: 0.25pt; width: 5%">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom; width: 1%">&#160;</td>
    <td style="padding: 0.25pt; width: 94%">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">AAA:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Highest credit quality. &#8216;AAA&#8217; ratings denote the lowest expectation of default risk. They are assigned only in cases of exceptionally strong capacity for payment of financial commitments. This capacity is highly unlikely to be adversely affected by foreseeable events.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">AA:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Very high credit quality. &#8216;AA&#8217; ratings denote expectations of very low default risk. They indicate very strong capacity for payment of financial commitments. This capacity is not significantly vulnerable to foreseeable events.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">A:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">High credit quality. &#8216;A&#8217; ratings denote expectations of low default risk. The capacity for payment of financial commitments is considered strong. This capacity may, nevertheless, be more vulnerable to adverse business or economic conditions than is the case for higher ratings.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">BBB:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Good credit quality. &#8216;BBB&#8217; ratings indicate that expectations of default risk are currently low. The capacity for payment of financial commitments is considered adequate, but adverse business or economic conditions are more likely to impair this capacity.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">BB:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Speculative. &#8216;BB&#8217; ratings indicate an elevated vulnerability to default risk, particularly in the event of adverse changes in business or economic conditions over time; however, business or financial flexibility exists that supports the servicing of financial commitments.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  </table>

<!-- Field: Page; Sequence: 120; Section: Appendix A -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">B:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Highly speculative. &#8216;B&#8217; ratings indicate that material default risk is present, but a limited margin of safety remains. Financial commitments are currently being met; however, capacity for continued payment is vulnerable to deterioration in the business and economic environment.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">CCC:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Substantial credit risk. Default is a real possibility.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">CC:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Very high levels of credit risk. Default of some kind appears probable.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">C:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Near default. A default or default-like process has begun, or the issuer is in standstill, or for a closed funding vehicle, payment capacity is irrevocably impaired. Conditions that are indicative of a &#8216;C&#8217; category rating for an issuer include:</span></td></tr>
  </table>
<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 75pt; text-align: center"><span style="font-family: Symbol">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">the issuer has entered into a grace or cure period following non-payment of a material financial
obligation;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 75pt; text-align: center"><span style="font-family: Symbol">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">the issuer has entered into a temporary negotiated waiver or standstill agreement following
a payment default on a material financial obligation;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 75pt; text-align: center"><span style="font-family: Symbol">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">the formal announcement by the issuer or their agent of a distressed debt exchange;</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 75pt; text-align: center"><span style="font-family: Symbol">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">a closed financing vehicle where payment capacity is irrevocably impaired such that it is
not expected to pay interest and/or principal in full during the life of the transaction, but where no payment default is imminent</td>
</tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">RD: Restricted default. &#8216;RD&#8217; ratings indicate an issuer that
in Fitch Ratings&#8217; opinion has experienced:</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 75pt; text-align: center"><span style="font-family: Symbol">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">an uncured payment default or distressed debt exchange on a bond, loan or other material
financial obligation, but</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 75pt; text-align: center"><span style="font-family: Symbol">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">has not entered into bankruptcy filings, administration, receivership, liquidation or other
formal winding-up,</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 75pt; text-align: center"><span style="font-family: Symbol">&#183;</span></td><td style="width: 5pt"/><td style="text-align: justify">has not otherwise ceased operating. This would include:</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-family: Courier New, Courier, Monospace">o</span></td><td>the selective payment default on a specific class or currency of debt;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-family: Courier New, Courier, Monospace">o</span></td><td>the uncured expiry of any applicable grace period, cure period or default forbearance period following a payment default on a bank
loan, capital markets security or other material financial obligation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.25in"><span style="font-family: Courier New, Courier, Monospace">o</span></td><td>the extension of multiple waivers or forbearance periods upon a payment default on one or more material financial obligations, either
in series or in parallel; ordinary execution of a distressed debt exchange on one or more material financial obligations.<br/>
<br/>
</td></tr></table>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; width: 5%"><span style="font-size: 9pt">D:</span></td>
    <td style="padding: 0.25pt"><span style="font-size: 9pt">Default. &#8216;D&#8217; ratings indicate an issuer that in Fitch Ratings&#8217; opinion has entered into bankruptcy filings, administration, receivership, liquidation or other formal winding-up procedure or that has otherwise ceased business. </span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">Default ratings are not assigned prospectively to entities or their
obligations; within this context, non-payment on an instrument that contains a deferral feature or grace period will generally not be
considered a default until after the expiration of the deferral or grace period, unless a default is otherwise driven by bankruptcy or
other similar circumstance, or by a distressed debt exchange.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">In all cases, the assignment of a default rating reflects the agency&#8217;s
opinion as to the most appropriate rating category consistent with the rest of its universe of ratings and may differ from the definition
of default under the terms of an issuer&#8217;s financial obligations or local commercial practice.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">&#8220;Imminent&#8221; default, categorized under &#8216;C&#8217;,
typically refers to the occasion where a payment default has been intimated by the issuer and is all but inevitable. This may, for example,
be where an issuer has missed a scheduled payment but (as is typical) has a grace period during which it may cure the payment default.
Another alternative would be where an issuer has formally announced a distressed debt exchange, but the date of the exchange still lies
several days or weeks in the immediate future.</p>


<!-- Field: Page; Sequence: 121; Section: Appendix A -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">The modifiers &#8220;+&#8221; or &#8220;-&#8221; may be appended
to a rating to denote relative status within major rating categories. For example, the rating category &#8216;AA&#8217; has three notch-specific
rating levels (&#8216;AA+&#8217;; &#8216;AA&#8217;; &#8216;AA-&#8217;; each a rating level). Such suffixes are not added to &#8216;AAA&#8217;
ratings and ratings below the &#8216;CCC&#8217; category.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><b>Recovery Ratings </b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 0">Recovery Ratings are assigned to selected individual securities and
obligations, most frequently for individual obligations of corporate finance issuers with IDRs in speculative grade categories.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">Among the factors that affect recovery rates for securities are the
collateral, the seniority relative to other obligations in the capital structure (where appropriate), and the expected value of the company
or underlying collateral in distress.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">The Recovery Rating scale is based on the expected relative recovery
characteristics of an obligation upon the curing of a default, emergence from insolvency or following the liquidation or termination of
the obligor or its associated collateral.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 12pt 0 0">Recovery Ratings are an ordinal scale and do not attempt to precisely
predict a given level of recovery. As a guideline in developing the rating assessments, the agency employs broad theoretical recovery
bands in its ratings approach based on historical averages and analytical judgement, but actual recoveries for a given security may deviate
materially from historical averages.</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding: 0.25pt; width: 4%">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom; width: 1%">&#160;</td>
    <td style="padding: 0.25pt; width: 95%">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">RR1:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt"><i>Outstanding recovery prospects given default.</i> &#8216;RR1&#8217; rated securities have characteristics consistent with securities historically recovering 91%-100% of current principal and related interest.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">RR2:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt"><i>Superior recovery prospects given default.</i> &#8216;RR2&#8217; rated securities have characteristics consistent with securities historically recovering 71%-90% of current principal and related interest.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">RR3:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt"><i>Good recovery prospects given default.</i> &#8216;RR3&#8217; rated securities have characteristics consistent with securities historically recovering 51%-70% of current principal and related interest.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">RR4:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt"><i>Average recovery prospects given default.</i> &#8216;RR4&#8217; rated securities have characteristics consistent with securities historically recovering 31%-50% of current principal and related interest.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">RR5:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt"><i>Below average recovery prospects given default.</i> &#8216;RR5&#8217; rated securities have characteristics consistent with securities historically recovering 11%-30% of current principal and related interest.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">RR6:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt"><i>Poor recovery prospects given default.</i> &#8216;RR6&#8217; rated securities have characteristics consistent with securities historically recovering 0%-10% of current principal and related interest.</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0.25in 0 0"><b>Short-Term Ratings Assigned to Issuers and Obligations </b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0 0">A short-term issuer or obligation rating is based in all cases on
the short-term vulnerability to default of the rated entity and relates to the capacity to meet financial obligations in accordance with
the documentation governing the relevant obligation. Short-term deposit ratings may be adjusted for loss severity. Short-Term Ratings
are assigned to obligations whose initial maturity is viewed as &#8220;short term&#8221; based on market convention. Typically, this means
up to 13 months for corporate, sovereign, and structured obligations and up to 36 months for obligations in U.S. public finance markets.</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding: 0.25pt; width: 3%">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom; width: 1%">&#160;</td>
    <td style="padding: 0.25pt; width: 96%">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">F1:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Highest short-term credit quality. Indicates the strongest intrinsic capacity for timely payment of financial commitments; may have an added &#8220;+&#8221; to denote any exceptionally strong credit feature.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">F2:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Good short-term credit quality. Good intrinsic capacity for timely payment of financial commitments.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">F3:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Fair short-term credit quality. The intrinsic capacity for timely payment of financial commitments is adequate.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">B:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Speculative short-term credit quality. Minimal capacity for timely payment of financial commitments, plus heightened vulnerability to near term adverse changes in financial and economic conditions.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">C:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">High short-term default risk. Default is a real possibility.</span></td></tr>
  </table>

<!-- Field: Page; Sequence: 122; Section: Appendix A -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">RD:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Restricted default. Indicates an entity that has defaulted on one or more of its financial commitments, although it continues to meet other financial obligations. Typically applicable to entity ratings only.</span></td></tr>
  <tr>
    <td style="padding: 0.25pt">&#160;</td>
    <td colspan="2" style="padding: 0.25pt">&#160;</td></tr>
  <tr>
    <td style="padding: 0.25pt; vertical-align: top"><span style="font-size: 9pt">D:</span></td>
    <td style="padding: 0.25pt; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: bottom"><span style="font-size: 9pt">Default. Indicates a broad-based default event for an entity, or the default of a short-term obligation.</span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 123; Section: Appendix A -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">Appendix&#160;B</p>

<p style="font: bold 9pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">PROXY VOTING POLICIES<br/>
FOR THE ADVENT-ADVISED FUNDS</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: center"><b>ADVENT CAPITAL MANAGEMENT, LLC<br/>
PROXY VOTING POLICY AND PROCEDURES</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Voting Policy</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">It is the policy of Advent that in every case where Advent is presented
with the opportunity to exercise voting authority with respect to a Client&#8217;s Securities, Advent will vote all Securities held by
the Client in the best interest of the Client unless under the facts and circumstances the Chief Compliance Officer determines that voting
is not reasonably practicable (such as, but not limited to, where English-language translations of proxy materials are not available).</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">Advent believes the best interest of the Client means the Client&#8217;s
best economic interests over the long-term &#8211; that is, the interest of the Client in seeing the value of its investment increase
over time. Advent generally invests in a company only if Advent believes that the company&#8217;s management seeks to serve shareholders&#8217;
best interests. As a result, Advent believes that management decisions and recommendations with respect to solicited issues generally
are likely to be in the shareholders&#8217; and Clients&#8217; best interests.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">In the case of social issue proxy proposals, which often range from
divestment from geographical or industrial representation to environmental or other matters, it is the policy of Advent that the merit
of the social issues should not take precedence over financial ones. Advent will consider voting for issues that have redeeming social
merit that neither compromises the company&#8217;s competitive position within an industry, nor adversely impacts the goal of maximizing
shareholder value.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Duty to Vote Proxies
</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">Advent acknowledges that it is part of its fiduciary duty to its
Clients to vote Client proxies, except in cases in which the cost of doing so, in the opinion of Advent, would exceed the expected benefits
to the Client. This may be particularly true in the case of non-U.S. Securities. While the proxy voting process is well established in
the United States and other developed markets with a number of tools and services available to assist an investment manager, voting proxies
of non-US companies located in certain jurisdictions, particularly emerging markets, may involve a number of logistical problems that
may have a detrimental effect on Advent&#8217;s ability to vote such proxies. The logistical problems include, but are not limited to:
(1) proxy statements and ballots being written in a language other than English; (2) untimely and/or inadequate notice of shareholder
meetings; (3) restrictions on the ability of holders outside the issuer&#8217;s jurisdiction of organization to exercise votes; (4) requirements
to vote proxies in person; (5) the imposition of restrictions on the sale of the Securities for a period of time in proximity to the shareholder
meeting; and (6) requirements to provide local agents with power of attorney to facilitate Advent&#8217;s voting instructions. Accordingly,
Advent may conduct a cost-benefit analysis in determining whether to attempt to vote its Clients&#8217; shares at a non-US company&#8217;s
meeting, whereby if it is determined that the cost associated with the attempt to exercise its vote outweighs the benefit Advent believes
its Clients will derive by voting on the company&#8217;s proposal, Advent may decide not to attempt to vote at the meeting.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Voting Procedure</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">Advent does not take investment positions outside of the Clients
it manages and therefore does not anticipate a situation where there would be a conflict between maximizing long-term investment returns
for Clients and interests of Advent. If such a situation should arise involving a Public Security, the Compliance Committee will independently
review and evaluate the proxy proposal and the circumstances surrounding the conflict to determine the vote, which will be in the best
interest of the Client. The Compliance Committee may also determine whether the conflict of interest involving the Public Security will
be disclosed to the Clients (and/or Investors) and whether to obtain consent prior to voting.</p>


<!-- Field: Page; Sequence: 124; Section: Appendix B; Options: NewSection -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">The Investment Team will identify a staff member who is responsible
for voting proxies, and in the absence of that person, the General Counsel or another individual designated by the Chief Administrative
Officer will vote proxies. In deciding how to vote a proxy, these persons are permitted but not required to consult with appropriate members
of the Investment Team. They may also consult with the Chief Financial Officer and such other Persons as they deem advisable.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">Although the proxy voting process is well established in the United
States, voting the proxies of foreign companies may involve a number of logistical problems that have a detrimental effect on Advent&#8217;s
ability to vote such proxies. The logistical problems include language barriers, untimely or inadequate notice of shareholder meetings,
restrictions on a foreigner&#8217;s ability to exercise votes, and requirements to vote in person. Such proxies are voted on a best-efforts
basis given the above logistical problems.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">Disclosure to Clients</span></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">Advent will disclose the Proxy Voting Procedures to its Clients.
Advent&#8217;s disclosure will consist of a &#8220;concise summary&#8221; of its proxy voting policies and procedures. This disclosure
will also tell Clients how to get a complete copy of Advent&#8217;s Proxy Voting Procedures. The proxy voting disclosure will be provided
to existing Clients. Advent will provide any Client, upon written request, with a tabulation of how such Client&#8217;s proxies were voted
by Advent.</p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 10pt 0 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 10pt; margin-bottom: 0">B-2</p>

<p style="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 10pt; margin-bottom: 0">&#160;</p>

<p style="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 10pt; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 125 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 10pt; margin-bottom: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 10pt; margin-bottom: 0">&#160;</p>

<p style="font: 16pt Times New Roman, Times, Serif; margin: 12pt 0 6pt; text-align: center"><b>Advent Convertible and Income Fund</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>11,533,627</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Common Shares</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Issuable Upon Exercise of </b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Transferrable Rights to Subscribe for Common Shares</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">_____________</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PROSPECTUS<br/>
SUPPLEMENT</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5in; text-align: center">_____________</p>
<p style="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 10pt; margin-bottom: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 9pt Times New Roman, Times, Serif; text-align: center; margin-top: 10pt; margin-bottom: 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjVsKwkAMRVfQPYT5LvbhA+2npYpYpRQRfwebymA7KZnxtSR36dgihkAI9557hfDFmlaqQYbTsszhgG3XSItQYo2M+ozOkW62Cbhb4kUZy1Lb/v2BKTkGHTMdxRPphN56VwarBMJFEM2DeALhLBkvoNgJ76unpGtVobZKNiB1BQVTxwqt5NeQcJBP0tS++qojslGkE4hG4SC/IQ6jGPZ0lw/iq4E8T4Xn9+OJNdOtc67saVF/ScgabF2dGej/eh8ROUqe -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>avk-20240918.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aMpw7xRiXgOn8uPaXpMSaCJKbOdwJd1iekxtGh8bSnKLysi7Rzopi00mv82IeUP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:AVK="http://guggenheiminvestments.com/20240918" elementFormDefault="qualified" targetNamespace="http://guggenheiminvestments.com/20240918">
    <annotation>
      <appinfo>
        <link:linkbaseRef xlink:type="simple" xlink:href="avk-20240918_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="avk-20240918_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="avk-20240918_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/cef/2024" schemaLocation="https://xbrl.sec.gov/cef/2024/cef-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/cef-pre/2024" schemaLocation="https://xbrl.sec.gov/cef/2024/cef-2024_pre.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>avk-20240918_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#SecurityOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/AddressTypeOnly" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#AddressTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#RiskOnly" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/AddressTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>avk-20240918_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>avk-20240918_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2Cover" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#N2Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#N2" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" xlink:title="995470 - Disclosure - N-2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#cef_ProspectusLineItems" xlink:label="loc_cefProspectusLineItems" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46518404645264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>N-2<br></strong></div></th>
<th class="th" colspan="2">
<div>Sep. 19, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001219120<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">424B2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Advent Convertible and Income Fund<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FeeTableAbstract', window );"><strong>Fee Table [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ShareholderTransactionExpensesTableTextBlock', window );">Shareholder Transaction Expenses [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_883_ecef--ShareholderTransactionExpensesTableTextBlock_zIEQaJaJBUEf" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - ShareholderExpenses">
<tr style="vertical-align: top">
    <td style="padding-right: 0.05in; padding-left: 5.4pt; width: 67%"><b>Shareholder Transaction Expenses</b></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 33%">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.05in; padding-left: 5.4pt">	Sales load (as a percentage of offering price)</td>
    <td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right">		<span id="xdx_903_ecef--SalesLoadPercent_c20240919__20240919_fKDEp_zBIEIjSLkX45">3.75%</span><sup>(1)</sup></td></tr>
<tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.05in; padding-left: 5.4pt">	Offering expenses borne by the Fund (<span id="xdx_901_ecef--BasisOfTransactionFeesNoteTextBlock_c20240919__20240919_zQfoEx0thtv5">as a percentage of offering price</span>)		</td>
    <td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"><span id="xdx_90B_ecef--OtherTransactionExpensesPercent_c20240919__20240919_fKDIp_zEewHJNBUBza">0.47%</span><sup>(2)</sup></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.05in; padding-left: 5.4pt">	Dividend Reinvestment Plan fees 		</td>
    <td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"><span id="xdx_902_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20240919__20240919_fKDMp_zVhJLu1xDkF">None</span><sup>(3)</sup></td></tr>
</table><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SalesLoadPercent', window );">Sales Load [Percent]</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_DividendReinvestmentAndCashPurchaseFees', window );">Dividend Reinvestment and Cash Purchase Fees</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesAbstract', window );"><strong>Other Transaction Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesPercent', window );">Other Transaction Expenses [Percent]</a></td>
<td class="nump">0.47%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_AnnualExpensesTableTextBlock', window );">Annual Expenses [Table Text Block]</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_ecef--AnnualExpensesTableTextBlock_zLc5FAh9pwJ6" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Expenses">
  <tr style="vertical-align: top">
    <td style="width: 67%; padding-right: 0.05in; padding-left: 5.4pt"><span style="font-size: 9pt"><b><br/>
Annual Expenses</b></span></td>
    <td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><b>Percentage of Net Assets <span style="text-decoration: underline"></span></b></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><b><span style="text-decoration: underline">Attributable to Common Shares</span></b></p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.05in; padding-left: 5.4pt"><span style="font-size: 9pt">Management fees<sup>(4)</sup></span></td>
    <td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"><span id="xdx_903_ecef--ManagementFeesPercent_c20240919__20240919_fKDQp_zhPleqhQFJN">0.95%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.05in; padding-left: 5.4pt"><span style="font-size: 9pt">Interest expense<sup>(5)</sup></span></td>
    <td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt"><span id="xdx_909_ecef--InterestExpensesOnBorrowingsPercent_c20240919__20240919_fKDUp_zTYx6gjEefm3">4.13%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: 0.05in; padding-left: 5.4pt"><span style="font-size: 9pt">Other expenses<sup>(6)</sup></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt"><span id="xdx_904_ecef--OtherAnnualExpensesPercent_c20240919__20240919_fKDYp_zUC3QYWAQ39c">0.78%</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 0.05in; padding-left: 5.4pt"><span style="font-size: 9pt">Total annual expenses </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"><span style="font-size: 9pt"><span id="xdx_90B_ecef--TotalAnnualExpensesPercent_c20240919__20240919_zwIUGFabTa8b">5.86%</span></span></td></tr>
  </table><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ManagementFeesPercent', window );">Management Fees [Percent]</a></td>
<td class="nump">0.95%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InterestExpensesOnBorrowingsPercent', window );">Interest Expenses on Borrowings [Percent]</a></td>
<td class="nump">4.13%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[5]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesPercent', window );">Other Annual Expenses [Percent]</a></td>
<td class="nump">0.78%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[6]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_TotalAnnualExpensesPercent', window );">Total Annual Expenses [Percent]</a></td>
<td class="nump">5.86%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleTableTextBlock', window );">Expense Example [Table Text Block]</a></td>
<td class="text"><div id="xdx_88B_ecef--ExpenseExampleTableTextBlock_dU_zTTUhF20tiq2">

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><b>Example</b></p>

<p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">As required by relevant SEC regulations, the
following Example illustrates the expenses that you would pay on a $1,000 investment in Common Shares, assuming (1) &#8220;Total annual
expenses&#8221; of 5.86% of net assets attributable to Common Shares, (2) the sales load of 3.75% and estimated offering expenses of 0.47%,
and (3) a 5% annual return*:</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 66%; padding-right: -5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="width: 9%; padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b><span style="text-decoration: underline">1 Year</span></b></span></td>
    <td style="width: 7%; padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b><span style="text-decoration: underline">3 Years</span></b></span></td>
    <td style="width: 9%; padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b><span style="text-decoration: underline">5 Years</span></b></span></td>
    <td style="width: 9%; padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><b><span style="text-decoration: underline">10 Years</span></b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="padding-right: -5.4pt; padding-left: 0.2in; text-indent: -0.2in"><span style="font-size: 9pt">Total Expenses Incurred</span></td>
    <td style="padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90E_ecef--ExpenseExampleYear01_c20240919__20240919_zxM7p4rOFDHb">$101</span></span></td>
    <td style="padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_907_ecef--ExpenseExampleYears1to3_c20240919__20240919_zQzS24PNnqBi">$216</span></span></td>
    <td style="padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_90C_ecef--ExpenseExampleYears1to5_c20240919__20240919_zA52UfuJ7c9l">$329</span></span></td>
    <td style="padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 9pt"><span id="xdx_909_ecef--ExpenseExampleYears1to10_c20240919__20240919_zTnhDx5sONRi">$604</span></span></td></tr>
  </table>
<p style="font: 9pt Times New Roman, Times, Serif; margin: 0">___________</p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><b>*</b></td><td><b>The Example should not be considered a representation of future expenses or returns. Actual expenses may be higher or lower than
those assumed</b>. <b>Moreover, the Fund&#8217;s actual rate of return may be higher or lower than the hypothetical 5% return shown in
the Example.</b> The Example assumes that all dividends and distributions are reinvested at NAV.</td></tr></table></div><span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3</a></td>
<td class="nump">216<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5</a></td>
<td class="nump">329<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10</a></td>
<td class="nump">$ 604<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PurposeOfFeeTableNoteTextBlock', window );">Purpose of Fee Table , Note [Text Block]</a></td>
<td class="text">The following table contains information about
the costs and expenses that Common Shareholders will bear directly or indirectly. The table is based on the capital structure of the Fund
as of	 April 30, 2024 (except as noted below) after giving effect to the Offer, assuming that the Offer is fully subscribed resulting
in the receipt of net proceeds from the Offer of approximately $126,155,600. If the Fund issues fewer Common Shares in the Offer and the
net proceeds to the Fund are less, all other things being equal, the total annual expenses shown would increase. The purpose of the table
and the example below is to help you understand the fees and expenses that you, as a holder of Common Shares, would bear directly or indirectly.<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BasisOfTransactionFeesNoteTextBlock', window );">Basis of Transaction Fees, Note [Text Block]</a></td>
<td class="text">as a percentage of offering price<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionFeesNoteTextBlock', window );">Other Transaction Fees, Note [Text Block]</a></td>
<td class="text">The fees and expenses of the Offer will be borne by the Fund and indirectly by all of its Common Shareholders, including those who
do not exercise their Rights, and will result in a reduction of the Fund&#8217;s NAV. Offering expenses borne by the Fund (including the
reimbursements described below) are estimated to be approximately $619,100 in the aggregate, or $0.01 per Common Share (assuming the Rights
are fully exercised). The Fund has agreed to pay the Dealer Manager up to $150,000 as a partial reimbursement for its expenses incurred
in connection with the Offer. Offering expenses will be borne by the Fund and indirectly by all of its Common Shareholders, including
those who do not exercise their Rights.<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherExpensesNoteTextBlock', window );">Other Expenses, Note [Text Block]</a></td>
<td class="text">&#8220;Other Expenses&#8221; are based on estimated amounts for the six months ended April 30, 2024.<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Dealer Manager will receive a fee for its financial structuring and soliciting services equal to 3.75% of the Subscription Price
per Share for each Share issued pursuant to the exercise of Rights, including the over-subscription privilege. The Dealer Manager will
reallow to broker-dealers in the selling group to be formed and managed by the Dealer Manager selling fees equal to 2.00% of the Subscription
Price per Share for each Share issued pursuant to the Offer as a result of their selling efforts. In addition, the Dealer Manager will
reallow to other broker-dealers that have executed and delivered a soliciting dealer agreement and have solicited the exercise of Rights
solicitation fees equal to 0.50% of the Subscription Price per Share for each Share issued pursuant to the exercise of Rights as a result
of their soliciting efforts, subject to a maximum fee based on the number of Common Shares held by each broker-dealer through The Depository
Trust Company (&#8220;DTC&#8221;) on the Record Date.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Common Shareholders will incur brokerage charges if they direct Computershare Trust Company, N.A., as Plan Agent for the Common Shareholders,
to sell their Common Shares held in a dividend reinvestment account.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span id="xdx_909_ecef--OtherTransactionFeesNoteTextBlock_c20240919__20240919_zj1ns6FgLET7">The fees and expenses of the Offer will be borne by the Fund and indirectly by all of its Common Shareholders, including those who
do not exercise their Rights, and will result in a reduction of the Fund&#8217;s NAV. Offering expenses borne by the Fund (including the
reimbursements described below) are estimated to be approximately $619,100 in the aggregate, or $0.01 per Common Share (assuming the Rights
are fully exercised). The Fund has agreed to pay the Dealer Manager up to $150,000 as a partial reimbursement for its expenses incurred
in connection with the Offer. Offering expenses will be borne by the Fund and indirectly by all of its Common Shareholders, including
those who do not exercise their Rights.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">The Fund pays the Adviser an annual management fee, payable monthly in arrears, in an amount equal to 0.54% of the Fund&#8217;s average
daily Managed Assets. Common Shareholders bear the portion of the investment advisory fee attributable to the assets purchased with the
proceeds of leverage, which means that Common Shareholders effectively bear the entire management fee. The contractual management fee
rate of 0.54% of the Fund&#8217;s Managed Assets represents an effective management fee rate of 0.95% of net assets attributable to Common
Shares, assuming leverage of 43.0% of the Fund&#8217;s Managed Assets (the Fund&#8217;s outstanding leverage as of April 30, 2024).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Includes interest payments on borrowed funds and interest expense on reverse repurchase agreements. Interest payments on borrowed
funds is based upon the Fund&#8217;s outstanding borrowings under the Credit Agreement as of April 30, 2024, in an amount equal to 21.5%
of the Fund&#8217;s Managed Assets, at an annual interest rate cost to the Fund of 5.97% (the weighted average interest rate paid by the
Fund during the six months ended April 30, 2024). Interest expenses on reverse repurchase agreements is based on the Fund&#8217;s outstanding
reverse repurchase agreements as of April 30, 2024, representing 21.5% of the Fund&#8217;s Managed Assets at an annual interest rate cost
to the Fund of 4.80% (the weighted average interest rate cost incurred by the Fund during the six months ended April 30, 2024). The actual
amount of interest expense incurred by the Fund will vary over time in accordance with the amount of borrowings and reverse repurchase
agreements and variations in market interest rates.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top"><span id="xdx_903_ecef--OtherExpensesNoteTextBlock_c20240919__20240919_zug6dTeFVxe6">&#8220;Other Expenses&#8221; are based on estimated amounts for the six months ended April 30, 2024.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BasisOfTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BasisOfTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendReinvestmentAndCashPurchaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendReinvestmentAndCashPurchaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYear01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYear01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FeeTableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FeeTableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InterestExpensesOnBorrowingsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InterestExpensesOnBorrowingsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherExpensesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherExpensesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PurposeOfFeeTableNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PurposeOfFeeTableNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SalesLoadPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SalesLoadPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ShareholderTransactionExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ShareholderTransactionExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_TotalAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_TotalAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( .N -%D'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #K@#19__2+>NX    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M2L0P$(=?17)O)^V*LJ';B^))07!!\1:2V=U@\X=DI-VW-XV[740?P&-F?OGF
M&YA.!:%\Q.?H T8RF*XF.[@D5-BP U$0 $D=T,I4YX3+S9V/5E)^QCT$J3[D
M'J'E_ 8LDM22),S *BQ$UG=:"151DH\GO%8+/GS&H<"T AS0HJ,$3=T Z^>)
MX3@-'5P ,XPPVO1=0+T02_5/;.D .R6G9);4.([UN"JYO$,#;T^/+V7=RKA$
MTBG,OY(1= RX8>?)KZN[^^T#ZUO>7E=\7;5\VW+!;T6S?I]=?_A=A*W79F?^
ML?%9L._@UUWT7U!+ P04    " #K@#19F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M .N -%GQ&C!PLPH  ,8F   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M[5IK;]LX%OV\^A6$)QTD X\MR:\D30(X3HLM=J<3-)E9+()B04NTQ:DDJB25
MQ/]^[R7UL!V%26=WL,!BBK9^2+SO>^XAK;,'(;^HA#%-'K,T5^>]1.OB=#A4
M4<(RJ@:B8#E<60F940T?Y7JH"LEH;!9EZ3#T_>DPHSSO79R9[Z[EQ9DH=<IS
M=BV)*K.,RLTE2\7#>2_HU5]\XNM$XQ?#B[."KMD-T[\4UQ(^#1LI,<]8KKC(
MB62K\]X\.%V$)[C W/$K9P]JZSU!5Y9"?,$/'^+SGH\6L91%&D50>+EG"Y:F
M* GL^%H)[34Z<>'V^UKZ>^,\.+.DBBU$^@\>Z^2\=]PC,5O1,M6?Q,-?6>70
M!.5%(E7F?_)0W>OW2%0J+;)J,5B0\=R^TL<J$*]9$%8+PKT%P>B9!:-JP<@X
M:BTS;EU132_.I'@@$N\&:?C&Q,:L!F]XCFF\T1*N<EBG+S[^&)X--0C"C\.H
M6G1I%X7/++IAQ8 $)WT2^N&8_')S10X/CG;%#,&.QIBP,28T<D?/R%V(>R;)
MW7RIM(3\?NZRS$H8=TO HC]5!8W8>0^J6C%YSWH7WW\73/VW#OM&C7TCE_2+
M=[GF>D,6+ ?[4O(AC]DC^1O;=-GIEN3[?A &)T'H.\P:-V:-G<+FT%8Q_-/D
M?4K77<:XUZ]HJIC#CDECQ\0IYTI$I3'C=E.P+C/<R\?A^#)TF#%MS)B^)DN?
MV)IC'8$]'VG6:8];SCR^1V<6(H>JU'R9,D+S&+(>B8R1]V4>.XR=-<;.G"7_
MGC%R2U&VN^QG?T#9'S<V'CL#<9-0R1*1QM"<MQ!012T$OWN$8:*8(G?6@UOV
MJ,EE*J(OG2[\9TJ\&YJ"JE30F!Q212@IF(P@03!LB%C!WQ63/%^30O*('9'1
M8#9Y0PZ#(^_G^@JK[5T*F3.RW!"=V$220_*B2.(/QC.0&!YY5_R>Q]!S4&,<
MBD-I4_77*<W)BH'\CP+$'XY<D'C2Q/[$'1;C]=_1Z[MK:UUG<*V4B9&"H_O^
MPA_XH]GD;'B_==O"K>PN^.PP.?#;F>*[@: S/M@\"ZH2<EW**('12Z#X5>?T
ML>*GV][L.?*"!7>ATY.MZ1@XV_-GJ)#GBM[9KY7<_V[#!NT@#9QST&FWJXPJ
ML7MUY(]G^^%WJ[\;.</?SMO /2;G>5["H/U&H'E!Z/5.DW\$JCQ7BFE%YEI+
MOBRUT:$%('^60>0,,BGO)YK#$E/)ILD/QT< "2>3-]Z'7#.X0]< 0PXG1V0\
M"$9O/)N'!G@.I[AF=OS&NQ4:'*/6O^;Z9' \?>.*7$L) O=,W[(6N^R%K(\[
MLWZRCQXOZ+P;.[/>THC 302:>#9YARQ<"@F" (U?\F72Y<LX&.W[XK;A;N+T
MI>4BP?05 /*DCMW8X>0EOQ<[6D82.,G$<R8[@S[K+*#9\7[0W9KOILZ@MWPE
M<',)VUS?YL%QEP>3XVGCP:XM[?P.W#.U4@]FT*Q FO<Z"'M)J!4V5["5_EIR
MR6*D,Q)VQ_=(>&_>+>##NDPI8K_J(]'Q5B)-30<UMO T+;$.-40'J5"#0SJA
MFFQ$"7OP,HU)03?8@I0<!'W8N9"MH<[S79CL Y%2989:@'N1[[\[#D/_[3;:
M>;46<RUXBR!L< _?Y(#&U*(Q=:%Q'WF8L5FUM!#66]:'3 ,,Y+#+9W%+XQKW
MX$9#YOH>W@E$#5PSRTS!2*9+F?]PZ@7DGXQ*,C(O ,[5:^#;-Q6&-_4%&X-2
M8B8. C\@!V$P)0>C\(0<3/TQ^5?[Q_N!W"9M0:C$Q#@7FBP9B2!=P)U0# 5+
M3(/#K#(C',Q>E6#;5J*$K,Q5 S*/],XPR2!K(#'A:^QGN!.R#V\@M[FG$P$U
M:5(%FGX2DN'6N]\08LQ-,'NK\)C%Q 0BB?JM,I=H(R+9% )>-8]@+42V6@:N
M/N10,IYN_1^XS@U:QAFZ^=Y>E_5MYOR@\P3A*;L,\,ZN/@];IA@Z&5VW!5 L
M6+JC3C.LO-F6&5 RSYBQ=8+B9EXN,R:=9H1/S("B?<:,EKB%+YR4.,P(_$X[
M1D^R GWSC!TM#0K=E 2V&@56.I1NN]/NPP9-(Q*[,?@%T=C#+:1:F(+NU93G
M"FK<GK":D\JE*+4I^4@H!#9$IQVDW88VNP56Y ' &7H,JC@&>(]TNL$^XWG]
M:6! Q*KERAQEQ@C21@\M.$(38'L9&<  _^O6]B@"X%_('':U*1GYU2G>(7N,
M6('HBU"$\P2/> $95T#&R!IV=(B@ *61QB2B-+.QW@)\XTMS :U:E2G8K<JE
MB@#+02C 69EJN-GCUE1PAG%06V%_(47$6 PKI<BV9,%E6L#%1X/I(/,@"*?]
M8#+I3WU_0#ZT[H%:54)@5PP1:6=HD$JG%8EIP+&XH[;RS B")01F"XXT2(4P
MK$@GAH$NF8G&5X!&BYFZD\Y;O+,SE.>19) DF[>BK4M=I]&K+(+U=C*8#& 8
MP:J$I869R& 9E(>N[S5;D:<5!7?V[9%&=:0"BO8&J#7+56$N9&[)?.@FTI=4
M<3-QMS>CN"5Y;1>ZQ;]X;.-RHF7QH?LH\.EV^EL\<,N^[<QB51BV5"LLZ#BW
MPC5MQO"2J=45X0 T';#2QSI,R]BV*U;@0R*\6!CZP1XACAR^ _%<$O.3#E8_
MZ# 6V.;%+D)J$I=1S4J>L(:/\U\'Y%7G;MOF,$\RGBU+J<S&59&8U;A1@Q%R
MGX;805M 4/9P81J<] /#48T6NEX#$89K?2SN ^#T 9;+3FSP/+&!,%;Y[>$%
MBU]U7.(CV[S&\@0K#V1;.Y AX]HK!G14$KO[EJ0L\.)!,/$-;[;%2J7FAF9N
M^0J31)J<-;'B%9M$H(2QDE<_>SUPG;25T17D/Z18O*98B*M8G)#1;D##UVQ
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MR$./2/O0E/V@16&>.UH*K45FWB:,0I3Q!KB^$L#KJ@^HH'ET[>+?4$L#!!0
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M8PT@WJ73R626>HO!+!>CUI;3ZX4$"D$*"G; 'N$<?_EN34X8,4>'\IV9_NW
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MOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ ZX T60=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #K
M@#19__2+>NX    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " #K@#19F5R<(Q &  "<)P  $P
M@ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( .N -%GQ&C!P
MLPH  ,8F   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " #K@#19O:-H8 (#  !K#P  #0
M@ 'V$@  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .N -%F7BKL<P    !,"
M   +              "  2,6  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( .N
M-%FV0E<F,@$  " "   /              "  0P7  !X;"]W;W)K8F]O:RYX
M;6Q02P$"% ,4    " #K@#19)!Z;HJT   #X 0  &@              @ %K
M&   >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #K@#19
M99!YDAD!  #/ P  $P              @ %0&0  6T-O;G1E;G1?5'EP97-=
:+GAM;%!+!08     "0 ) #X"  ":&@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="gug88033-424b2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>avk-20240918.xsd</File>
    <File>avk-20240918_def.xml</File>
    <File>avk-20240918_lab.xml</File>
    <File>avk-20240918_pre.xml</File>
    <File doctype="424B2" isUsgaap="true" original="gug88033-424b2.htm">gug88033-424b2.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="18">http://xbrl.sec.gov/cef/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "gug88033-424b2.htm": {
   "nsprefix": "AVK",
   "nsuri": "http://guggenheiminvestments.com/20240918",
   "dts": {
    "schema": {
     "local": [
      "avk-20240918.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/cef/2024/cef-2024.xsd",
      "https://xbrl.sec.gov/cef/2024/cef-2024_pre.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "avk-20240918_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "avk-20240918_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "avk-20240918_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "gug88033-424b2.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 194,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2024": 18,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-19",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gug88033-424b2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-19",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gug88033-424b2.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllCoregistrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AllCoregistrantsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Coregistrants [Member]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "cef_CoregistrantAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "CoregistrantAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Coregistrant [Axis]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r74"
     ]
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r74"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r71",
      "r72",
      "r73"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r71",
      "r72",
      "r73"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference"
       }
      }
     },
     "auth_ref": []
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001821268-24-000276-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001821268-24-000276-xbrl.zip
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M\B6^F+I:':8Z'5A?=NO)-VFN:Q=LZO<O4$L#!!0    ( .N -%D^<W[W+0(
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M"&\$4BY[JXJR:5 !7&8QN[RKJ73#+<)X6:1W[H/T[D.0_L'R>>8B*9/15V)
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MB3-M59=:*:A2ND.P 4VY!KERZD8<,40W4K\@OTP,,F$1!F,@NM-HC5BC4#.
MNH6#M-*UD@!.([:E@4$X&,QGQ7SBWGR,RB^)JR1T@ WK6/GJP+Y$7AGCO/@A
M><I.(;U,R8W6_>Q>*4DU@__SE[Q @#0<%R<49>]?8PF+-YG8H0.TLB0F)U*/
M4F!1A(%DF#8N]>98I+.8$C>BV16B#:!X']/-)4(/O*F/SR&5$ /?4^&EFL[X
ME'NU"($=+;U+X\O8%[BBU%RJJY?*\>5WT4P2;;+")9CCA7>.Z3-%768O/YH8
M 8!7)[M"%]_<TST'2IJ**TP\\]^XEQC.@D%K$S@'>:M!E>!8WJ26@9:!D2![
M"@2:.G<YY!RAS*K<T.UBI'QB!;$7+_0&B9MFLIR+W'P4!7Y$2&'DWF4Q<!33
MB;3;_)K1 Y$.& Z;L]3SC44[<VVDX>UEN^M4[<YA7;-DB8162([E6*S8[E2"
M"0:JV)"Y#2WTX\C%3-"\5ZW],KUJ?TFWFL03U'ZB6>IDV4Z(&K@=.(!R7"#E
M;Y:PY"?O,TD8,9MUUT$<PFS(#4!5=M$/B+!)3@<S,'*V,U.O<=4H44]&$NNK
MB1=FEKC WK!,"7DKF..I.8&$3_S9!)8IC=HVNJO8\HD .8Y%:N(1'E\&(WG%
MM"/*;[V41405GU^(&9ZQO3,0[).IN2!LSW@:$+S5!?0&@Q@UR,#W^G[ E];,
MR3,_U[8E. BB@J!V3J6_9@ H1WM6\ZT@;^2KZ)G &=[[2:H< ^=WDWX45'#]
M3,VLRBDE)8:Y:TFT/8I"K!3,2=%1[U:$+]>4*%E3N8!H]0'=5LJ<2I.IP5$F
MA@./4IHH<I-1@O:I\+3[ZR_*WP6X6F7;T2IP29:5F6L)DB>PO^]:[4:[DQE0
M,JA4IN4IF7%./H>Y&SW+9C'4WM&!W'2RZFKBS9%;:#::N]];N;YYP+H5@/6&
M0*52F<Q3ECFFP>P4P.R>72A #]D=Q?'E:.%5@(VDRB)'EF1(+M*<1^I1R-)G
M&)4$$Z=^4.I8=:)B9AN=0W^6@)228"#+'1X#;BDJLUH\^_MME2FIL*MJK#)D
M%FFISE*+/=#X@,[YE$D0]4$(4.(ZXS!J^OC&U<S#VB*",QA$.(QB2EB^XW2P
MOA=^HA&(NH(V/L/++X>.,)D@!+J3SK3(K\8="4 ?-, XZB5EGN<OW$.YO*-0
MZ0 '$5!F/JR:]>B90/^F<-]&7DS+Q)7QBJZ0+X9,<X"G#590AZ'BA ]8R?$_
MH[)++OA9HM76S+B)>Z>EW?B)<)3X#,1#J;&X,62>@,\)^?^N0JT^3]0]J:";
MR\1C=5ZHY/@7%!WA?UOE 7O5^7/=M^][[LD[]^#D^*)W?'&^FLC$+UB),?$7
MYNMT8]\+:N[/:/)#QRPL"V3*>M'1JW)RJN+*<5D[M'[YTE[K^R^N098=_\)X
M]FS>0B!PMI35KF2)% 7&\,IDA&S1F/U2'PL.P6ZUMAX79C+C2MV_?KY6T5R8
M*EQ<Y9*Q'!Q<XR_(\>$]/"C-YW%. ;=4)H\ORLI:!I\?%UL>!/7YV3>/ ^HN
M1<GGC=RX A/LSP?DU]\*CO]&-N3?HYE[  .\ \9$TW_ G)FC4%>L_S9A_S4P
M'0NG:<$<I?@S5:SY6<'8_U80O)2"2\HRP3(>SPGLY_76BT9N"5(T,I!%MB=]
MZ\\+QKO?"FYK)?K9T>CS^MZ+1N1+MI2I--)O%;1?&7^+N1?/"]"M^^:S/R\D
M+@LIH04\0U"WV]\*4I\&'H5Q'!H17,\,UIT7C=;OQ947N!^\-!7Q,Z/,[:UO
M!8NQA<Y4D)G2Y9KIZ*>D)9S.^H$_<+L#*G6%)O5W?CSY9@_B:Z"X97GZALQ-
M?YM1'V1&+4T'>UPGP=<A7"MR/73?GEQ>N!<_'YV[6:N2E5^EU3@G7K;B_]O/
MO;.>^_O)I7O0/7;?'1T?LAGQ!#X].GYW<O:A>W%T<OR<R-@W(W >'1^<G)V>
MG!&$W;>_NV>]=W :QP>];Q/<7P._C4Y'YY<?/G3/?G].L"TOS/0"45G"%CWR
M[RZ/#]W>?T][Q^>]U=/L!ZSQ91NV@#1WCP^.NN_=GX]^^OD]_'OQK*"[0I/+
MUS9N_=PC)'Y6T'W95/CRG()U@!@?]'J'SPMOOQEQ @CP+[T+MPOD]QA_GI_W
M+F@!OW;?7SY;:>Z%8_;1\:^]\PML6>B>O/TW"!I'O_9H 7@,IR?OCPZ.GA<7
M;*W.AOA,Z+2, SYWL[/X5B'^%6GW^]ZOO;/N3\]*-6E],PZULZ/S7YX5TKYP
M5\.'[C'@*I/E=RY0"IK]N4EU[6]&_],"!PL;SPK(+]NC<'AT?G%V]/82Y;;G
M12%*"XV_1.0]//KUZ+ '\MI9+Q,AV&/VOONLA.7VZB*@O@HN]\X/SHY.R=R)
MN1O=TZ.+[GN.Z;LXNSRXN#Q[7J3CFPDXRT'^_/*M_IO6<4;V)&"4W0OW0_=W
M]RWHB^?GE[UGQ2X[+SNJIWM\<52_Z/[2.P%)&FTAOQZ=(U&G11P=NP5]YB=\
M\/CH^"?W\.3@\MGI-9W5>;Z^=CAF[^RB"R>0.Q.X*(>]]]W?NF<]%W[4Z(0.
M>P?ON])E@Z+EV>4YVUS>_EZ'AY[7";ULV\K!^Y/SWF$=.3,Y%9XEC^A\,Y%#
M%]W_ NV_N.B=/2\D7IV<^54<D"!"$B4QY/CG!-[-;\;^?=X[^_7H -DEJ/['
M%_#U6??X_%WOC.VQ_-D!D.N3PR,X$Z39W<,/1\=X,-V+D[-G=2JKLPQ\E4C/
MWD_=]\^1F*P0KE\]>.2P=PJL$4U<9[V? (E[9ST.WCF]?/O^Z,#M'AR<7(+,
M"1?BW='9AV_T&+Z.+_[\ /#[]U[WS$7II"NCILYZIR=GJ$:=N.<_@]3X\\G[
MP[\OP*-%]AS]VCWX'83VH^.#H]/W/2VT/T<'_N;+MD(6ZFTH6)]?="^TG;U[
M>'B$\@W<C6?J;=XL%R97T KO2VJ'J##G590N67NS1%&<S9=9%.?ZKU<39[7]
M\-J5'23[Y;'6[OGE*9!4O-@K0,^JSB0F\+G99=:X3]V6-H&=^O8-H\&,DL"Q
M84!Z$U&I:5E'<N3'2<JM9[!T;V5)/E5D6Q5<EK4;"_F,/&HBL!Z;,:Q=DLJQ
M2OG1N-BWPO/#Q)U@(08N+XGE6'5!!ME7TJY1R76S= E7*H)--?&Y1#Z E+(
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M$MR7GYU@BF$.FA(['CMXX'GPO6H7^3@R" &WQE#$1;HX^(I-W'6KQ83IV*<
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MUSHE6I*:3U+RS'>'WQ2MQXH"3&"ZB$Z"4;'JJ!!(<FCY'?H-G!&ZRY+"/?W
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M!(TL0$>Y.]B=HO*'=7F');;_V*?[@T\<-5E <M1=RF40--P?7OGS#11#8H<
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MT![D1]"9+\ ^62&>%UK>I9+/SZBYT+0*2@4OR$X?6NSTO0J+H6#$8MH?6FD
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MICFC1L$T\#HGU,VHX3/LAB)7%19NL>>,^AK6!MS%I PH+\^S:]%%CG@2;-8
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M1MAFW:5DA!MVCW4KGF\R%*2TC.(8FDL*5R:AX]AX(QJ,:!0 4_"HK8R?:PA
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M1+;$[6A6:!YKM;(INOK;%E?)M%G*2GJ)@BM U'*44$4/"QP9]NBY';Z)\M-
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M$J9UWE(7SZ=HD$"S.3G5K:#!B=YK@?L-"_D@,#*[[HUTZ:)?#_#KE<P:]:G
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M:.'#\AS78K-AM[N.%#O59?,GJK[\%MH-YHOUT\X,9^#$RJSJ1@]:UX.4"0[
MF@KNVY+5B.]Z69QT"<F5H"<ULVA75L>P%'B,D6=Y]W;:NS_T!E"??YMF^5AY
M!3,E3!VL]C:.=-?C9PGKS=(FD$"J 1)W_WR;_#* Z ?302,3SQ67GYZD_6S,
MCCCR#G'27GJ,$$\"6J/# 43+BV280.^OA5@W-CS;5M(;0""B]+Z]E*7;:1^
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MC!K,0(JNE"6#;:X,4JJ+-)QVZZVML!.^#;>\>.Q!M0:LDFJRB)'QA.DZ&$/
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MTDW]L-(OO%1P@$60 19IT/4A&VP^,:[![8,1 G9>$0*>,4+ (B2+!(ZW(F@
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M/JDXC8<)>B3970II460#QFUQ#7XDM1>SG3;K+@='3JD(</+X]B,&,RVZZ"+
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M!24T$:O?H3[-ATV0!S%_FCJ#!/7\2EN5-X55I<>].1PW1!4EPVB'9VI[I($
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M[_^LFL8V2PT@=PK4.#=)TTFE6$/?Q?C$/DCX#6&I69";/)PJR"69>^Q]R8@
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MV]Y$"&<$:53?L&'2$ F-AF(CL6HJ"Y/XKU!9U ;("@P4/^ZP>L"5.O/87<L
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MMU56L>$<SCF**'/N1=0'71BXENP_LS?LTAZ^+"G+ID*>ZE2/$?KQ;H77[3U
MZMGJ-=FFJH)ZFAGH?SOJ'0T.WS:EQPZKZ;%C3H2%8?!^U9J@;OQ*9FQO:YFQ
M7U"AX;0I[ZPS9-'#1^%/06-44V2?O0N#XQ?UGL7#^BX<<(HBL'#ZA]R5<,?V
M'&]M<ZS2MK[.C/?G8;*7W_UT0M6MOWMC2N_'YH0!]W W]J%^_H[O-: ,'8'0
M>WW<K17<-(N^/2?ONX.M&/M8X'VO N*U=,.;G$JX6[P"?$[C2AUVC];SBK:Y
M2.\3ZM#CBCNR8>DZK+<<=*Z;%^/!,_%W'^! 6?2[O<>A++[[B:UWG!!8\&L5
MG("1W-!.O.%5D1*&HVYM99KKN+:D1__6.QS (87_/^#T67>UW;^O-OM!I[=_
MW)A*O_?%\AA$7[)PO>[@J=^F_N9O4W55OK';U'PH'N-MVCMJ+DSY^FKJ+W"Q
M>M_RQ3HX^H8OUGZG-WA64YN]3;O/M^D;O4U[G<'NLYIZJ(O5._Z&+U:_M_L-
M7ZQ!Y^#HX%E-;?0V'7W+MVFP_TW?IL%1[UE-/=3%.OR&+U9O_]M64X/]9S6U
MV=MT\"W?IL-O^S;U-W6;GM54_6+M/U^L;_9B#0[WGM741F_3WO-M^F9OT\%@
MO_$VN:;IS\&0!5*PH\-[8L@>;11#%JFQFV%D][L/7_'5UQ52]X&-[>_3R#<H
M%L*JLW7_)QB) :RF8#E3@Z(KWY'/WE8@&>>Y71OL:F7HU2'"KMX/E=HNZB2=
M+P%Y/,ZN! HTBV:3> C@W,3A:Y?@7EB*;;6G4AO5$P;=;8,I5JOI'@Y,<0N0
MBO7_FE8L1?O'+WD1-'5@#\(D)9BQR_PF\?W^43PI\^@Z'C7B:COBE0:0SO4H
M%3S.\?WA%0^>7B- []MI!.CUM]@)=O'OIW?V@*&N )KY=>K_"9^]1;>Z:2(0
M[#%J$CO1H^WT?YV,;H!RX$V>H9864O6S;)A/^=*F);&BV#N9CM-DU(F&D[Q,
M1CO0T:5@_A4<XY#X7'2[E(?Q[AWO[0*."'5'$0PPM(D55W%F1S8RR(;\-IG$
MM\C,-(_GBSGP.LR1*R;/HE^2RP*;(*F5='<@% B:T07^!??!:K0B1D'#"-3O
M_GE^"G^G]GSJ+I)'!#U77E?FXW$Z1!"(23XD4-AY='1T9)<5EN\Z.KE)NAUK
MO]OQ_3+)\Z*#6_#/O/CH_P;F4^^8NYA '2>39':=9TF4+;#1R3[^9;_7?V4M
M[OZ.O4^[=S=WWGFJB%3)<\MO^5C%LQ2@+CTY:2?Z]=<W49D4-]0<6&LGK!)Z
M(-<)'D*[J3, KM&M@.KX*3#O+VR*[<L=?'2 +S2PK0K#/\Y/S>^_K*> WW_X
M_<WIZ=OS#<O$;1_>"\:(T.)+)QJB^,I:&E< 5I1FZ3PE 4&$;,C6#F=1-9A9
M*Z9<Q)D#@"^XZ1);7$&\N0-,+#+8\OK>\<L9%,"SN+ 2\X\,85$!]JBXM9<C
M@L^@5";R*O^MZ-RQTBD#C#!L$*Z$+AK^"J!@-:U-G/D)!5,Q#=CLZ3RXM/GE
MOY@!!J[MS/K90^X#QIF.7$^O'VHW.IO#!4=\^&P^L6Y#9AU&*WGA\PX_UP'&
MFTO[< ;GY5F4BTNP)V$OX.N3B8B#M:?6!#N_:FK&30T^BI.RUJ< @\?C>>*8
MR.PV"+16N;#[*P/H1N\3,H&QJWF!'&K^;6-VV!H'W[&#LVMF:BN%<R_@P(1$
M2>XY"+E_*<Q)M"%_=,^[T3^@<R7#=ZL&;OLL 'F(KJP2M:9\>6T?NV,G-X6I
M)DM&R+<'PY[H!1K?0H9T'=\D AQ6V: :2)CW$-Q\2NM5%!GI;="]<VS<AE5:
M^K%75LCH[;W'AG:CDVAD#8ZE]$7K95V4>*'=:X8(I493D.D1M\!H,4SJ"#,:
MB+F*)\T-W%^HL+S?^]@4UC9U57O([+>3#_]Y>F%.WKV-WIU>1"?GY_:_?Y[\
M^L=I=/;NE]\__'9R<?;[NXVHJZ]A;%U43YP7I-K/KI&>=ARS:/@KO$&(<*#U
M5B"RE79Q#X'+AF:_?9E1'V6!TP$9 /<-'I?E<]:3:0GO&-I?<\Q 6>F;,.LW
M9D)3?]Y7W-20KQ*$*ZP 1.]RH(^=(T5M,DT74]P2_(&5/0A/T0BBUH0 S]#O
M%P"K$ WM7"X3D^4(XEB@''7J.!P/;C*.)QR)51]Z#-57>CWIE>*YG$+M9WJI
M;>B4@6X:%QCS@(.N7KWB?74GKS8B48\DS>V+[7$;I581V)=XH)0X,]J,J*_'
M:.' BH"]IZPI?]&2\CXB\"4R0* ']!%9&C3P >.:Z-<8';A]Z8$%A\F,M UL
M%KZ6Z(0!43,'[H!7^%<\1$!9-** &['WP25",[:LO4_4H[4/\FP$'CBI_ZXY
M ;"689'$R/1#IA=YM;5GQ#=Q.G& +C@O&(S]U6*"3 ZC_#:SKO\(H1%+@"+E
M*\YL/&1CPY>#!W?-N37 F.'E0UI^1&*77O^'W^AK;^5<P.^$\^4KP;75  7E
M.%3A30+TJ[6<, )$:8R 5L7?H(Y+46-#&+!EL?$,QU.D1+#?@N'^_;M]-XH:
M@V!#7OF@U]U;*XFXT1P7-G"_R0N*F\!X<![O[%7 WO?H3Q1X[Y.B%9W>S;=?
MFR]C9"-"UR.9V7O2.:^CEW+57T482WP/$C&;$QUH=;+KU2+42PZJA0(/>#?N
MV))[YKEW&S%1]@Z9_'G;!1!V*TE K\6LT./DZ+ 18&$;"S78JV.H;VF=%$W[
M>AAUH!>_VCHAM\176:=W?)A(S*VU5"@+6Y;J<R7$^KA%O3JMQ^"1U">%\$3_
MM8@+L-C76M,ZK-"7U.J(/A_4UZH1H&) 54N50]EMBT-\A7*>/J_OO]M7KKD^
M..&&Q=G\\NT^JI7:YZ7Z-;_=_DDBV[=^E&KW\2F=I#76IW_7^K#ET(#8]1<[
M*7OKK41_@!0?CP);[F&.Q)T+(36CW<,G<20>587_YZ)/'6]:YP/+P+U1"!ZD
M(+GQ</4;J8W6U5<;7JU59<I]ZU(]_'*LK:FW./->=__HX6<^H.##4S@(_2TL
M1\-BK*V;M[H8NP</N!@L-QL"4P\O.MNGO=<]V'NQ!=&XNTZGQL85QLY:_N"@
M>WSTHD%+?/UNH$>C>3%Y2:IW#3KY9]6[0LCT-ML;](14KT(!?5:]_6X(B_E-
MJUXH%'IXU=NO.W_;D)WK*J&CXR8E]$#RLK<>T>]76HR#[NY@LQKY+^T6$_72
MLV>\"4%TV/LFU?.Q]0.>M;/2SH-G[2R+L=L]VH)C_*BU\WYW;XO:N7?,+?^/
M5#VC+?_L,3\$?L9#,"4\?:5\_)#RYS$KY?[ALU)62OGP62DKI?R0ENI34,H'
MSTI9*^6];G__V6E^T%SRLW)^5LYJYKM;B!4\(>U\]*R=U:UXR,5X"MKYL-OO
M;3&@_9@3S$?=WN&SN_P ">9G?5R3/'9,6TBS/E)]O 5+Y,GHXT'W8 N5!D]'
M'S_D8CP%?3SH[AT\ZV,V378;E^)1><H-74)/*KO\(+JY_Y15<[^[O]EP;M-J
M/$;-O/%89=/$GY!BWG A7--J/!&]W.\J,N.-K\534,M[W>.'"6(WGHK''L/N
M=??WGCWE!TDL/PAI^-/VE:U$_$:+L7>[>\_%V/H@]+;0$/=$='*O>_B09^-Q
M]D&%Y=??;A*YU]W=<"_4<Q+Y61'?+7_WO]F@]>$6-,^34<3[5OP\*V)?A/Z0
MB_$4O.-!]Z"QIND;#%K;J]$8*'AVC;\PB?RLCVN2YZ![M(7"X\>HCZU;\@P0
MH@_"@_J"3TL?[VVEJ.N1.<:[W:-O'B!DO[NW^^P4/W3"^%D/UR3.\5;:4!^C
M'M[?"CS&4]'#_=WN8 NUYD]$#Q]T#S:;-'YZ?C$$S)[]8NX"ZZ]6SHY]_'-(
M=BA>'_4057>+/)6ER<?1R>(*F$7[ ^ ,ZN]UHL%>YV!WMW-TU*O2W  MCB)5
M(FZ626R_72"71S)BJA4D*>FT<^P0/9XC)C!"F-- DN._ _1&X5B1.A5"6 ?'
M'?QS<(!/MC\X?-%!SDRB.)LL%=_J,,ZR'(A4DE$ZG$>WUPD0"@(]FFFE]6&F
ME/%B#HPL <F/';/F^1D7^;0ZB4[$[#3 ]CPA,KME$TN0\/^8-OZ?:&W^GZ9Q
MA'Q0JRFA#Y\>)73_VZ&$[CO2NX>F0#U[]^?I^<5OI^\NS.\__\?IFXNS/T\C
M()-;CZSB]U_/WIR=KDV*NE),'C"]_?[V2,C2S)Z(:8Q\4D/[@=CJ(DWG?)T@
M#5LIS$MG_J;^+OR*G>B](P*UE_F](U;6-$U-7Z2/\W<[3-ID^$TGEU82>_XK
M(ADNZD][?YU:09+/KI?"^@1/7><AD7X*\#^6I2>.,H^".*K&&$7\3P%QU!?2
M2PX>*;?D]B0 ,,(#V3OO]/EZ-]_+C<U=_D$?:7JV*P+:"+KA#([MY<R1P&T(
MY-PE$M?ZSSC*.,^=-[<JC/CP',NL$ [:LYSET=4B+F*[A8IL<&Q'8(@J;Q'P
M^S8\#*P)X&Q5GU)CGB?#ZRRU>K%DOES[VE%2#HOTTEV>+[POL$^]'ANR6]JF
M'].?WN091L6L$6Y P+W+LQWU,\UU?#)!'GLKTG]\G?X$M-(@S3.0\Q-AV0.&
MOQ0^4@;\T;"0)1A:DP2LWJ/=%[CA]F<D.D?$NE-&+^/2C)(Q:HLZY_,KXJNV
MAD%2E$1@[4\34@;Z@:NMA7EE=E[ZUR#]ID@#/%K !0S.%<[,K#$S/%S,)NUF
M-VB=79JM&N(T%H[B:#$#\_AP]X5I?5#+A"K7@X:IG@R,QJ"[)NDTG9-^;AW5
M)D[TKDB>_@#/]$:/KWX27I51,LR)(OU[,C; !_XN..3^0//L@,:Y8?[+"!G4
M+^VV=^Q=O[17< 'LM]8% E;:>3[\"#(#2=6CTJ[F)"[\=U%*P+)?)O)P/-'H
M])CDT_ ZSF _Q\2Z73A9$D_1"U'\E^&;K'$.SW<O8EE56IN>&+Q'*1+Q9G,D
MR;7?8*9Q(H-/APL[3F.=PS0?X9?M$I,'Y$GAF8Z^@-%-[>=;5P@F&$_*'&8)
M3-Y#6"+KR^8T_Y0(VM4W23";?*9)QHG.6EP]&C5Z?HKZUQX':_/DQ9(?5]KO
M=Z.?T>]0/^JTW2\@+35VT8MX:+6N53CIL'2[AM3"F?ZFW>^ SSS-G%:Q2UY8
MTS4N[)$%\7&3@@L)TT_B*:DQO(A('7Z59$F!Y.5 AVYERA*\F%*3F-=V.MQ0
M&2,MB[W4;UH$2 '_S%+[%3M8JPD_:M9P?#(< B,VGUTL3Q(<SZPLF/@M!'&$
M4J[ !>ZH>4#@(9U825>6D5W'CS(5V(6&)ZOW=^Q1 =ES=8TVL+VN"='M$H<I
M$L[B$^V9$1[=43*S?CRNOUT$Z_A-K82% 2YFS.XZ2JZ*)/&/H9$TG-42^$&C
M^#*_23!DP53"<,?'Z2>\G%J +C<@_(Z1 NIA9)]86/;J3=+D1@P3G'[EF+<K
MQFG\$:GGIU$\LT?9WGOK# 1V&,JGK!Y(@?5,/EJ]:6(\VCY",\_A*!'%/82>
M0'MA*(444ED?GUWXR6*4$ UQ#J<BM4] IEX^F# Z*YQ87=$%H?VCVV)(U@.'
M>/7($[LPZ^PBF<04UJ)!XVVT/QTF]H<C"OU8X\+>:+NP>)/L*$%KSN(EK4=<
MT@* F*O<+R/?)&UN51&^>H2'&G?!_@CT$9QF#F_)@(3UN6T>GA@Z+<+CFL5P
M8:V$AH-,;,C&<4N+6(S&24S:ZSJ_M1M5=-C Y>F!#TCA-)[[S-,'YZ ZVO2C
MEPLH$% 6W.:+"1Q+O.5#I'8>"_^S'#R,B$(P43VX&[U=(#4V*2=<,;MT\)-@
MH'8O2;',\K+$$;F3WWAZS%6<9BNFP5K:3P ?!['&< ] \]IM0\U*$Z+CDV?M
M0B<M2;?B[3#XX&%LW8P2IF W%(12&'_<A,UUR%[$ XB=4SO'I5FUCGBRK?;
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M<B_2N]'PTJ;.'LIX!&^77_$0YOD5,?#!  PSX_ XN%#*ZIWT8X),Z%0QQ6,
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M *&5SI!]-)G.K&K&!9&B$^!+'F*&4A:_8RU_1&XM(;MOF(]C;+<MAN?%$Z3
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M@M'DBP(I(Y9J5&T5SG$63Y; 5;"QLOI'6=K\&#"7WIZ=7WPX^_F/B[/?WVV
M;*S7ZPZ^!I00"RS$#)O%RTHZB1$(H;RJF1;'?JO.LP!^<8%$&4W$0=7PIBN,
M4R-1C#V P@[OGN1 :PEH/0)^0'R%+2- P#E("E)G^&2I0$@!H-6%8H.A&61K
MR 780;%A4+2<*X=4+9-='8"TK"4LE\("PBM5Q=MH1HH1^ALC7X*9E]?6T:M/
MG:$MB <)9+2$W:^3T974,;DJ[8(1X%PNO$-HFO""X*DO':$DA"2!H((JE=KW
M@$15RTB!:N-51^K@["O35PU,/O=(E/6>7J+LX!M*E&V]%/Z9$FT]2K0G5K "
M3; /R3W4QM?32AUG'H@ZKA+UO9LZSJRBCOM0XZ5Z.-HM*0=>0;2T%=HM<R?M
M5K0UVBVS@G:KD4JJ1KNU ?(K<P_RJ^@SR*_6XR<TS?R$T;;Y"4TS/V&5<NP!
M^ F!GC#2_(0F@ Y6#(';YR<T 3]A].7\A)_#CF=67=,ZVG++->U4[NE:7X1;
MP(B/2[/N10V:$+MRR3:VJ>;N36V#H&:@L,JAQE=+S4U]4YK'2D7P]4]C*!W"
M**/P%'JJZ'4Z_W5ETD:"%%NW3.PY3PJ(M-TD6*BIS05J\?/.JS?=VEWH9KN
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M?PW\:.DZIOSI46%W#%J842.;!GDK/!E!V+H#G@P?U-7\\HI6%-D,&26)L&,
M\&83!.>IK\*>#L1[DYE36KM)8TU$P-H[\&O?(='=WWZY4*D'\W$-/_,]GZ.-
M784'KQB#NPT=<=ZC>'M(ZYG.4<S1FEH2 E==0 @&..:@V\XX3"&)6>V94>P;
MIDT^N1;ZS*($$I*F&!INE(3<+1CKS,9CP'M!7T0/ZT(:V:"K$R!N*SB&!3$*
M>;0^WLVBVK"##)YT[O?B56.J5*$)6KM>%_D-Z0(< 54:S/*RH=,Q9ATU*B9S
MI7&+6O6!<>25U=">Y%BM].AG*"8P6;CT\7=2^T3H@2/L'U[?P<)!7QVHQ1P
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MA'/T:%;9N<$O<^G*1S?]^7Q@[_T9R-O9V9EH@-?G%\<BIH-\F$US'QC 9$'
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M%-UU^!EGM#/814@;+X6,$)? 8WOL,#@Z3AH;NF1BUG XN5W3<\J %U);7TO
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M 8<^52D/D6UPMQB1#T!1EE_6;@6QL\[DM+A!/9'F6\8O??3P[N/LRM( 534
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MT'76VG_^<]1N?*.M7-;K)UYFT]S5G)"XIH&(@C"NI,Q$>F-%UM-R^U% OIV
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MULEUD6'A/E/N)SLW-S=[33[<NZRN=^&G5F&1).PE)Z3QD K97F;3)ID#'>>
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M'\EK!6499.7G>CYKAQ*5!T\3T*%TDUMYIL6AB B/'Q8TO\HF8XT"CW8#<N8
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M-JIZO7N/81]1 3E;,G/R"D=N"%Y&3H'P6,>0=;E=H57XF#MEMD=$V8*F0LH
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MJK0PX>&$"%:B3"/J#\--'NDU4:2X'\C&%5LTY\GF\CJL"JE'F2*^K="[XUX
MF ;<PE%&X>0U<R*Z-Z-A9"<0,17?&GR@"H+DT.EP,3 BVL>!3-S@28]X5=%C
M)X@?]?3[E]T;O->*KFO&54@\6WWG-#/"?80SZ2,<F4+P($TE*<6Y]A:$WTC3
M)8YJUDW$02?TC!R!8)<[ J_<\SWT%BZ00@U$6)Z/6FKH)W/"/(:,%W.*%\NU
M)]L'Z76&GP\NQ4=#EEGX?9G0WK#S]8K;?H;:A,^\&*\"A:&0^+QZ\_F5,O=X
MD_+3$EJM07SZR?:!20B'AQZ),W X#EQ KXX. P$B?%XZ6L!QGE9 QT4^"$%
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MH<9!YA#93=+-,$@W,$B\ES!C;>A )U6G#)3-LM-;[)Z-PL-@"'_">#D$@?F
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MB3'#T*L1/(ZHAJ7 BX-]'16L.(632NT$%R0L!!&G$6<(+91^!7JME#BH)GH
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MVWI'&0Y\E!A)=$'!#<%KO"Q0T)(@(L3*@"WO>\<?D$NUPO+]\P8:<DL+O(B
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M&',BZ]7*S\"L%E#"<T?0Y//;65CX&.E*/9L7$<^WG";X'?K<O!(.JYU&! *
M96$K8N@U;/\2?E6J#>:Q$1[E\.,C- #VZR$PT-SB_8K&:<,F"OU4")DAGJVO
MY'T2^N$:Q+@'2N0:ZV8Q(,4$[5##P9"7'(DB)$G<V5I@NK8#:1P5CE,>\L)
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M7(.)TQ2[/,UL%B5);EZ?9.$41L1<MB)MX]UM2!40F^\D&-:!)**](E:^5IN
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MG"YG2CA!EKG08BR1^6?!]=UQTD?3_2P/7YG\U:FK8$"@O/KZ'9;_6KYV40;
M&7SPY.C5BO6]2ZS0N\/WA[\<(5;HPYOL\W\<96]^??_Z#LM7?FZ@88F?TV<(
M7Y9W2O-'4F*+W\&9HQ80P=X#'"N(@A DXQ$\#E_"$[[WHXS/W"(]'?!3D9VU
MY?0?C\X6B_/NA\>/+R\OM_V9VSYM+AY77__7I!G_X_&AUV( QWY<3DZ+]O&D
M6!2/=_=V7^SN[3S>V=G9A;<]?;[G7?2=O;V]QZ?+T]/G3Y\>/-L^6\R!/:A>
M(F,3Y -^>ER\A"@2Y("X ] DXU@NQGN9V.4NZXUX';+_LBSX#U&7>,M]]%]Q
M'YD8Z@?@\#\"VN;,;F/8U>Q(6[;X8<53HRCGR1>O815W?>O-O^&F/\%_[\.F
M/W_V?/]I<?&%MOTCN(K$]P&:&#8^>^"-/_KJ+P_40Q^ <<E?RG^]3<?#Z_J'
M5T;\N_?O+@^O"X?WH?>0M.U;OVB<)3F1*IJ_WE[>[ "OGM'W?%9I5:@_X!U?
MJG]P=SL7MC>[Z?:&B=C*ED>W><0[BN!UCR3+^L#RD*7RX.Y?'M:0"_S11^_X
M_]G%.(=(FZ[EIX;:=GT"[J8/X+Q!U?@=2B"^^ ^*X>^0PFLF^#VKFT_E?(DE
M/>Q+R_)18X:>M7!-]''_VXX^'GQWT<<_Q6('&&59=VKE?5]G;RUOC"S1"3)/
M?A!(#!Q 6V/TQRZ W[O%D;IU:[?8:(_LY[(N_;\@MOG!8GQ"&\5U0I!<P>D>
MN7O9HYVXI.MN5.VQ7]IY'=K/^240!8OK)4OY8_;6Y.C\!]]*[[F')O5\'8 -
M>C?@4'^^VGI;7'9N@ULJ(=TO13:%*A-+#4!^7@NSA!;D#9>$8!RTXC6ZPHA@
M=!DU=JT(O<>?Q1!K.3^?-5<E@:&\@L2D);>LMQ"+B"3=2]*RI71E#\@)G^<8
M<Q4Q'W)L49I* Q(*FB!Q8Z#*!H$3Y(&)/&)?MX'@XZRX--27=0,9&V7,'%A4
MZ3/ B'&6,  <R^KELG*YKI$N492FE]6"5&AH=ZCLC!AE9=0%)6U"2-DTK$KZ
M3SGS-94KV&J(R\ZK;EH6'2#>\VQ4 -\7%G"?MDW707MJ?_53]A7;S'W!S/:D
MZB#X3Z%'1-LNJ2Y=]D.8!9MZLB2@_IFWV:'3O G0WZ4-=0B]8<KV+OEZ/BY;
MJ 2@QL#"G4K-I.!ED*+65$K4_8YVDL&@/+"H1L&4,QS*HP[E40--G\XA3P@_
MR<,*9F/!1TQ!OJ00'OMYS^Z [)@7X5>]BY3[8!$79/1GD$=CK8#^#NGD*J%-
M18DIKKQMMC4!MKXPEZ'44(!NQU166BA(\($.F-,D00'HS 09-&6T-ZD!TS/.
M;"S 2PIOU-QIO?;:M<K.B@E)%S6*A%7&5;ALLBL_%E26#A'&A%DD$A#,89;4
MX@+3(?!9$%3\;S6EYH07V 6QIC[K -CAS$HO:\ IE@2;TZO>=;<I>@30447O
M[)<!ZXLOSQJE*>73(>!E8 %#G:6VR09D8JDF5!((DO#9O)%O].3;]HV>?D>^
M$1\@>SFRYF#%@J346'<^+JB @"]&"SG+@'3,2XMH'<[6@ABRR *R%'.7>&"@
M-^3U9Y:(,J@MZM(O6+%@8DQF'2(N">T[*-SV\BWJ+PQE]-X$*F8+_-[3'8*#
M0#$)L/7X X&M4\DZ:\[% !3NZP+AFJ 7(#O>TC&3,OS^@5MU<ET$D /+_L\H
MNG8W  :NF\6=%5V[W_6R![PNV&X7\@;ADAQU@I!CN\[]0;L.#DR"FB ^I*74
M1;4E^JDYC)*=0@065\J.[HU85[9M@V6UTA$6Q:7R:_D%APMU#=HNV=N\,+AN
MB6";202&R*PY=@,3A$<%!&ZGP#Y93J@Z2 A!I6E@#?U*I(4!?B?QA/$#1B3N
M=+.I=F94SIK+#%%1?B$69U%<H!@)X0;!IV++KR/Z+[-2,#F:R!W$278P8FQ,
M;%CE-W!Q?V36,7K5G=C=B<=O"HML(5%::!2][?DM"XM&" K90EJV\\[?C_*O
M1W"OK:DGHIOR$=]^O>*AO3W_<![E%LK<#]F3[7VX:N6WLW(JOY3'Z-+QL.0Z
M_AF;L.UL'_C9==X2G@#TZ/:+Z_?PC:!PJ@ZXBOX'K,4C@!S*!F*]SXI)[>_>
M9E+#B!C9X-5O>?+L+[=TPU/QRSE\"$+-U.^3H3^XQ%$-$$QVJZM^*W'&CUY^
M&"^:$;3;PTJ?W3S;V]G;YU*?P5VYQ4X,[6W;7,*S__%H_]'O>&*RMW>U<W][
MDN^^>)8_>;J+FN;>7O)L]VG^8N?%?;[D('^R[U_T[.#V@N>U7Z] [)]4(/9G
M2^3>W4OD-W0>=^]Q]E+$>2=!-WG!W<7<0*=JN(<H7/YTH)0$[1;EG";\?-OU
M!XG4>MY\+2=;_D+E7Z.5UB,OJ2+NX>\(2;4V[8:VZ^'$N\BA?EGM^7L6 8K8
MQN_NJ)NG>)+"\M2$$G^_..]^??,+;["WK$[D*QN_GFSFV=NWKY1X'3X8(KOG
M-K2,Y'SIVZ^)+,/C3!\F#!#C6(J(EG?HR=YID"!L5^HL>Q%DB3Q0_) XCCMJ
M'(@=M:$(I&Q!QT$31P&_,^I]4D##@(2"R89RV+<R[L_V7\CH#TK7_X7,E[V>
M^4)D!%;Y*AD! WLBQ8]"-RG'#6W##\S:ZO7,HT'1]TZ67@.C]5?!-2,9O@1[
M3QLTG'>#V<Q+^-2:Y]>O02P#*Z=RPY?O'=SJY9^\T*Y\)3_R^<V?>,.%O.'3
MWE1MM\C^MK>SD^_0__Z13=[9WME[=O#WNY>3U60"U]B*U[SMO3\/V=_V[V[V
M_F@_P"FYU>P.[FQVNP?W,;O[VEM ]65_VY6YW\7\[V%W[\ 47FO0D#4 D>*'
M,F.BC'4V\/Z>,8&<:+]XX["LS\IJCK_KLM?"P-$ ]98U8WYY\UHA)#:C[7\_
M]+Y5N6SX>,&V!R0AIM2U8F=[;U?#[V)+K";R2*DA[SP'OJ["?S MOF(9<OB#
M,Z%[L>204+^D+$VPQ )7%:18H#WY%1?;84>ZCEF%$I]ES+ 4?3KFA4U[-B&?
MQYH^[SLX^[<\&[7-%_X09<I&,TA"8GZDJ"8& N-]D0:ZC$+F'CN40K-I;Q9&
M%IZ05[7E*98)2UX+8434_R)JD3?,M??^?TZ.N/4ENB7\0F 3Y/;V8_*Y@,Z$
MK-VZF%U1GTYX_((*_Z5Q@5TSW@\_96RA!IV3L%:4)CFIO%1AOHX3;^F+S*-P
ME?PRC1MF21<8 I;FEB7^&&HCAV39&.E-"\^[V'03: S2G,O#I#,]_IQ=EB/H
MZ!?555+2_6+3O!>DZ4:I\8-O.S7^[#M*C4MY)E0J+V?,-$QM-[")54?>(SBH
MF@?S@KH 44\Z2SE!:!5]1Q&2L%SV(2)+P)$"J\ZEIH1R@<WTOLN55^C6%8 8
M=ST@9A48YL^:"#1B(H@ 7&(;!4!G#&(IP0SDU&.D AC QO[.)J('A. H!A'D
MMP(']-8#"O+=QF@3H1+(6['Q=.W[X'5^DH2D6#5;8A^/X1.*D$@1C FJPC$6
M <%2!K*08(*2MC@Q<J)9=V$C9 .;6X<A]3[NS-;9X2)>P[SJ#&OAL2,;BET+
M/7#*R=KW)P_D6 Q]53+M1$Q)A"(.5G]CE[<E$Z@8MNT50:=OPWMH7  6B/=-
M..CP@W_6,1A$.+@^P@%0!*R][AG@ ".E-7<QNB&[,W3#_5,1?/SPZ?.;#V^/
M/V2?/QV^/SF\]ZXE)X&34EDE;/_%5>J7" 0#>C1+T:/G,XP+!L9G!'PBAV\[
M$7 Z>A"S61-P_F3?POW;0'MUKWZF=POK6"_N,B&$V!,(/+;_M6NC/\U=B8A^
M/TFQRH';$BO(2^J^V*GA!WT $U85L@/@3<B3"(IV04/V1N$7/WD$OF,].JT-
M(N#HN:2U>;1N8/G#V$A7P/A R(&AMVR)FP[N8M14EE\W<)19FW4[^R=0VO5)
MS/ NQTY^#FD\J 5-C"V&Z72"YI&ENL3.Y&/E-05F$V5UZ82NJ:A:7"7H@-W0
ME2LWK&UZ*UVQ0-^K'IXUE]@:RQ]G7!;[+LP6 "P 2(: (K9JQ\LY8,?&R>+2
M!6,&=E:R>78A/4(O(=B.#,9$B;Q$MA;@7H)S$OQ$F3IUK(-]H/;>WC$\:YJ.
M/(;>5A6=?>25[3T6(:TCQIV'.B<#W:F0<>DWC3ETS72Q-8'0?2NL(MAHF-)N
M79QE(7BCK)-4OPC>.R1[V"Y0]0-+LEBV)+.B4'3%09M$BZ-E(Y$2 VN"2&N0
M5*RA_W)C201OPFU!MT)_2/A-W6'@K<N0S7F"K>WI>E.2H411Z,AR)TA4:MZ*
M[C8>>W[R'11LV:+F5^9( $KF;@!B^@:3^0+6*;#MOU9SXO;%\AYMBV7/)AQ]
MFJV;+%M185/"0A':OCMK+NM^0YR_'@"-"*V'<QI/G_0A5 ?;3_I  ?SE-0@%
M2,VF:+$L@2W\0-N[&K4@<WYZFX']#CC%;;)NAUX[_TSB$&7:KIW%WLY?:1;3
MJ=>*J [63^8& !@O4T.@H/9TM+&W\R3?VW^>[QT<;%Z+D/G=LG9+,-J=+OK?
M=E_LY@?/;@,]NMOW[]S-;MT,PO5'MNC/6Z*GN_OY[L[!M[Y%#WJ@;H,FN]O5
MVMM_FN_]B=(RO%MWD/;[EH#JZ^R$9P,H]7NU$PANG'U4X%!W4\MA[_GMAGH[
MY.>??DZMN8RF>2'7.KH+6/AAVXW]\&<=*DC#?P.WU']+TOAG]=.B;FVKUGCQ
M%U[C>\4KO.[Y0\#HV$RR<O4Y-JT^T T3"PK;K^BZ6P<,4A9V&W#1X;U_>_KD
M>;[S;"\_>+IGW#0.-D$E<.O=.XS(<&OU4=%5'=$WD\/LU&%.P)KBAC] D/7S
MX?^;O3O\_/GHT_WV@ZZP,14!13G8.?&[MJ0^/IP\^,BI_F7G-KI2PR:?BZ_9
M.\H&]MA BJQ;SN>0V8=PDS_)A7_6K]LGV]FTG$#W$.F7M_ /D<@5!\]-*_6(
MW%B#D@X?=&(!"::@NS_J39S;^Z;>NO47,5+'?;22_C$Q78HS&!;[ ET96E[_
M-.SE%36GZ+)Q<5X91G/F=H='0H\,D&NE2_#+72/Q[$59+X%^:5)2^\KG3X&,
MP$%S;BS#ND&J_NFWG:I__AVFZBU6"O8^@*CTV.2A"\^9'P%#?"0&NPEH;SCV
M?#XU/,KG7NA6.E[.T E.H[@LFI_@QN)(M!QC^R6JAH^^B3F+D>H88E\ ;OE9
M>0'QU7#TLI.E/_P8B:0W6+74@=*&LHISUN&P$CGIE\\0AU_ZB7U"O!!3!_]K
M.2'2JF*Y.&NDW2="DR"'Y ++CQRT3R>F$ZM11-$#"B'^$,0 CV<"M@"A&0@0
M0>V&*'9<M*7MLT;I"(RF8V\ @@XQF3JKQ W.$%P)G?JB;0KJ%THOWH1%&MI5
M;T>T$/4W#8_.&V J@L58IY!E)RE9P<P#PPH9D5X-)2F@2ZU?'I* BNL9(%_4
M4/$S+0$_SJP"(Z?P]>UR!AD.?\K]OT#YG7F]-@*T8=.J"'4 "EN$;D^P8921
M)9C3%2-5@JQQ*0H^V"O:90N9%#]B2.)EIWXMZY @AZ<1+Q(N(C 58#\!6@VH
MC5BV"_.);MG!%0>]:K19*-5/M-H+2QK!^!D6*.6=J8.@TH4,RI8"L"XL((23
MX5V,U(';IFKI451,C=<([\E-MA5/-=YKB.V"2TG@8=SPE"Z=Z,Z+V&X@F4["
M1Z>=VG-"7F.628-<' F\>E9<0F+@3NN[O/VA.5D1Q0<B54,HAEB4E =<>+U#
M?9FX&0+@7Q>-X_9@E,:$U$!.-2^?CE]Q6=C)<N1UP#G(ZCN9"RBT[>QP/$8<
MX*GPL5$/-B]K.;3 T$85R"OFYP$H3^S$46KBU"\^MH1"])+VG7NQHVW1">7
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M AU.[U--4+.7.#YN_R6#IE]FB%^G\AB(R?B]U?XM7)LQZ;<_^@R(U=*+,E'
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MWEJ/\"9"]\#R<[V/;,3H9(4<6;_VEG+C_A2YL8P-&NMN;9K<EJ*AV"08C_N
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MSAD<6F/6MX*;5)L>! @\ ]$.LNL;$Q9'29\.,$22CH9Y>PP0_TG:U4;\/W3
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M.4 7[$<$1!A*1HPH/)O9;CG \BW*"U85L/=%>D:RK6/'3TW;K,0BD1HO#^P
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M+GAS9%!+ 0(4 Q0    ( .N -%D^<W[W+0(  )8*   4              "
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2      4 !0!$ 0  =HD"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>gug88033-424b2_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="avk-20240918.xsd" xlink:type="simple"/>
    <context id="AsOf2024-09-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001219120</identifier>
        </entity>
        <period>
            <startDate>2024-09-19</startDate>
            <endDate>2024-09-19</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-09-19" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-09-19" id="Fact000004">0001219120</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-09-19" id="xdx2ixbrl0010">424B2</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="AsOf2024-09-19" id="Fact000011">Advent Convertible and Income Fund</dei:EntityRegistrantName>
    <cef:PurposeOfFeeTableNoteTextBlock contextRef="AsOf2024-09-19" id="Fact000012">The following table contains information about
the costs and expenses that Common Shareholders will bear directly or indirectly. The table is based on the capital structure of the Fund
as of	 April 30, 2024 (except as noted below) after giving effect to the Offer, assuming that the Offer is fully subscribed resulting
in the receipt of net proceeds from the Offer of approximately $126,155,600. If the Fund issues fewer Common Shares in the Offer and the
net proceeds to the Fund are less, all other things being equal, the total annual expenses shown would increase. The purpose of the table
and the example below is to help you understand the fees and expenses that you, as a holder of Common Shares, would bear directly or indirectly.</cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ShareholderTransactionExpensesTableTextBlock contextRef="AsOf2024-09-19" id="Fact000014">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_ecef--ShareholderTransactionExpensesTableTextBlock_zIEQaJaJBUEf" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - ShareholderExpenses"&gt;
&lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 0.05in; padding-left: 5.4pt; width: 67%"&gt;&lt;b&gt;Shareholder Transaction Expenses&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 33%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 0.05in; padding-left: 5.4pt"&gt;	Sales load (as a percentage of offering price)&lt;/td&gt;
    &lt;td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"&gt;		&lt;span id="xdx_903_ecef--SalesLoadPercent_c20240919__20240919_fKDEp_zBIEIjSLkX45"&gt;3.75%&lt;/span&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 0.05in; padding-left: 5.4pt"&gt;	Offering expenses borne by the Fund (&lt;span id="xdx_901_ecef--BasisOfTransactionFeesNoteTextBlock_c20240919__20240919_zQfoEx0thtv5"&gt;as a percentage of offering price&lt;/span&gt;)		&lt;/td&gt;
    &lt;td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_90B_ecef--OtherTransactionExpensesPercent_c20240919__20240919_fKDIp_zEewHJNBUBza"&gt;0.47%&lt;/span&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 0.05in; padding-left: 5.4pt"&gt;	Dividend Reinvestment Plan fees 		&lt;/td&gt;
    &lt;td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_902_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20240919__20240919_fKDMp_zVhJLu1xDkF"&gt;None&lt;/span&gt;&lt;sup&gt;(3)&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:SalesLoadPercent
      contextRef="AsOf2024-09-19"
      decimals="INF"
      id="Fact000015"
      unitRef="Ratio">0.0375</cef:SalesLoadPercent>
    <cef:BasisOfTransactionFeesNoteTextBlock contextRef="AsOf2024-09-19" id="Fact000016">as a percentage of offering price</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:OtherTransactionExpensesPercent
      contextRef="AsOf2024-09-19"
      decimals="INF"
      id="Fact000017"
      unitRef="Ratio">0.0047</cef:OtherTransactionExpensesPercent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="AsOf2024-09-19"
      decimals="0"
      id="Fact000018"
      unitRef="USD">0</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:AnnualExpensesTableTextBlock contextRef="AsOf2024-09-19" id="Fact000020">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_ecef--AnnualExpensesTableTextBlock_zLc5FAh9pwJ6" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Expenses"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 67%; padding-right: 0.05in; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&lt;br/&gt;
Annual Expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;Percentage of Net Assets &lt;span style="text-decoration: underline"&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Attributable to Common Shares&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 0.05in; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;Management fees&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span id="xdx_903_ecef--ManagementFeesPercent_c20240919__20240919_fKDQp_zhPleqhQFJN"&gt;0.95%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 0.05in; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;Interest expense&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_909_ecef--InterestExpensesOnBorrowingsPercent_c20240919__20240919_fKDUp_zTYx6gjEefm3"&gt;4.13%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: 0.05in; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;Other expenses&lt;sup&gt;(6)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_904_ecef--OtherAnnualExpensesPercent_c20240919__20240919_fKDYp_zUC3QYWAQ39c"&gt;0.78%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 0.05in; padding-left: 5.4pt"&gt;&lt;span style="font-size: 9pt"&gt;Total annual expenses &lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 48.6pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_90B_ecef--TotalAnnualExpensesPercent_c20240919__20240919_zwIUGFabTa8b"&gt;5.86%&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="AsOf2024-09-19"
      decimals="INF"
      id="Fact000021"
      unitRef="Ratio">0.0095</cef:ManagementFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="AsOf2024-09-19"
      decimals="INF"
      id="Fact000022"
      unitRef="Ratio">0.0413</cef:InterestExpensesOnBorrowingsPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="AsOf2024-09-19"
      decimals="INF"
      id="Fact000023"
      unitRef="Ratio">0.0078</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="AsOf2024-09-19"
      decimals="INF"
      id="Fact000024"
      unitRef="Ratio">0.0586</cef:TotalAnnualExpensesPercent>
    <cef:OtherTransactionFeesNoteTextBlock contextRef="AsOf2024-09-19" id="Fact000027">The fees and expenses of the Offer will be borne by the Fund and indirectly by all of its Common Shareholders, including those who
do not exercise their Rights, and will result in a reduction of the Fund&#x2019;s NAV. Offering expenses borne by the Fund (including the
reimbursements described below) are estimated to be approximately $619,100 in the aggregate, or $0.01 per Common Share (assuming the Rights
are fully exercised). The Fund has agreed to pay the Dealer Manager up to $150,000 as a partial reimbursement for its expenses incurred
in connection with the Offer. Offering expenses will be borne by the Fund and indirectly by all of its Common Shareholders, including
those who do not exercise their Rights.</cef:OtherTransactionFeesNoteTextBlock>
    <cef:OtherExpensesNoteTextBlock contextRef="AsOf2024-09-19" id="Fact000032">&#x201c;Other Expenses&#x201d; are based on estimated amounts for the six months ended April 30, 2024.</cef:OtherExpensesNoteTextBlock>
    <cef:ExpenseExampleTableTextBlock contextRef="AsOf2024-09-19" id="Fact000034">&lt;div id="xdx_88B_ecef--ExpenseExampleTableTextBlock_dU_zTTUhF20tiq2"&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"&gt;&lt;b&gt;Example&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"&gt;As required by relevant SEC regulations, the
following Example illustrates the expenses that you would pay on a $1,000 investment in Common Shares, assuming (1) &#x201c;Total annual
expenses&#x201d; of 5.86% of net assets attributable to Common Shares, (2) the sales load of 3.75% and estimated offering expenses of 0.47%,
and (3) a 5% annual return*:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 66%; padding-right: -5.4pt; padding-left: 5.4pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 9%; padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;1 Year&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%; padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;3 Years&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;5 Years&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%; padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;10 Years&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-right: -5.4pt; padding-left: 0.2in; text-indent: -0.2in"&gt;&lt;span style="font-size: 9pt"&gt;Total Expenses Incurred&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_90E_ecef--ExpenseExampleYear01_c20240919__20240919_zxM7p4rOFDHb"&gt;$101&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_907_ecef--ExpenseExampleYears1to3_c20240919__20240919_zQzS24PNnqBi"&gt;$216&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_90C_ecef--ExpenseExampleYears1to5_c20240919__20240919_zA52UfuJ7c9l"&gt;$329&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: -5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&lt;span id="xdx_909_ecef--ExpenseExampleYears1to10_c20240919__20240919_zTnhDx5sONRi"&gt;$604&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Times New Roman, Times, Serif; margin: 0"&gt;___________&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;*&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;The Example should not be considered a representation of future expenses or returns. Actual expenses may be higher or lower than
those assumed&lt;/b&gt;. &lt;b&gt;Moreover, the Fund&#x2019;s actual rate of return may be higher or lower than the hypothetical 5% return shown in
the Example.&lt;/b&gt; The Example assumes that all dividends and distributions are reinvested at NAV.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="AsOf2024-09-19"
      decimals="0"
      id="Fact000035"
      unitRef="USD">101</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="AsOf2024-09-19"
      decimals="0"
      id="Fact000036"
      unitRef="USD">216</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="AsOf2024-09-19"
      decimals="0"
      id="Fact000037"
      unitRef="USD">329</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="AsOf2024-09-19"
      decimals="0"
      id="Fact000038"
      unitRef="USD">604</cef:ExpenseExampleYears1to10>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000015"
          xlink:label="Fact000015"
          xlink:type="locator"/>
        <link:footnote id="Footnote000025" xlink:label="Footnote000025" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Dealer Manager will receive a fee for its financial structuring and soliciting services equal to 3.75% of the Subscription Price
per Share for each Share issued pursuant to the exercise of Rights, including the over-subscription privilege. The Dealer Manager will
reallow to broker-dealers in the selling group to be formed and managed by the Dealer Manager selling fees equal to 2.00% of the Subscription
Price per Share for each Share issued pursuant to the Offer as a result of their selling efforts. In addition, the Dealer Manager will
reallow to other broker-dealers that have executed and delivered a soliciting dealer agreement and have solicited the exercise of Rights
solicitation fees equal to 0.50% of the Subscription Price per Share for each Share issued pursuant to the exercise of Rights as a result
of their soliciting efforts, subject to a maximum fee based on the number of Common Shares held by each broker-dealer through The Depository
Trust Company (&#x201c;DTC&#x201d;) on the Record Date.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000015"
          xlink:to="Footnote000025"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000017"
          xlink:label="Fact000017"
          xlink:type="locator"/>
        <link:footnote id="Footnote000026" xlink:label="Footnote000026" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span id="xdx_909_ecef--OtherTransactionFeesNoteTextBlock_c20240919__20240919_zj1ns6FgLET7">The fees and expenses of the Offer will be borne by the Fund and indirectly by all of its Common Shareholders, including those who
do not exercise their Rights, and will result in a reduction of the Fund&#x2019;s NAV. Offering expenses borne by the Fund (including the
reimbursements described below) are estimated to be approximately $619,100 in the aggregate, or $0.01 per Common Share (assuming the Rights
are fully exercised). The Fund has agreed to pay the Dealer Manager up to $150,000 as a partial reimbursement for its expenses incurred
in connection with the Offer. Offering expenses will be borne by the Fund and indirectly by all of its Common Shareholders, including
those who do not exercise their Rights.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000026"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000018"
          xlink:label="Fact000018"
          xlink:type="locator"/>
        <link:footnote id="Footnote000028" xlink:label="Footnote000028" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common Shareholders will incur brokerage charges if they direct Computershare Trust Company, N.A., as Plan Agent for the Common Shareholders,
to sell their Common Shares held in a dividend reinvestment account.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000018"
          xlink:to="Footnote000028"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000021"
          xlink:label="Fact000021"
          xlink:type="locator"/>
        <link:footnote id="Footnote000029" xlink:label="Footnote000029" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fund pays the Adviser an annual management fee, payable monthly in arrears, in an amount equal to 0.54% of the Fund&#x2019;s average
daily Managed Assets. Common Shareholders bear the portion of the investment advisory fee attributable to the assets purchased with the
proceeds of leverage, which means that Common Shareholders effectively bear the entire management fee. The contractual management fee
rate of 0.54% of the Fund&#x2019;s Managed Assets represents an effective management fee rate of 0.95% of net assets attributable to Common
Shares, assuming leverage of 43.0% of the Fund&#x2019;s Managed Assets (the Fund&#x2019;s outstanding leverage as of April 30, 2024).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000029"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000022"
          xlink:label="Fact000022"
          xlink:type="locator"/>
        <link:footnote id="Footnote000030" xlink:label="Footnote000030" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes interest payments on borrowed funds and interest expense on reverse repurchase agreements. Interest payments on borrowed
funds is based upon the Fund&#x2019;s outstanding borrowings under the Credit Agreement as of April 30, 2024, in an amount equal to 21.5%
of the Fund&#x2019;s Managed Assets, at an annual interest rate cost to the Fund of 5.97% (the weighted average interest rate paid by the
Fund during the six months ended April 30, 2024). Interest expenses on reverse repurchase agreements is based on the Fund&#x2019;s outstanding
reverse repurchase agreements as of April 30, 2024, representing 21.5% of the Fund&#x2019;s Managed Assets at an annual interest rate cost
to the Fund of 4.80% (the weighted average interest rate cost incurred by the Fund during the six months ended April 30, 2024). The actual
amount of interest expense incurred by the Fund will vary over time in accordance with the amount of borrowings and reverse repurchase
agreements and variations in market interest rates.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000022"
          xlink:to="Footnote000030"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000023"
          xlink:label="Fact000023"
          xlink:type="locator"/>
        <link:footnote id="Footnote000031" xlink:label="Footnote000031" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span id="xdx_903_ecef--OtherExpensesNoteTextBlock_c20240919__20240919_zug6dTeFVxe6">&#x201c;Other Expenses&#x201d; are based on estimated amounts for the six months ended April 30, 2024.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000031"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
